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 Functionalized aliphatic C(sp3)–H scaffolds are being increasingly incorporated into 
small molecule pharmaceutical molecules to gain access to novel chemical space and 
bioactivities. Given the ubiquitous of C—H bonds and their inertness toward a wide range of 
reaction conditions, late-stage aliphatic C—H functionalizations afford unique opportunities to 
quickly diversify complex bioactive molecules and access novel heterocyclic substitution 
patterns on the aliphatic core structures. Although methods with preparative yields and site-
selectivities for aliphatic C—H functionalization are emerging, a significant challenge remained 
with an apparent inverse correlation between reactivity and chemoselectivity: catalysts that are 
highly reactive to strong aliphatic C—H bonds usually lacks chemoselectivity for p-
functionalities (aromatics and olefins). My doctoral research in the White group has focused on 
developing novel manganese catalysts for C—H amination and C—H hydroxylation reactions 
with unprecedented amalgamation of high reactivity with strong C—H bonds (2º and even 1º) 
while maintaining high chemoselectivity for aromatic p-functionalities. These new catalysts 
afford opportunities to fully realize the potential of using late-stage aliphatic C—H 
functionalizations in drug discovery processes. 
 The first chapter of this dissertation discussed the discovery of a novel manganese 
catalyst, Mn[tBuPc], for intramolecular C—H aminations. Mn[tBuPc] showcase as an outliner of 
the inverse correlation between reactivity and chemoselectivity traditionally shown in 
metallonitrene mediated intramolecular C—H aminations. Collectively in this project, we 
demonstrated Mn[tBuPc] is uniquely effective to aminate all types of C(sp3)–H bonds 
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intramolecularly while maintaining chemoselectivity for the olefin p-functionality. Particularly, I 
demonstrated Mn[tBuPc] capable to preparatively aminate a wide range of benzylic C—H bonds 
of aromatic and medicinally important heteroaromatic substrates. Impressively, even strongest 1º 
C—H bonds can be preparatively aminated with Mn[tBuPc] in simple and complex molecules 
settings with perfect site-selectivity. Mechanistic studies suggest the Mn[tBuPc] catalyst transfers 
the bounded nitrene to C—H bonds via a stepwise C—H abstraction/ fast rebound pathway with 
attenuated radical character on the metallonitrene compared to the iron catalyst. Late-stage C—H 
amination and sequential C—H hydroxylation/ C—H amination were demonstrated to quickly 
install heteroatomic functionalities (O and N) onto the aliphatic core of complex natural 
products.  
 The second chapter of this dissertation described the discovery of a novel manganese 
catalyst Mn(CF3-PDP), that for the first time enabled highly reactive methylene C—H oxidation 
with high chemoselectivity tolerating a wide range of oxidatively labile aromatic functionalities 
via a synergetic effect between catalyst design and chloroacetic acid additive. A total of 50 
aromatic substrates housing medicinally important halogen, oxygen, nitrogen, heteroaromatic 
and biaryl moieties were demonstrated with Mn(CF3-PDP) to afford preparative yields for 2º 
oxidation products. Late-stage oxidative derivatization on four aromatic pharmaceutical 
molecule scaffolds were shown with Mn(CF3-PDP), including a sequential 2º benzylic/remote 2º 
C—H hydroxylations on an ethinylestradiol derivative where other oxidant only oxidize the 
doubly activated tertiary benzylic site. Mn(CF3-PDP) was also demonstrated to potentially serve 
as a general approach to rapidly access and identify drug metabolites (piragliatin) from advanced 
synthetic intermediates. Additionally, the high chemoselectivity observed in 2º C—H oxidation 
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with Mn(CF3-PDP) can be maintained in the 3º C—H oxidation of substrates housing a range of 
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CHAPTER 1: HIGHLY REACTIVE C—H AMINATION ON BENZYLIC AND 
PRIMARY SITES WITH A NOVEL MANGANESE CATALYSTa 
 
1.1 Introduction 
The intramolecular C(sp3)—H amination via metallonitrenes can afford unique 
opportunities to introduce nitrogen functionalities onto the hydrocarbon core of complex 
molecules to strategically alter their biological activities or to serve as functional handles for 
further manipulations.1,2,3,4 Despite significant advances have been made in this field, a major 
challenge remained: the apparent inverse correlation between reactivity and chemoselectivity 
with existing catalytic systems. (Figure 1.a) Nobel metal rhodium catalysts, i.e., Rh2(OAc)4 and 
Rh2(esp)2, are capable to aminate strong aliphatic 2º and 3º C—H bonds in stereospecific fashion 
but lack chemoselectivity for p-bonds (e.g., olefins) to yield aziridination products.5 Conversely, 
ruthenium catalyst6 and base metal catalyst Fe[Pc]7 afford good chemoselectivity tolerating 
olefins however with significantly diminished reactivity primarily limited to allylic C—H bonds. 
Herein I describe the discovery of Mn[tBuPc] catalyst as an outlier of the apparent inverse 
correlation and for the first time to achieve unprecedented combination of high reactivity and 
high chemoselectivity for the intramolecular C—H amination reaction (Figure 1.b). Mn[tBuPc] 
catalyst is effective to aminate all types of C(sp3)—H bonds to afford synthetic useful level of 
reactivity while maintaining high level of chemoselectivity for allylic C—H bonds observed with 
Fe[Pc]. Interestingly, Mn[tBuPc] catalyst even demonstrates preparative reactivity for aminating 
strong 1º C—H bonds which is uncommon for metallonitrene-based reactions.5 With the high 
functional group tolerance, site-selectivity and stereospecificity, Mn[tBuPc] is capable to rapidly 
                                               
a The material in this chapter is adapted from Paradine, S. M.; Griffin, J. R.; Zhao, J.; Petronico, A. L.; Miller, S. M.; 
White, M. C. Nat. Chem. 2015, 7, 987.  
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functionalize complex biological active molecules at late-stage to strategically alter their 
biological and physical properties. 
Figure 1. Intramolecular C—H Amination with High Reactivity and High Chemoselectivity 
 
Rhodium catalysts are known to perform C—H amination via a concerted, asynchronous 
mechanism.8 Alternatively, base metal catalysts (i.e., Fe[Pc]) afford excellent chemoselectivity 
tolerating olefins with lowered reactivity limited to allylic C—H bonds via orthogonal single 
electron C—H abstraction/rapid rebound nitrene transfer pathway.6,7,9 Based on these mechanism 
considerations, I hypothesized that a metal catalyst may achieve high reactivity and maintain 
high chemoselectivity by transferring bounded nitrene in a stepwise manner with attenuated 


























































































































sulfamate ester N-centered free radical specials are not capable to aminate tertiary C—H bond 
intramolecularly10 also suggested that metallonitrene with attenuated radical character may be 
more reactive to stronger aliphatic C—H bonds. Despite being rarely used in nature, high valent 
manganese heteroatom complexes have long been studied parallel to their iron counterparts for 
atom transfer reactions proceed via mechanism similar single electron transfer pathways.11 
Interestingly, higher reactivity are observed with manganese porphyrins than iron porphyrins for 
hydroxylating strong aliphatic C—H bonds.11 Stoichiometric nitrene transfer reactivity has been 
demonstrated by well-characterized nitridomanganese(V) porphyrin species, suggesting 
manganese complexes can be capable candidates for developing catalytic nitrene transfer 
reactivity similar to their iron counterparts.12,13,14 Importantly, manganese complexes exhibiting 
smaller KIE values in C—H hydroxylation suggests an attenuated radical character relative to 
the iron counterparts15 and can potentially be superior candidates for highly reactive C—H 
amination reactions based on our hypothesis.  
 
1.2 Results and Discussion 
1.2.1 Reaction Development 
 I started by investigating into benzylic C—H amination which has been demonstrated to 
perform with limited reactivity with Fe[Pc] catalysis.7 (Table 1) Phenol derived sulfamate ester 1 
and alcohol derived sulfamate ester 3 both gave low reactivity with Fe[Pc] (Entry 1 and 4). 
While Fe[Pc] gave non-optimal results, the direct manganese analogue Mn[Pc] gave a significant 
boost in reactivity to afford synthetically useful yields (Entry 2 and 5). Introduction of t-butyl 
groups at the ligand periphery, Mn[tBuPc] catalyst showed modest increased reactivity for 4 
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(Entry 6); however, enabled me to use lower catalyst loadings (5 mol%, Entry 3) with 1 and also 
a range of challenging heterocyclic substrates (vide infra).  
Table 1. Catalysts Comparison for Intramolecular Benzylic C—H Amination 
 
 
1.2.2 Substrate Scope 
 With the optimal reaction conditions at hand, I next investigated into the substrate scope 
and demonstrated Mn[tBuPc] 7 catalyst capable intramolecularly aminate a wide scope of 
benzylic C—H bonds with good functional group tolerance and site-selectivity (Table 2). 

























Entry Catalyst Loading Yield (rsm)Substrate Product
1 1 Fe[Pc]* 5 10 mol% 2 43% (22%)
1 2 3 4
2 1 Mn[Pc] 6 10 mol% 2 69% (<5%)
3 1 Mn[tBuPc] 7 5 mol% 2 69% (<5%)
4 3 Fe[Pc]* 5 5 mol% 4 22% (65%)
5 3 Mn[Pc] 6 5 mol% 4 71% (<5%)
6 3 Mn[tBuPc] 7 5 mol% 4 74% (<5%)
Isolated yields are average of threee runs. Conditions: catalyst and AgSbF6 loading are listed in the table, 2 






































catalyst, readily cyclized with Mn[tBuPc] 7 to give desired amination product in 69% yield (8). 
Iron catalyst Fe[Pc] was poorly reactive when the aromatic ring is electronically deactivated and 
gives only 30% yield (9). In contrast, Mn[tBuPc] 7 was effective to promote benzylic C—H 
amination on substrates bearing electron-withdrawing functionalities of various degrees, such as 
para-Br- and para-CF3- groups (9, 68%; 10, 58%, respectively), which are challenging even 
with Rh catalysts.16 Branched sulfate esters at both a- and b- positions are effectively aminated 
with Mn[tBuPc] 7 and yield excellent level of diastereoselectivity (>20:1) to give the 
conformationally preferred syn- and anti- amination products (11, 64% and 12, 68% 
respectively)5. While sulfamate esters usually favor functionalization on the g-position to give 
the geometrically favored six membered ring oxathiazinane product)5, an exception was 
observed with a cyclopropane-containing substrate where amination occurred at the much 
weaker 2º b C—H bond (BDE ~ 95 kcal/mol) over the significantly stronger γ C—H bond (BDE 
~ 106 kcal/mol)17 to give five membered sulfamidate product (13, 51%). 
 Heteroaromatic rings are prevalent in pharmaceuticals and biological active molecules 
and I next evaluated the tolerance of a range of heterocyclic substrates with this Mn[tBuPc] 
catalyzed C—H amination. Pharmaceutically important pyrrole and indole motifs afforded good 
yields and diastereoselectivities for C—H amination products (14, 69%, 7:1 d.r. and 15, 71%, 
12:1 d.r.). N-aryloxazolidinone and oxadiazole heterocycles were compatible with Mn[tBuPc] to 
afford amination products in high yields (56% for 16, 63% for 17). Amination of oxazole-based 






Table 2. Substrate Scope of Mn[tBuPc] Catalyzed Benzylic C—H Amination 
 
 
1.2.3 Discovery of Reactivity on 1º C—H Bonds 
 C—H functionalization methods proceed via organometallic intermediates with noble 
metal catalysts usually favor functionalization on methyl 1º C—H bonds due to strong steric 
preference.18 Despite the success of previous reported metal catalyst proceed through high valent 
metallonitrene intermediates in performing aliphatic C—H amination on 3º (BDE ~96 kcal/mol) 














































































17, 63%* 18, 63%
oxaprozin derivative
Isolated yields are average of threee runs. Conditions: Mn[tBuPc] and AgSbF6 (10 mol%), 2 equiv. PhI(OPiv)2, 9:1 C6H6:MeCN 















the fact that 1º (BDE ~101 kcal/mol) C—H is the strongest and has low basicity within all 
aliphatic C—H bonds. Developing new methodologies to functionalize 1º sites directly can both 
gain access to novel reactivity of intramolecular C—H amination and to access underexplored 
chemical space for the derivatizations of complex biological molecules. 
 The 1º C—H amination reactivity was first suggested plausible during the investigation 
of benzylic substrate scope. A b, b-dimethyl substituted substrate 19, in addition to the benzylic 
amination product 20, gave an unexpected 1º C(sp3)—H amination product 21 in 10% yield 
(Figure 2.a). This observation suggests Mn[tBuPc] is capable to aminate strong 1º C—H bonds 
when they are geometrically accessible to form the preferred six membered oxathiazinane 
product. The primary amination reactivity is rare even with the most reactive rhodium catalysts5 
and prompts me to further investigate the generality of 1º C—H amination with Mn[tBuPc] 
(Figure 2.b). A systematic evaluation of phthalocyanine catalysts with a model substrate 22 
having only primary C—H bonds accessible revealed that Mn[tBuPc] was significantly more 
reactive (64% for 23).  
Figure 2. Intramolecular C—H Amination on 1º C—H Bonds 
 













      Mn[tBuPc]:
      Mn[Pc]:























1.2.4 Late-stage Derivatization of Complex Molecules 
 The preparative reactivity for benzylic and for the first time 1º C—H bonds, combined 
with the site-selectivity trends established with Mn[tBuPc] on relatively simple substrates are 
maintained in biological active complex molecules that are significantly more topologically and 
functionally complex (Figure 3). Oxygen functionalities are widespread in medicinal compounds 
and natural products and can be used as handles to install nitrogen functionality via 
intramolecular C—H amination with Mn[tBuPc]. Based on the finding that strong g 1º C—H 
bond can be aminated over weaker b C—H bonds, I wanted to further test this exciting reactivity 
and site-selectivity in more complex molecules. Betulinic acid, a readily available pentacyclic 
triterpenoid natural product with mitochondrial-targeted antitumor activity19, derived sulfamate 
ester 24 from the native alcohol yields 1º amination product 25 on the equatorial C23 methyl 
group in 76% yield as a single regio- and stereoisomer (Figure 3.a). It is significant to note that a 
2º site C2 is also accessible; however, amination at 1º site C23 gives the geometrically favored 6-
membered ring oxathiazinane product. The introduction of nitrogen provides a handle for further 
modifications to potentially attenuate the high lipophilicity of betulinic acid and to increase its 
antiproliferative bioactivity. 
 Alternatively, oxygen functionalities can readily be installed onto complex molecules 
with traditional strategies or aliphatic C—H hydroxylation reactions. A sequential, formal 
aromatic oxidation via a Friedel-Crafts/ Baeyer-Villiger sequence on a leelamine derivative gave 
the phenolic sulfamate ester 27. The desired benzylic amination product 28 was obtained in 70% 
yield with the following Mn[tBuPc] catalyzed C—H amination. (Figure 3.b) Aliphatic C—H 
bonds can also readily be oxidized with Fe(PDP) to introduce alcohol functionality. 
Dihydropleuromutilone housing 14 aliphatic sites possible for oxidation was selectively 
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hydroxylated at C7 with Fe(PDP) catalyst.20 The corresponding sulfamate ester 30, provided an 
excellent opportunity to further investigate into the site-selectivity treads with Mn[tBuPc] in 
complex molecule settings. 30 can feasibly be aminated at 3 possible sites: C16 g 1º C—H to 
give 6-membered ring product, C8 equatorial b 2º C—H to give 55-membered ring product and 
C6 axial b 3º C—H to give 5-membered ring product. Following the same site-selectivity trend 
favoring the formation of 6-membered oxathiazinane products from sulfate ester starting 
materials with Mn[tBuPc], I observed the exclusive formation of 1º C—H amination product 31 
at C16 in 84% yield, a remarkably high level of reactivity under metallonitrene mediated C—H 
amination on 1º C—H bond. This strategy of sequential C—H hydroxylation/C—H amination 
reactions can potentially provide a general solution to install valuable 1,3- and 1,2- amino 
alcohol moieties onto the hydrocarbon cores of a wide range of bioactive complex molecules and 














Figure 3. Late-stage Derivatization of Complex Molecules 
 
 
1.2.5 Hammett Analysis 
 Working together with my coworkers, we collected demonstrate the unique generality of 
Mn[tBuPc] catalyst capable of intramolecularly aminating all types C(sp3)—H bonds (3º, 2º, 1º, 
benzylic, allylic, ethereal, propargylic) with preparative reactivity and high chemoselectivity 
a. 1º C—H Amination on betulinic acid derivative
Isolated yields for C—H aminations are average of threee runs. (i) AcCl, AlCl3, 94%. (ii) mCPBA, CF3CO2H, 83%. (iii) NaHCO3, 
H2O, 63%. (iv)ClSO2NCO, HCO2H, 68%. (v) Fe(PDP), AcOH, H2O2, 40%. (vi) AcCl, pyridine, 72%. (vii) ClSo3NCO, HCO2H, NEt3, 
48%.



































































































tolerating olefins. I next performed mechanism studies to investigate into the original hypothesis 
that the unprecedented combination of reactivity and chemoselectivity can be attributed to the 
mechanism where Mn[tBuPc] still proceed with a stepwise radical abstraction/rebound pathway 
but with attenuated radical character of the manganese metallonitrene relative to the iron 
counterpart. To probe the C—H abstraction step of the catalytic cycle independently from the 
entire reaction kinetics, intramolecular competition experiments were performed. I synthesized a 
series of substrates having two electronically distinct benzylic sites to probe into the electronic 
nature of the C—H cleavage transition state. (Figure 4) Fe[Pc], Mn[Pc] and Mn[tBuPc] catalysts 
were examined under their standard conditions. Plotting log(kAr/kH) against σ+ of substituents 
furnished good linear correlations for all three catalysts. Mn[Pc] and Mn[tBuPc] afford ρ values 
(ρ = -0.88) less negative than Fe[Pc] (ρ = -1.12) but more negative than the reported value for 
rhodium catalysts (ρ = -0.55)8. The less electronic sensitivity with manganese catalysts relative 
to Fe[Pc] is in good accordance with the observed reactivity trend with electronically deactivated 
substrates. The intermediacy ρ value with and Mn[tBuPc] suggests it lies between Rh2(OAc)4 
which has little positive charge build up and Fe[Pc] that has substantially more. This 
intermediate value for Mn catalysts was also observed in the intramolecular KIE values. These 
results are consistent with the hypothesis that Mn[tBuPc] proceed via a metallonitrene 
intermediate with more attenuated radical character relative to Fe. My coworkers also performed 
stereoretention and olefin isomerization studies and the results suggested Mn[tBuPc] proceed 
through a stepwise mechanism but with fast radical rebound to enable complete stereoretention 










 Here I discussed the discovery of a novel base metal catalyst Mn[tBuPc], which can be 
synthesized from commercially available materials in a single step, that readily functionalize all 
types C(sp3)—H bonds intramolecularly. Compared to the previous state-of-the-art noble metal 
rhodium catalysts5, manganese benefit from the high abundance (about 10 million times more 
OSO2NH2
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Rh2(OAc)4     ρσ+ =  –0.55  
Mn[tBuPc]       ρσ+ =  –0.88        
Fe[Pc]            ρσ+ =  –1.12
PhI(OPiv)2
[Mn(tBu4Pc)] Blue
y = -0.8827x + 0.0276
R² = 0.9913
[Mn(Pc)] Red
y = -0.8761x + 0.0868
R² = 0.971
[Fe(Pc)] Green






























abundant than rhodium)21 and low toxicity. Mechanistic study reveals that Mn[tBuPc] proceed 
metallonitrene insertion to C—H bonds lies between the concerted asynchronous C—H insertion 
mechanism of rhodium catalyst and the stepwise C—H abstraction/rebound mechanism of iron 
catalyst. Importantly, rather than showing intermediate reactivity and chemoselectivity between 
the two extremes, Mn[tBuPc] demonstrates unprecedented combination of high reactivity 
including preparative reactivity on strong 1º C—H bonds and high chemoselectivity for olefins, 
challenging the existing paradigm of inverse correlation between reactivity and chemoselectivity 
in C—H functionalization reactions mediated via high valent metal-heteroatom species (oxos 
and nitrenes). The stereospecificity, site-selectivity and high functional group tolerance enabled 
the use of this methodology in rapid diversification of complex bioactive molecules at late stage 
to install nitrogen functionality or medicinally important 1,3- and 1,2- amino alcohol moieties 
via a C—H hydroxylation/C—H amination sequence. These findings can both facilitate the drug 
discovery processes and to inspire the development of new C—H functionalization reactions 
with high reactivity and high chemoselectivity.  
 
1.4 Experimental Section 
1.4.1 General Information 
The following commercially obtained reagents were used as received: iron(III) 
phthalocyanine chloride ([FePc]Cl, Sigma-Aldrich), manganese(III) phthalocyanine chloride 
([MnPc]Cl, Sigma-Aldrich), 5,10,15,20-Tetraphenyl-21H,23H-porphine iron(III) chloride 
(Fe(TPP)Cl, Strem), 5,10,15,20-Tetraphenyl-21H,23H-porphine manganese(III) chloride 
(Mn(TPP)Cl, Strem), Mn(R,R-salen)Cl (Sigma-Aldrich), silver hexafluoroantimonate (AgSbF6, 
Strem), and bis (tert-butylcarbonyloxy)iodobenzene (PhI(OPiv)2, Sigma-Aldrich). All reactions 
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were run in flame- or oven-dried glassware under an atmosphere of N2 or Ar gas with dry 
solvents unless otherwise stated. All products were filtered through a glass wool plug prior to 
obtaining a final weight. Solid reagents were stored in a dessicator or glovebox, and anhydrous 
solvents were purified by passage through a bed of activated alumina immediately prior to use 
(Glass Countour, Laguna Beach, California). Chloroform-d was stored over 3Å molecular sieves 
in a secondary container with drierite. Fe(R,R-PDP)(SbF6)2, Mn(R,R-PDP)(SbF6)2, and Fe(R,R-
salen)Cl were prepared according to methods described in the literature and stored at 4oC. 
Chlorosulfonyl isocyanate (ClSO2NCO, Sigma-Aldrich or TCI America) was transferred to a 
Schlenk-type flask and stored at 4oC under an inert atmosphere. 4Å MS beads were crushed with 
a mortar and pestle until fine, then activated in a 180°C oven for at least 48h and stored in a 
dessicator or glovebox. Thin-layer chromatography (TLC) was conducted with E. Merck silica 
gel 60 F254 pre-coated plates (0.25 mm) and visualized with UV and ethanolic anisaldehyde or 
potassium permanganate stains. Flash chromatography was performed as described by Still22 
using American International ZEOprep 60 ECO silica gel (230-400 mesh). Achiral gas 
chromatographic (GC) analysis was performed on an Agilent 6890N Series instrument equipped 
with FID detectors using a HP-5 (5%-Phenyl)-methylpolysiloxane column (30m, 0.32mm, 
0.25mm), and chiral GC analysis using a CycloSil-B column (30m, 0.25mm, 0.25mm). 
1H-NMR spectra were recorded on a Varian Inova-500 (500 MHz) or Varian Unity-500 (500 
MHz) spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 
ppm). Data reported as: s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sxt = sextet, 
spt = septet, m = multiplet, br = broad, app = apparent; coupling constant(s) in Hz; integration. 
Proton-decoupled 13C-NMR spectra were recorded on a Varian Unity-500 (125 MHz) 
spectrometer and are reported in ppm using solvent as an internal standard (CDCl3 at 77.16 
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ppm). Kinetic isotope effect analyses were recorded on a Varian Inova-600 (600 MHz) 
spectrometer. IR spectra were recorded as thin films on NaCl plates or by ATR on a Perkin 
Elmer Frontier FTIR and are reported in frequency of absorption (cm-1). Optical rotations were 
measured using a 1 mL cell with a 50 mm path length on a Jasco P-1020 polarimeter. Optical 
rotations were obtained with a sodium lamp and are reported as follows: [α]λToC (c = g/100 mL, 
solvent). High-resolution mass spectra were obtained at the University of Illinois Mass 
Spectrometry Laboratory. Electrospray ionization (ESI) spectra were performed on a Waters Q-
Tof Ultima spectrometer, and electron ionization (EI) and field desorption (FD) spectra were 
performed on a Micromass 70-VSE spectrometer. Elemental analysis was performed by 
Robertson Microlit Laboratories. 
 
1.4.2 Synthesis of Mn[tBuPc]Cl Catalyst 7 
[Mn(tBuPc)]Cl from phthalonitrile: A flame dried 100 mL round-bottom flask 
equipped with a stir bar and reflux condenser (the flask and stir bar should be free of trace metal 
impurities) was sequentially charged with 4-tert-butyl-phthalonitrile (2.211 g, 12.0 mmol, 4.0 
equiv, TCI America), 1-hexanol (24 mL, freshly distilled over MgSO4 and degassed), Mn(OAc)2 
(519 mg, 3.00 mmol, 1.0 equiv, Sigma-Aldrich) and DBU (3.59 mL, 24.0 mmol, 8.0 equiv, 
Sigma-Aldrich). Reaction flask was evacuated under vacuum and refilled with N2 three times, 
then heated to 155ºC. The reaction mixture changed from colorless to turquoise green over 10 
min. After stirring at 155ºC overnight (12-15h), the heat was ceased and the condenser was 
removed. Brine (15 mL) was cautiously added into the reaction dropwise via a pasteur pipette 
while the reaction temperature was maintained over 100ºC, then the reaction was stirred open to 
air while cooling to room temp for 1h. Brine and chloroform were added to the flask and the 
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mixture was extracted with chloroform 3 times. The combined organic layer was dried over 
Na2SO4, filtered, and concentrated by rotatory evaporation. The remaining solution was 
transferred to a round-bottom flask equipped with stir bar and short path distillation head, placed 
under high vac, and then heated to ~60-80ºC until crude material was a sticky solid (~2-3 days). 
The crude catalyst was taken up in CH2Cl2 with 50 mL neutral alumina (Brockmann Type I, Alfa 
Aesar), then concentrated to dryness and applied to a plug of 200 mL neutral Al2O3 (50 mm 
fritted glass column) pre-wetted with 5% EtOAc/hexanes. Nonpolar impurities were eluted with 
10% EtOAc/hexanes à 20% EtOAc/hexanes (~2L) until eluting solution turned green. 
[Mn(tBuPc)]Cl 7 was eluted as a separate dark green fraction by flushing with EtOAc (~2-4L). 
The solution was concentrated by rotatory evaporation and was dried under high vac overnight to 
afford 971 mg (1.17 mmol) of Mn[tBuPc]Cl 7 as a dark green powder (39% yield). Catalyst 
obtained by this method contains a minor unknown impurity (visible in IR at 1711 cm-1), which 
has no observable impact on reactivity or reaction rate for any of the substrate classes examined. 
Due to the convenience and economy of this procedure, this was the standard method for 
preparing the catalyst used in this report. [Mn(tBuPc)]Cl 7 prepared in this way can be made 
analytically pure by column chromatography on silica using a gradient of 10% à 20% à 30% 
à 50% à 100% EtOAc/hexanes. 
[Mn(tBuPc)]Cl from ligand: The following procedure was adapted from a literature 
preparation.23 2,9,16,23-Tetra-tert-butyl-29H,31H-phthalocyanine (250 mg, 0.338 mmol, 1.0 
equiv, Sigma-Aldrich) was taken up in degassed DMF (16 mL) in a 50 mL round-bottom flask 
equipped with stir bar and septum (the flask and stir bar should be free of trace metal impurities). 
Mn(OAc)2 (58.5 mg, 0.338 mmol, 1.0 equiv, Sigma-Aldrich) was added under a stream of N2, 
then reaction was warmed to 60°C and stirred for 12h. Upon completion, the reaction cooled to 
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rt, then was diluted with water (10 mL), transferred to a separatory funnel, and the aqueous layer 
was washed with hexanes (20 mL) to remove unreacted ligand. Brine (15 mL) was added, and 
then complex was extracted with chloroform (3x30 mL). The combined organic layers were 
dried over Na2SO4 and filtered. Neutral alumina (15 mL) was added to the solution of crude 
complex and concentrated to dryness. The adsorbed catalyst-alumina powder was then applied to 
a flash column with dry neutral alumina (45 mm column, 100 mm Al2O3). Remaining 
uncomplexed ligand, which is a bright turquoise color, was eluted with 9:1 hex/EtOAc (ca. 
1.5L). Once ligand fully eluted, [Mn(tBuPc)]Cl 7, which is a dark evergreen color, was eluted 
with neat EtOAc (ca. 1L). Pure product was isolated as a flaky dark green solid in 89% yield. 
Characterization of [Mn(tBuPc)]Cl: UV-Vis (CHCl3, lmax = nm, ε = M-1cm-1): 729 (ε = 
73400), 662 (ε = 15900), 531 (ε = 10100), 369 (ε = 32400), 280 (ε = 39200); IR (ATR, cm-1) 
2955, 2865, 1612, 1506, 1482, 1459, 1394, 1363, 1328, 1280, 1255, 1199, 1147, 1075, 932, 893, 
828, 763, 746; HRMS (ESI) m/z calculated for C48H48MnN8 [M-Cl]+: 791.3382, found 791.3380. 
LRMS (FD) m/z 792.9 (Mn(tBuPc)+H), 827.8 (M+). Anal. calculated for C48H48ClMnN8 (FW = 
827.36), C 69.68, H 5.85, N 13.54, Mn 6.64; found C 70.07, H 6.05, N 13.21, Mn 6.62. 
UV-Vis Studies: 4.2 mg (0.005 mmol) of [MnIII(tBuPc)] was taken up in CHCl3 to 5 mL 
solution (1.0 mM). 100 µL of this solution was diluted to 10 mL (10.0 µM). UV-Vis was taken 








Chart 1. UV-Vis Study for Mn[tBuPc] 
 
 
1.4.3 General Procedures for Preparing Sulfamte Esters 
Method A: 
Preparation of ClSO2NH2 solution (2M in MeCN): A round-bottom flask equipped with 
stir bar and rubber septum was charged with ClSO2NCO (1.5 equiv) and MeCN (2M relative to 
isocyanate). The flask was cooled to 0oC, and then neat formic acid (1.5 equiv) was added 
dropwise. The reaction stirred vigorously at 0oC (1 h) then room temp (~20oC) overnight.  
Sulfamate ester formation: A 50 mL round-bottom flask equipped with stir bar and 
rubber septum was charged with 95% NaH (1.1 equiv) and 5 mL DMF (1M relative to starting 
material) and cooled to 0oC. The alcohol starting material (1.0 equiv) in DMF was slowly added. 
The reaction was stirred at room temp for 1h, after which it was cooled again to 0oC. The freshly 
prepared 2M MeCN solution of ClSO2NH2 (vide supra) was then added dropwise via syringe, 
and the reaction stirred at room temp. for 2-4 h. Upon complete consumption of starting material 




















mL). The reaction mixture was partitioned between H2O (15 mL) and Et2O (60 mL) and 
separated. The aqueous layer was then extracted with Et2O (2x30 mL). The organic layers were 
combined, dried over MgSO4, filtered, and concentrated under reduced pressure. Although the 
sulfamate esters were generally pure by NMR after a single column, as a precaution they were 
subjected to a second column to remove minor NMR-silent impurities that have been shown to 
inhibit the amination reaction. Following purification, sulfamate esters were thrice dissolved in 
benzene and concentrated under reduced pressure to remove trace H2O, then stored in a 
dessicator until use. 
Method B: 
A round-bottom flask equipped with stir bar and rubber septum was charged with 
ClSO2NCO (2.0 equiv) and CH2Cl2 (2M relative to isocyanate). The flask was cooled to 0oC, and 
then neat formic acid (2.0 equiv) was added dropwise. The reaction stirred vigorously at 0oC (1 
h) then room temp (~20oC) overnight. After cooling the reaction flask back to 0oC, the alcohol 
starting material (1.0 equiv) with Et3N (2.0 equiv) in CH2Cl2 (0.75M relative to starting material) 
was slowly added via syringe. After complete addition, the reaction warmed back to room temp. 
and stirred for 4-6 h. If conversion is low after 3-4 h, additional Et3N (1-2 equiv) can be added. 
Upon complete consumption of starting material as monitored by TLC, the reaction was 
quenched with H2O until the mixture turned clear (~8 mL). The reaction mixture was partitioned 
between H2O (15 mL) and CH2Cl2 (30 mL) and separated. The aqueous layer was then extracted 
with CH2Cl2 (2x30 mL). The organic layers were combined, dried over MgSO4, filtered, and 
concentrated under reduced pressure. Although the sulfamate esters were generally pure by 
NMR after a single column, as a precaution they were subjected to a second column to remove 
minor NMR-silent impurities that have been shown to inhibit the amination reaction. Following 
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purification, sulfamate esters were thrice dissolved in benzene and concentrated under reduced 
pressure to remove trace H2O, then stored in a dessicator until use. 
Method C: 
A round-bottom flask equipped with stir bar and rubber septum was charged with 
ClSO2NCO (1.5 equiv). The flask was cooled to 0ºC, and then neat formic acid (1.5 equiv) was 
added dropwise. After vigorously stirring for 5 min at 0ºC, MeCN (2M relative to isocyanate) 
was added, and the reaction stirred vigorously at 0ºC (1 h) then room temp (~20ºC) overnight. 
After cooling the reaction flask back to 0ºC, the phenol (1.0 equiv) in N,N-dimethylacetamide 
(DMA, 1.6M) was slowly added via syringe. After complete addition, the reaction warmed back 
to room temp and stirred for 4-6 h. Upon complete consumption of starting material as monitored 
by TLC, the reaction was quenched with H2O (~5 mL). The reaction mixture was partitioned 
between H2O (15 mL) and Et2O (30 mL) and separated. The aqueous layer was then extracted 
with Et2O (2x30 mL). The organic layers were combined, dried over MgSO4, filtered, and 
concentrated under reduced pressure. Following purification of the crude product via flash 
column chromatography, the pure product was dissolved in CH2Cl2 and filtered through a short 
silica plug, then twice dissolved in benzene and concentrated under reduced pressure to remove 
trace H2O, then stored in a desiccator until use. 
NOTE: Some sulfamate esters exhibited suboptimal reactivity after storing for more than 
a month (although some are bench stable for much longer); repurification usually restored 






1.4.4 Preparation of Sulfamte Ester Starting Materials 
2-isopropylphenyl sulfamate [1]. 
Prepared according to method C. 681 mg (5.00 mmol) of 2-isopropylphenol were 
used, along with ClSO2NCO (653 µL, 7.50 mmol, 1.5 equiv), formic acid (283 
µL, 7.50 mmol, 1.5 equiv), MeCN (3.8 mL, 2M), DMA (3.0 mL). Flash column chromatography 
on silica (35 mm fritted glass column, 150 mm SiO2) using 3:1 hexanes/EtOAc as eluent gave 
877 mg (4.07 mmol) of pure product as a white solid (81% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.37 (dd, J = 7.9, 1.4 Hz, 2H), 7.30-7.26 (m, 1H), 7.23-7.19 (m, 
1H), 5.14 (br. s, 2H), 3.39 (hept, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H); 13C-NMR (125 MHz, 
CDCl3) δ 147.7, 141.7, 127.6, 127.5, 127.0, 121.7, 27.0, 23.4; IR (ATR, cm-1): 3374, 3279, 2986, 
2928, 1540, 1488, 1445, 1379, 1359, 1201, 1182, 1151, 1077, 1033, 945, 928, 900, 873, 860; 
HRMS (ESI) m/z calculated for C9H13NNaO3S [M+Na]+: 238.0514, found 238.0512. 
(±)-3-phenylpropan-1-yl sulfamate [3]. 
Prepared according to method A. 1.634 g (12.0 mmol) of 3-phenyl-1-
propanol were used, along with NaH (333 mg, 13.2 mmol, 1.1 equiv), DMF 
(12 mL + 9 mL), ClSO2NCO (1.57 mL, 18.0 mmol, 1.5 equiv), formic acid (679 μL, 18.0 mmol, 
1.5 equiv) and MeCN (9 mL). Flash column chromatography on silica (100 mL SiO2) using 2:1 
hexanes/EtOAc as eluent gave 1.592 g (7.40 mmol) of pure product as a white solid (62% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.5 Hz, 2H), 7.23-7.19 (m, 3H), 4.75 (br s, 2H), 4.22 
(t, J = 6.5 Hz, 2H), 2.76 (dd, J = 7.5 Hz, 2H), 2.08 (dt, J = 7.5, 7.0 Hz, 2H). These data are in 





5-((tert-butoxycarbonyl)oxy)-2-isopropylphenyl sulfamate [S1]. 
Prepared according to method C. 1.030 g (4.08 mmol) of tert-butyl (3-
hydroxy-4-isopropylphenyl) carbonate was used, along with ClSO2NCO 
(533 µL, 6.12 mmol, 1.5 equiv), formic acid (231 µL, 6.12 mmol, 1.5 equiv), 
3.1 mL MeCN and 6 mL DMA. Flash column chromatography on silica (35 mm fritted glass 
column, 150 mL SiO2) using 15% EtOAc/hexanes à 30% EtOAc /hexanes as eluent gave 1.113 
g (3.36 mmol) of pure product as a yellowish oil (82% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.35 (d, J = 8.6 Hz, 1H), 7.28 (d, J = 2.4 Hz, 1H), 7.11 (dd, J = 
8.6, 2.4 Hz, 1H), 4.97 (br. s, 2H), 3.36 (hept, J = 7.0 Hz, 1H), 1.56 (s, 9H), 1.23 (d, J = 6.9 Hz, 
6H); 13C-NMR (125 MHz, CDCl3) δ 151.9, 149.0, 147.3, 139.4, 127.8, 120.4, 115.2, 84.4, 27.8, 
26.8, 23.3; IR (ATR, cm-1): 3389, 3242, 3081, 2970, 1725, 1589, 1562, 1498, 1417, 1399, 1370, 
1294, 1264, 1244, 1184, 1154, 1131, 1084, 964, 887, 870, 813, 778; HRMS (ESI) m/z calculated 
for C14H21NO6SNa [M+Na]+: 354.0987, found 354.0992. 
3-(4-bromophenyl)propyl sulfamate [S2]. 
Prepared according to method B. 1.617 g (7.52 mmol) of 3-(4-
bromophenyl)propan-1-ol were used, along with ClSO2NCO (982 µL, 
11.28 mmol, 1.5 equiv), formic acid (425 µL, 11.28 mmol, 1.5 equiv), Et3N (1.57 mL, 11.28 
mmol, 1.5 equiv) and CH2Cl2 (5.7 mL + 10.5 mL). Flash column chromatography on silica (35 
mm fritted glass column, 150 mL SiO2) using 25% EtOAc/hexanes à 30% EtOAc/hexanes as 
eluent gave 1.493 g (5.08 mmol) of pure product as a white solid (68% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.42 (d, J = 8.3 Hz, 2H), 7.07 (d, J = 8.3 Hz, 1H), 4.67 (br. s, 
2H), 4.21 (t, J = 6.2 Hz, 1H), 2.72 (t, J = 7.6 Hz, 2H), 2.12-2.00 (m, 2H); 13C-NMR (125 MHz, 
CDCl3) δ 139.5, 131.7, 130.4, 120.2, 70.4, 31.1, 30.3; IR (ATR, cm-1): 3357, 3270, 2977, 1548, 
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1487, 1471, 1350, 1183, 1164, 1072, 1010, 967, 917, 829, 790; HRMS (ESI) m/z calculated for 
C9H11NO3SBr [M-H]-: 291.9643, found 291.9644. 
3-(4-(trifluoromethyl)phenyl)propyl sulfamate [S3]. 
Prepared according to method B. 1.865 g (9.13 mmol) of 3-(4-
trifluoromethyl)propan-1-ol were used, along with ClSO2NCO (1.19 
mL, 13.70 mmol, 1.5 equiv), formic acid (517 µL, 13.70 mmol, 1.5 equiv), Et3N (1.92 mL, 13.70 
mmol, 1.5 equiv) and CH2Cl2 (6.9 mL + 12.8 mL). Flash column chromatography on silica (50 
mm fritted glass column, 300 mL SiO2) using 25% EtOAc/hexanes à 45% EtOAc /hexanes as 
eluent gave 1.989 g (7.02 mmol) of pure product as a white solid (77% yield).  
1H-NMR (500 MHz, Acetonitrile-d3) δ 7.61 (d, J = 7.9 Hz, 2H), 7.42 (d, J = 7.9 Hz, 2H), 5.66 
(br. s, 2H), 4.12 (t, J = 6.3 Hz, 2H), 2.80 (t, J = 7.7 Hz, 2H), 2.06-2.01 (m, 2H); 13C-NMR (125 
MHz, Acetonitrile-d3) δ 146.9, 130.1, 128.6 (q, J = 32.0 Hz), 126.1 (q, J = 3.9 Hz), 125.5 (q, J = 
270.1 Hz), 70.2, 32.0, 30.8; 19F-NMR (470 MHz, Acetonitrile-d3) δ -62.45; IR (ATR, cm-1): 
3370, 3270, 1619, 1544, 1357, 1324, 1162, 1111, 1068, 1009, 931, 846, 833, 816; HRMS (EI) 
m/z calculated for C10H12NO3SF3 [M+]: 283.0490, found 283.0497. 
(±)-ethyl 4-phenyl-2-(sulfamoyloxy)butanoate [S4]. 
Prepared according to method B. 1.553 g (7.46 mmol) of (±)-ethyl 4-phenyl-
2-(hydroxy)butanoate were used, along with Et3N (1.56 mL, 11.2 mmol, 1.5 
equiv), ClSO2NCO (973 µL, 11.2 mmol, 1.5 equiv), formic acid (422 μL, 
11.2 mmol, 1.5 equiv) and CH2Cl2 (6 mL + 7 mL). Flash column chromatography on silica (35 
mm fritted glass column, 150 mL SiO2) using 4:1 hexanes/EtOAc à 2:1 hexanes/EtOAc as 
eluent gave 611 mg (2.16 mmol) of pure product as a white solid (29% yield). 
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1H-NMR (500 MHz, CDCl3) δ 7.31 (t, J = 7.3 Hz, 2H), 7.24-7.20 (m, 3H), 5.13 (br. s, 2H), 4.95 
(dd, J = 8.0, 4.0 Hz, 1H), 4.22 (q, J = 7.0 Hz, 2H), 2. 79 (t, J = 7.8 Hz, 2H), 2.30-2.17 (m, 2H), 
1.30 (t, J = 7.3 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 170.5, 139.9, 128.8, 128.7, 126.6, 79.2, 
62.5, 33.5, 31.0, 14.2. These data are in agreement with that previously reported in the literature.  
(±)-2-methyl-3-phenylpropyl sulfamate [S5]. 
Prepared according to method A. 719 mg (4.79 mmol) of (±)-2-methyl-3-
phenylpropan-1-ol were used, along with NaH (133 mg, 5.27 mmol, 1.1 
equiv), DMF (5.0 + 4.0 mL), ClSO2NCO (625 µL, 7.19 mmol, 1.5 equiv), formic acid (271 µL, 
7.19 mmol, 1.5 equiv) and MeCN (3.6 mL). Flash column chromatography on silica (50 mm 
fritted glass column, 300 mL SiO2) using 3:2 hexanes/EtOAc as eluent gave 954 mg (4.16 mmol) 
of pure product as a colorless oil (87% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.35-7.28 (m, 2H), 7.27-7.21 (m, 1H), 7.20-7.16 (m, 2H), 5.20 
(br. s, 2H), 4.06 (qd, J = 9.4, 5.8 Hz, 2H), 2.79 (dd, J = 13.6, 6.4 Hz, 1H), 2.51 (dd, J = 13.6, 8.0 
Hz, 1H), 2.25-2.15 (m, 1H), 0.99 (d, J = 6.8 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 139.4, 
129.2, 128.5, 126.3, 75.1, 39.1, 34.7, 16.3; IR (ATR, cm-1): 3360, 3275, 2920, 1544, 1497, 1453, 
1391, 1330, 1260, 1177, 971, 951, 924, 887, 820, 805; HRMS (ESI) m/z calculated for 
C10H16NO3S [M+H]+: 230.0851, found 230.0855. 
2-cyclopropylethyl sulfamate [S6]. 
Prepared according to method B. 431 mg (5.00 mmol) of 2-cyclopropylethan-1-
ol were used, along with ClSO2NCO (653 µL, 7.50 mmol, 1.5 equiv), formic acid (283 µL, 7.50 
mmol, 1.5 equiv), Et3N (1.05 mL, 7.50 mmol, 1.5 equiv) and CH2Cl2 (3.8 mL + 7 mL). Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% à 25% 
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EtOAc/hexanes as eluent gave 478 mg (2.89 mmol) of pure product as a colorless oil (58% 
yield).  
1H-NMR (500 MHz, CDCl3) δ 4.71 (br. s, 2H), 4.28 (td, J = 6.7, 1.4 Hz, 2H), 1.73-1.61 (app. q, 
2H), 0.82-0.74 (m, 1H), 0.52-0.49 (m, 2H), 0.13-0.10 (m, 2H); 13C-NMR (125 MHz, CDCl3) δ 
71.7, 33.9, 7.3, 4.3; IR (ATR, cm-1): 3384, 3283, 3082, 3004, 1557, 1467, 1428, 1352, 1172, 
1079, 1050, 1018, 916, 802, 765; HRMS (ESI) m/z calculated for C5H11NO3SNa [M+Na]+: 
188.0357, found 188.0357. 
(±)-4-(1-(phenylsulfonyl)-1H-pyrrol-3-yl)butan-2-yl sulfamate [S7].  
Prepared according to method B. 838 mg (3.00 mmol) 4-(1-(phenylsulfonyl)-1H-
pyrrol-3-yl) butan-2-ol were used, along with Et3N (455 µL, 4.50 mmol, 1.5 
equiv), CH2Cl2 (2.25 mL + 4.5 mL), ClSO2NCO (391 μL, 4.50 mmol, 1.5 equiv), 
formic acid (170 μL, 4.50 mmol, 1.5 equiv). Flash column chromatography on silica (45 mm 
fritted glass column, 180 mm SiO2) using 9:1 hexanes/acetone à 3:2 hexanes/acetone as eluent 
gave 751 mg (2.10 mmol) of pure product as a white solid (70% yield).  
1H NMR (51H NMR (500 MHz, CDCl3) δ 7.76 (dd, J = 7.5, 1.8 Hz, 2H), 7.61 (t, J = 7.6 Hz, 
1H), 7.52 (t, J = 7.8 Hz, 2H), 7.29 (dd, J = 3.5, 1.7 Hz, 1H), 6.22 (t, J = 3.4 Hz, 1H), 6.04-6.03 
(m, 1H), 4.87 (s, 2H), 4.77-4.70 (m, 1H), 2.80 (dd, J = 9.2, 6.5 Hz, 2H), 1.97 – 1.92 (m, 2H), 
1.41 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 139.2, 134.2, 134.1, 129.7, 126.9, 122.8, 
112.8, 111.8, 80.4, 35.8, 23.0, 20.8; HRMS (ESI) m/z calculated for C14H19N2O5S2 [M+H]+: 
359.0735, found 359.0734. 
(±)-4-(1-(phenylsulfonyl)-1H-indol-3-yl)butan-2-yl sulfamate [S8].  
Prepared according to method B. 988 mg (3.00 mmol) 4-(1-(phenylsulfonyl)-
1H-indol-3-yl)butan-2-ol were used, along with Et3N (455 µL, 4.5 mmol, 1.5 
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equiv), CH2Cl2 (2.25 mL + 4.5 mL), ClSO2NCO (392 μL, 4.50 mmol, 1.5 equiv), formic acid 
(170 μL, 4.50 mmol, 1.5 equiv). Flash column chromatography on silica (45 mm fritted glass 
column, 200 mm SiO2) using 9:1 hexanes/EtOAc à 3:2 hexanes/EtOAc as eluent gave 897 mg 
(2.20 mmol) of pure product as an off-white solid (73% yield).  
1H NMR (500 MHz, CDCl3) δ 7.99-7.97 (m, 1H), 7.88-7.86 (m, 2H), 7.52-7.39 (m, 5H), 7.33-
7.30 (m, 1H), 7.24-7.21 (m, 1H), 4.96 (s, 2H), 4.77-4.71 (m, 1H), 2.83-2.73 (m, 2H), 2.12-2.05 
(m, 1H), 1.99-1.92 (m, 1H), 1.44 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 138.2, 
135.5, 133.9, 130.8, 129.4, 126.9, 125.0, 123.4, 123.1, 122.1, 119.5, 114.0, 80.6, 35.7, 20.8, 
20.7; HRMS (ESI) m/z calculated for C18H20N2O5S2Na [M+Na]+: 431.0711, found 431.0709. 
3-(4-(2-oxooxazolidin-3-yl)phenyl)propyl sulfamate [S9].  
Prepared according to method B. 487 mg (2.20 mmol) 3-(4-(3-
hydroxypropyl)phenyl)oxazolidin-2-one were used, along with Et3N (614 μL, 
4.40 mmol, 2.0 equiv), DCM (2 mL + 4ml), ClSO2NCO (383 μL, 4.40 mmol, 
2.0 equiv), formic acid (166 μL, 4.40 mmol, 2.0 equiv). Flash column chromatography on silica 
(45 mm fritted glass column, 200 mm SiO2) using 10% EtOAc/hexanes à 80% EtOAc/hexanes 
as eluent gave 390 mg (1.30 mmol) of pure product as an off white solid (59% yield). 
1H NMR (500 MHz, Acetone-d6) δ 7.55 – 7.53 (m, 2H), 7.26-7.25 (m, 2H), 6.63 (s, 2H), 4.49 
(dd, J = 9.5, 7.0 Hz, 2H), 4.16-4.11 (m, 4H), 2.72 (dd, J = 8.5, 6.7 Hz, 2H), 2.09-1.99 (m, 2H); 
13C NMR (125 MHz, Acetone) δ 155.9, 138.2, 137.1, 129.7, 119.0, 69.7, 62.3, 45.9, 31.6, 31.5; 
HRMS (ESI) m/z calculated for C12H17N2O5S [M+H]+: 301.0858, found 301.0857. 
3-(4-(1,3,4-oxadiazol-2-yl)phenyl)propyl sulfamate [S10].  
Prepared according to method A. 600 mg (2.90 mmol) of 3-(4-(1,3,4-
oxadiazol-2-yl)phenyl)propan-1-ol were used, along with NaH (81 mg, 
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3.20 mmol, 1.1 equiv), DMF (5.8 mL), ClSO2NCO (500 μL, 5.80 mmol, 2.0 equiv), formic acid 
(220 μL, 5.80 mmol, 2.0 equiv) and MeCN (2.9 mL). Flash column chromatography on silica 
(45 mm fritted glass column, 200 mm SiO2) using 20% acetone/hexanes à 60% 
acetone/hexanes as eluent gave 390 mg (1.38 mmol) of pure product as a white solid (48% 
yield).  
1H NMR (500 MHz, Acetone-d6) δ 8.96 (s, 1H), 8.01 (d, J = 8.5 Hz, 2H), 7.50 (d, J = 8.0 Hz, 
2H), 6.67 (s, 2H), 4.19 (t, J = 6.3 Hz, 2H), 2.88-2.83 (m, 2H), 2.11-2.09 (m, 2H); 13C NMR (125 
MHz, Acetone-d6) δ 165.2, 154.5, 146.7, 130.4, 127.9, 122.8, 69.7, 32.5, 31.2; HRMS (ESI) m/z 
calculated for C11H14N3O4S [M+H]+: 284.0705, found 284.0699. 
3-(4,5-diphenyloxazol-2-yl)propyl sulfamate [S11].  
Prepared according to method A. 1.310 g (4.70 mmol) 3-(4,5-
diphenyloxazol-2-yl)propan-1-ol were used, along with NaH (130 mg, 
5.12 mmol, 1.1 equiv), DCM (3.6 mL), ClSO2NCO (617 μL, 7.10 
mmol, 1.5 equiv), formic acid (268 μL, 7.10 mmol, 1.5 equiv) and DMF (7 mL). Flash column 
chromatography on silica (45 mm fritted glass column, 200 mm SiO2) using 20% 
EtOAc/hexanes à 70% EtOAc/hexanes as eluent gave 1.090 g (3.00 mmol) of pure product as a 
white solid (64% yield).  
1H NMR (500 MHz, CDCl3) δ 7.62-7.60 (m, 2H), 7.57 (dt, J = 6.9, 2.3 Hz, 2H), 7.40-7.32 (m, 
6H), 5.16 (s, 2H), 4.40 (td, J = 5.9, 0.9 Hz, 2H), 3.05 (t, J = 6.9 Hz, 2H), 2.32-2.27 (m, 2H); 13C 
NMR (125 MHz, CDCl3) δ 162.1, 145.8, 135.1, 132.2, 128.8, 128.8, 128.8, 128.4, 128.0, 126.6, 





2,2-dimethyl-3-phenylpropyl sulfamate [20]. 
Prepared according to method A. 821 mg (5.00 mmol) of 2,2-dimethyl-3-
phenylpropan-1-ol were used, along with NaH (139 mg, 5.50 mmol, 1.1 
equiv), DMF (5.0 mL + 4.0 mL), ClSO2NCO (653 µL, 7.50 mmol, 1.5 equiv), formic acid (293 
µL, 7.50 mmol, 1.5 equiv) and MeCN (3.8 mL). Flash column chromatography on silica (50 mm 
fritted glass column, 300 mL SiO2) using 35% EtOAc/hexanes as eluent gave 726 mg (2.98 
mmol) of pure product as a white solid (60% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.31-7.27 (m, 2H), 7.25-7.21 (m, 1H), 7.16-7.14 (m, 2H), 4.90 
(br. s, 2H), 3.86 (s, 2H), 2.62 (s, 2H), 0.97 (s, 6H); 13C-NMR (125 MHz, CDCl3) δ 137.5, 130.7, 
128.2, 126.5, 78.2, 44.6, 35.3, 24.2; IR (ATR, cm-1): 3327, 3238, 2975, 1602, 1561, 1494, 1452, 
1471, 1395, 1353, 1194, 1161, 1007, 975, 930, 921, 906, 844, 826; HRMS (ESI) m/z calculated 
for C11H18NO3S [M+H]+: 244.1007, found 244.1003. 
Neopentyl sulfamate [22]. 
Prepared according to method B. 2,2-dimethylpropan-1-ol (440 mg, 5.00 mmol) 
was used, along with ClSO2NCO (653 µL, 7.50 mmol, 1.5 equiv), formic acid 
(283 µL, 7.50 mmol, 1.5 equiv), Et3N (1.05 mL, 7.50 mmol, 1.5 equiv) and CH2Cl2  (3.8 mL + 
7.0 mL). Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 15% EtOAc/hexanes à 40% EtOAc/hexanes as eluent gave 728 mg (4.35 mmol) of pure 
product as a white solid (87% yield).  
1H-NMR (500 MHz, CDCl3) δ 4.69 (br, s, 2H), 3.88 (s, 2H), 1.00 (s, 9H); 13C-NMR (125 MHz, 
CDCl3) δ 80.5, 31.7, 26.2; IR (ATR, cm-1) 3364, 3274, 2958, 2872, 1552, 1477, 1465, 1355, 




1.4.5 General Procedures for Intramolecular C—H Amination 
General procedure for [MnPc] and [Mn(tBuPc)]-mediated C—H amination 
Into a 10 mL round-bottom flask was added AgSbF6 (0.05 equiv or 0.10 equiv), 
[Mn(tBuPc)]Cl (0.05 equiv or 0.10 equiv), crushed 4Å MS, and a stir bar in a glovebox. The 
flask was then sealed with a rubber septum, covered in aluminum foil, and taken out of the box. 
Sulfamate ester (1.0 equiv), 9:1 C6H6/MeCN (0.5M), and, lastly, PhI(OPiv)2 (2.0 equiv) were 
then added under an inert atmosphere; if sulfamate ester was an oil, it was taken up in the solvent 
mixture and added to the flask via syringe. After addition of oxidant, the dark red solution 
gradually turned dark brown. The reaction stirred for 8h at room temperature unless otherwise 
specified (~20°C). Upon completion, the reaction mixture was applied directly to a silica column 
for purification. Alternatively, the reaction can be concentrated under reduced pressure, and the 
remaining dark brown residue suspended in Et2O and filtered through a small pad of Celite. 
Upon removal of solvent under reduced pressure, the brown residue was taken up in minimal 
CH2Cl2 and applied to a column. Any variation of these reaction conditions is noted for 
individual substrates. 
General procedure for [FePc]-mediated intramolecular C—H amination7 
Into a 10 mL round-bottom flask was added AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
[FePc]Cl (24.0 mg, 0.040 mmol, 0.10 equiv), and a stir bar in a glovebox. The flask was then 
sealed with a rubber septum, covered in aluminum foil, and taken out of the box. 4:1 
PhMe/MeCN (800 μL, 0.5M), sulfamate ester (0.400 mmol, 1.0 equiv), and PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) were then added sequentially; if sulfamate ester was an oil, it was taken 
up in the solvent mixture and added to the flask via syringe. After addition of oxidant, the deep 
violet solution gradually turned dark brown. The reaction stirred for 8h at room temperature 
30 
 
unless otherwise specified (~20°C). Upon completion, the reaction mixture was applied directly 
to a silica column (35 mm fritted glass column, 150 mm SiO2) for purification. Alternatively, the 
reaction can be concentrated under reduced pressure, and the remaining dark brown residue 
suspended in Et2O and filtered through a small pad of Celite. Upon removal of solvent under 
reduced pressure, the brown residue was taken up in minimal CH2Cl2 and applied to a column. 
Any variation of these reaction conditions is noted for individual substrates. 
 
1.4.6 Optimization of Mn-catalyzed Intramolecular C—H Amination 
Entry 1. The reaction was performed with general Fe[Pc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (35 mm fritted glass column, 
150 mL SiO2) using 15% EtOAc/hexanes with 0.5% AcOH as eluent. 2-isopropylphenyl 
sulfamate 1 (86.1 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 mg, 0.040 mmol, 0.10 equiv), 
AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 
4:1 PhMe/MeCN (800 μL) were used. The reaction was stirred for 6h at rt (~20ºC). 
Run 1: (35.5 mg, 0.167 mmol, 42%), (18.7 mg rsm, 0.087 mmol, 22%). Run 2: (37.7 mg, 0.177 
mmol, 44%), (20.1 mg rsm, 0.093 mmol, 23%). Run 3: (37.0 mg, 0.174 mmol, 43%), (17.2 mg 
rsm, 0.080 mmol, 20%). Average: 43% yield ± 1.0, 22% rsm ± 1.5. 
Entry 2. The reaction was performed with general Mn[Pc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (35 mm fritted glass column, 
150 mL SiO2) using 15% EtOAc/hexanes with 0.5% AcOH as eluent. 2-isopropylphenyl 
sulfamate 1 (86.1 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24.1 mg, 0.040 mmol, 0.10 equiv), 
AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 
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mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used. The reaction was stirred for 
6h at rt (~20ºC). 
Run 1: (58.8 mg, 0.276 mmol, 69%), <5% rsm. 
Entry 3. The reaction was performed with general Mn[tBuPc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (35 mm fritted glass column, 
150 mL SiO2) using 15% EtOAc/hexanes with 0.5% AcOH as eluent. 2-isopropylphenyl 
sulfamate 1 (86.1 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 
equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), crushed 4Å MS (100 mg), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 μL) were used. The reaction was stirred 
for 17h at rt (~20ºC). 
Run 1: (61.2 mg, 0.287 mmol, 72%), 0% rsm. Run 2: (59.0 mg, 0.277 mmol, 69%), 0% rsm. Run 
3: (55.9 mg, 0.262 mmol, 66%), 0% rsm. Average: 69% yield ± 3.0, 0% rsm. 
4,4-dimethyl-3,4-dihydrobenzo[e][1,2,3]oxathiazine 2,2-dioxide [2]. 
Product was isolated as an off-white solid. 1H-NMR (500 MHz, CDCl3) δ 7.31-7.18 
(m, 3H), 7.01-6.97 (m, 1H), 4.74 (br. s, 1H), 1.73 (s, 6H); 13C-NMR (125 MHz, 
CDCl3) δ 149.4, 129.3, 128.0, 126.6, 125.8, 119.3, 60.3, 30.8. IR (ATR, cm-1): 3267, 
2983, 2937, 1610, 1578, 1483, 1446, 1430, 1417, 1386, 1362, 1353, 1284, 1211, 1170, 1117, 
1085, 1038, 989, 889, 845; HRMS (ESI) m/z calculated for C9H12NO3S [M+H]+: 214.0538, 
found 214.0534. 
Entry 4. The reaction was performed with general Fe[Pc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (25 mm fritted glass column, 
150 ml SiO2) using 4:1 hexanes/EtOAc as eluent, affording oxathiazinane product and starting 
material separately. 3-phenylpropyl sulfamate 3 (86.5 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl 
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(12.0 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (800 µL, 0.5M) were used. 
Run 1: (18.5 mg, 0.086 mmol, 22%), (54.9 mg rsm, 0.254 mmol, 63%). Run 2: (19.0 mg, 0.089 
mmol, 22%), (58.2 mg rsm, 0.269 mmol, 67%). Run 3: (17.8 mg, 0.083 mmol, 21%), (56.2 mg 
rsm, 0.260 mmol, 65%). Average: 22% yield ± 0.5, 65% rsm ± 1.6.  
Entry 5. The reaction was performed with general Mn[Pc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (25 mm fritted glass column, 
150 ml SiO2) using 4:1 hexanes/EtOAc as eluent, affording oxathiazinane product and starting 
material separately. 3-phenylpropyl sulfamate 3 (86.5 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl 
(12.0 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 
mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were 
used. 
Run 1: (59.1 mg, 0.276 mmol, 69%), (<5% rsm). Run 2: (59.8 mg, 0.279 mmol, 70%), (<5% 
rsm). Run 3: (62.6 mg, 0.292 mmol, 73%), (<5% rsm). Average: 71% yield ± 1.7, <5% rsm.  
Entry 6. The reaction was performed with general Mn[tBuPc] condition described above. Crude 
reaction was purified via flash column chromatography on silica (25 mm fritted glass column, 
150 ml SiO2) using 4:1 hexanes/EtOAc as eluent, affording oxathiazinane product and starting 
material separately. 3-phenylpropyl sulfamate 3 (86.5 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 
µL, 0.5M) were used. 
Run 1: (63.0 mg, 0.294 mmol, 74%), (<5% rsm). Run 2: (65.2 mg, 0.304 mmol, 76%), (<5% 
rsm). Run 3: (61.5 mg, 0.287 mmol, 72%), (<5% rsm). Average: 74% yield ± 1.6, <5% rsm.  
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(±)-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [4]. 
Pure product was isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 7.43-7.35 
(m, 5H), 4.90-4.85 (m, 2H), 4.66 (ddd, J = 11.5, 5.0, 1.5 Hz, 1H), 4.35 (br. d, J = 
9.0 Hz, 1H), 2.30-2.21 (m, 1H), 2.05-2.00 (m, 1H); 13C-NMR (125 MHz, CDCl3) δ 
137.7, 129.0, 128.7, 126.1, 71.8, 58.7, 30.0. These data are in agreement with that previously 
reported in the literature.  
 
1.4.7 Substrate Scope of Mn-catalyzed Intramolecular C—H Amination 
tert-butyl (4,4-dimethyl-2,2-dioxido-3,4-dihydrobenzo[e][1,2,3]oxathiazin-7-yl) carbonate [8]. 
5-((tert-butoxycarbonyl)oxy)-2-isopropylphenyl sulfamate S1 (99.4 mg, 
0.300 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (12.4 mg, 0.015 mmol, 0.05 equiv), 
AgSbF6 (5.2 mg, 0.015 mmol, 0.05 equiv), crushed 4Å MS (75 mg), 
PhI(OPiv)2 (244 mg, 0.600 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (600 μL) were used.  The 
reaction was stirred for 17h at rt (~20ºC). Flash column chromatography on silica (35 mm fritted 
glass column, 150 mm SiO2) using 15% EtOAc/hexanes à 20% EtOAc/hexanes with 0.5% 
AcOH as eluent afforded product as white solid. 
Run 1: (69.1 mg, 0.210 mmol, 70%), <5% rsm. Run 2: (68.7 mg, 0.209 mmol, 70%), <5% rsm. 
Run 3: (65.9 mg, 0.200 mmol, 67%), <5% rsm. Average: 69% yield ± 1.7, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.22 (d, J = 8.5 Hz, 1H), 7.05 (dd, J = 8.5, 2.5 Hz, 1H), 6.90 (t, J 
= 1.8 Hz, 1H), 4.64 (br. s, 1H), 1.71 (s, 6H), 1.56 (s, 9H).;13C-NMR (125 MHz, CDCl3) δ 151.3, 
150.9, 149.6, 127.2, 125.4, 118.9, 112.4, 84.6, 60.1, 30.8, 27.7; IR (ATR, cm-1): 3237, 2984, 
1734, 1498, 1435, 1417, 1392, 1365, 1288, 1247, 1205, 1175, 1139, 1119, 1090, 961, 887, 856, 
811; HRMS (ESI) m/z calculated for C14H19NO6SNa [M+Na]+: 352.0831, found 352.0831. 
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(±)-4-(4-bromophenyl)-1,2,3-oxathiazinane 2,2-dioxide [9]. 
In both cases, the reaction was stirred for 12h at rt (~20ºC). Crude material was 
purified via flash column chromatography on silica (35 mm fritted glass column, 
150 mm SiO2) using 25% EtOAc/hexanes à 30% EtOAc/hexanes with 0.5% 
AcOH as eluent. 
FePc conditions: 2,3-(4-bromophenyl)propyl sulfamate S2 (118.0 mg, 0.400 mmol, 1.0 equiv), 
[FePc]Cl (12.1 mg, 0.02 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), 
PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (800 μL) were used. Product 
and recovered starting material were isolated as a mixture. 
Run 1: (30.4 mg, 0.104 mmol, 26%), (48.7 mg rsm, 0.166 mmol, 41%). Run 2: (39.2 mg, 0.134 
mmol, 34%), (51.9 mg rsm, 0.176 mmol, 44%). Run 3: (36.1 mg, 0.123 mmol, 31%), (50.5 mg 
rsm, 0.172 mmol, 43%). Average: 30% yield ± 4.0, 43% rsm ± 1.5. 
Mn(tBuPc) conditions: 3-(4-bromophenyl)propyl sulfamate S2 (118.0 mg, 0.400 mmol, 1.0 
equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.05 
equiv), crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 
C6H6/MeCN (800 μL) were used. 
Run 1: (80.1 mg, 0.274 mmol, 69%), 0% rsm. Run 2: (77.2 mg, 0.264 mmol, 66%), 0% rsm. Run 
3: (79.1 mg, 0.271 mmol, 68%), 0% rsm. Average: 68% yield ± 1.5, 0% rsm. 
Product was isolated as a white solid. 1H-NMR (500 MHz, acetone-d6) δ 7.59 (d, J = 8.1 Hz, 
2H), 7.47 (d, J = 8.1 Hz, 2H), 6.40 (br. d, J = 9.9 Hz, 1H), 4.92-4.83 (m, 1H), 4.79 (td, J = 12.0, 
2.5 Hz, 1H), 4.69 (ddd, J = 12.0, 4.8, 1.8 Hz, 1H), 2.30-2.18 (m, 1H), 2.14 (m, 1H); 13C-NMR 
(500 MHz, acetone-d6) δ 139.5, 132.6, 129.6, 122.4, 72.7, 59.3, 30.8; IR (ATR, cm-1): 3258, 
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2961, 1490, 1406, 1434, 1420, 1297, 1235, 1193, 1184, 1174, 1063, 1018, 1007, 937, 904, 868, 
833, 806; HRMS (ESI) m/z calculated for C9H9NO3SBr [M-H]-: 289.9487, found 289.9489. 
(±)-4-(4-(trifluoromethyl)phenyl)-1,2,3-oxathiazinane 2,2-dioxide [10]. 
3-(4-trifluoromethyl)propyl sulfamate S3 (113.3 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (33.1 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 
mmol, 0.10 equiv), crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 
mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 μL) were used.  The reaction was stirred for 12h at rt 
(~20ºC). Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 25% EtOAc/hexanes à 35% EtOAc/hexanes with 0.5% AcOH as eluent afforded product 
as white solid. 
Run 1: (67.3 mg, 0.239 mmol, 60%), <5% rsm. Run 2: (64.2 mg, 0.228 mmol, 57%), <5% rsm. 
Run 3: (65.4 mg, 0.233 mmol, 58%), <5% rsm. Average: 58% yield ± 1.5, <5% rsm. 
1H-NMR (500 MHz, Acetonitrile-d3) δ 7.73 (d, J = 8.2 Hz, 2H), 7.60 (d, J = 8.1 Hz, 2H), 5.60 
(br. d, J = 10.0 Hz, 1H), 4.91 (ddd, J = 12.6, 10.1, 3.0 Hz, 1H), 4.77 (td, J = 12.1, 2.5 Hz, 1H), 
4.67 (ddd, J = 11.6, 5.0, 1.8 Hz, 1H), 2.21-2.14 (m, 1H), 2.09-2.05 (m, 1H); 13C-NMR (125 
MHz, Acetonitrile-d3) δ 144.0, 130.6 (q, J = 32.3 Hz), 128.3, 126.5 (q, J = 3.9 Hz), 125.2 (q, J = 
271.3 Hz), 73.3, 59.3, 30.3; 19F-NMR (470 MHz, Acetonitrile-d3) δ -62.82; IR (ATR, cm-1): 
3232, 1623, 1444, 1412, 1364, 1350, 1326, 1249, 1187, 1159, 1115, 1067, 1018, 946, 915, 870, 
845, 816; HRMS (EI) m/z calculated for C10H10NO3SF3 [M+]: 281.03335, found 281.03377. 
(±)-ethyl-4-phenyl-1,2,3-oxathiazinane-6-carboxylate 2,2-dioxide [11]. 
(±)-ethyl 4-phenyl-2-(sulfamoyloxy)butanoate S4 (114.9 mg, 0.400 mmol, 
1.0 equiv), [Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 
mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv), 100 mg crushed 4Å 
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MS, and 9:1 C6H6/MeCN (800 µL, 0.5M) were used. Product was purified via flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 4:1 hexanes/EtOAc. 
Pure product was isolated as a white solid. 
Run 1: (74.9 mg, 0.263 mmol, 66%), <5% rsm. Run 2: (74.0 mg, 0.259 mmol, 65%), <5% rsm. 
Run 3: (70.1 mg, 0.246 mmol, 61%), <5% rsm.  Average: 64% yield ± 2.2, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.44-7.37 (m, 5H), 5.33 (dd, J = 12.5, 2.5 Hz, 1H), 4.88 (ddd, J= 
12.5, 10.0, 3.0 Hz, 1H), 4.69 (br. d, J = 9.5 Hz, 1H), 4.29 (q, J = 7.0 Hz, 2H), 2.41 (dt, J = 14.0, 
3.0 Hz, 1H), 2.29 (dt, J = 14.5, 12.0 Hz, 1H), 1.31 (t, J = 7.0 Hz, 3H); 13C-NMR (125 MHz, 
CDCl3) δ 167.4, 137.5, 129.3, 129.2, 126.7, 78.8, 62.9, 58.5, 32.4, 14.1. These data are in 
agreement with that previously reported in the literature.  
(±)-trans-5-methyl-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [12]. 
(±)-2-methyl-3-phenylpropyl sulfamate S5 (91.7 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
0.05 equiv), crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 
C6H6/MeCN (800 μL) were used. The reaction was stirred for 8h at rt (~20ºC). Flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 20% 
EtOAc/hexanes à 30% EtOAc/hexanes with 0.5% AcOH as eluent gave product as white solid 
as a single diastereomer. 
Run 1: (64.8 mg, 0.285 mmol, 71%), 0% rsm. Run 2: (59.1 mg, 0.260 mmol, 65%), 0% rsm. Run 
3: (61.5 mg, 0.271 mmol, 68%), 0% rsm. Average: 68% yield ± 3.0, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.43-7.34 (m, 3H), 7.34-7.29 (m, 2H), 4.70 (d, J = 8.9 Hz, 1H), 
4.52-4.44 (m, 2H), 4.34 (dd, J = 11.0, 9.0 Hz, 1H), 2.42-2.31 (m, 1H), 0.69 (d, J = 6.7 Hz, 3H); 
13C-NMR (125 MHz, CDCl3) δ 137.1, 129.3, 129.2, 127.4, 76.7, 65.6, 34.0, 12.0; IR (ATR,    
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cm-1): 3260, 2983, 2940, 1459, 1424, 1354, 1193, 1175, 1088, 1072, 1016, 968, 923, 887; 
HRMS (ESI) m/z calculated for C10H14NO3S [M+H]+: 228.0694, found 228.0691. 
 
Stereochemistry Assignment: To avoid potential proton peak overlap with the exchangeable NH 
proton, D2O was added into NMR sample to saturate the NH peak. 1H-NMR (500 MHz, CDCl3, 
D2O) δ 7.43-7.34 (m, 3H), 7.34-7.29 (m, 2H), 4.52-4.44 (m, 2H), 4.34 (d, J = 11.0 Hz, 1H), 2.42-
2.31 (m, 1H), 0.69 (dd, J = 6.9, 1.3 Hz, 3H). Notably the coupling pattern of benzylic proton Ha 
(4.34 ppm) changed from dd (J = 11.0, 9.0 Hz) to d (J = 11.0 Hz).  
A series of 1D nOe difference experiments were conducted to assign the relative stereochemistry 
of the structure. When Ha was irradiated, 2.64% nOe was observed on corresponding methyl 
peak while only 0.94% nOe was observed on Hb peak. Similarly, when Hb was irradiated, 2.33% 
nOe of methyl was observed while Ha only gave 0.09% nOe. These results indicate Ha and Hb are 
in an anti-configuration. 
(±)-4-cyclopropyl-1,2,3-oxathiazolidine 2,2-dioxide [13]. 
2-cyclopropylethyl sulfamate S6 (66.1 mg, 0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl  
(33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN 
(800 μL, 0.5M) were used. The reaction was stirred for 24h at rt (~20ºC). Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% EtOAc/hexanes 
à 30% EtOAc/hexanes with 0.5% AcOH as eluent gave product as colorless oil. 
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Run 1: (33.1 mg, 0.203 mmol, 51%), (7.4 mg rsm, 0.045 mmol, 11%). Run 2: (34.1 mg, 0.209 
mmol, 52%), (11.1 mg rsm, 0.067 mmol, 17%). Run 3: (32.9 mg, 0.202 mmol, 50%), (10.0 mg 
rsm, 0.060 mmol, 15%). Average: 51% yield ± 1.0, 14% rsm ± 3.1. 
1H-NMR (500 MHz, CDCl3) δ 4.83 (br. d, J = 8.0 Hz, 1H), 4.64 (dd, J = 8.5, 6.4 Hz, 1H), 4.34 
(t, J = 8.2 Hz, 1H), 3.32 (app. p, J = 7.4 Hz, 1H), 1.04 (qt, J = 8.5, 4.7 Hz, 1H), 0.71 - 0.61 (m, 
2H), 0.44 (dq, J = 9.7, 5.0 Hz, 1H), 0.31 (dq, J = 10.1, 5.0 Hz, 1H); 13C-NMR (125 MHz, 
CDCl3) δ 74.6, 61.5, 12.6, 3.3, 2.6; IR (thin film, cm-1): 3267, 3011, 1391, 1339, 1189, 1054, 
966, 832, 789; HRMS (ESI) m/z calculated for C5H9NO3SNa [M+Na]+: 186.0201, found 
186.0208. 
(±)-6-methyl-4-(1-(phenylsulfonyl)-1H-pyrrol-3-yl)-1,2,3-oxathiazinane 2,2-dioxide [14]. 
4-(1-(phenylsulfonyl)-1H-pyrrole-3-yl)butan-2-yl sulfamate S7 (143 mg, 
0.400 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), 
AgSbF6 (6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 
2.0 equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 μL, 0.5M) were used. By 1H 
NMR analysis of the crude mixture, the d.r. was determined to be 7:1 syn:anti. Flash column 
chromatography on silica (35 mm fritted glass column, 150mL SiO2) using 10% EtOAc/hexanes 
à 60% EtOAc/hexanes as eluent gave oxathiazinane product as a ~7:1 syn:anti mixture of 
diastereomers. Pure syn diastereomer can be isolated using flash column chromatography on 
silica (35 mm fritted glass column, 150 mm SiO2) using 9:1 hexanes/EtOAc à 1:1 
hexanes/EtOAc. Anti diastereomer always eluted with syn diastereomer and trace rsm.  
Run 1: (96.3 mg (6.8:1 syn:anti), 0.270 mmol, 68%), <5% rsm. Run 2: (101.1 mg (6.9:1 
syn:anti), 0.284 mmol, 71%), <5% rsm. Run 3: (99.8 mg (7.1:1 syn:anti), 0.280 mmol, 70%), 
<5% rsm. Average: 69% yield ± 1.7 (7:1 syn:anti), <5% rsm. 
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Syn diastereomer: Pure product was isolated as a white solid. 1H NMR (500 MHz, CDCl3) δ 
7.92 (dd, J = 7.6, 1.8, Hz, 2H), 7.64-7.60 (m, 1H), 7.53 (t, J = 7.7 Hz, 2H), 7.42-7.41 (m, 1H), 
6.31-6.30 (m, 1H), 6.27 (t, J = 3.4 Hz, 1H), 5.44 (ddd, J = 12.5, 10.2, 2.6 Hz, 1H), 4.95 (dqd, J = 
12.5, 6.3, 1.9 Hz, 1H), 3.69-3.67 (m, 1H), 2.08 (dt, J = 14.2, 2.4 Hz, 1H), 1.84 (dt, J = 14.4, 11.9 
Hz, 1H), 1.45 (d, J = 6.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 138.3, 134.5, 131.3, 129.5, 
127.8, 124.3, 113.5, 111.4, 80.5, 50.5, 37.0, 21.2; HRMS (ESI) m/z calculated for C14H17N2O5S 
[M+H]+: 357.0579, found 357.0576. 
(±)-6-methyl-4-(1-(phenylsulfonyl)-1H-indol-3-yl)-1,2,3-oxathiazinane2,2-dioxide [15]. 
4-(1-(phenylsulfonyl)-1H-indol-3-yl)butan-2-yl sulfamate S8 (164 mg, 0.400 
mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 
(6.9 mg, 0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 
equiv), 100 mg crushed 4Å MS, and 9:1 C6H6/MeCN (800 μL) were used. By 1H NMR analysis 
of the crude mixture, the d.r. was determined to be 12:1 syn:anti. Flash column chromatography 
on silica (25 mm fritted glass column, 150 mL SiO2) using 9:1 hexanes/EtOAc à 3:2 
hexanes/EtOAc as eluent gave oxathiazinane product as a ~12:1 syn:anti mixture of 
diastereomers. Pure syn diastereomer can be isolated using flash column chromatography on 
silica (35 mm fritted glass column, 150 mm SiO2) using 4:1 hexanes/EtOAc as eluent. 
Run 1: (115.8 mg, 0.285 mmol, 71%), <5% rsm. Run 2: (112.9 mg, 0.278 mmol, 70%), <5% 
rsm. Run 3: (119.3mg, 0.294 mmol, 73%), <5% rsm. Average: 71% yield ± 1.2, <5% rsm. 
Syn diastereomer: Pure product was isolated as a white solid. 1H NMR (500 MHz, CDCl3) δ 
7.97 (d, J = 8.3 Hz, 1H), 7.90-7.88 (m, 2H), 7.71 (d, J = 7.9 Hz, 1H), 7.58-7.53 (m, 2H), 7.47 (t, 
J = 7.7 Hz, 2H), 7.38-7.35 (m, 1H), 7.29-7.26 (m, 1H), 5.08-5.03 (m 2H), 4.14 (d, J = 10.3 Hz, 
1H), 2.23 (dt, J = 14.1, 2.5 Hz, 1H), 2.02 (dt, J = 14.2, 11.9 Hz, 1H), 1.52 (d, J = 6.2 Hz, 3H); 
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13C NMR (126 MHz, CDCl3) δ 137.9, 135.3, 134.4, 129.6, 128.4, 127.0, 125.9, 123.9, 123.2, 
120.6, 120.1, 113.8, 80.6, 51.5, 36.0, 21.3; HRMS (ESI) m/z calculated for C18H19N2O5S2 
[M+H]+: 407.0735, found 407.0731. 
(±)-3-(4-(2,2-dioxido-1,2,3-oxathiazinan-4-yl)phenyl)oxazolidin-2-one [16]. 
3-(4-(2-oxooxazolidin-3-yl)phenyl)propyl sulfamate S9 (60.0 mg, 0.200 mmol, 
1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg,  0.020 mmol, 0.10 equiv), AgSbF6 (6.9 
mg, 0.020 mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) 
and 2:1:1 C6H6/Acetone/MeCN (600 µL, 0.33M) were used. Reaction stirred at 45oC for 18h. 
Flash column chromatography on silica (35 mm fritted glass column, 75 mL SiO2) using 30% 
EtOAc/hexanes à 75% EtOAc/hexanes as eluent gave oxathiazinane product as a white solid.  
Run 1: (33.5 mg, 0.112 mmol, 56%), <5% rsm. Run 2: (32.1 mg, 0.108 mmol, 54%), <5% rsm. 
Run 3: (35.3 mg, 0.118 mmol, 59%), <5% rsm. Average: 56% yield ± 2.1, <5% rsm. 
1H NMR (500 MHz, Acetone-d6) δ 7.67-7.64 (m, 2H), 7.52-7.50 (m, 2H), 6.32 (d, J = 10.1 Hz, 
1H), 4.87-4.76 (m, 2H), 4.69 (ddd, J = 11.5, 5.0, 1.7 Hz, 1H), 4.52-4.48 (m, 2H), 4.17-4.14 (m, 
2H), 2.30-2.21 (m, 1H), 2.12-2.08 (m, 1H); 13C NMR (125 MHz, Acetone-d6) δ 155.9, 139.9, 
135.0, 128.0, 118.8, 72.7, 62.3, 59.4, 45.7, 31.0; HRMS (ESI) m/z calculated for C12H15N2O5S 
[M+H]+: 299.0702, found 299.0702. 
(±)-4-(4-(1,3,4-oxadiazol-2-yl)phenyl)-1,2,3-oxathiazinane 2,2-dioxide [17]. 
(4-(1,3,4-oxadiazol-2-yl)phenyl)propyl sulfamate S10 (113 mg, 0.400 mmol, 
1.0 equiv), [Mn(tBuPc)]Cl (33.2 mg,  0.040 mmol, 0.10 equiv), AgSbF6 (13.7 
mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) 
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and 4:1 CH2Cl2/MeCN (1.2 mL, 0.33M) were used. The reaction stirred at rt for 18h. Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 30% 
EtOAc/hexanes à 90% EtOAc/hexanes as eluent gave oxathiazinane product.  
Run 1: (72.9 mg, 0.259 mmol, 65%), <5% rsm. Run 2: (70.1mg, 0.249 mmol, 62%), <5% rsm. 
Run 3: (71.2 mg, 0.253 mmol, 63%), <5% rsm. Average: 63% yield ± 1.3, <5% rsm. 
1H NMR (500 MHz, CD3OD) δ 9.04 (s, 1H), 8.12 (d, J = 8.0 Hz, 2H), 7.66 (d, J = 8.5 Hz, 2H), 
4.93 (dd, J = 11.9, 3.1 Hz, 1H), 4.81 (td, J=12.0, 2.6 Hz, 1H), 4.68 (ddd, J = 11.5, 4.8, 1.8 Hz, 
1H), 2.24-2.10 (m, 2H); 13C-NMR (125 MHz, CD3OD) δ165.8, 155.5, 144.9, 128.6, 124.3, 73.1, 
59.7, 31.0; HRMS (ESI) m/z calculated for C11H12N3O4S [M+H]+: 282.0549, found 282.0541. 
(±)-4-(4,5-diphenyloxazol-2-yl)-1,2,3-oxathiazinane 2,2-dioxide [18]. 
3-(4,5-diphenyloxazol-2-yl) propyl sulfamate S11 (143 mg, 0.400 mmol, 1.0 
equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 
0.020 mmol, 0.05 equiv), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 
9:1 C6H6/MeCN (800 μL, 0.5M) were used. The reaction stirred at rt for 12h. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 30% EtOAc/hexanes 
à 80% EtOAc/hexanes gave oxathiazinane product. Significant EtOAc remains on the product 
after prolonged vacuum; the peaks corresponding to EtOAc are labeled in the provided spectrum 
and yields reported account for this by integration in 1H NMR. 
Run 1: (87.4 mg, 0.245 mmol, 61%), <5% rsm. Run 2: (89.8 mg, 0.252 mmol, 63%), <5% rsm. 
Run 3: (90.2 mg, 0.253 mmol, 63%), <5% rsm. Average: 63% yield ± 1.1, <5% rsm. 
1H NMR (500 MHz, CDCl3) δ 7.65-7.63 (m, 2H), 7.61-7.58 (m, 2H),  7.43-7.36 (m, 6H), 5.15 
(ddd, J = 11.9, 10.3, 3.2 Hz, 1H), 4.98-4.90 (m, 2H), 4.70 (ddd, J = 11.8, 5.0, 2.0 Hz, 1H), 2.38 
(dddd, J = 14.8, 12.6, 11.8, 4.9 Hz, 1H), 2.25-2.20 (m, 1H); 13C NMR (126 MHz, CDCl3) δ 
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158.5, 146.7, 135.6, 131.6, 129.4, 129.0, 128.9, 128.8, 128.2, 128.0, 71.4, 53.1, 28.9; HRMS 
(ESI) m/z calculated for C18H17N2O4S [M+H]+: 357.0909, found 357.0910. 
(±)-5,5-dimethyl-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [20]. 
2,2-dimethyl-3-phenylpropyl sulfamate 19 (97.3 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.05 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
0.05 equiv), crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 
C6H6/MeCN (800 μL, 0.5M) were used.  The reaction was stirred for 17h at rt (~20ºC). Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 15% 
EtOAc/hexanes à 20% EtOAc/hexanes with 0.5% AcOH as eluent gave product as white solid. 
Minor 1° C—H amination product S37 was also isolated separately as white solid. 
Run 1: (59.7 mg benzylic, 0.247 mmol, 62%), (8.8 mg 1°, 0.036 mmol, 9%), 0% rsm. Run 2: 
(58.8 mg benzylic, 0244 mmol, 61%), (9.3 mg 1°, 0.039 mmol, 10%), 0% rsm. Run 3: (63.3 mg 
benzylic, 0.262 mmol, 66%), (10.7 mg 1°, 0.045 mmol, 11%), 0% rsm. Average: 63% benzylic 
± 2.6, 10% 1° ± 1.0, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.41-7.33 (m, 3H), 7.24-7.17 (m, 2H), 5.11 (d, J = 7.9 Hz, 1H), 
4.62 (d, J = 7.4 Hz, 1H), 4.60 (d, J = 3.9 Hz, 1H), 4.10 (d, J = 11.4 Hz, 1H), 1.09 (s, 3H), 0.80 (s, 
3H); 13C-NMR (125 MHz, CDCl3) δ 135.1, 128.8, 128.5, 128.0, 82.5, 67.3, 34.0, 21.5, 17.4; IR 
(ATR, cm-1): 3272, 2974, 1711, 1469, 1459, 1428, 1365, 1349,1188, 1047, 1013. 960, 908, 851, 
803; HRMS (ESI) m/z calculated for C11H16NO3S [M+H]+: 242.0851, found 242.0847. 
(±)-5-benzyl-5-methyl-1,2,3-oxathiazinane 2,2-dioxide [21]. 
1H-NMR (500 MHz, CDCl3) δ 7.36 -7.27 (m, 3H), 7.17-7.11 (m, 2H), 4.76 (t, J = 
7.5 Hz, 1H), 4.35 (d, J = 11.8 Hz, 1H), 4.23 (d, J = 11.6 Hz, 1H), 3.39-3.28 (m, 
2H), 2.82 (d, J = 13.4 Hz, 1H), 2.60 (d, J = 13.4 Hz, 1H), 0.94 (s, 3H); 13C-NMR 
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(125 MHz, CDCl3) δ 135.4, 130.5, 128.7, 127.2, 79.7, 54.1, 40.6, 32.5, 19.1; IR (ATR, cm-1): 
3280, 2925, 1496, 1446, 1418,1391, 1356, 1337, 1174, 1155, 1028, 951, 931, 854; HRMS (ESI) 
m/z calculated for C11H16NO3S [M+H]+: 242.0851, found 242.0845. 
5,5-dimethyl-1,2,3-oxathiazinane 2,2-dioxide [23]. 
In all cases, the reaction was stirred at rt for 24h. The crude reaction mixture was 
purified via flash column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 15% EtOAc/hexanes à 20% EtOAc/hexanes with 0.5% AcOH as eluent. 
Fe[Pc] conditions: Neopentyl sulfamate 22 (66.9 mg, 0.400 mmol, 1.0 equiv), [FePc]Cl (24.2 
mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), PhI(OPiv)2 (325 mg, 
0.800 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (800 μL) were used. Product and recovered 
starting material were isolated as a mixture after column purification.   
Run 1: (2.0 mg, 0.012 mmol, 3% yield), (50.2 mg, 0.300 mmol, 75% rsm). Run 2: (2.4 mg, 0.015 
mmol, 4% yield), (48.0 mg, 0.287 mmol, 72% rsm). Run 3: (2.1 mg, 0.013 mmol, 3% yield), 
(52.2 mg, 0.312 mmol, 78% rsm). Average: 3% yield ± 0.6, 75% rsm ± 3.0. 
Mn[Pc] conditions: Neopentyl sulfamate 22 (66.9 mg, 0.400 mmol, 1.0 equiv), [MnPc]Cl (24.2 
mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), crushed 4Å MS (100 
mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (800 μL) were used. 
Product and starting material were isolated separately. 
Run 1: (24.8 mg, 0.150 mmol, 38% yield), (25.9 mg, 0.155 mmol, 39% rsm). Run 2: (22.1 mg, 
0.134 mmol, 33% yield), (27.0 mg, 0.161 mmol, 40% rsm). Run 3: (26.8 mg, 0.162 mmol, 41% 
yield), (29.5 mg, 0.176 mmol, 44% rsm). Average: 37% yield ± 4.0, 41% rsm ± 2.6. 
Mn[tBuPc] conditions: Neopentyl sulfamate 22 (66.9 mg, 0.400 mmol, 1.0 equiv), 
[Mn(tBuPc)]Cl (33.2 mg, 0.040 mmol, 0.10 equiv), AgSbF6 (13.7 mg, 0.040 mmol, 0.10 equiv), 
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crushed 4Å MS (100 mg), PhI(OPiv)2 (325 mg, 0.800 mmol, 2.0 equiv) and 9:1 C6H6/MeCN 
(800 μL) were used. Product and starting material were isolated separately. 
Run 1: (42.6 mg, 0.258 mmol, 64% yield), (6.0 mg, 0.036 mmol, 9% rsm). Run 2: (41.3 mg, 
0.250 mmol, 63% yield), (10.4 mg, 0.062 mmol, 16% rsm). Run 3: (42.6 mg, 0.258 mmol, 64% 
yield), (8.6 mg, 0.051 mmol, 13% rsm). Average: 64% yield ± 0.6, 13% rsm ± 3.5. 
Product was isolated as a white solid. 1H-NMR (500 MHz, CDCl3) δ 4.69 (br. s, 1H), 4.27 (s, 
2H), 3.27 (d, J = 7.5 Hz, 2H), 1.07 (s, 6H); 13C-NMR (125 MHz, CDCl3) δ 81.7, 55.4, 29.1, 
21.9; IR (ATR, cm-1): 3315, 2967, 1425, 1399, 1350, 1336, 1314, 1282, 1183, 1046, 954, 930, 
922, 910, 844; HRMS (ESI) m/z calculated for C5H12NO3S [M+H]+: 166.0538, found 166.0535. 
 
1.4.8 Diversification of Complex Molecules 
(+)-3-(sulfamoyloxy) betulinic acid methyl ester [24]. 
Prepared according to method B. Betulinic acid methyl ester19 
(304 mg, 0.645 mmol, 1.0 equiv) was used, along with ClSO2NCO 
(169 µL, 1.94 mmol, 3.0 equiv), formic acid (73 µL, 1.94 mmol, 
3.0 equiv), Et3N (273 µL, 1.94 mmol, 3.0 equiv) and CH2Cl2 (1.0 mL + 2.0 mL). Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 
acetone/hexanes as eluent afforded 196 mg (0.357 mmol) of pure product as a white solid (55% 
yield). NOTE: the product should be stored and transferred under an Ar atmosphere. 
1H NMR (500 MHz, CDCl3) δ 5.00 (br. d, J = 8.7 Hz, 2H), 4.72 (d, J = 2.5 Hz, 1H), 4.62 - 4.55 
(br. s, 1H), 4.18 (dd, J = 12.1, 4.6 Hz, 1H), 3.65 (s, 3H), 2.97 (td, J = 10.9, 4.5 Hz, 1H), 2.26-
2.13 (m, 2H), 2.05-1.97 (m, 1H), 1.93-1.78 (m, 3H), 1.75-1.64 (m, 2H), 1.67 (s, 3H), 1.56 (t, J = 













0.79 (m, 2H), 1.00 (s, 3H), 0.94 (s, 3H), 0.89 (s, 3H), 0.83 (s, 3H), 0.82 (s, 3H), 0.79-0.73 (m, 
1H); 13C-NMR (125 MHz, CDCl3) δ 176.8, 150.6, 109.8, 91.9,56.6, 55.7, 51.4, 50.5, 49.5, 47.1, 
42.5, 40.7, 38.8, 38.6, 38.3, 37.1, 37.1, 34.3, 32.2, 30.7, 29.7, 28.1, 25.5, 24.5, 21.0, 19.5, 18.4, 
16.3, 16.2, 16.0, 14.8; IR (ATR, cm-1):3269, 2947, 2868, 1728, 1642, 1449, 1328, 1186, 1136, 
929, 903, 874, 846; [α]27D = +14.2o (c = 1.1, CHCl3);  HRMS (ESI) m/z calculated for 
C31H52NO5S [M+H]+: 550.3566, found 550.3571. 
(-)-3,23-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-24-methyl betulinic acid methyl ester [25]. 
54 (110.0 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 
0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 equiv), 
50 mg crushed 4Å MS, PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) 
and 9:1 C6H6/MeCN (600 μL, 0.33 M) were used. The reaction was 
stirred for 24h at rt (~20ºC). Flash column chromatography on silica (35 mm fritted glass 
column, 150 mm SiO2) using 10% acetone/hexanes à 15% acetone/hexanes with 0.5% AcOH as 
eluent afforded product as white solid. We observed a minor product resulting from epoxidation 
of the aminated product (confirmed by 1H NMR and HRMS), likely due to the presence of 
exogenous water or oxygen. This normally accounted for an additional ~5% of the total C—H 
amination, although in some cases accounted for 10-15% yield if special precautions were not 
taken. 
Run 1: (78.9 mg, 0.144 mmol, 72%), 0% rsm. Run 2: (83.5 mg, 0.152 mmol, 76%), 0% rsm. Run 
3: (86.6 mg, 0.158 mmol, 79%), 0% rsm. Average: 76% yield ± 3.5, 0% rsm. 
1H NMR (500 MHz, acetone-d6) δ 6.53 (dd, J = 9.8, 5.0 Hz, 1H), 4.73 (d, J = 2.4 Hz, 1H), 4.60 
(d, J = 2.3 Hz, 1H), 4.50 (dd, J = 12.2, 4.1 Hz, 1H), 3.65 (s, 3H), 3.25 (dd, J = 13.8, 5.0 Hz, 1H), 
3.15 (dd, J = 13.8, 9.5 Hz, 1H), 3.02 (td, J = 11.0, 5.0 Hz, 1H), 2.28 (ddd, J = 12.9, 11.4, 3.6 Hz, 
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1H), 2.23-2.18 (m, 1H), 1.92-1.76 (m, 4H), 1.76-1.57 (m, 3H), 1.70 (s, 3H), 1.55-1.10 (m, 14H), 
1.09 (s, 3H), 1.05-1.00 (m, 1H), 1.04 (s, 3H), 0.96 (s, 3H), 0.95 (s, 3H); 13C-NMR (125 MHz, 
Acetone-d6) δ 176.8, 151.5, 110.3, 91.0, 57.3, 56.6, 52.6, 51.7, 51.2, 50.2, 48.1, 43.4, 41.8, 39.6, 
39.1, 38.5, 37.5, 37.0, 34.7, 32.8, 31.4, 30.6, 26.3, 24.5, 21.7, 19.6, 18.8, 17.7, 16.5, 15.2, 11.5; 
IR (ATR, cm-1): 3285, 2946, 2870, 1723, 1642, 1450, 1432, 1359, 1184, 1153, 1134, 1044, 938, 
881, 843, 825; [α]26D = -12.4o (c = 1.05, CHCl3); HRMS (ESI) m/z calculated for C31H50NO5S 
[M+H]+: 548.3410, found 548.3414. 
(-)-(N-nitroisoindolyl)dihydroabietylamine [26]. 
(+)-Dehydroabietylamine (2.89 g, 90% purity) was dissolved in 21 
mL pyridine. 4-nitrophthalic anhydride (2.145 g, 11.1 mmol) was 
added and the reaction was allowed to stir under reflux overnight. 
Upon completion, the reaction was poured into 80 mL ice and 
extracted with Et2O (3x50 mL). The combined organic layer was washed with 2M HCl (2x30 
mL), H2O (2x30 mL) and brine (30 mL), then dried over MgSO4. The product was loaded on 
celite and was purified via MPLC separation (Silica 40g Gold column, 40 mL/min, hexanes à 
5% EtOAc/hexanes) to give 2.301 g (5.0 mmol) 26. 
1H NMR (500 MHz, CDCl3) δ 8.63 (d, J = 1.9 Hz, 1H), 8.59 (dd, J = 8.1, 2.0 Hz, 1H), 8.01 (d, J 
= 8.1 Hz, 1H), 7.13 (d, J = 8.1 Hz, 1H), 6.97 (dd, J = 7.9, 2.1 Hz, 1H), 6.94-6.92 (s, 1H), 3.76 (d, 
J = 13.8 Hz, 1H), 3.56 (d, J = 13.8 Hz, 1H), 3.06-2.96 (m, 2H), 2.82 (hept, J = 6.9 Hz, 1H), 2.25 
(ddt, J = 12.0, 8.2, 3.2 Hz, 2H), 1.84 (m, 1H), 1.68 (m, 2H), 1.52 (dt, J = 13.4, 3.5 Hz, 1H), 1.44-
1.38 (m, 1H), 1.36-1.25 (m, 2H), 1.24 (s, 3H), 1.22 (d, J = 7.0 Hz, 6H), 1.08 (s, 3H); 13C-NMR 
(125 MHz, CDCl3) δ 167.2, 166.9, 151.7, 147.1, 145.7, 136.4, 134.9, 133.4, 129.2, 127.1, 124.5, 
123.8 (2 peaks), 118.7, 49.5, 45.1, 39.7, 38.1, 37.6, 37.0, 33.4, 30.0, 25.9, 24.1, 24.0, 19.5, 19.2, 
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18.5; IR (film, cm-1): 2958, 2955, 2872, 1780, 1722, 1543, 1496, 1437, 1383, 1344, 1092, 910; 
[α]27D = -66.3o (c = 0.63, CHCl3); HRMS (ESI) m/z calculated for C28H33N2O4 [M+H]+: 
461.2440, found 461.2452. 
(-)-12-acetyl-(N-nitroisoindolyl)dihydroabietylamine [S12]. 
26 (1.842 g, 4.00 mmol, 1.0 equiv) was dissolved in 25 mL (CHCl)2 
in a flame dried 100 mL recovery flask. Acetyl chloride (1.099 g, 
14.0 mmol, 3.5 equiv) and AlCl3 (1.600 g, 12.0 mmol, 3.0 equiv) 
was added at 0ºC. The reaction was allowed to warm up slowly to rt 
and stirred for 22h. The reaction mixture was poured into 30 mL cold 6M HCl and extracted with 
Et2O (3x50 mL). The combined organic layers were washed by brine and dried over CaCl2. Flash 
column chromatography on silica (50 mm fritted glass column, 200 mL SiO2) using 10% 
EtOAc/hexanes à 15% EtOAc/hexanes as eluent gave 1.889 g (3.76 mmol) product as a pale 
yellow solid (94% yield). 
1H NMR (500 MHz, CDCl3) δ 8.63 (d, J = 2.0 Hz, 1H), 8.59 (dd, J = 8.1, 2.0 Hz, 1H), 8.01 (d, J 
= 8.1 Hz, 1H), 7.35 (s, 1H), 7.08 (s, 1H), 3.76 (d, J = 13.9 Hz, 1H), 3.56 (d, J = 13.9 Hz, 1H), 
3.44 (hept, J = 6.8 Hz, 1H), 3.02 (dd, J = 9.0, 4.5 Hz, 2H), 2.51 (s, 3H), 2.29-2.25 (m, 2H), 1.89 - 
1.80 (m, 1H), 1.78-1.64 (m, 2H), 1.55-1.51 (m, 1H), 1.43-1.26 (m, 3H), 1.24 (s, 3H), 1.22 (d, J = 
6.9 Hz, 3H), 1.18 (d, J = 6.9 Hz, 3H), 1.08 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 203.3, 167.3, 
167.0, 151.8, 146.8, 145.0, 139.1, 136.4, 136.3, 133.4, 129.3, 127.3, 124.6, 124.1, 118.8, 49.5, 
45.1, 39.7, 38.1, 37.6, 37.0, 30.6, 30.1, 28.8, 26.0, 24.3, 24.2, 19.4, 19.3, 18.5. IR (ATR, cm-1): 
2929, 1781, 1719, 1678, 1539, 1435, 1384, 1338, 1262, 1232, 1194, 1088; [α]26D = -23.8o (c = 





S12 (1.898 g, 3.76 mmol, 1.0 equiv.) was dissolved in 10 mL 
anhydrous CH2Cl2. mCPBA (2.292 g, 9.30 mmol, 2.5 equiv, 70% in 
H2O) was added at 0ºC followed by dropwise addition of CF3CO2H 
(429 mg, 3.76 mmol, 1.0 equiv.). The reaction was allowed to warm 
up to rt and stir for 24h. The reaction was sequentially washed by 10% Na2SO3 (10 mL), H2O (10 
mL), saturated aq. NaHCO3 (10 mL), H2O (10 mL), then organic layer was dried over CaCl2. 
Flash column chromatography on silica (50 mm fritted glass column, 300 mL SiO2) using 10% 
EtOAc/hexanes à 15% EtOAc/hexanes as eluent gave 1.622 g (3.13 mmol) product as white 
solid (83% yield). 
1H NMR (500 MHz, CDCl3) δ 8.64-8.63 (m, 1H), 8.59 (dd, J = 8.2, 1.8 Hz, 1H), 8.01 (dd, J = 
8.1, 1.6 Hz, 1H), 6.97 (s, 1H), 6.76 (s, 1H), 3.78 (d, J = 13.9, 1H), 3.51 (d, J = 13.8, 1H), 3.0 - 
2.97 (m, 2H), 2.89 (hept, J = 6.8 Hz, 1H), 2.30-2.23 (m, 1H), 2.28 (s, 3H), 2.15-2.12 (m, 1H), 
1.85-1.80 (m, 1H), 1.71-1.59 (m, 2H), 1.51 (dq, J = 13.5, 2.7 Hz, 1H), 1.37 (dd, J = 12.2, 2.0 Hz, 
1H), 1.30 (ddd, J = 21.0, 12.8, 4.1 Hz, 2H), 1.22 (s, 3H), 1.19 (d, J = 6.8 Hz, 3H), 1.15 (d, J = 
7.0 Hz, 3H), 1.07 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 170.1, 167.3, 167.0, 151.8, 148.4, 
146.1, 137.0, 136.5, 133.5, 133.2, 129.3, 127.3, 124.6, 118.9, 117.6, 49.4, 44.5, 39.8, 38.1, 37.7, 
37.1, 29.5, 27.2, 25.9, 23.1 (2 peaks), 21.1, 19.5, 19.3, 18.5; IR (ATR, cm-1): 2931, 1756, 1719, 
1622, 1540, 1497, 1435, 1397, 1383, 1339, 1205, 1164, 1087, 1060, 1041, 1017, 941, 911; [α]26D 







S13 (1.540 g, 2.97 mmol, 1.0 equiv) was taken up in 8 mL MeOH. 
NaHCO3 (1.072 g, 12.8 mmol, 4.3 equiv) was added into the 
mixture followed by 1 drop of H2O. The reaction was stirred at rt for 
24h then 40ºC for 72h. Upon completion as determined by TLC, 
CH2Cl2 (20 mL) and H2O (20 mL) were added and the mixture was acidified with 3M H2SO4 to 
pH~5. The aqueous layer was extracted with TBME (3x30 mL). The combined organic layers 
were washed with brine and dried over MgSO4. Flash column chromatography on silica (50 mm 
fritted glass column, 200 mL SiO2) using 20% EtOAc/hexanes as eluent gave 896 mg (1.88 
mmol) product as an orange solid (63% yield). 
1H NMR (500 MHz, CDCl3) δ 8.63 (d, J = 1.8 Hz, 1H), 8.58 (dd, J = 8.2, 1.8 Hz, 1H), 8.01 (dd, 
J = 8.1, 1.6 Hz, 1H), 6.87 (s, 1H), 6.59 (s, 1H), 4.63 (br. s, 1H), 3.75 (dd, J = 13.9, 1.6 Hz, 1H), 
3.57 (dd, J = 13.8, 1.6 Hz, 1H), 3.10 (hept, J = 6.8 Hz, 1H), 2.99-2.88 (m, 2H), 2.24-2.19 (m, 
1H), 2.17-2.13 (m, 1H), 1.85-1.76 (m, 1H), 1.75-1.60 (m, 2H), 1.51 (dq, J = 13.5, 2.7 Hz, 1H), 
1.38 (dd, J = 12.2, 2.0 Hz, 1H), 1.30 (ddd, J = 21.0, 12.8, 4.1 Hz, 2H), 1.25-1.19 (m, 9H), 1.07 
(s, 3H); 13C-NMR (125 MHz, CDCl3) δ 167.3, 167.0, 151.9, 150.8, 148.2, 136.5, 133.5, 131.8, 
129.3, 127.2, 127.0, 124.6, 118.8, 110.7, 49.7, 45.3, 39.8, 38.2, 37.7, 37.2, 29.4, 26.9, 25.8, 22.8, 
22.7, 19.7, 19.3, 18.6; IR (thin film, cm-1): 2960, 2935, 2892, 1780, 1720, 1620, 1543, 1466, 
1437, 1416, 1398, 1385, 1344, 1165, 1090, 910; [α]26D = -41.6o (c = 0.93, CHCl3); HRMS (ESI) 
m/z calculated for C28H33N2O5 [M+H]+: 477.2389, found 477.2388. 
(-)-12-sulfamoyloxy-(N-nitroisoindolyl)dihydroabietylamine [27]. 
Prepared according to method C. S14 (238 mg, 0.50 mmol, 1.0 
equiv), ClSO2NCO (65 µL, 0.75 mmol, 1.5 equiv), formic acid (28 
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µL, 0.75 mmo, 1.5 equiv), MeCN (1 mL) and DMA (1 mL) were used. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 20% 
EtOAc/hexanes as eluent gave 189 mg (0.34 mmol) of pure product as a white solid (68% yield). 
1H NMR (500 MHz, CDCl3) δ 8.64 (s, 1H), 8.59 (dd, J = 8.2, 1.9 Hz, 1H), 8.02 (d, J = 8.2 Hz, 
1H), 7.16 (s, 1H), 7.00 (s, 1H), 4.85 (br. s, 2H), 3.75 (d, J = 13.8 Hz, 1H), 3.55 (d, J = 13.8 Hz, 
1H), 3.26 (hept, J = 7.5, 7.0 Hz, 1H), 2.98 (dd, J = 8.9, 4.5 Hz, 2H), 2.28-2.17 (m, 2H), 1.82 
(ddd, J = 18.0, 12.8, 9.0 Hz, 1H), 1.67 (dtd, J = 18.4, 10.3, 4.0 Hz, 2H), 1.56-1.50 (m, 1H), 1.36-
1.14 (m, 12H), 1.07 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 167.4, 167.0, 151.8, 148.7, 145.7, 
138.2, 136.4, 134.6, 133.4, 129.4, 127.7, 124.7, 118.9, 117.2, 49.5, 44.8, 39.7, 38.0, 37.8, 36.9, 
29.5, 26.6, 25.8, 23.5, 23.4, 19.4, 19.3, 18.4; IR (thin film, cm-1): 3402, 3383, 3296, 3107, 2964, 
2937, 2870, 1780, 1722, 1624, 1543, 1495, 1464, 1437, 1385, 1344, 1248, 1190, 1153, 1088, 
933; [α]25D = -23.1o (c = 0.86, CHCl3); HRMS (ESI) m/z calculated for C28H34N3O7S [M+H]+: 
556.2117, found 556.2128. 
(-)-12,15-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-(N-nitroisoindolyl)dihydroabietylamine [28]. 
27 (111.1 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 
0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 
equiv), crushed 4Å MS (50 mg), PhI(OPiv)2 (163 mg, 0.400 mmol, 
2.0 equiv) and 9:1 C6H6/MeCN (400 μL) were used. The reaction 
was stirred for 24h at rt (~20ºC). Flash column chromatography on silica (35 mm fritted glass 
column, 150 mm SiO2) using 20% EtOAc/hexanes à 30% EtOAc/hexanes with 0.5% AcOH as 
eluent gave product as slightly yellow solid.  
Run 1: (77.7 mg, 0.140 mmol, 70%), 0% rsm. Run 2: (75.8 mg, 0.137 mmol, 68%), 0% rsm. Run 
3: (79.1 mg, 0.143 mmol, 72%), 0% rsm. Average: 70% yield ± 2.0, 0% rsm. 
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1H NMR (500 MHz, CDCl3) δ 8.64 (d, J = 2.0 Hz, 1H), 8.59 (dd, J = 8.1, 2.0 Hz, 1H), 8.02 (d, J 
= 8.1 Hz, 1H), 6.88 (s, 1H), 6.80 (s, 1H), 4.50 (d, J = 4.2 Hz, 1H), 3.75 (d, J = 13.8 Hz, 1H), 3.54 
(d, J = 13.9 Hz, 1H), 2.97 (dd, J = 9.1, 4.6 Hz, 2H), 2.27 (dtd, J = 11.5, 4.7, 2.4 Hz, 1H), 2.16-
2.13 (m, 1H), 1.82 (tt, J = 13.0, 9.1 Hz, 1H), 1.73-1.63 (m, 1H), 1.69 (s, 3H), 1.67 (s, 3H), 1.54-
1.51 (m, 1H), 1.34-1.24 (m, 4H), 1.21 (s, 3H), 1.07 (s, 3H); 13C-NMR (125 MHz, CDCl3) δ 
167.3, 167.0, 151.9, 151.5, 147.4, 136.4, 133.4, 132.9, 129.4, 126.8, 125.0, 124.7, 118.9, 114.4, 
60.1, 49.4, 44.6, 39.7, 38.0, 37.9, 36.9, 31.0, 30.9, 29.3, 25.7, 19.4, 19.3, 18.4; IR (thin film,   
cm-1): 3267, 2933, 2870, 1780, 1720, 1624, 1541, 1493, 1429, 1400, 1387, 1344, 1207, 1173, 
1155, 1092, 910; [α]25D = -43.6o (c = 0.66, CHCl3); HRMS (ESI) m/z calculated for 
C28H32N3O7S [M+H]+: 554.1961, found 554.1968. 
(+)-(7S)-hydroxy-dihydropleuromutilone-acetate [S15]. 
(-)-(7S)-hydroxy-dihydropleuromutilone19 29 (25.0 mg, 0.063 mmol, 1.0 equiv.) 
was dissolved in 0.2 mL pyridine. Acetyl chloride (45.0 mg, 0.063 mmol, 1.0 
equiv.) was added at 0ºC. The reaction was allowed to stir at 0ºC for 3h. The 
reaction was diluted with 10 mL CH2Cl2, washed with 1M HCl (2x5 mL), H2O (5 mL) and dried 
over Na2SO4. Flash column chromatography on silica (35 mm fritted glass column, 30 mL SiO2) 
using 30% EtOAc/hexanes à 50% EtOAc/hexanes as eluent gave 19.9 mg (0.0456 mmol) 
product as white solid (72% yield). 
1H NMR (500 MHz, CDCl3) δ 5.91 (d, J = 8.8 Hz, 1H), 4.61-4.51 (ab q., 2H), 3.86 (td, J = 11.0, 
4.6 Hz, 1H), 3.41 (q, J = 6.6 Hz, 1H), 2.31-2.16 (m, 4H), 2.18 (s, 3H), 2.10-2.03 (m, 1H), 1.99 
(dd, J = 15.8, 8.8 Hz, 1H), 1.64-1.63 (m, 1H), 1.57-1.46 (m, 4H), 1.49 (s, 3H), 1.35 (d, J = 15.8 
Hz, 1H), 1.14 (d, J = 6.4 Hz, 3H), 1.11-1.03 (m, 1H), 0.98 (s, 3H), 0.95 (d, J = 7.2 Hz, 3H), 0.79 
(t, J = 7.5 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 217.4, 216.1, 170.4, 167.1, 70.7, 69.3, 61.5, 
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58.5, 51.6, 45.8, 44.5, 43.7, 43.4, 43.2, 39.2, 34.5, 29.9, 24.4, 22.1, 20.6, 15.1, 13.0, 12.1, 9.2; IR 
(ATR, cm-1): 3497, 2972, 2942, 1735, 1693, 1454, 1421, 1377, 1282, 1242, 1199, 1080, 1029, 
972, 958, 916; [α]25D = +9.9o (c = 1.11, CHCl3); HRMS (ESI) m/z calculated for C24H37O7 
[M+H]+: 437.2539, found 437.2540. 
(+)-(7S)-sulfamoyloxy-dihydropleuromutilone-acetate [30]. 
Prepared according to method B. 29 (258.9 mg, 0.59 mmol) was used, along 
with ClSO2NCO (154 µL, 1.77 mmol, 3.0 equiv), formic acid (69 µL, 1.77 
mmol, 3.0 equiv), Et3N (247 µL, 1.77 mmol, 3.0 equiv) and CH2Cl2 (1.0 mL 
+ 1.0 mL). Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 30% EtOAc/hexanes à 50% EtOAc/hexanes as eluent gave 145.3 
mg (0.28 mmol) of pure product as a white solid (48% yield).  
1H NMR (500 MHz, CDCl3) δ 6.07 (d, J = 8.4 Hz, 1H), 4.82 (br. s, 2H), 4.68 - 4.62 (m, 2H), 
4.44 (d, J = 16.2 Hz, 1H), 3.44 (q, J = 6.6 Hz, 1H), 2.47 (ddd, J = 14.1, 4.6, 2.3 Hz, 1H), 2.30-
2.18 (m, 3H), 2.17 (s, 3H), 2.00 (dd, J = 15.9, 8.5 Hz, 1H), 1.82 (dq, J = 11.4, 7.1 Hz, 1H), 1.64 
(d, J = 2.5 Hz, 1H), 1.60-1.45 (m, 3H), 1.50 (s, 3H), 1.42-1.32 (m, 2H), 1.16 (d, J = 6.5 Hz, 3H), 
1.03 (d, J = 7.1 Hz, 3H), 0.99 (s, 3H), 0.81 (t, J = 7.4 Hz, 3H); 13C-NMR (125 MHz, CDCl3) δ 
216.9, 215.5, 171.0, 167.6, 81.2, 70.5, 61.6, 58.4, 51.5, 46.0, 44.1, 43.6, 43.1, 42.1, 37.0, 34.4, 
29.8, 24.5, 22.0, 20.6, 15.2, 13.0, 12.0, 9.2; IR (ATR, cm-1): 3273, 2973, 1735, 1694, 1563, 1455, 
1376, 1284, 1199, 1182, 1080, 973, 956m 918, 863; [α]25D = +34.4o (c = 0.95, CHCl3); HRMS 
(ESI) m/z calculated for C24H37NO9SNa [M+Na]+: 538.2087, found 538.2083. 
(-)-7,16-(2,2-dioxido-1,2,3-oxathiazinan-3-yl)-dihydropleuromutilone-acetate [31]. 
30 (103.1 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), 
AgSbF6 (6.9 mg, 0.020 mmol, 0.10 equiv), crushed 4Å MS (50 mg), PhI(OPiv)2 (163 mg, 0.400 
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mmol, 2.0 equiv) and 9:1 C6H6/MeCN (400 μL, 0.5M) were used.  The reaction 
was stirred for 24h at rt (~20ºC). Flash column chromatography on silica (35 
mm fritted glass column, 150 mm SiO2) using 20% EtOAc/hexanes à 30% 
EtOAc/hexanes with 0.5% AcOH as eluent gave product as colorless oil. 
Run 1: (82.2 mg, 0.160 mmol, 80%), <5% rsm. Run 2: (88.6 mg, 0.172 mmol, 86%), <5% rsm. 
Run 3: (89.0 mg, 0.173 mmol, 87%), <5% rsm. Average: 84% yield ± 3.8, <5% rsm. 
1H NMR (500 MHz, CDCl3) δ 5.72 (d, J = 8.7 Hz, 1H), 5.05 (td, J = 11.4, 4.9 Hz, 1H), 4.76 (dd, 
J = 10.6, 4.2 Hz, 1H), 4.59 (s, 2H), 3.45 (dt, J = 14.0, 3.3 Hz, 1H), 3.37 (q, J = 6.5 Hz, 1H), 3.28 
(dt, J = 14.3, 11.2 Hz, 1H), 2.37-2.12 (m, 5H), 2.16 (s, 3H), 1.93-1.84 (m, 2H), 1.75 (d, J = 2.5 
Hz, 1H), 1.57-1.49 (m, 2H), 1.51 (s, 3H), 1.39 (d, J = 15.9 Hz, 1H), 1.30-1.23 (m, 1H), 1.13 (d, J 
= 6.5 Hz, 3H), 0.96 (s, 3H), 0.77 (t, J = 7.4 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ 216.6, 
215.5, 170.5, 166.7, 81.4, 70.4, 61.4, 58.1, 51.5, 45.6, 45.2, 44.6, 43.3, 42.8, 42.4, 35.4, 34.2, 
29.7, 23.9, 22.0, 20.5, 14.1, 13.0, 9.2. IR (ATR, cm-1): 3262, 2969, 1736, 1693, 1420, 1368, 
1283, 1183, 1072, 1038, 978, 960, 921, 865, 824; [α]25D = -7.8o (c = 0.83, CHCl3); HRMS (ESI) 
m/z calculated for C24H36NO9S [M+H]+: 514.2111, found 514.2109. 
 
1.4.9 Hammett Study 
(±)-1-(4-nitrophenyl)-5-phenylpentan-3-yl sulfamate [S16].  
Prepared according to method B. 1.997 g (7.00 mmol) (±)-1-(4-
nitrophenyl)-5-phenylpentan-3-ol were used, along with Et3N (1.9 mL, 
14.0 mmol, 2.0 equiv), CH2Cl2 (7 mL + 14 mL), ClSO2NCO (1.22 
mL, 14.0 mmol, 2.0 equiv), formic acid (530 μL, 14.0 mmol, 2.0 equiv). Flash column 
chromatography on silica (45 mm fritted glass column, 200 mL SiO2) using 4:1 hexanes/EtOAc 
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à 3:2 hexanes/EtOAc as eluent gave 1.79 g (4.92 mmol) of pure product as a yellow solid (70% 
yield). 
1H NMR (500 MHz, CDCl3) δ 8.14 (d, J = 9.0 Hz, 2H), 7.34-7.28 (m, 4H), 7.23-7.18 (m, 3H), 
4.73-4.65 (m, 3H), 2.90-2.81 (m, 2H), 2.80-2.72 (m, 2H), 2.19-2.03 (m, 4H); 13C NMR (125 
MHz, CDCl3) δ 148.6, 146.4, 140.5, 129.1, 128.5, 128.2, 126.2, 123.7, 83.0, 35.4, 35.2, 31.1, 
30.8; HRMS (ESI) m/z calculated for C17H20N2O5SNa [M+Na]+: 387.0991, found 387.0986. 
These data agree with that previously reported in the literature.6  
(±)-1-phenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-yl sulfamate [S17].  
Prepared according to method A. 1.634 g (5.30 mmol) of (±)-1-
phenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-ol were used, along 
with NaH (148 mg, 5.84 mmol, 1.1 equiv), DMF (5 mL + 4 mL), 
ClSO2NCO (696 μL, 7.95 mmol, 1.5 equiv), formic acid (300 μL, 9.75 mmol, 1.5 equiv) and 
MeCN (4 mL). Flash column chromatography on silica (45 mm fritted glass column, 175 mL 
SiO2) using 3:1 hexanes/EtOAc as eluent gave 1.250 g (3.23 mmol) of pure product as a white 
solid (61% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.54 (d, J = 8.0 Hz, 2H), 7.31-7.28 (m, 4H), 7.23-7.17 (m, 3H), 
4.70-4.64 (m, 3H), 2.83-2.73 (m, 4H), 2.17-2.03 (m, 4H); 13C-NMR (125 MHz, CDCl3) δ 145.2, 
140.8, 128.8, 128.7, 128.5, 126.4, 125.6 (q, JC-F = 3.9 Hz), 83.6, 35.7, 35.6, 31.3, 31.0. These 
data agree with that previously reported in the literature.6   
(±)-1-phenyl-5-(p-tolyl)pentan-3-yl sulfamate [S18].  
Prepared according to method A. 3.200 g (12.6 mmol) of (±)-1-phenyl-5-
(p-tolyl)pentan-3-ol were used, along with NaH (350 mg, 13.9 mmol, 1.1 
equiv), DMF (13 + 10 mL), ClSO2NCO (1.7 mL, 19.1 mmol, 1.5 equiv), 
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formic acid (712 μL, 19.1 mmol, 1.5 equiv) and MeCN (10.4 mL). Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 3:1 hexanes/EtOAc 
à 2:1 hexanes/EtOAc as eluent gave 2.01 g (6.03 mmol) of pure product as a white solid (48% 
yield).  
1H-NMR (500 MHz, CDCl3) δ 7.31-7.28 (m, 2H), 7.22-7.18 (m, 3H), 7.11-7.06 (m, 4H), 4.68 
(app. p, J = 6.5 Hz, 1H), 4.54 (br. s, 2H), 2.79-2.66 (m, 4H), 2.32 (s, 3H), 2.15-2.01 (m, 4H); 
13C-NMR (125 MHz, CDCl3) δ 141.1, 137.9, 135.8, 129.4, 128.7, 128.5, 128.4, 126.3, 84.8, 
35.9, 35.8, 31.2, 30.8, 21.1. These data agree with that previously reported in the literature.6   
(±)-1-(4-methoxyphenyl)-5-phenylpentan-3-yl sulfamate [S19].  
Prepared according to method A. 1.351 g (5.00 mmol) (±)-1-(4-
methoxyphenyl)-5-phenylpentan-3-ol were used, along with NaH 
(140 mg, 5.50 mmol, 1.1 equiv), MeCN (5 mL), ClSO2NCO (870 μL, 
10.0 mmol, 2 equiv), formic acid (380 μL, 10.0 mmol, 2 equiv) and DMF (10 mL). Flash column 
chromatography on silica (45 mm fritted glass column, 200 mL SiO2) using 4:1 hexanes/EtOAc 
à 3:2 hexanes/EtOAc as eluent gave 1.290 g (3.69 mmol) of pure product as a pale yellow oil 
(74% yield).  
1H NMR (500 MHz, CDCl3) δ 7.35 (t, J = 7.4 Hz, 2H), 7.28 – 7.23 (m, 3H), 7.15 (d, J = 8.3 Hz, 
2H), 6.89 (d, J = 8.2 Hz, 2H), 5.19 (br. s, 2H), 4.72 (p, J = 5.9 Hz, 1H), 3.82 (s, 3H), 2.83-2.69 
(m, 4H), 2.15-2.04 (m, 4H); 13C NMR (125 MHz, CDCl3) δ 157.8, 141.1, 133.1, 129.3, 128.5, 
128.4, 126.1, 113.9, 83.8, 55.2, 35.9, 35.6, 31.0, 30.1. These data agree with that previously 





Para-nitrophenyl versus phenyl. 
In all cases, the product ratio was established by HPLC analysis of the crude reaction mixture 
(reaction aliquots were filtered through a short silica plug with iPrOH into a HPLC vial. Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 9:1 
hexanes/EtOAc à 3:2 hexanes/EtOAc as eluent gave oxathiazinane product as a mixture of 
constitutional isomers. Each pure constitutional isomer can be isolated using flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 9:1 hexanes/EtOAc 
à 2:1 hexanes/EtOAc. Products retained EtOAc after prolonged drying in vacuo; this mass was 
accounted for when calculating yields. Additionally, free Pc ligand co-elutes with the minor 
products and its peaks are labeled and its mass accounted for in yields. 
Fe[Pc] conditions: 1-(4-nitrophenyl)-5-phenylpentan-3-yl sulfamate S16 (73.0 mg, 0.200 mmol, 
1.0 equiv), [FePc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 
equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (400 μL, 0.5M) were 
used. By HPLC analysis of the crude product, γ:γ’ was 5.34 ± 0.29 : 1. 
Run 1: (39.1 mg, 0.108 mmol, 54%), (12.3 mg rsm, 0.034 mmol, 17%), γ:γ’ = 5.02:1. Run 2: 
(38.4 mg, 0.106 mmol, 53%), (11.6 mg rsm, 0.032 mmol, 16%), γ:γ’ = 5.58:1. Run 3: (37.0 mg, 
0.102 mmol, 51%), (10.1 mg rsm, 0.028 mmol, 14%), γ:γ’ = 5.41:1. Average: 53% yield ± 1.5, 
16% rsm ± 1.5. 
Mn[Pc] conditions: 1-(4-nitrophenyl)-5-phenylpentan-3-yl sulfamate S16 (73.0 mg, 0.200 
mmol, 1.0 equiv), [MnPc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (400 μL, 0.5M) 
were used. By HPLC analysis of the crude product, γ:γ’ was 3.26 ± 0.17 : 1. 
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Run 1: (48.5 mg, 0.134 mmol, 67%), <5% rsm, γ:γ’ = 3.07:1. Run 2: (46.4 mg, 0.128 mmol, 
64%), <5% rsm, γ:γ’ = 3.40:1. Run 3: (45.7 mg, 0.126 mmol, 63%), <5% rsm, γ:γ’ = 3.31:1. 
Average: 65% yield ± 2.1, <5% rsm.  
Mn[tBuPc] conditions: 1-(4-nitrophenyl)-5-phenylpentan-3-yl sulfamate S16 (73.0 mg, 0.200 
mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 
mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (400 μL, 
0.5M) were used. By HPLC analysis of the crude product, γ:γ’ was 4.00 ± 0.09 : 1. 
Run 1: (59.4 mg, 0.164 mmol, 82%), <5% rsm, γ:γ’ = 4.11:1. Run 2: (61.6 mg, 0.170 mmol, 
85%), <5% rsm, γ:γ’ = 3.97:1. Run 3: (63.4 mg, 0.175 mmol, 88%), <5% rsm, γ:γ’ = 3.93:1. 
Average: 85% yield ± 3.0, <5% rsm.  
(±)-4-(4-nitrophenyl)-6-phenethyl-1,2,3-oxathiazinane 2,2-dioxide [S20]. 
Product was isolated as a white solid. 1H NMR (500 MHz, CDCl3) δ 
8.18 (d, J = 9.0 Hz, 2H), 7.43-7.36 (m, 5H), 7.34-7.32 (m, 2H), 4.85-
4.76 (m, 2H), 4.21 (d, J = 9.1 Hz, 1H), 3.01 (ddd, J = 14.1, 9.3, 4.9 
Hz, 1H), 2.91 (dt, J = 14.0, 8.3 Hz, 1H), 2.19-2.14 (m, 1H), 2.08-1.93 (m, 3H); 13C NMR (125 
MHz, CDCl3) δ 148.1, 146.9, 137.8, 129.6, 129.4, 129.2, 126.4, 124.1, 82.6, 58.3, 36.5, 36.4, 
30.7. These data agree with that previously reported in the literature.6  
(±)-6-(4-nitrophenethyl)-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [S21]. 
Product was isolated as a white solid. 1H NMR (500 MHz, CDCl3) δ 
8.27 (d, J = 7.0 Hz, 2H), 7.54 (d, J = 8.5 Hz, 2H), 7.34-7.31 (m, 2H), 
7.26-7.20 (m, 3H), 4.90 (dtt, J = 11.7, 5.9, 3.4 Hz, 2H), 4.18 (d, J = 9.2 
Hz, 1H), 2.89 (ddd, J = 14.0, 8.9, 5.2 Hz, 1H), 2.80 (dt, J = 13.9, 8.2 Hz, 1H), 2.21-2.09 (m, 2H), 
2.02-1.89 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 144.7, 140.1, 134.5, 128.9, 128.7, 127.5, 
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126.6, 124.5, 83.1, 57.6, 37.1, 36.1, 30.7; HRMS (ESI) m/z calculated for C17H18N2O5SNa 
[M+Na]+: 385.0834, found 385.0830. 
Para-(trifluoromethyl)phenyl versus phenyl. 
In all cases, the product ratio was established by HPLC analysis of the crude reaction mixture 
(reaction aliquots were filtered through a short silica plug with iPrOH into a HPLC vial. Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 4:1 
hexanes/EtOAc as eluent gave oxathiazinane product as a mixture of constitutional isomers. 
Each pure constitutional isomer can be isolated using flash column chromatography on silica (35 
mm fritted glass column, 150 mL SiO2) using 9:1 hexanes/EtOAc à 4:1 hexanes/EtOAc. 
Fe[Pc] conditions: (±)-1-phenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-yl sulfamate S17 (77.5 
mg, 0.200 mmol, 1.0 equiv), [FePc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 
0.020 mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN 
(400 μL, 0.5M) were used. By HPLC analysis of the crude product, γ:γ’ was 4.27 ± 0.12 : 1. 
Run 1: (88.1 mg , 0.229 mmol, 57%), (>5% rsm), γ:γ’ = 4.4:1. Run 2: (84.8 mg, 0.220 mmol, 
55%), (>5% rsm), γ:γ’ = 4.2:1. Run 3 (80.7 mg, 0.209 mmol, 52%), (>5% rsm), γ:γ’ = 4.2:1. 
Average: 55% yield ± 2.4, <5% rsm. 
Mn[Pc] conditions: (±)-1-phenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-yl sulfamate S17 (77.5 
mg, 0.200 mmol, 1.0 equiv), [MnPc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 
0.020 mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN 
(400 μL, 0.5M) were used. By HPLC analysis of the crude product, γ:γ’ was 3.13 ± 0.06 : 1. 
Run 1: (108.3 mg, 0.281 mmol, 70%), (>5% rsm), γ:γ’ = 3.1:1. Run 2: (102.4 mg, 0.266 mmol, 
66%), (>5% rsm), γ:γ’ = 3.2:1. Run 3: (106.2 mg, 0.276 mmol, 69%), (>5% rsm), γ:γ’ = 3.1. 
Average: 69% yield ± 1.9, <5% rsm. 
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Mn[tBuPc] conditions: (±)-1-phenyl-5-(4-(trifluoromethyl)phenyl)pentan-3-yl sulfamate S17 
(77.5 mg, 0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 
(6.9 mg, 0.020 mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 9:1 
C6H6/MeCN (400 μL, 0.5M) were used. By HPLC analysis of the crude product, γ:γ’ was 3.71 ± 
0.12 : 1. 
Run 1: (56.7 mg, 0.147 mmol, 73%), <5% rsm, γ:γ’ = 3.75:1. Run 2: (52.4 mg, 0.136 mmol, 
68%), <5% rsm, γ:γ’ = 3.57:1. Run 3: (55.1 mg, 0.143 mmol, 72%), <5% rsm, γ:γ’ = 3.80:1. 
Average: 71% yield ± 2.6, <5% rsm.  
4-phenyl-6-(4-(trifluoromethyl)phenethyl)-1,2,3-oxathiazinane 2,2-dioxide [S22]. 
 1H-NMR (500 MHz, CDCl3) δ 7.57 (d, J = 8.0 Hz, 2H), 7.40-7.30 (m, 
7H), 4.86-4.76 (m, 2H), 4.42-4.37 (m, 1H), 2.95-2.80 (m, 2H), 2.16-
2.12 (m, 1H), 2.04-1.93 (m, 3H); 13C-NMR (125 MHz, CDCl3) δ 
144.6, 138.0, 129.2, 129.0, 126.4, 125.6 (q, JC-F = 3.8 Hz), 83.0, 58.4, 36.6, 36.2, 30.5. These 
data agree with that previously reported in the literature.6   
6-phenethyl-4-(4-(trifluoromethyl)phenyl)-1,2,3-oxathiazinane 2,2-dioxide [S23]. 
1H-NMR (500 MHz, CDCl3) δ 7.67 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 
8.0 Hz, 2H), 7.31 (dd, J = 8.0, 7.0 Hz, 2H), 7.25-7.19 (m, 3H), 4.90-
4.81 (m, 2H), 4.45 (d, J = 9.0 Hz, 1H), 2.89-2.74 (m, 2H), 2.19-2.11 
(m, 1H), 2.07-1.91 (m, 3H); 13C-NMR (125 MHz, CDCl3) δ 141.8, 140.2, 128.8, 128.6, 126.3 (q, 
JC-F = 3.8 Hz), 83.3, 57.9, 37.0, 36.2, 30.7; IR (thin film, cm-1): 3262, 3029, 2931, 1623, 1497, 
1437, 1419, 1365, 1327, 1191, 1127, 1070, 1018, 918, 879, 756; HRMS (ESI) m/z calculated for 




Para-methylphenyl versus phenyl. 
In all cases, the product ratio was determined by 1H NMR analysis of the 
crude product mixture after reaction work-up. Flash column 
chromatography on silica (35 mm fritted glass column, 75 mL SiO2) 
using 3:1 hexanes/EtOAc as eluent gave oxathiazinane product as a mixture of constitutional 
isomers. Pure constitutional isomers cannot be isolated and as such the 1H NMR spectrum of the 
mixture is provided but not tabulated. 
Fe[Pc] conditions: 1-phenyl-5-(p-tolyl)pentan-3-yl sulfamate S18 (67 mg, 0.200 mmol, 1.0 
equiv), [FePc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 equiv), 
PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (400 μL, 0.5M) were used. 
By 1H NMR analysis of the crude product, γ:γ’ was 1 : 2.38 ± 0.09. 
Run 1: (38.0 mg, 0.115 mmol, 57%), <5% rsm, γ:γ’ = 1:2.30. Run 2: (39.7 mg 0.120 mmol, 
60%), <5% rsm, γ:γ’ = 1:2.37. Run 3: (40.7 mg 0.123 mmol, 61%), <5% rsm, γ:γ’ = 1:2.47. 
Average: 59% yield ± 2.0, <5% rsm. 
Mn[Pc] conditions: 1-phenyl-5-(p-tolyl)pentan-3-yl sulfamate S18 (67 mg, 0.200 mmol, 1.0 
equiv), [MnPc]Cl (12.0 mg,  0.020 mmol, 0.1 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.1 equiv), 
PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 4:1 PhMe/MeCN (400 μL, 0.5M) were used. 
By 1H NMR analysis of the crude product, γ:γ’ was 1 : 1.74 ± 0.05. 
Run 1: (41.0 mg, 0.124 mmol, 62%), <5% rsm, γ:γ’ = 1:1.7. Run 2: (43.3 mg 0.131 mmol, 65%), 
<5% rsm, γ:γ’ = 1:1.72. Run 3: (43.9 mg 0.132 mmol, 66%), <5% rsm, γ:γ’ = 1:1.8. Average: 
64% yield ± 2.0, <5% rsm. 
Mn[tBuPc] conditions: 1-phenyl-5-(p-tolyl)pentan-3-yl sulfamate S18 (67 mg, 0.200 mmol, 1.0 
equiv), Mn(tBuPc)Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 0.10 
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equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (400 μL, 0.5M) were 
used. By 1H NMR analysis of the product mixture, γ:γ’ was 1 : 1.83 ± 0.05. 
Run 1: (45.5 mg, 0.137 mmol, 69%), <5% rsm, γ:γ’ = 1:1.88. Run 2: (44.2 mg, 0.133 mmol, 
67%), <5% rsm, γ:γ’ = 1:1.83. Run 3: (50.0 mg, 0.151 mmol, 76%), <5% rsm, γ:γ’ = 1:1.79. 
Average: 70% yield ± 4.6, <5% rsm.  
Para-methoxyphenyl versus phenyl. 
In all cases, the product ratio was established by HPLC analysis of the crude reaction mixture 
(reaction aliquots were filtered through a short silica plug with iPrOH into a HPLC vial). Flash 
column chromatography on silica (35 mm fritted glass column, 75 mL SiO2) using 30% 
EtOAc/hexanes as eluent gave oxathiazinane product as a mixture of constitutional isomers. Pure 
major constitutional isomer can be isolated as a white solid using flash column chromatography 
on silica (35 mm fritted glass column, 75 mL SiO2) using 9:1 hexanes/EtOAc à 3:1 
hexanes/EtOAc as eluent. The minor constitutional isomer was always isolated as a mixture with 
the major product. 
Fe[Pc] conditions: 1-(4-methoxyphenyl)-5-phenylpentan-3-yl sulfamate S19 (70.0 mg, 0.200 
mmol, 1.0 equiv), [FePc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv), and 4:1 PhMe/MeCN (400 µL, 0.5M) 
were used. By HPLC analysis of the crude product, γ:γ’ was 1 : 10.57± 0.50. 
Run 1: (38.4 mg, 0.111 mmol, 55%), <5% rsm, γ:γ’ = 1:11.1. Run 2: (39.2 mg, 0.113 mmol, 
56%), <5% rsm, γ:γ’ = 1:10.5. Run 3: (40.2 mg, 0.116 mmol, 58%), <5% rsm, γ:γ’ = 1:10.1. 
Average: 56% yield ± 1.2, <5% rsm. 
Mn[Pc] conditions: 1-(4-methoxyphenyl)-5-phenylpentan-3-yl sulfamate S19 (70.0 mg, 0.200 
mmol, 1.0 equiv), [MnPc]Cl (12.0 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 0.020 mmol, 
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0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv), and 9:1 C6H6/MeCN (400 µL, 0.5M) 
were used. By HPLC analysis of the crude product, γ:γ’ was 1 : 7.47 ± 0.25. 
Run 1: (41.1 mg, 0.118 mmol, 59%), <5% rsm, γ:γ’ = 1:7.2. Run 2: (42.9 mg, 0.123 mmol, 
62%), <5% rsm, γ:γ’ = 1:7.7. Run 3: (44.8 mg, 0.129 mmol, 64%), <5% rsm, γ:γ’ = 1:7.5. 
Average: 62% yield ± 2.5, <5% rsm. 
Mn[tBuPc] conditions: 1-(4-methoxyphenyl)-5-phenylpentan-3-yl sulfamate S19 (70.0 mg, 
0.200 mmol, 1.0 equiv), [Mn(tBuPc)]Cl (16.6 mg, 0.020 mmol, 0.10 equiv), AgSbF6 (6.9 mg, 
0.020 mmol, 0.10 equiv), PhI(OPiv)2 (163 mg, 0.400 mmol, 2.0 equiv) and 9:1 C6H6/MeCN (400 
μL, 0.5M) were used. By HPLC analysis of the crude product, γ:γ’ was 1 : 5.68 ± 0.22. 
Run 1: (57.7 mg, 0.166 mmol, 83%), <5% rsm, γ:γ’ = 1:5.44. Run 2: (56.6 mg, 0.163 mmol, 
82%), <5% rsm, γ:γ’ = 1:5.86. Run 3: (52.5 mg, 0.151 mmol, 75%), <5% rsm, γ:γ’ = 1:5.74. 
Average: 80% yield ± 4.0, <5% rsm.  
(±)-6-(4-methoxyphenethyl)-4-phenyl-1,2,3-oxathiazinane 2,2-dioxide [S24]. 
Product was isolated as a white solid. 1H NMR (500 MHz, CDCl3) δ 
7.33-7.30 (m, 2H), 7.26-7.20 (m,5H), 6.92-6.90 (m, 2H), 4.87-4.82 
(m, 1H), 4.72 (ddd, J = 12.0, 8.7, 2.8 Hz, 1H), 4.13 (d, J = 9.2 Hz, 
1H), 3.81 (s, 3H), 2.87 (ddd, J = 14.1, 9.1, 5.2 Hz, 1H), 2.77 (ddd, J = 13.9, 8.9, 7.6 Hz, 1H), 
2.18-2.10 (m, 1H), 2.02-1.91 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 160.0, 140.4, 130.2, 128.8, 
128.7, 127.7, 126.5, 114.6, 83.2, 57.8, 55.5, 37.2, 36.4, 30.8. These data agree with that 






Hammett Study Data Analysis: 
Least Squared (LS) Regression was performed on each catalyst with 13 data point sets (3 
runs for each of the 4 substrates and (0,0)). Analysis of the Hammett ρ values is listed in the 
following table. These data were obtained in Excel with LINEST function. 
 
Table 3. Hammett Study Result Summary 
Catalyst ρ from LS SD (ρ) ρ Value 
[Mn(tBuPc)] -0.883 0.025 -0.883 ± 0.025 
[MnPc] -0.876 0.046 -0.876 ± 0.046 
















Table 4. Raw Data for [FePc] 
Substrate σ + γ:γ’ kAr/kH log(kAr/kH) 
NO2 0.79 5.02:1 0.1992 -0.7007 
NO2 0.79 5.58:1 0.1792 -0.7466 
NO2 0.79 5.41:1 0.1848 -0.7332 
CF3 0.61 4.4:1 0.2273 -0.6435 
CF3 0.61 4.2:1 0.2381 -0.6232 
CF3 0.61 4.2:1 0.2381 -0.6232 
Me -0.31 1:2.30 2.3000 0.3617 
Me -0.31 1:2.37 2.3700 0.3747 
Me -0.31 1:2.47 2.4700 0.3927 
OMe -0.78 1:11.1 11.1000 1.0453 
OMe -0.78 1:10.5 10.5000 1.0212 
OMe -0.78 1:10.1 10.1000 1.0043 











Table 5. Raw Data for [MnPc] 
Substrate σ + γ:γ’ kAr/kH log(kAr/kH) 
NO2 0.79 3.07:1 0.3257 -0.4871 
NO2 0.79 3.4:1 0.2941 -0.5315 
NO2 0.79 3.31:1 0.3021 -0.5198 
CF3 0.61 3.1:1 0.3226 -0.4914 
CF3 0.61 3.2:1 0.3125 -0.5051 
CF3 0.61 3.1:1 0.3226 -0.4914 
Me -0.31 1:1.7 1.7000 0.2304 
Me -0.31 1:1.72 1.7200 0.2355 
Me -0.31 1:1.8 1.8000 0.2553 
OMe -0.78 1:7.2 7.2000 0.8573 
OMe -0.78 1:7.5 7.5000 0.8751 
OMe -0.78 1:7.7 7.7000 0.8865 











Table 6. Raw Data for [Mn(tBuPc)] 
Substrate σ + γ:γ’ kAr/kH log(kAr/kH) 
NO2 0.79 3.93:1 0.2545 -0.5944 
NO2 0.79 3.97:1 0.2519 -0.5988 
NO2 0.79 4.11:1 0.2433 -0.6138 
CF3 0.61 3.80:1 0.2632 -0.5798 
CF3 0.61 3.75:1 0.2667 -0.5740 
CF3 0.61 3.57:1 0.2801 -0.5527 
Me -0.31 1:1.79 1.7900 0.2529 
Me -0.31 1:1.83 1.8300 0.2625 
Me -0.31 1:1.88 1.8800 0.2742 
OMe -0.78 1:5.74 5.7400 0.7589 
OMe -0.78 1:5.86 5.8600 0.7679 
OMe -0.78 1:5.44 5.4400 0.7356 
H 0 1.00:1 1.0000 0.0000 
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CHAPTER 2: CHEMOSELECTIVE C—H HYDROXYLATION IN AROMATIC 
MOLECULES WITH MANGANESE CATALYSTSb 
 
2.1 Introduction 
Atomistic change from a C(sp3)—H to C(sp3)—O can greatly impact the physical and 
biological activity of pharmaceutical molecules.1,2 As small molecule pharmaceuticals are 
comprised with increasingly more aliphatic scaffolds, late-stage functionalization reactions on 
aliphatic C—H bonds afford powerful strategies in drug discovery processes by avoiding lengthy 
de novo synthesis of lead compound derivatives and metabolites.3,4,5 Despite significant advances 
has been made in site-selective aliphatic C—H hydroxylation during the past decades, none of 
these stoichiometric oxidants and small molecule catalysts are capable of hydroxylating strong 
methylene C—H bonds (BDE ~98 kcal/mol) while maintaining compatible with a wide range of 
aromatic groups.6,7,8,9,10,11,12,13 Unlike C—H amination, alkylation and halogenation proceed via 
lower energy metallonitrene and metallocarbene intermediates that enabled higher 
chemoselectivity for p-functionalities,14,15,16,17 the high energy methylene C—H hydroxylation 
via metal oxos has been demonstrated to be only compatible with aromatic groups with strong 
electron withdrawing substitutions (that is nitro, trifluoromethyl and triflate with >0.5 sp 
values).11,12 Only in the oxidation of weaker 3º (BDE ~96 kcal/mol) and benzylic C—H (BDE 
~85 kcal/mol, Figure 5.c) that stoichiometric small molecule oxidant TFDO 
(methyl(trifluoromethyl)dioxirane)18 and small molecule ruthenium6 and manganese8,9 catalyst 
have been demonstrated to tolerate benzoate and phenyl functionality in few isolated cases. 
These current state-of-the-art studies are in accordance with the long-standing inverse correlation 
                                               
b The material in this chapter is adapted from Zhao, J.; Nanjo, T.; de Lucca, E. C., Jr.; White, M. C. Nat. Chem. 
2019, 11, 213 and unpublished works. 
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within C—H functionalizations that in order to divert the undesired oxidation of the labile 
aromatic p-functionality, the ability toward strong 2º aliphatic C—H bonds oxidation must be 
reduced. The only catalyst that is known to be capable of hydroxylating strong 2º C—H bond 
while maintaining compatibility with aromatic functionalities is the iron enzymes using an 
approach restriction strategy19 to keep the oxidative labile p-functionality away from active 
oxidant iron oxo (Figure 5.a and b); however this supramolecular approach to achieve 
chemoselective has not been successfully mimicked in laboratory settings with small molecule 
catalysts. The challenges related to use P450 enzymes in preparative scales also limit the 
potential of this enzymatic approach. 
Herein I describe the discovery of a combination of small molecule catalyst Mn(CF3-
PDP) 32 (Figure 5.d) and chloroacetic acid additive that for the first time achieve a combination 
of high chemoselectivity, i.e. tolerates aromatics, and high reactivity, i.e. hydroxylates aliphatic 
methylene C—H bonds- in the absence of directing groups or molecular recognition elements. 
Remote 2º oxidation with preparative reactivity are demonstrated in a total of 50 aromatic 
substrates housing pharmaceutically important oxygen, nitrogen, halogen and biaryl moieties. 
Mn(CF3-PDP) 32 provides a powerful approach for late-stage derivatizations on remote 2º C—H 
bonds to install oxygen functionalities as demonstrated in 4 drug molecules, including an 
ethinylestradiol scaffold example where previous known small molecule oxidants that tolerate 
benzoate aromatic groups can only effect oxidation on the doubly activated 3º benzylic sites. 
Mn(CF3-PDP) 32 can potentially serve as a general approach for medicinal chemists to quickly 
identify and access drug metabolites, as demonstrated with piragliatin, where the metabolite is 

















































































A chemoselective small molecule catalyst capable of strong 
methylene C—H bond oxidations in the presence of the more 
oxidatively labile π-functionality of aromatic groups was previously 
unknown. a. Cytochrome P450 enzymes (CYPs) achieve such 
chemoselective oxidation of methylene C—H bonds by restricting 
the substrate’s approach to the iron oxidant, however these 
enzymes are challenging to use preparatively. b. The two major 
pathways of aromatic oxidation with the iron(oxo) oxidants 
generated in CYPs are electron transfer (top) or epoxidation 
followed by hydride shift (e.g. the “NIH shift”, bottom). c. Small 
molecule catalyst Mn(CF3-PDP) 32 achieves chemoselective 
hydroxylation of strong methylene C—H bonds in presence of 
aromatic functionalities. This reactivity is orthogonal to other 
oxidants that perform weaker bond oxidations (for example benzylic 
C—H) in the presence of aromatic functionality as demonstrated 
with an ethinylestradiol derivative (the site of oxidation is 
highlighted in yellow). d. The crystal structure of the Mn(CF3-
PDP)Cl2 precatalyst shows the bulky ligand framework thought to 
be critical for the high chemoselectivity achieved with Mn(CF3-PDP)
(CH3CN)2•(SbF6)2 catalyst [Mn(CF3-PDP)] 32.
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2.2 Results and Discussion 
2.2.1 Reaction Development 
I started the investigation for developing highly reactive and chemoselective catalyst by 
examining substrate 33 containing remote 2º C—H for oxidation and a mildly electron 
deactivating bromo-substituted aromatic ring. (Table 7) Halogens are estimated to appear in half 
of top selling pharmaceuticals20; however halogenated aromatic rings are rarely demonstrated in 
aliphatic C—H hydroxylation reactions due to their mildly electron deficient nature which still 
suffer significantly from aromatic oxidation and yielding low chemoselectivity. Stoichiometric 
oxidant TFDO was evaluated under -20 ºC condition that was reported to prevent free radical 
formation18 (Entry 1) and at 0 ºC with elevated oxidant loading to force the reaction21 (Entry 2). 
Only the forcing condition yielded an observable amount of desired 2º oxidation product 34 
(11%) however with only 18% chemoselectivity suggesting aromatic oxidation predominated. 
Ruthenium catalysts reported to be compatible with benzoate functionality in the oxidation of 
weak benzylic and tertiary C—H bonds were evaluated; both [Ru(Me3TACN)]7 and cis-
[Ru(dtbyp)2Cl2]5 were not effective to result appreciable oxidation on stonger methylene C—H 
bonds (Entry 3, 4). In contrast, manganese catalyst including Mn(OTf)2/bipyridine7 and 
Mn(PDP)(OTf)26 were evaluated under reported conditions for C(sp3)—H hydroxylation and 
resulted desired oxidation product 34 in low yields but with promising level of chemoselectivity 
for the first time (Entry 5, 6). Given these existing stoichiometric oxidant and small molecule 
catalyst were not effective, development of novel catalyst is a necessity. 
Extensive mechanism studies in P450 enzymes housing iron oxo center provided 
valuable insights for catalyst design. The two major pathways for aromatic oxidation with P450 
enzymes are single electron transfer at protein aromatic residues to generate radicals22 and NIH 
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shift which proceed through aromatic epoxidation followed by hydride shift to generate 
phenols23. Switching from iron to manganese in C—H amination proceed via high valent 
metallonitrene intermediate has been demonstrated to significiantly alter the catalyst’s reactvity 
and chemoselectivity.14 The lower reduction potential in manganese porphyrins relative to the 
iron counterpart24 may attenuate the electron transfer pathway of aromatic oxidation and 
encouraged me to inverstigate manganese catalysts and to compare with Fe(PDP) that has been 
demonstrated to hydroxylate strong 3º and 2º C—H bonds with stereospecificity and high site-
selectivity13. Fe(PDP)(SbF6)2 35, thought to proceed via iron oxo intermediate13, gives low yield 
and low chemoselectivity favoring oxidation on the more labile aromatic ring as expected (Entry 
7). The manganese counterpart Mn(PDP)(SbF6)2 36 gives enouring result with a promising level 
chemoselectivity (Entry 8, 9% yield, 59% chemoselectivity). Switching to the slow addition 
protocal from the iterative addition protocal gives similar chemoselectivity and significantly 
higher reactivity but still not at a synthetic useful level (Entry 9, 36% yield).  
Epoxidation of the relatively electron-deficient and sterically demanding p-system25 of 
aromatic ring, which is the first step of the NIH shift mechanism for aromatic oxidation, will be 
less favored relative to C—H oxidation with a bulky, electrophilic metal oxo species. I 
hypothesized by rationally designing the ligand framework of the catalyst to form a metal oxo 
intermediate with enhanced steric demand compared with Mn(PDP) will further enhance the 
chemoselectivity. Fe(CF3-PDP)(SbF6)2 37 has been reported to prefer C—H oxidation on more 
sterically accessible 2º sites over 3º sites12 due to the steric bulky and electronic deficient 
modifications on the ligand framework13. Both Fe(CF3-PDP) 37 and its manganese counterpart 
Mn(CF3-PDP)(SbF6)2 32 were evaluated and I was delighted to see while they both gave inferior 
yield of desired 2º oxidation than Mn(PDP) 36 (Entry 10, 11), improved chemoselectivity were 
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obtained in both cases compare to the PDP ligand framework (Entry 7, 8). Importantly, Mn(CF3-
PDP) 32 for the first time gave excellent 95% chemoselectivity (Entry 11) despite the relative 
low yield, which was subject to further optimization. 
Bronsted acid and Lewis acid additives have previously been shown to modulate the 
reactivity and selectivity of metal oxo species26,27,28. Specifically, acetic acid has been 
demonstrated to enhance the reactivity of olefin epoxidation27 and C—H hydroxylation10 with 
nonhaem iron catalysts, probably by delivering a proton to H2O2 and binding to iron center to 
facilitate the formation of the presumed iron oxo carboxylate intermediate13. Compelling 
evidence for carboxylate as auxiliary ligand for Fe(PDP) is demonstrated where altered site-
selectivity to electronically and sterically unfavored sites can be observed with carboxylic acid 
containing substrates in Fe(PDP) catalyzed C—H hydroxylation28. To probe this effect with 
Mn(CF3-PDP) 32, I investigated into a series of electron deficient carboxylic acid additives to 
increase the electrophilicity of the presumed manganese oxo intermediate and to potentially lead 
to higher reactivity. While both chloroacetic acid and dichloroacetic acid significantly increased 
the reactivity with Mn(CF3-PDP) 32 and yielded synthetic useful level of reactivity (Entry 12, 
13), only chloroacetic acid condition maintained the high chemoselectivity of 90% (Entry 12). 
Interestingly, Mn(PDP) 36 did not have the same beneficial effect for the oxidation of strong 2º 
C—H bonds (Entry 14). Modification on addition protocal by cooling the reaction from room 
temperature to 0 ºC and increasing the loading of oxidant H2O2 and chloroacetic acid additive, 
the catalyst loading can be significant lowered from 25 mol% to 10 mol% (Entry 15). Control 
experiments were conducted and compared to the optimal condition. Both Mn(PDP) 36 and 
Fe(CF3-PDP) 37 gave significantly inferior results (Entry 16, 17) suggesting the catalyst played a 
key part for the optimal reactivity. Swapping chloroacetic acid back to acetic acid resulted 
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lowered reactivity and chemoselectivity, highlighting the importance of acid additive (Entry 18). 
Combined, these results showcased a synergetic effect between catalyst and acid additive to 
furnish this unprecedented combination of high reactivity for strong 2º C—H bonds and high 
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5 Mn(OTf)2, 0.1%;bipy, 1% —
AcOOH
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c 94%




10 equiv. 0 ºC
c 85%
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3 (6) equiv. 0 ºC
N.D. 
(18%)
1 — trace— TFDO3 equiv. -20 ºC N.D.











4 cis-Ru(dtbpy)2Cl2 (5%) —
H5IO6


















Isolated yields are an average of two (TFDO) or three (all catalytic reactions) runs.
TFDO, Methyl(trif luoromethyl)dioxirane; Me3TACN, N,N',N''-tr imethyl-1,4,7-
triazacyclononane; CAN, ceric ammonium nitrate; dtbpy, 4,4’-di-tert-butyl-2,2’-bipyridine; 
bipy, 2,2'-bipyridine; PDP, 1,1'-bis(pyridin-2-ylmethyl)-2,2'-bipyrrolidine; CF3-PDP, 1,1'-
bis((5-(2,6-bis(trifluoromethyl)phenyl)pyridin-2-yl)methyl)-2,2'-bipyrrolidine; RT, room 
temperature. SbF6- [hexafluoroantimony(V)] is used as counterion for catalyst 32, 35-37.
aIterative addition protocol; see ref. 9. bSlow addition protocol. cSingle catalyst addition 
(method A), standard procedure for Mn(CF3-PDP) 32 used unless otherwise noted: 
substrate (0.3 mmol) with Mn(CF3-PDP) 32 (0.03 mmol) and ClCH2CO2H (4.5 mmol) 
dissolved in MeCN (0.6 mL) maintained at 0 ºC, a solution of H2O2 (50% wt., 3.0 mmol) in 
MeCN (3.75 mL, 0.8 M) was added via syringe pump over 3 hours.
76 
 
2.2.2 Substrate Scope with Mn(CF3-PDP) 
To evaluate the scope of aromatic groups that can be compatible with Mn(CF3-PDP) 
catalyzed 2º C—H oxidations, I started by evaluating with a series of substrates with identical 
aliphatic sites but with aromatic groups bearing electronic and sterically varied substitutions. A 
phenyl substituted cyclopentane substrate gave low yield of 38 with low chemoselectivity due to 
competitive aromatic oxidation. For substrate bearing an electron rich but sterically demanding 
tert-butyl substitution, significant improvement in chemoselectivity was observed and resulted a 
synthetic useful 65% yield 39. This improvement was consistent with the hypothesis that 
aromatic p-oxidation is more sterically demanding than aliphatic C—H oxidation. The trend that 
electron rich and sterically accessible unsubstituted aromatic rings are more susceptible to 
aromatic oxidation is also observed with P450 enzymes, which could explain why most aromatic 
rings in pharmaceutical compounds are substituted with electron deactivating groups such as 
halogens20. Mildly electronic deactivating bromine (sp = 0.23, 34, 86%, Table 7, entry 15), 
chlorine (sp = 0.23, 40, 81%) and even fluorine (sp = 0.06, 41, 56%) substituted aromatic rings 
were well tolerated and gave synthetic useful yields of methylene oxidation products. The 
resonance electron donation from the aniline moiety can be effectively tuned down by the 
phthalimide protecting group and to diminish aromatic oxidation to afford 2º oxidation product 
42 in 63% yield. Due to the hyperconjugative activation by the alcohol after the first oxidation 
on methylene sites, Mn(CF3-PDP) usually oxidize 2º sites to ketones. The site-selectivity of 
Mn(CF3-PDP) followed the reported site-selectivity rules13 established with iron catalysts and 
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NPhth 42, 63%  (78%)
45, 84% (95%)
cat. 37b: 28% (30%)
46, 72% (90%)
cat. 37b: 55% (60%)
44, 66% (82%)














54, 82% (91%)  3:1 δ:γ
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MeCN, 0 °C, 3 hours






R =H 64, 0%   (0%)













R = CH3 67, 35% (42%)




X =CO2Me 69, 52% (57%)













Aromatic substrates with multiple substitutions of varied electronic and steric properties
Method A is used unless otherwise noted. Isolated yields are average of two-three runs. Site of oxidation is highlighted in yellow. Chemoselectivity (2º C—H [O]/total conversion) in 
parenthesis. NPhth, phthalimide; N(4-NO2Phth), 4-nitrophthalimide. aIterative catalyst addition protocol (method B): a total of 15 mol% Mn(CF3-PDP) 32 was added in 3 portions (5 mol%, 3 
times). See methods section for more details. b25 mol% Fe(CF3-PDP) 37, slow addition protocol (ref. 28). cStarting material recycled once. dRatios are statistically corrected. e7% 























The high chemoselectivity was not simply limited to aromatic with para-substitutions; 
compounds with meta-ester (43) or meta-difluoro substitutions (44) gave high yields of 2º 
oxidation. When aromatic rings were substituted with strong electron deactivating groups such as 
esters and nitriles that were somewhat tolerated with the previously reported Fe(CF3-PDP) 
catalyst, excellent chemoselectivities and yields for remote oxidation were observed (45, 46). In 
sharp contrast with Mn(CF3-PDP), Fe(CF3-PDP) routinely gave significant lower 
chemoselectivity under the reported optimal condition, even when stronger electron-deactivating 
groups were incorporated to aromatics (43-46). Substrates with trifluoromethyl and 
difluoromethyl protected phenols, which are increasingly being used in pharmaceuticals due to 
their special pharmacokinetics and physical properties, were effectively oxidized with Mn(CF3-
PDP) to afford 2º oxidation products 47 and 48 in good yields. Substrates containing common 
motifs in drug molecules such as primary amine masked with phthalimide, isobenzofuranone and 
oxindole seen in fluorescein an sunitinib, were examined with Mn(CF3-PDP). I was delighted to 
see satisfactory chemoselectivities and preparative yields can be obtained across the board (60% 
for 49, 62% for 50 and 52% for 51). 
Spirocyclic structures were not uniquely effective to be oxidized with Mn(CF3-PDP). I 
next investigated into substrates bearing various modes of aliphatic connections. Aromatic 
substrates containing cycloalkyl moieties and linear aliphatic chains afforded good yields for 
remote 2º oxidation (64% for 52, 61% for 53, 82% for 54). Tertiary C—H at b-position of 52 
was both electronically disfavored due to the sulfonyl and sterically disfavored; no 3º alcohol 
oxidation product was observed with Mn(CF3-PDP). The electrophilic nature of the presumed 
manganese oxo carboxylate intermediate favored the oxidation on the more electron rich d-site 
over the proximal g-site to afford d-ketones as the exclusive (53) or major (54) product. 
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To move away from the traditional, sp2 carbon rich planar structure and gain access to 
novel chemical space with novel physicochemical and biological properties, small sized 
carbocycles are being increasingly incorporated into pharmaceutical compounds.29 Substrate 
with a cyclohexyl ring was oxidized at both d and g sites with good reactivity (55, 64%) however 
poor site-selectivity (1:1) due to the competing factors in determining site-selectivity: d site was 
electronically preferred while g site was favored stereoelectronically due to the relief of 1,3-
diaxil strain11,13. Despite cyclobutyl moieties are widely found in natural products and sometimes 
in pharmaceuticals, intermolecular C—H functionalization on cyclobutyl ring moiety is very rare 
due to the partial sp2 character of the C—H bonds. I was delighted to see the methylene site in 
the cyclobutyl ring was effectively oxidized with Mn(CF3-PDP) to give 57% yield as a single 
regioisomer (56). The high reactivity toward strong remote 2º C—H bonds and the high 
chemoselectivity with a wide range of aromatic rings were maintained in a series of bioactive 
biaryl molecules, further highlighting the utility of this methodology with Mn(CF3-PDP). The 
exciting reactivity on cyclobutyl group was maintained in a pesticide proclonol analogue to 
afford methylene oxidation product 57 with 52% yield and 4:1 site selectivity. Derivative of 
vitamin K antagonist chloridione gave remote oxidation product 58 with 60% yield at d-site as a 
single isomer. Non-steroidal anti-inflammatory drug ketoprofen derivative was oxidized at the 
cyclopentyl ring to afford 52% yield of ketone products 59 with 9:1 d:g selectivity. 
Importantly, similar to Fe(PDP) and Fe(CF3-PDP) that proceed through presumed metal 
oxo carboxylate intermediates, the site-selectivity with Mn(CF3-PDP) catalyst was not solely 
based on the bond dissociation energy of C—H bonds. Rather, these catalysts were capable to 
interpret the physical organic properties of C—H bonds including electronic, steric and 
stereoelectronic, with different weight on each property based on the ligand structure of the 
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catalyst.13 It has been demonstrated that the site-selectivity can be predicted based on these 
properties both qualitatively10,11 and quantitatively12. To highlight, substrate with 3 types of 
different sites possible for oxidation was examined (precursor of 60): the 2º benzylic site 
proximal to ketone, the 3º site and the remote 2º site. Based on the electrophilic and sterically 
demanding nature of Mn(CF3-PDP) catalyst, site-selectivity can be rationally predicted: the 
benzylic site was electronically disfavored by the electronically deactivating ketone group, the 3º 
site was sterically disfavored and the oxidation should favor the remote methylene sites. Indeed, 
with Mn(CF3-PDP) I observed 53% yield on the remote methylene sites despite having highest 
BDEs among the possible sites (60); no benzylic or 3º oxidation products were isolated in this 
reaction. To further highlight the orthogonal site-selectivity between Mn(CF3-PDP) and existing 
methods, I examined both cyclic and linear substrates where oxidation on the weaker 3º C—H 
bond was favored as the major (61) or exclusive (62) product with existing electrochemical 
radical21 and TFDO18 oxidation methods. I was delighted to see with Mn(CF3-PDP) the more 
sterically accessible methylene sites were favored in both cases. Unlike existing manganese 
catalyst8,9 that has been reported to give low yields with cyclopropane containing substrates, 
Mn(CF3-PDP) effectively oxidized the stereoelectronically activated a-position with a 54% 
combined yield (63) and with no detectable ring-opening products. 
Many pharmaceutically important molecules contain aromatic groups bearing multiple 
substitutions of varied electronic and steric properties and I next investigated into substrates with 
multi-substituted aromatics. While electron donating tert-butoxyl substitution lead to aromatic 
oxidation (64), the addition of a mildly electron deactivating chlorine group significantly 
improved the chemoselectivity and gave synthetic useful 73% yield (65). Same aromatic group 
with alternative topology by extending the cyclopentane by 1 carbon was also effectively 
81 
 
oxidized to afford 54% yield (66) however lowered site-selectivity. Switching from Ot-Bu to 
OMe lead to a lower chemoselectivity possibly due to competitive ethereal oxidation (67). 
Consistent with the hypothesis of unproductive ethereal oxidation, the deuterated analogue 
afforded higher chemoselectivity and higher yield (68). When phenol was protected with 
strongly electronic deactivating triflate group, ethereal and benzylic C—H bonds at the ortho 
positions were shielded from oxidation: higher chemoselectivity were observed in 69 and 70 lead 
to synthetic useful level of remote 2º yield. Alternatively, when the oxidative labile ethereal C—
H bonds were replaced by C—F bonds in the difluorobenzodioxole substrate, a common strategy 
for pharmaceutical compounds, both the ethereal and the aromatic group were shielded from 
oxidation and a 55% remote oxidation yield could be observed with 76% chemoselectivity (71). 
Our group has previously reported a HBF4 protection strategy30 to enable C—H oxidation 
of basic nitrogen containing substrates with iron catalysts. Quick glance of pharmaceutical 
molecules shows the combination of basic nitrogen containing heterocycles (pipyridines, 
pyridines, imidazoles, etc.) and mildly deactivated aromatics (halogens, etc.) are ubiquitous31. I 
next investigated into using this HBF4 strategy with Mn(CF3-PDP) to enable remote 2º C—H 
oxidation on these commonly found structures (Figure 6.a). 4-Arylpipyridine and benzyl-derived 
piperidine have been demonstrated to be privileged structures in pharmaceuticals with opioid 
analgesics and cognition enhancing activities, for example ketobemidone and donepezil. 
Substrates containing these structures were well tolerated and gave good yields for remote 2º 
oxidation product (72 - 74). In the absence of HBF4, no desired product was observed indicating 
the chloroacetic acid additive in the reaction alone was not capable to protonate the basic amine 
and shield it from binding to the catalyst. Haloperidol analogue with piperidine structure and 4-
fjuorophenyl butyl ketone pharmacophores was oxidized with Mn(CF3-PDP) in 84% yield (75). 
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Similar to piperidines, pyridine moieties were also well compatible with Mn(CF3-PDP) using 
HBF4 protonation strategy. Substrates bearing 1,1-disubstituted pyridine-aryl pharmacophore 
(76) and 4-chlorophenyl pyridine biaryl core (77) were effectively oxidized afforded good yields 
favoring the remote d-position. For the first time, imidazole, benzimidazole and quinoline 
heterocycles were demonstrated to be compatible with metal oxo mediated aliphatic C—H 
hydroxylation reactions to give good yields of remote ketone products (78 – 80). Despite less 
basic than piperidine, HBF4 protection is still necessary to shield these heterocycles from 
deactivating the Mn(CF3-PDP) catalyst. Importantly, Fe(CF3-PDP) failed to give any appreciable 
amount of the desired remote 2º oxidation products (78 – 80) with low mass balance observed, 
indicating Mn(CF3-PDP) is uniquely effective for enhancing chemoselectivity to prevent 
undesired (hetero)aromatic oxidation. 
Iron catalysts have been demonstrated to perform impressive pre-assembly and post-
assembly oxidative derivatization on amino acids and short peptides to rapidly gain access 
derivatives.32 One limitation with this iron methodology is the only aromatic side chain tolerated 
is the strongly electron deactivating triflate protected phenol (sp = 0.53). To broaden the scope of 
aromatics with the more chemoselective Mn(CF3-PDP) catalyst, I examined a series of dipeptide 
substrates with various mildly deactivated aromatic rings (Figure 6.b). Remote oxidation of 
dipeptide substrates on both linear norleucine residue (81) and cyclopentyl (82) 2º sites were 
performed with high yields tolerating chlorophenylglycin residue with Mn(CF3-PDP) catalysis. 
Similar to non-peptide substrates, the sterically demanding Mn(CF3-PDP) catalyst favored 
oxidation on the more accessible methylene site of isoleucine residue with 9:1 2º:3º ratio and 
44% overall yield (83). N-terminal proline dipeptides containing halogenated phenylalanine and 
easily removable pivalate protected tyrosine residues were compatible with Mn(CF3-PDP) to 
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afford the synthetic versatile 5-hydroxyl functionality onto the proline residue in good yields (84 
- 87). The improved chemoselectivity provideed a strategical advantage in synthesis. 
Bromophenyl group in 88 now tolerated with Mn(CF3-PDP) during C—H oxidation can serve as 
p-nucleophile to cyclize with the N-acyl iminium generated from the 5-hydroxylproline 
oxidation intermediate intramolecularly to afford the tricyclic tetrahydroisoquinoline derivative 
89 in 46% overall yield over 2 steps. Impressively, previously reported Fe(CF3-PDP) still gave 
predominant aromatic oxidation and only afforded trace yields (81, 86, 87) even at 


















Figure 6. Chemoselective Methylene C—H Oxidation with Mn(CF3-PDP) 
 
 
2.2.3 Late-Stage Oxidation with Mn(CF3-PDP) on Pharmaceuticals and Complex Natural 
Products 
A wide range of aromatic and heteroaromatic moieties have been demonstrated to be 
tolerated with Mn(CF3-PDP) with excellent chemoselectivity and high reactivity for the 



















80, 84% 4:1 δ:γ
no HBF4c: <5%
cat. 37d: <5%
79, 55%e 10:1 δ:γ
no HBF4c: <5%
cat. 37d: <5%
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a. Mn(CF3-PDP) 32 catalyzed remote 2º C—H oxidation in the presence of aromatic functionality with basic nitrogen containing heterocycles or 
heteroaromatics. b. Mn(CF3-PDP) 32 oxidation of peptides containing amino acids with mildly deactivated aromatic groups. This enables for the first time 
intramolecular functionalizations with arene π-nucleophiles to furnish medicinally relevant tricyclic cores. Isolated yields are average of two-three runs. 
Site of oxidation is highlighted in yellow. Ns, 4-nitrophenylsulfonyl. aHBF4•OEt2 protected as described in ref. 30 followed by slow catalyst addition 
protocol (method C): both H2O2 (10 equiv.) and Mn(CF3-PDP) 1 (10 mol%) were simultaneously added over 3 hours. See experimental section for more 
details. bMethod C used at 0 ºC. cWithout HBF4 complexation under optimal condition with 32. d25 mol% Fe(CF3-PDP) 37, slow addition protocol (ref. 
30). eMethod B used. fStarting material recycled once. gMethod A used with AcOH (15 equiv.) and H2O2 (5.0 or 7.5 equiv.) at -36 ºC. hCrude hemiaminal, 
TfOH (2.0 equiv.), 90 ºC, 2 hours.
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oxidation of strong remote methylene C—H bonds. This unique amalgamation of reactivity and 
chemoselectivity of Mn(CF3-PDP) enabled a powerful strategy to oxidatively derivatize complex 
pharmaceutically related compounds at late-stage to impact their physical and biological 
activities. (Figure 7.a) A hexanoyl derivative of efavirenz 90, a WHO essential drug for treating 
HIV-1, housing both aromatic rings and oxidative labile alkyne p-functionalities was examined 
with Mn(CF3-PDP). Excellent level of chemoselectivity was obtained to give remote oxidation 
product 91 in 58% yield and 3:1 site-selectivity. No oxidation on aromatic ring or alkyne 
moieties were observed in this reaction. A g-secretase modulator analogue 92 housing two 
aromatic groups and a tertiary amine underwent effective remote methylene oxidation with 
Mn(CF3-PDP) using the HBF4 protection strategy. Remote d-ketone 93 was isolated as the single 
product in 55% yield. Importantly, the doubly activated tertiary benzylic site a to nitrogen, 
which is susceptible to oxidation with TFDO and radical mediated reactions, was not touched in 
the Mn(CF3-PDP) catalyzed oxidation; no epimerized product was observed. Top selling 
antidepressant drug citalopram 94 housing two aromatic rings and a tertiary amine was oxidized 
at the activated benzylic position to give hemiacetal intermediate. Previous iron catalysts have 
been demonstrated to effectively generate hemiaminals32; however hemiacetal formation has not 
been described, probably due to the high reactivity with iron catalyst quickly lead to a second 
oxidation from a hemiacetal to a carbonyl. With BF3•OEt2 the hemiacetal intermediate was 
transformed to oxocarbenium. Followed by functionalization with electron-rich 2-napthol, I was 
able to generate the arylated derivative 95 in 42% yield. 
Oxidative metabolism of C—H hydroxylation via P450 enzymes on pharmaceutical 
compounds is a major pathway for drug clearance in vivo; and the identification and structure 
elucidation of these metabolites are important for drug development and safety evaluations.33 
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Priagliatin, a drug candidate for type II diabetes which advanced to clinic trials, was initially 
discovered in in vivo metabolism study (MetID) of the lead compound 96 (Figure 7.b).34 Given 
MetID studies were only capable to generate analytical amounts of the metabolites, the 
piragliatin and all other possible metabolites including its diastereomer and ketone regioisomers 
on the cyclopentyl ring, were independently de novo synthesized with longer step counts than 96 
for purpose of structure confirmation and evaluations for safety and effectiveness. With the 
unprecedented combination of high reactivity and high chemoselectivity of Mn(CF3-PDP), I 
intercepted an advanced intermediate 97, whose acid was used in the last step of lead compound 
96 synthesis, and oxidized with Mn(CF3-PDP) to afford the ketone product in 54% yield at the 
same C3 position as in piragliatin (98, 1:1 d.r.). Further manipulations of the ester moiety 
followed by amide formation with 2-pyrazine resulted piragliatin and its diastereomers in 54% 
yield. This example showcaseed the potential for using Mn(CF3-PDP) catalyzed C—H 
hydroxylation as a powerful strategy to quickly identify and generate aromatic drug metabolites 
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a. Derivatives of the HIV-1 drug efavirenz and a  γ-secretase  modulator  analogue  that house oxidatively sensitive π-functionality such as aryl halides, 
acetylenes, piperidine, and tertiary amines are oxidized with Mn(CF3-PDP) 32 at remote methylene sites in preparative yields. Antidepressant citalopram is 
oxidized to a hemiacetal and arylated with an arene π-nucleophiles via an intermediate oxocarbenium. b. Drug candidate piragliatin, identified as a metabolite 
of drug lead 96, required de novo synthesis to furnish quantities for further evaluation. Mn(CF3-PDP) 32 catalysis enables an advanced lead intermediate to be 
rapidly transformed to piragliatin. c. Sequential Mn(CF3-PDP) 32 catalyzed 2o benzylic/2o aliphatic C—H oxidation of an ethinylestradiol derivative. 2º 
benzylic oxidation can be tuned with oxidant to give ketone 101 or diastereomerically pure alcohol 102 that undergo further diastereoselective C12 β 
methylene hydroxylation to alcohols 104 and 105 (crystal structures confirm the 12β configuration). In contrast, TFDO furnishes oxidation at the doubly 
activated 3º benzylic site. All reactions run with limiting substrate and isolated yields reported as an average (2-3 reactions, using 32). See the experimental 
section for more details. Ac, acetyl; Piv, pivaloyl. a Method A used at 0 ºC. b HBF4•OEt2 protected, ref. 28 followed by method C at 0 ºC. c Method A using 2 
equiv. H2O2; arylation protocol, ref. 32. d LiOH•H2O (5 equiv.); oxalyl chloride (1.1 equiv.); 2-aminopyrazine (2.2 equiv.), pyridine (2.2 equiv.). e Method A 
with modifications: 32 (5 mol%; 2 mol% for gram scale), ClCH2CO2H (7.5 equiv.), H2O2 (10 equiv. for 101 or 2 equiv. for 102), 4:1 MeCN:CH2Cl2 at -36 ºC. 
f Ac2O (2.4 equiv.), NEt3 (2.4 equiv.), CH2Cl2, 86%. g Method A with 4:1 MeCN:CH2Cl2 at 0 ºC. h TFDO: 103 (0.05 mmol) in CH2Cl2 (0.5 mL) at -20 ºC. 
TFDO (0.4 M solution, 0.25 mL, 2 equiv.) added at -20 ºC and stirred for 40 minutes in dark.
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Natural products have historically been an important source of new pharmaceuticals due 
to their wide range of biological activities5,35 and they usually contain aromatic moieties. 
Traditionally, chemical manipulations on these complex molecules are mainly limited to the 
native functional handles. With the unprecedented level of chemoselectivity and reactivity 
observed with Mn(CF3-PDP), I envisioned this methodology can be used to rapidly introduce 
hydroxyl functionalities onto these complex molecules at late-stage and at sites that are remote 
from existing functionalities. Medicinally important steroid such as ethinylestradiol, used as 
oestrogen supplement, containing both oxidative labile aromatic and alkyne functionalities, was 
examined with Mn(CF3-PDP) for a quick, sequential installation of remote alcohol to access 
novel derivatives. In sharp contrast to TFDO that only oxidized the doubly activated 3º benzylic 
site on estrogen structures (99)36, the sterically demanding Mn(CF3-PDP) catalyst diverted the 
site-selectivity to the more sterically accessible 2º benzylic site with high yields. The oxidation 
state of the 2º benzylic oxidation can be controlled by simply controlling the amount of hydrogen 
peroxide oxidant used in the reaction: 10 equivalence of H2O2 fully oxidize the 2º benzylic site to 
afford benzylic ketone 101 in 72% yield (gram scale 74% yield); by reducing H2O2 loading to 2 
equivalence, benzylic alcohol 102 was formed as the major product as a single diastereomer. 
These benzylic functionalized products were further hydroxylated with Mn(CF3-PDP) at remote 
C12 methylene sites to afford C12b alcohol products 104 and 105 as single diastereomers in 
47% and 32% yield, respectively. The C12b alcohol stereochemistry was assigned by 2D NMR 
studies and later confirmed with X-ray crystallography structures. In sharp contrast with 
Mn(CF3-PDP), TFDO treatment on the 2º benzylic OAc functionalized compound 103 still lead 
to the oxidation on tertiary benzylic site to yield 106 in 84% yield; no C12 oxidation or any other 
remote oxidation products were observed within TFDO reaction. Traditionally, hydroxylation on 
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methylene sites of steroid core structures are usually limited to enzymatic oxidation37 and 
directing group approaches38. Despite C12 alcohols occurs in a range of steroidal natural 
products including cholic acid, digoxigenin and polyoxypregnanes, direct access via non-directed 
C—H hydroxylations at this and other methylene positions have only been achieved with PDP-
inspired small molecule catalysts13,39. This sequential late-stage oxidation on ethinylestradiol 
structure suggests Mn(CF3-PDP) may be a powerful tool for quick diversification of aromatic 
natural products. 
 
2.2.4 Gram-Scale Methylene Oxidation with Mn(CF3-PDP) 
It has been a long concern that aliphatic C—H oxidation reactions mediated via metal 
oxo carboxylate intermediate, such as Fe(PDP) and Fe(CF3-PDP) catalysts, are not easily 
scalable to gram scale due to the tricky reaction setup that requires precise manual control of 
oxidant addition10 and in some cases high catalyst loading (25 mol%)30. During the development 
of Mn(CF3-PDP) catalyzed chemoselective methylene C—H oxidation, I focused on developing 
conditions that would friendly for gram-scale oxidation. Syringe pump addition of oxidant was 
utilized for all Mn(CF3-PDP) catalyzed reactions to avoid challenges for reproduce the precise 
manual slow addition. Relatively low catalyst loading (10 mol%) was used for all oxidations on 
strong 2º C—H bonds, including on challenging complex pharmaceutical related substrates. To 
further probe the scalability of Mn(CF3-PDP) catalysis, I performed gram scale oxidations on 
both relative simple molecule as well as on complex pharmaceutical compounds (Table 9). 
Gram-scale oxidation was first examined on a simple substrate with pharmaceutically 
prevalence halogenated aromatic ring with 1-gram substrate (5 mmol scale). Delightly, the 
loading of both Mn(CF3-PDP) catalyst and chloroacetic acid additive can be further reduced by 
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half from standard condition (10 mol% to 5 mol% catalyst, 15 equiv. to 7.5 equiv. additive) with 
only marginally lowed isolated yield for the desired oxidation product 40 (72% yield versus 81% 
yield with standard condition).  
Table 9. Gram-Scale Oxidation with Mn(CF3-PDP) 
 
Probably the most important utility for the Mn(CF3-PDP) catalyzed chemoselective C—
H oxidation is the derivatization of pharmaceutical compounds to access novel derivatives. The 
larger molecule weight, lower solubility and susceptibility for unproductive decompositions of 
these complex pharmaceutical molecules present bigger challenge for Mn(CF3-PDP). I next 
examined the oxidation of HIV-1 drug efavirenz derivative 90 at 2.5-gram scale (6 mmol). By 
reducing the Mn(CF3-PDP) loading from 10 mol% to 5 mol% at the same small scale (0.2 
mmol), slightly lowered conversion is observed (see experimental sections for details); however 
by simply recycling the recovered 90 in the first oxidation and subjecting to identical conditions 
again, an overall 52% yield of remote oxidation product 91 can be obtained, only 6% lower 
compared to standard conditions. However this significantly lowered loading of Mn(CF3-PDP) 




Mn(CF3-PDP) 32 (5 mol%)




















aReaction performed at 1g scale. 7.5 equiv. ClCH2CO2H used. bReaction Performed at 2.5g scale. 
15 equiv. ClCH2CO2H used. Result is an average of two runs. cRecycled 1X.
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Mn(CF3-PDP) catalysis in large scale reactions to obtain large amount of derivatives for further 
biological studies or in case of oxidations on a wide variety of drug candidates. 
 
2.2.5 Chemoselective 3º C—H Oxidations with Mn(PDP) 
The development of Mn(CF3-PDP) catalyst has for the first time demonstrate the 
amalgamation of high reactivity toward strong methylene C—H bonds and high 
chemoselectivity tolerating a wide range of aromatic p-functionalities in aliphatic C—H 
hydroxylation proceed via metal oxos in simple and complex molecule settings. One question 
remained is if this unprecedented high chemoselectivity for a wide range of aromatic groups can 
be maintained in the oxidation of easier 3º C—H bonds. Existing ruthenium5,7 and manganese 
catalysts6,7 showcased isolated examples of preparative 3º C—H oxidation in presence of 
benzoate functionalities; however, the scope of aromatic rings has not been thoroughly 
investigated. To address this limitation, I next investigated into expanding the high reactivity and 
high chemoselectivity in 2º C—H oxidation with Mn(CF3-PDP) to 3º C—H oxidations. 
 As tertiary C—H oxidation is more sterically demanding than 2º oxidation, the CF3-PDP 
ligand framework is less desirable than PDP ligand which provides a wider approach cone12 to 
accommodate the 3º C—H sites. I started by comparing Fe(PDP) and Mn(PDP) with substrate 
housing halogenated aromatic ring and remote 3º C—H (107) under the reported iterative 
addition protocol (Table 10, Entry 1 and 2). Similar to the results in 2º C—H oxidations, the 
Fe(PDP) failed to give desired tertiary C—H oxidation product 108 due to competitive aromatic 
oxidation (Entry 1); significant higher 81% chemoselectivity and 32% yield was observed with 
Mn(PDP) and acetic acid additive (Entry 2). Switching to the single slow addition protocol with 
a 1 hour addition of H2O2 oxidant at room temperature with Mn(PDP) further increase the 
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reactivity to a synthetic useful 52% yield of tertiary alcohol 108 (Entry 3). Cooling the reaction 
from room temperature to -36 ºC further increased the conversion (Entry 4, 5). Acid additives 
has been demonstrated to significantly impact the reactivity of Mn(CF3-PDP) which is thought to 
proceed via a manganese oxo carboxylate intermediate. Similar acid additives effect was also 
observed with Mn(PDP); modestly higher reactivity was observed when switching to 
chloroacetic acid (Entry 6). Extending the oxidant addition time from 1 hour to 3 hours further 
increase the conversion to give 69% 108 while maintain excellent 85% chemoselectivity (Entry 
7), and this condition is used as the optimal condition for 3º C—H oxidation. Fe(PDP) under 
optimal condition still resulted full aromatic oxidation (Entry 8), suggesting the switch from iron 
to manganese accounted for the chemoselectivity improvement. Unlike the more electron 
withdrawing benzoate functionality, less deactivating chlorophenyl moiety was not well tolerated 
with the previously reported ruthenium catalyst5 (Entry 9), indicating the Mn(PDP) may show 













Table 10. Reaction Development for Chemoselective 3º C—H Oxidation with Mn(PDP) 
 
After establishing the optimal condition for 3º C—H hydroxylation with Mn(PDP), I next 
probed into the substrate scope within a general scaffold, focusing on investigating various 
aromatic substitution patterns (Table 11). Substrate with phenyl substitution afforded modest 
35% yield (109); aromatic oxidation was observed with a 35% chemoselectivity. The relatively 
lower energy demand in 3º C—H oxidation compared to stronger 2º C—H may account for the 
higher chemoselectivity observed with 109 relatives to 2º substrate with phenyl substitution 38. 
para-Halogens and medicinally relevant substitutions that are mildly deactivating were effective 











Entry Catalyst (mol%) Additive Oxidant Temperature (ºC) Yield (%)
1 CH3COOH(3X 0.5 equiv.)
H2O2
(3X 1.2 equiv.) RT
a 0Fe(PDP) 35(3X 5%)
Sel. (%)
0
2 CH3COOH(3X 0.5 equiv.)
H2O2
(3X 1.2 equiv.) RT
























c <5%Fe(PDP) 35(10%) <5%
aIterative addition protocal. bSingle catalyst additionprotocal, 1 hour addition. cSingle catalyst 
additionprotocal, 3 hours addition.












3º alcohol products (111 - 115). Aromatic rings were required to be para-substituted; substrates 
with halogen substitutions at meta- and ortho- positions were also tolerated with Mn(PDP) and 
resulted synthetic useful yields (56% for 116, 56% for 117) albeit with slightly lowered 
chemoselectivity. Despite chloroacetic acid was used as suprastoichiometric additive, substrate 
with 3º benzylic alcohol which could be sensitive to acidic conditions afforded 69% yield (118). 
A broader scope of substrates, including basic amine heterocyclic and heteroaromatic containing 
motifs, will examined by me and my co-works with the HBF4 protection strategy30. 
Table 11. Substrate Scope for 3º C—H Hydroxylation with Mn(PDP) 
 
Fe(PDP) and Fe(CF3-PDP) catalysts are hypothesized to generate metal-bound oxidants, 
presumably iron oxo carboxylate intermediates, to mediate C—H hydroxylations via a radical 
abstraction/ fast rebound mechanism.13 The carbon centered radical is thought to be short-lived; 
C—H oxidation with Fe(PDP) and Fe(CF3-PDP) is stereospecific on stereodefined chiral centers 
with no racemization. This mechanism enables several benefits: site-selectivity of C—H 







Mn(PDP) 36 (10 mol%)
ClCH2COOH (15 equiv.)
H2O2 (5 equiv.)





X = H, 109, 35% (37%)
tBu, 110, 60% (67%)
F, 111, 66% (75%)
Br, 112, 67% (79%)
OCF3, 113, 73% (86%)
CO2tBu, 114, 73% (87%)















mediated by long-lived carbon-centered and oxygen-centered radicals; catalyst control on both 
C—H abstraction and functionalization steps. To probe if the novel manganese catalyst 
Mn(PDP) proceed through similar mechanism pathways as iron catalysts, I performed a 
stereoretention study (Figure 8). Under standard conditions, enantiomerically enriched tertiary 
substrate 119 was oxidized with Mn(PDP) to give 3º alcohol 120 in 28% yield as the major 
oxidation product. Importantly, no loss in enantioexcess (e. e.) in 120 was observed suggesting 
manganese catalysts enable C—H hydroxylations in analogous mechanism to the previous iron 
catalyst. Further mechanism studies are necessary for a deeper mechanism understanding of the 
novel Mn(PDP) and Mn(CF3-PDP) catalysts. 




As drug designs are moving away from flat C(sp2) rich structures, aliphatic C(sp3)—H 
scaffolds are increasing being incorporated into aromatic pharmaceutical compounds to access 
novel chemical space. Here I described the discovery of a novel manganese catalyst Mn(CF3-
PDP) that for the first time enabled preparative oxidation on strong 2º C—H bonds with high 
chemoselectivity for aromatic p-functionalities. A wide range of medicinally relevant aromatic 
rings substituted with halogens, oxygen and nitrogen functionalities are well compatible with 
Mn(CF3-PDP) to afford remote aliphatic 2º C—H oxidation products in preparative yields. 












MeCN, -36 ºC, 3 hours
+
97% e.e. 97% e.e.
119 120, 28% 121, 16%
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difference between C—H bonds to achieve site-selectivity in a range of structurally diverse 
compounds. This unprecedented amalgamation of reactivity and chemoselectivity with Mn(CF3-
PDP) can further realize the strategical advantage of late-stage aliphatic C(sp3)—H 
functionalizations on complex aromatic molecules. Late-stage C—H oxidation on complex 
pharmaceuticals are demonstrated with Mn(CF3-PDP) to rapidly access derivatives with novel 
oxidative patterns and verified drug metabolites. Sequential installation of hydroxyl 
functionalities on steroid core structure is demonstrated with an ethinylestradiol substrate to 
obtain the C12b alcohol that is challenging to be accessed with traditional methods. In addition 
to oxidation on strong methylene C—H bonds, preparative 3º C—H oxidation with Mn(PDP) is 
also demonstrated with good chemoselectivity for wide range of aromatics. Similar to previously 
reported iron catalysts, both Mn(PDP) and Mn(CF3-PDP) catalysts are proposed to hydroxylate 
C—H bonds via a presumed metal oxo carboxylate intermediate with C—H abstraction/ fast 
rebound mechanism. The observed stereospecificity and apparent decoupling between site-
selectivity rules and C—H BDEs support this mechanistic hypothesis. Further studies for deeper 
mechanistic understandings of these manganese catalysts will benefit future development of 
aliphatic C—H functionalization catalysts to achieve novel reactivity, chemoselectivity and site-
selectivity. 
 
2.4 Experimental Section 
2.4.1 General Methods 
All C—H oxidations were carried out under air with magnetic stirring, with no 
precautions to exclude oxygen or moisture. All other reactions were performed with oven dried 
or flame dried glassware under inert atmosphere of dry nitrogen or argon. Fe(PDP)10, Fe(CF3-
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PDP)12, (Me3tacn)RuCl37 and cis-[Ru(dtbpy)2Cl2]6 catalysts were synthesized according to 
literature procedures. Preparation of Mn(PDP)(MeCN)2(SbF6)2 and Mn(CF3-
PDP)(MeCN)2(SbF6)2 catalysts are described in section 2.4.2. All catalysts were stored at 0 ºC. 
The catalysts were warmed to room temperature prior to use and weighted out in air. 
Chloroacetic acid was purchased from Sigma-Aldrich and broke into small pieces before use. 
H2O2 (50% wt. aqueous solution) was purchased from Sigma-Aldrich and used as received. 
AgSbF6 used for catalyst metathesis was purchased from Strem Chemicals and stored in the 
glove box to avoid light prior to use. Solvents including THF, DCM, diethyl ether, DMF, toluene 
and benzene were dried by passing through a bed of activated alumina (Glass Contour, Laguna 
Beach, CA). Triethylamine and pyridine were distilled over calcium hydride prior to use. All 
other commercially available reagents were purchased from common sources (e.g. Sigma-
Aldrich, Strem Chemicals, Oakwood, Alfa-Aesar, TCI America, etc.) and were used as received.  
Thin-layer chromatography was conducted with E. Merck silica gel 60 F254 precoated 
plates (0.25 mm) and visualized with UV and/or staining including potassium permanganate, 
ceric ammonium molybdate, or phosphomolybdic acid/cerium sulfate. Flash column 
chromatography was performed as described by Still et. al40 using EM reagent silica gel 60 (230-
400 mesh).  
1H NMR were recorded using a Varian Unity-500 (500 MHz), Varian Unity Inova-500 
(500 MHz), Bruker Avance-500 (500 MHz) and Agilent VNMRS NMR (750 MHz) 
spectrometer, using solvent as internal standard (CDCl3 at 7.26 ppm). Data are reported as: 
s=singlet, d=doublet, t=triplet, q=quartet, p=pentat, oct=octet, m=multiplet, br=broad, 
app=apparent; coupling constants in Hz; integration. Proton-decoupled 13C NMR were recorded 
using a Varian Unity-500 (500 MHz), Bruker Avance-500 (500 MHz) and Agilent VNMRS 
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NMR (750 MHz) spectrometer, using solvent as internal standard (CDCl3 at 77.16 ppm). 19F 
NMR were recorded using a Varian Unity-500 (470 MHz), Bruker Avance-500 (500 MHz) and 
Agilent VNMRS NMR (750 MHz) spectrometer, using external standard (CFCl3 at 0 ppm). High 
resolution mass spectrometry (HRMS) was performed with a Waters Q-TOF Ultima 
spectrometer or Waters GCT Premier EI spectrometer. Optical rotations were obtained using a 
JASCO P2000 polarimeter (cell dimensions: 3.5 X 50 mm) and were reported as [a]DT/ºC 
concentration (c = g/100 mL, solvent). 
 
2.4.2 Synthesis of Manganese Catalysts 
Synthesis and Characterization of Mn(PDP)(MeCN)2(SbF6)2 
(R,R)-Mn(PDP)Cl2 [S25]. 
In a 50 mL recovery flask was charged (2R,2'R)-1,1'-bis(pyridin-2-
ylmethyl)-2,2'-bipyrrolidine ligand (1.0684 g, 3.31 mmol) synthesized 
according to literature procedure10, a stir bar and MeCN (20 mL, 0.166 M). 
Freshly grinded MnCl2•4H2O (purchased from Strem, 655.7 mg, 3.313 
mmol, 1.0 equiv.) was added and the reaction was allowed to stir 
vigorously for 24 hours under nitrogen atmosphere. Fine white solid was formed during the 
course of reaction and there should be no pink non-ligated manganese salt remained. Diethyl 
ether freshly taken from solvent delivery system was added to the reaction to precipitate out the 
complex. The solvent was removed via pipette and the remaining solids were washed thoroughly 
with diethyl ether five times and dried under a stream of dry nitrogen gas overnight to yield 
(R,R)-Mn(PDP)Cl2 (1.3566 g, 3.03 mmol, 91% yield) as white solid. HRMS (TOF ESI+) m/z 












In a flamed dried 100 mL recovery flask was charged (R,R)-
Mn(PDP)Cl2 S25 (1.2073 g, 2.69 mmol), a stir bar and 35 mL 
anhydrous MeCN. AgSbF6 (purchased from Strem, 1.8508 g, 
5.39 mmol, 2.0 equiv.) was weighed under argon atmosphere 
in glove box and then added to the reaction under a stream of 
nitrogen. The flask was wrapped with aluminum foil to protect from light and the reaction was 
vigorously stirred for 24 hours. AgCl precipitated out and the reaction was filtered through a pad 
of Celiteâ and concentrated under vacuum to a minimum amount of MeCN remaining. The 
residue was redissolved in a minimum amount of MeCN and filtered through a 0.22 µm 
Acrodiscâ LC PVDF filter (HPLC certified) and concentrated. The filtration-concentration 
process was repeated two more times and the residue was concentrated to a minimum amount of 
MeCN remaining and then dried under a positive stream of nitrogen for 24 hours. (R,R)-
Mn(PDP)(MeCN)2(SbF6)2 36 was obtained as a white solid (2.3795 g, 2.56 mmol, 95% yield). 
HRMS (TOF ESI+) m/z calculated for C20H26N4F6MnSb [M-SbF6-2(MeCN)]+: 612.0480, found 
612.0469. 
 The (S,S)-Mn(PDP)(MeCN)2(SbF6)2 can be synthesized with the same procedure from 
(2S,2'S)-1,1'-bis(pyridin-2-ylmethyl)-2,2'-bipyrrolidine ligand.  
A single crystal for X-ray crystallography was obtained by dissolving ~20 mg (S,S)-
Mn(PDP)(MeCN)2(SbF6)2 (S,S)-36 in 0.2 mL MeCN and 0.1 mL benzene, followed by diethyl 














Diagram 1. Crystal Structure for (S,S)-36 
 
--------------------------------------------------------------------------------------------------------------------- 
Table 12. Crystal Data and Structure Refinement for (S,S)-36 
Empirical formula  C24 H32 F12 Mn N6 Sb2 
Formula weight  930.99 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Trigonal 
Space group  P3221 
Unit cell dimensions a = 10.5506(4) Å a= 90°. 
 b = 10.5506(4) Å b= 90°. 
 c = 25.2210(12) Å g = 120°. 















Table 12. (cont.) 
Density (calculated) 1.908 Mg/m3 
Absorption coefficient 2.134 mm-1 
F(000) 1359 
Crystal size 0.404 x 0.385 x 0.327 mm3 
Theta range for data collection 2.229 to 30.510°. 
Index ranges -15<=h<=15, -15<=k<=15, -36<=l<=36 
Reflections collected 49619 
Independent reflections 4947 [R(int) = 0.0425] 
Completeness to theta = 25.242° 100.0 %  
Absorption correction Integration 
Max. and min. transmission 0.64747 and 0.51756 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4947 / 0 / 206 
Goodness-of-fit on F2 1.130 
Final R indices [I>2sigma(I)] R1 = 0.0204, wR2 = 0.0420 
R indices (all data) R1 = 0.0214, wR2 = 0.0423 
Absolute structure parameter -0.029(7) 
Extinction coefficient 0.0046(2) 
Largest diff. peak and hole 0.434 and -0.592 e.Å-3 
--------------------------------------------------------------------------------------------------------------------- 
Crystallographic data for 36 can be obtained free of charge from 
www.ccdc.cam.ac.uk/structures/ with deposit number CCDC 1869257. 
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Synthesis and Characterization of Mn(CF3-PDP)(MeCN)2(SbF6)2 
(R,R)-Mn(CF3-PDP)Cl2 [S26]. 
In a 50 mL recovery flask was charged (2R,2'R)-1,1'-bis((5-(2,6-
bis(trifluoromethyl)phenyl)pyridin-2-yl)methyl)-2,2'-
bipyrrolidineligand (1.5076 g, 2.02 mmol) synthesized according to 
literature procedure12, a stir bar and MeCN (12 mL, 0.166 M). Freshly 
grinded MnCl2•4H2O (purchased from Strem, 399.6 mg, 2.02 mmol, 
1.0 equiv.) was added and the reaction was allowed to stir vigorously 
for 24 hours under nitrogen atmosphere. Fine white solid was formed 
during the course of reaction and there should be no pink non-ligated manganese salt remained. 
Diethyl ether freshly taken from solvent delivery system was added to the reaction to precipitate 
out the complex. The solvent was removed via pipette and the remaining solids were washed 
thoroughly with diethyl ether five times and dried under a stream of dry nitrogen gas overnight to 
yield (R,R)-Mn(CF3-PDP)Cl2 (1.6075 g, 1.84 mmol, 91% yield) as white solid. HRMS (TOF 
ESI+) m/z calculated for C36H30N4ClMnF12 [M-Cl]+: 836.1348, found 836.1353.  
A single crystal for X-ray crystallography was obtained by dissolving ~20 mg (R,R)-
Mn(CF3-PDP)Cl2 S26 in 0.2 mL MeCN and 0.1 mL benzene, followed by diethyl ether diffuse 




















Diagram 2. Crystal Structure for S26 
 
--------------------------------------------------------------------------------------------------------------------- 
Table 13. Crystal Data and Structure Refinement for S26 
Empirical formula  C36 H30 Cl2 F12 Mn N4 
Formula weight  872.48 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Hexagonal 
Space group  P65 
















Table 13. (cont.) 
 b = 9.2109(4) Å b= 90°. 
 c = 76.327(3) Å g = 120°. 
Volume 5608.1(5) Å3 
Z 6 
Density (calculated) 1.550 Mg/m3 
Absorption coefficient 5.029 mm-1 
F(000) 2646 
Crystal size 0.431 x 0.296 x 0.160 mm3 
Theta range for data collection 3.474 to 68.327°. 
Index ranges -11<=h<=11, -10<=k<=11, -91<=l<=91 
Reflections collected 35026 
Independent reflections 6638 [R(int) = 0.0531] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7531 and 0.5280 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6638 / 1 / 497 
Goodness-of-fit on F2 1.129 
Final R indices [I>2sigma(I)] R1 = 0.0493, wR2 = 0.1197 
R indices (all data) R1 = 0.0495, wR2 = 0.1199 
Absolute structure parameter 0.198(9) 
Extinction coefficient n/a 
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Table 13. (cont.) 
Largest diff. peak and hole 0.470 and -0.414 e.Å-3 
--------------------------------------------------------------------------------------------------------------------- 
Crystallographic data for S26 can be obtained free of charge from 
www.ccdc.cam.ac.uk/structures/ with deposit number CCDC 1869260. 
(R,R)-Mn(CF3-PDP)(MeCN)2(SbF6)2 [32]. 
In a flamed dried 100 mL recovery flask was charged (R,R)-
Mn(CF3-PDP)Cl2 S26 (1.6075 g, 1.84 mmol), a stir bar and 24 
mL dry MeCN. AgSbF6 (purchased from Strem, 1.2662 g, 
3.68 mmol, 2.0 equiv.) was weighed under argon atmosphere 
in glove box and then added to the reaction under nitrogen 
protection. The flask was wrapped with aluminum foil to 
protect from light and the reaction was vigorously stirred for 
24 hours. AgCl was precipitated out and the reaction was filtered through a pad of Celiteâ and 
concentrated under vacuum to a minimum amount of MeCN remaining. The residue was 
redissolved in a minimum amount of MeCN and filtered through a 0.22 µm Acrodiscâ LC 
PVDF filter (HPLC certified) and concentrated. The filtration-concentration process was 
repeated two more times and the residue was concentrated to a minimum amount of MeCN 
remaining and dried under a positive stream of nitrogen for 24 hours. (R,R)-Mn(CF3-
PDP)(MeCN)2(SbF6)2 was obtained as a white solid (2.3420 g, 1.73 mmol, 94% yield). HRMS 
(TOF ESI+) m/z calculated for C36H30N4F18MnSb [M-SbF6-2(MeCN)]+: 1036.0602, found 
1036.0624.  
















A single crystal for X-ray crystallography was obtained by dissolving ~20 mg (S,S)-
Mn(CF3-PDP)(MeCN)2(SbF6)2 in 0.2 mL MeCN and 0.1 mL benzene, followed by diethyl ether 
diffuse into the catalyst solution at room temperature. However, a concise resolved structure 
from the single crystal cannot be obtained due to heavy modulation. 
UV-Vis spectra for Mn(CF3-PDP) 32: In a 10 mL volumetric flask, 19.8 mg (0.0146 
mmol) of (R,R)-Mn(CF3-PDP) 32 was dissolved in MeCN to make a 10 mL solution (1.46 M). 
250 µL of this solution was diluted to a 10 mL solution (0.0365 M) in a 10 mL volumetric flask. 
A UV-Vis spectra was taken from 800-220 nm in a quartz cuvette (path length = 1 cm). 
Chart 2. UV-Vis Spectra for Mn(CF3-PDP) 
 
A single crystal for X-ray crystallography was obtained by dissolving ~20 mg (S,S)-
Mn(CF3-PDP)(MeCN)2(SbF6)2 32 in 0.2 mL MeCN and 0.1 mL hexafluoroisopropanol, 













220 320 420 520 620 720
UV-Vis for Mn(CF3-PDP) 32 (wavelength in nm)
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Diagram 3. Crystal Structure for (S,S)-32 
 
--------------------------------------------------------------------------------------------------------------------- 
Table 14. Crystal Data and Structure Refinement for (S,S)-32 
Identification code  dd20rs 
Empirical formula  C41.37 H42.17 F24 Mn N5.31 O1.37 Sb2 
Formula weight  1390.19 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 9.9977(2) Å a= 90°. 
 b = 15.1980(4) Å b= 95.8246(6)°. 
 c = 16.9784(4) Å g = 90°. 
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Table 14. (cont.) 
Volume 2566.46(10) Å3 
Z 2 
Density (calculated) 1.799 Mg/m3 
Absorption coefficient 1.414 mm-1 
F(000) 1363 
Crystal size 0.162 x 0.125 x 0.023 mm3 
Theta range for data collection 2.268 to 25.380°. 
Index ranges -12<=h<=12, -18<=k<=18, -20<=l<=20 
Reflections collected 74745 
Independent reflections 9411 [R(int) = 0.0392] 
Completeness to theta = 25.242° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7452 and 0.6915 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9411 / 533 / 821 
Goodness-of-fit on F2 1.046 
Final R indices [I>2sigma(I)] R1 = 0.0269, wR2 = 0.0558 
R indices (all data) R1 = 0.0296, wR2 = 0.0571 
Absolute structure parameter -0.025(4) 
Extinction coefficient 0.00410(19) 




2.4.3 Optimization of Methylene C—H Oxidations 
 Chemoselectivity is defined as the yield of desired remote oxidation product over the 
conversion of starting material. 
 
 
Synthesis of 1-(4-bromophenyl)cyclopentane-1-carbonitrile [33]. 
In a flamed dried 50 mL flask, 1.9604 g (10.0 mmol) of 2-(4-
bromophenyl)acetonitrile was dissolved in 15 mL anhydrous DMF. 632.0 mg 
(95% purity, 25.0 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC and 
the reaction was allowed to stir for 1 hour at 0 ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 equiv.) of 
1,4-dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir overnight at 
room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
30 mL EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 2.1143 
g (8.45 mmol) of pure product as a white solid (85% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.50 (d, J = 8.6 Hz, 2H), 7.33 (d, J = 8.5 Hz, 2H), 2.49 – 2.43 (m, 
2H), 2.08 – 1.89 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 139.0, 132.0, 127.9, 124.0, 121.9, 













Generation of TFDO: Methyl(trifluoromethyl)dioxirane (TFDO) was synthesized according to 
the reported procedure in literature.21 Titration according to the reported method shows the 
concentration of the TFDO trifluoroacetone solution is about 0.4M. The TFDO solution was 
stored at -78 ºC and was used up within a week. The quality of TFDO was checked by oxidizing 
2-methylpentyl 4-chlorobenzoate under the reported condition.21 Reported: 60% combined 
yield, 1.9:1 d:b ratio. Observed with home-made TFDO: 60% combined yield, 2.1:1 d:b ratio. 
General precautions of reactions using TFDO: All solvents and TFDO transfer during the 
reaction setup was done with a plastic syringe equipped with plastic micropipette tips to avoid 
any metal contamination. Due to the sensitivity of TFDO to light, the reaction was wrapped with 
aluminum foil during the course of reaction.  
Entry 1 
The reaction was proceeded with the reported condition under low temperature that prevent free-
radical formation.18 In a 1-dram vial charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 
33 (12.5 mg, 0.05 mmol, 1.0 equiv.) and a stir bar. 0.5 mL dichloromethane (DCM) freshly 
obtained from SDS was transferred into the vial via plastic syringe equipped with micropipette 
tip. The reaction was cooled to -20 ºC, and 0.38 mL 0.4M TFDO solution was added into the vial 
in 1-2 portions and the reaction was kept at -20 ºC for 48 h. The reaction was concentrated on 
rotvap to remove all volatiles and the crude mixture was analyzed by quantitative 1H NMR with 
nitrobenzene added as internal standard. 
Run 1: <5% product, (10.0 mg, 0.040 mmol, 80.0% rsm). Run 2: <5% product, (10.3 mg, 0.041 






The reaction was proceeded at 0 ºC according to the reported condition.21 In a 1-dram vial 
charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (25.0 mg, 0.10 mmol, 1.0 equiv.) 
and a stir bar. 1.0 mL DCM freshly obtained from SDS was transferred into the vial via plastic 
syringe equipped with micropipette tip. The reaction was cooled to 0 ºC, and 0.75 mL 0.4M 
TFDO solution was added into the vial in 2-3 portions and the reaction was kept at 0 ºC for 6 h. 
The reaction was concentrated on rotvap to remove all volatiles and the crude mixture was 
analyzed by quantitative 1H NMR with nitrobenzene added as internal standard. 
Run 1: <5% product, (18.6 mg, 0.075 mmol, 74.5% rsm). Run 2: <5% product, (18.8 mg, 0.075 
mmol, 75.1% rsm). Average: <5% product, 74.8% rsm. 
TFDO oxidation with 3+3 equiv. oxidant: The reaction was proceeded at 0 ºC with an extra 
addition of TFDO to push the conversion. In a 1-dram vial charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (12.5 mg, 0.05 mmol, 1.0 equiv.) and a stir bar. 0.5 
mL DCM freshly obtained from SDS was transferred into the vial via plastic syringe equipped 
with micropipette tip. The reaction was cooled to -0 ºC, and 0.38 mL 0.4M TFDO solution was 
added into the vial in 1-2 portions and the reaction was kept at 0 ºC for 6 h. Another portion of 
0.38 mL 0.4M TFDO solution was added into the vial in 1-2 portions and the reaction was 
allowed to react at 0 ºC for another 12 h. The reaction was concentrated on rotvap to remove all 
volatiles and the crude mixture was analyzed by quantitative 1H NMR with nitrobenzene added 
as internal standard. 
Run 1: (1.6 mg, 0.006 mmol, 12.3% product), (5.0 mg, 0.020 mmol, 39.9% rsm). Run 2: (1.3 
mg, 0.005 mmol, 10.1% product), (4.8 mg, 0.019 mmol, 38.3% rsm). Average: 11.2% product, 




This reaction was conducted according to the reported general procedure.7 In a 16 x 125 mm 
disposable test tube fitted with a stir bar and a rubber septum. 2 mg (5 µmol, 0.02 equiv.) 
Ru(Me3TACN)Cl3, 2.0 mL H2O and 4 mg AgClO4 (0.02 mmol, 0.08 equiv.) was added 
sequentially and stirred at 80 ºC for 5 min. White AgCl participated was observed and the 
mixture was cooled to room temperature. 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 
(62.5 mg, 0.25 mmol, 1.0 equiv.) was dissolved in 2.0 mL tert-butanol and added to the reaction 
followed by ceric ammonium nitrate (411 mg, 0.75 mmol, 3.0 equiv.). The dark red reaction was 
allowed to stir at room temperature for 30 min and another batch of ceric ammonium nitrate (411 
mg, 0.75 mmol, 3.0 equiv.) was added.  The reaction was further stirred for 14 hours and 
quenched with 1 mL of MeOH, diluted with water and extracted with 25 mL X3 ethyl acetate. 
The combined organic layer was dried with MgSO4, filtered and concentratred under reduced 
pressure. The crude mixture was analyzed by quantitative 1H NMR analysis with nitrobenzene 
added as internal standard. 
Run 1: trace product, (58.2 mg, 0.233 mmol, 93.1% rsm). Run 2: trace product, (53.7 mg, 0.215 
mmol, 85.9% rsm). Run 3: trace product, (54.9 mg, 0.220 mmol, 87.9% rsm). Average: trace 
product, 89.0% rsm ± 3.7%. 
Entry 4 
This reaction was conducted according to the reported general procedure.6 In a 20 mL vial 
charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (62.5 mg, 0.25 mmol, 1.0 
equiv.), a magnetic stir bar and a solution of cis-Ru(dtbpy)2Cl2 (8.9 mg, 13 µmol, 0.05 equiv.) in 
2.0 mL acetic acid. 2.0 mL water was added to the vial and the purple solution was stirred at 
room temperature for 2 min before a single portion of H5IO6 (114 mg, 0.50 mmol, 2.0 equiv.) 
113 
 
was added. The reaction was wrapped with aluminum foil and stirred at room temperature for 4 
hours. The reaction was transferred to a separatory funnel with 4 mL CH2Cl2 and 30 mL water. 
The aqueous layer was extracted with 3 x 15 mL CH2Cl2 and the combined organic layer was 
dried over Na2SO4. The crude reaction was concentrated and analyzed by quantitative 1H NMR 
analysis with nitrobenzene added as internal standard. 
Run 1: 0% product, (57.9 mg, 0.231 mmol, 92.5% rsm). Run 2: 0% product, (52.4 mg, 0.209 
mmol, 83.8% rsm). Run 3: 0% product, (54.2 mg, 0.217 mmol, 86.6% rsm). Average: 0% 
product, 87.6% rsm ± 4.4%. 
Entry 5 
This reaction was conducted according to the reported general procedure.9 To a 20 mL vial 
containing 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (62.5 mg, 0.25 mmol, 1.0 equiv.), 
AcOH (1.25 mL), Mn(OTf)2 solution (20 µL, 12.5 mM solution in 9:1 AcOH/H2O, 0.25 µmol, 
0.001 equiv.) and bipyridine solution (100 µL, 0.025 M solution in AcOH, 2.5 µmmol, 0.01 
equiv.). The mixture was stirred for 10 minutes and modified peracetic acid solution (220 µL, 
prepared by mixing 1.0 mL of commercial peracetic acid (35% Sigma-Aldrich) with 0.3 mL of 
10% KOH solution, 0.75 mmol, 3.0 equiv.) was added dropwise in 30 seconds. The reaction was 
stirred for another 60 seconds and then diluted with 5 mL acetone. After 30 seconds stirring, the 
mixture was filtered through Celite® and the filtrate was concentrated under reduced 
temperature. The crude mixture was analyzed by quantitative 1H NMR analysis with 
nitrobenzene added as internal standard. 
Run 1: (18.7 mg, 0.071 mmol, 28.3% yield), (25.1 mg, 0.100 mmol, 40.1% rsm). Run 2: (16.2 
mg, 0.061 mmol, 24.5% yield), (23.5 mg, 0.094 mmol, 37.6% rsm). Run 3: (17.1 mg, 0.065 
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mmol, 25.9% yield), (24.1 mg, 0.096 mmol, 38.5% rsm). Average: 26.2% yield ± 1.9%, 38.7% 
rsm ± 1.3%. Selectivity = 26.2/(100-38.7) = 42.7%. 
Entry 6 
This reaction was conducted according to the “cyclohexane oxidation under practical conditions” 
procedure.8 Mn(PDP)(OTf)2 was prepared by metathesis between Mn(PDP)Cl2 and AgOTf 
according to a similar procedure as Mn(PDP)(MeCN)2(SbF6)2 reported in Section 2.4.2 of 
Supplementary Information. To a 20 mL vial containing 1-(4-bromophenyl)cyclopentane-1-
carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv.), AcOH (0.24 mL, 14 equiv.), Mn(PDP)(OTf)2 
solution (60 µL, 5 mM solution in MeCN, 0.30 µmol, 0.001 equiv.) and MeCN (1.14 mL). The 
mixture was thermostatted at 0 ºC and a solution of H2O2 (50%, 51.0 mg, 0.75 mmol, 2.5 equiv.) 
in 0.3 mL MeCN was added via syringe pump over 1h. The reaction was stirred for another 1h at 
0 ºC before concentrated on rotvap. The crude mixture was analyzed by quantitative 1H NMR 
analysis with nitrobenzene added as internal standard. 
Run 1: (7.6 mg, 0.029 mmol, 9.6% yield), (66.3 mg, 0.265 mmol, 88.4% rsm). Run 2: (6.5 mg, 
0.025 mmol, 8.2% yield), (65.5 mg, 0.262 mmol, 87.3% rsm). Run 3: (7.2 mg, 0.027 mmol, 
9.0% yield), (64.2 mg, 0.256 mmol, 85.5% rsm). Average: 8.9% yield ± 0.7%, 87.1% rsm ± 
1.5%. Selectivity = 8.9/(100-87.1) = 69.0%. 
Entry 7 
The reaction was conducted according to the iterative addition protocol.10 In a 40 mL vial was 
charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 
equiv.), (R,R)-Fe(PDP) catalyst 35 (14.0 mg, 0.015 mmol, 0.05 equiv.), AcOH (9.0 mg, 0.15 
mmol, 0.5 equiv.), MeCN (0.45 mL) and a stir bar. The vial was stirred vigorously and a solution 
of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL syringe equipped with 
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25G needle was added dropwise over 60-75 seconds.  The reaction was allowed to stir for 10 
minutes at room temperature and a second batch of catalyst (14.0 mg, 0.015 mmol, 0.05 equiv.) 
and AcOH (9.0 mg, 0.15 mmol, 0.5 equiv.) dissolved in 0.3 mL MeCN was added via pipette. 
This was followed by a solution of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 
10 mL syringe equipped with 25G needle dropwise over 60-75 seconds. After another 10 
minutes a third batch of catalyst and H2O2 was added in the same manner. The third addition was 
allowed to stir for 10 minutes for a total reaction time of 30 minutes. Significant decrease in 
yield was observed when the peroxide solution was added rapidly. 
Upon completion of the reaction, the mixture was concentrated in vacuo to a minimum amount 
of MeCN. 20 mL ether was added to crush the iron complex out and the mixture was filtered via 
a Celite® plug. The filtrate was dried over Na2SO4, concentrated and analyzed by quantitative 1H 
NMR analysis with nitrobenzene added as internal standard. 
Run 1: (1.2 mg, 0.005 mmol, 1.5% yield), (35.4 mg, 0.141 mmol, 47.1% rsm). Run 2: (1.3 mg, 
0.005 mmol, 1.5% yield), (35.0 mg, 0.140 mmol, 46.5% rsm). Run 3: (0.6 mg, 0.002 mmol, 
0.9% yield), (33.8 mg, 0.135 mmol, 45.1% rsm). Average: 1.3% yield ± 0.3%, 46.2% rsm ± 
1.0%. Selectivity = 1.3/(100-46.2) = 2.4%. 
Entry 8 
The reaction was conducted according to the iterative addition protocol.10 In a 40 mL vial was 
charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 
equiv.), (R,R)-Mn(PDP) catalyst 36 (14.0 mg, 0.015 mmol, 0.05 equiv.), AcOH (9.0 mg, 0.15 
mmol, 0.5 equiv.), MeCN (0.45 mL) and a stir bar. The vial was stirred vigorously and a solution 
of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL syringe equipped with 
25G needle was added dropwise over 60-75 seconds.  The reaction was allowed to stir for 10 
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minutes at room temperature and a second batch of catalyst (14.0 mg, 0.015 mmol, 0.05 equiv.) 
and AcOH (9.0 mg, 0.15 mmol, 0.5 equiv.) dissolved in 0.3 mL MeCN was added via pipette. 
This was followed by a solution of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 
10 mL syringe equipped with 25G needle dropwise over 60-75 seconds. After another 10 
minutes a third batch of catalyst and H2O2 was added in the same manner. The third addition was 
allowed to stir for 10 minutes for a total reaction time of 30 minutes. Significant decrease in 
yield was observed when the peroxide solution was added rapidly. 
Upon completion of the reaction, the mixture was concentrated in vacuo to a minimum amount 
of MeCN. 20 mL ether was added and the mixture was filtered via a Celite® plug. The filtrate 
was dried over Na2SO4, concentrated and analyzed by quantitative 1H NMR analysis with 
nitrobenzene added as internal standard. 
Run 1: (5.6 mg, 0.021 mmol, 7.1% yield), (66.3 mg, 0.265 mmol, 88.4% rsm). Run 2: (4.5 mg, 
0.017 mmol, 5.7% yield), (65.5 mg, 0.262 mmol, 87.3% rsm). Run 3: (5.5 mg, 0.021 mmol, 
6.9% yield), (68.0 mg, 0.272 mmol, 90.6% rsm). Average: 6.6% yield ± 0.8%, 88.8% rsm ± 
1.7%. Selectivity = 6.6/(100-88.8) = 58.9%. 
Entry 9 
The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 
1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged with a 
solution of (R,R)-Mn(PDP) catalyst 36 (69.9 mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.375 
mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in 
MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was added 
dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
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concentrated in vacuo to a minimum amount of MeCN and purified by column chromatography 
on silica (35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% 
acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (28.5 mg, 0.108 mmol, 36.0% yield), (38.0 mg, 0.152 mmol, 50.6% rsm). Run 2: (28.1 
mg, 0.106 mmol, 35.5% yield), (38.7 mg, 0.155 mmol, 51.6% rsm). Run 3: (28.2 mg, 0.107 
mmol, 35.6% yield), (35.6 mg, 0.142 mmol, 47.4% rsm). Average: 35.7% yield ± 0.3%, 49.9% 
rsm ± 2.2%. Selectivity = 35.7/(100-49.9) = 71.3%. 
Entry 10 
The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 
1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged with a 
solution of (R,R)-Fe(CF3-PDP) catalyst 37 (101.6 mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.375 
mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in 
MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was added 
dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
concentrated in vacuo to a minimum amount of MeCN and purified by column chromatography 
on silica (35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% 
acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (18.5 mg, 0.070 mmol, 23.3% yield), (7.2 mg, 0.029 mmol, 9.6% rsm). Run 2: (21.2 mg, 
0.080 mmol, 26.8% yield), (7.5 mg, 0.030 mmol, 10.0% rsm). Run 3: (17.0 mg, 0.064 mmol, 
21.5% yield), (7.5 mg, 0.030 mmol, 10.0% rsm). Average: 23.9% yield ± 2.7%, 9.9% rsm ± 





The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 
1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged with a 
solution of (R,R)-Mn(CF3-PDP) catalyst 32 (101.6 mg, 0.075 mmol, 0.25 equiv.) in MeCN 
(0.375 mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 
equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was 
added dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
concentrated in vacuo to a minimum amount of MeCN and purified by column chromatography 
on silica (35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% 
acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (16.6 mg, 0.063 mmol, 20.9% yield), (58.6 mg, 0.234 mmol, 78.1% rsm). Run 2: (17.2 
mg, 0.065 mmol, 21.7% yield), (57.3 mg, 0.229 mmol, 76.4% rsm). Run 3: (14.9 mg, 0.056 
mmol, 18.8% yield), (60.4 mg, 0.241 mmol, 80.5% rsm). Average: 20.5% yield ± 1.5%, 78.3% 
rsm ± 2.1%. Selectivity = 20.5/(100-78.3) = 94.5%. 
Entry 12 
The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), ClCH2COOH 
(141.7 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged 
with a solution of (R,R)-Mn(CF3-PDP) catalyst 32 (101.6 mg, 0.075 mmol, 0.25 equiv.) in 
MeCN (0.375 mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 
9.0 equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was 
added dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
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concentrated in vacuo to a minimum amount of MeCN. The residue was dissolved in ~20 mL 
DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) to remove 
ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM twice and the combined 
organic layer was dried with Na2SO4. After filtration, the filtrate was concentrated and purified 
by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 
acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered starting material and 
product.  
Run 1: (55.6 mg, 0.210 mmol, 70.2% yield), (17.4 mg, 0.070 mmol, 23.2% rsm). Run 2: (58.7 
mg, 0.222 mmol, 74.1% yield), (12.5 mg, 0.050 mmol, 16.7% rsm). Run 3: (58.1 mg, 0.220 
mmol, 73.3% yield), (14.1 mg, 0.056 mmol, 18.8% rsm). Average: 72.5% yield ± 2.1%, 19.6% 
rsm ± 3.3%. Selectivity = 72.5/(100-19.6) = 90.2%. 
Entry 13 
The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), Cl2CHCOOH 
(193.4 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged 
with a solution of (R,R)-Mn(CF3-PDP) catalyst 32 (101.6 mg, 0.075 mmol, 0.25 equiv.) in 
MeCN (0.375 mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 
9.0 equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was 
added dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
concentrated in vacuo to a minimum amount of MeCN. The residue was dissolved in ~20 mL 
DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) to remove 
Cl2CHCO2H. The aqueous layer was extracted with ~15 mL DCM twice and the combined 
organic layer was dried with Na2SO4. After filtration, the filtrate was concentrated and purified 
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by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 
acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered starting material and 
product.  
Run 1: (53.9 mg, 0.204 mmol, 68.0% yield), (10.3 mg, 0.041 mmol, 13.7% rsm). Run 2: (50.8 
mg, 0.192 mmol, 64.1% yield), (10.3 mg, 0.041 mmol, 13.7% rsm). Run 3: (53.0 mg, 0.201 
mmol, 66.9% yield), (9.3 mg, 0.037 mmol, 12.4% rsm). Average: 66.3% yield ± 2.0%, 13.3% 
rsm ± 0.8%. Selectivity = 66.3/(100-13.3) = 76.5%. 
Entry 14 
The reaction was conducted in slow addition protocol.30 In a 40 mL vial was charged with 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 mg, 0.30 mmol, 1.0 equiv), ClCH2COOH 
(141.7 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged 
with a solution of (R,R)-Mn(PDP) catalyst 36 (69.8 mg, 0.075 mmol, 0.25 equiv.) in MeCN 
(0.375 mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 
equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was 
added dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
concentrated in vacuo to a minimum amount of MeCN. The residue was dissolved in ~20 mL 
DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) to remove 
ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM twice and the combined 
organic layer was dried with Na2SO4. After filtration, the filtrate was concentrated and purified 
by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 




Run 1: (26.4 mg, 0.110 mmol, 33.3% yield), (39.2 mg, 0.157 mmol, 52.2% rsm). Run 2: (24.1 
mg, 0.091 mmol, 30.4% yield), (39.6 mg, 0.158 mmol, 52.8% rsm). Run 3: (25.9 mg, 0.098 
mmol, 32.7% yield), (35.2 mg, 0.141 mmol, 46.9% rsm). Average: 32.1% yield ± 1.5%, 50.6% 
rsm ± 3.2%. Selectivity = 32.1/(100-50.6) = 65.0%. 
Entry 15 
The reaction was conducted with Method A: single catalyst addition protocol (vide infra, Section 
2.4.4). In a 40 mL vial was charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 
mg, 0.30 mmol, 1.0 equiv), ClCH2COOH (425.3 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-
PDP) catalyst 32 (40.7 mg, 0.03 mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL 
syringe was charged with a solution of H2O2 (204 mg, 3.0 mmol, 10.0 equiv.) in MeCN (3.75 
mL), fitted with 25G needles and the solution was added dropwise via syringe pump over 3 
hours (1.25 mL/hour) while the reaction vial was maintained at 0 ºC. Upon completion of 
addition, the reaction was concentrated in vacuo to a minimum amount of MeCN. The residue 
was dissolved in ~20 mL DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 
was released) to remove ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM 
twice and the combined organic layer was dried with Na2SO4. After filtration, the filtrate was 
concentrated and purified by column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered 
starting material and product.  
Run 1: (67.8 mg, 0.257 mmol, 85.6% yield), (8.7 mg, 0.035 mmol, 11.6% rsm). Run 2: (68.3 
mg, 0.259 mmol, 86.2% yield), (5.5 mg, 0.022 mmol, 7.3% rsm). Run 3: (67.2 mg, 0.254 mmol, 
84.8% yield), (5.9 mg, 0.024 mmol, 7.9% rsm). Average: 85.5% yield ± 0.7%, 8.9% rsm ± 




The reaction was conducted with Method A: single catalyst addition protocol (vide infra, Section 
2.4.4). In a 40 mL vial was charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 
mg, 0.30 mmol, 1.0 equiv), ClCH2COOH (425.3 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(PDP) 
catalyst 36 (27.9 mg, 0.03 mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe 
was charged with a solution of H2O2 (204 mg, 3.0 mmol, 10.0 equiv.) in MeCN (3.75 mL), fitted 
with 25G needles and the solution was added dropwise via syringe pump over 3 hours (1.25 
mL/hour) while the reaction vial was maintained at 0 ºC. Upon completion of addition, the 
reaction was concentrated in vacuo to a minimum amount of MeCN. The residue was dissolved 
in ~20 mL DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) 
to remove ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM twice and the 
combined organic layer was dried with Na2SO4. After filtration, the filtrate was concentrated and 
purified by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 
20% acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered starting material 
and product.  
Run 1: (31.0 mg, 0.117 mmol, 39.1% yield), (41.6 mg, 0.166 mmol, 55.4% rsm). Run 2: (30.3 
mg, 0.115 mmol, 38.2% yield), (40.4 mg, 0.162 mmol, 53.8% rsm). Run 3: (28.0 mg, 0.106 
mmol, 35.3% yield), (43.5 mg, 0.174 mmol, 58.0% rsm). Average: 37.5% yield ± 2.0%, 55.7% 
rsm ± 2.1%. Selectivity = 37.5/(100-55.7) = 84.7%. 
Entry 17 
The reaction was conducted with Method A: single catalyst addition protocol (vide infra, Section 
2.4.4). In a 40 mL vial was charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 
mg, 0.30 mmol, 1.0 equiv), ClCH2COOH (425.3 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Fe(CF3-
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PDP) catalyst 37 (40.7 mg, 0.03 mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL 
syringe was charged with a solution of H2O2 (204 mg, 3.0 mmol, 10.0 equiv.) in MeCN (3.75 
mL), fitted with 25G needles and the solution was added dropwise via syringe pump over 3 
hours (1.25 mL/hour) while the reaction vial was maintained at 0 ºC. Upon completion of 
addition, the reaction was concentrated in vacuo to a minimum amount of MeCN. The residue 
was dissolved in ~20 mL DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 
was released) to remove ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM 
twice and the combined organic layer was dried with Na2SO4. After filtration, the filtrate was 
concentrated and purified by column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered 
starting material and product.  
Run 1: (4.2 mg, 0.016 mmol, 5.3% yield), (18.7 mg, 0.075 mmol, 24.9% rsm). Run 2: (4.5 mg, 
0.017 mmol, 5.7% yield), (18.8 mg, 0.075 mmol, 25.1% rsm). Run 3: (4.2 mg, 0.016 mmol, 
5.3% yield), (17.8 mg, 0.071 mmol, 23.7% rsm). Average: 5.4% yield ± 0.2%, 24.6% rsm ± 
0.8%. Selectivity = 5.4/(100-24.6) = 7.2%. 
Entry 18 
The reaction was conducted with Method A: single catalyst addition protocol (vide infra, Section 
2.4.4). In a 40 mL vial was charged with 1-(4-bromophenyl)cyclopentane-1-carbonitrile 33 (75.0 
mg, 0.30 mmol, 1.0 equiv), CH3COOH (270.2 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) 
catalyst 32 (40.7 mg, 0.03 mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe 
was charged with a solution of H2O2 (204 mg, 3.0 mmol, 10.0 equiv.) in MeCN (3.75 mL), fitted 
with 25G needles and the solution was added dropwise via syringe pump over 3 hours (1.25 
mL/hour) while the reaction vial was maintained at 0 ºC. Upon completion of addition, the 
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reaction was concentrated in vacuo to a minimum amount of MeCN. The residue was dissolved 
in ~20 mL DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) 
to remove CH3CO2H. The aqueous layer was extracted with ~15 mL DCM twice and the 
combined organic layer was dried with Na2SO4. After filtration, the filtrate was concentrated and 
purified by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 
20% acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered starting material 
and product.  
Run 1: (16.0 mg, 0.061 mmol, 20.2% yield), (56.3 mg, 0.225 mmol, 75.0% rsm). Run 2: (13.1 
mg, 0.050 mmol, 16.5% yield), (55.9 mg, 0.223 mmol, 74.5% rsm). Run 3: (17.8 mg, 0.067 
mmol, 22.5% yield), (53.5 mg, 0.214 mmol, 71.3% rsm). Average: 19.7% yield ± 3.0%, 73.6% 
rsm ± 2.0%. Selectivity = 19.7/(100-73.6) = 74.6%. 
Characterization of 1-(4-bromophenyl)-3-oxocyclopentane-1-carbonitrile [34]. 
1H-NMR (500 MHz, CDCl3) δ 7.59 – 7.57 (m, 2H), 7.35 – 7.32 (m, 2H), 3.05 
(d, J = 18.1 Hz, 1H), 2.83 (ddd, J = 10.3, 8.5, 3.9 Hz, 1H), 2.75 (d, J = 18.2 
Hz, 1H), 2.70 – 2.64 (m, 1H), 2.56 – 2.50 (m, 1H), 2.41 (ddd, J = 12.9, 9.9, 
8.2 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 211.6, 136.6, 132.7, 127.6, 123.1, 122.1, 49.8, 43.9, 
36.7, 36.3. HRMS (TOF ESI+) m/z calculated for C11H10OBr [M-CN]+: 236.9915, found 
236.9915. Enantiomeric excess (ee) of cyclic ketone oxidation products were not evaluated due 










2.4.4 General Oxidation Procedures with Mn(CF3-PDP) 
Method A: Single Catalyst Addition Protocol 
A 40 mL vial was charged with substrate (0.3 mmol, 1.0 equiv.), catalyst (0.03 mmol, 10 
mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.) and a stir bar. MeCN (0.6 mL, 0.50 M) 
was added along the wall to ensure all compounds were washed beneath the solvent level and the 
vial was sealed with a screw cap fitted with a PTFE/Silicone septum. The vial was cooled to 0 ºC 
with ice/water bath. A separate solution of H2O2 [(204 mg, 3.0 mmol, 10.0 equiv.), 50% wt. in 
H2O, purchased from Sigma-Aldrich] in MeCN (3.75 mL) was loaded into a 10 mL syringe 
fitted with a 25G needle and was added dropwise to the stirring reaction over 3 hours via a 
syringe pump (1.25 mL/h addition rate) while maintain the reaction vial at 0 ºC. Upon 
completion, the reaction mixture was concentrated to a minimum amount of solvent. The residue 
was dissolved in ~20 mL DCM and washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 
was released) to remove ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM two 
times and the combined organic layer was dried with Na2SO4. The filtrate was concentrated and 
purified by flash chromatography on silica gel.  
Method B: Iterative Catalyst Addition Protocol 
This protocol was used when Method A gave low conversions. A 40 mL vial was charged 
with substrate (0.3 mmol, 1.0 equiv.), catalyst (0.015 mmol, 5 mol%), ClCH2CO2H (425 mg, 4.5 
mmol, 15.0 equiv.) and a stir bar. MeCN (0.6 mL, 0.50 M) was added along the wall to ensure all 
compounds were washed beneath the solvent level and the vial was sealed with a screw cap fitted 
with a PTFE/Silicone septum. The vial was cooled to -36 ºC with 1,2-dichloroethane/dry ice bath 
or to 0 ºC with ice/water bath. A separate solution of H2O2 [(204 mg, 3.0 mmol, 10.0 equiv.), 
50% wt. in H2O, purchased from Sigma-Aldrich] in MeCN (3.75 mL) was loaded into a 10 mL 
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syringe fitted with a 25G needle and was added dropwise to the stirring reaction over 3 hours via 
a syringe pump (1.25 mL/h addition rate) while maintain at the corresponding temperature. The 
initial time is recorded as the time the first drop of H2O2 solution was added into the reaction. 
One hour after the initial time, another batch of catalyst (0.015 mmol, 5 mol%) was dissolved 
with 0.1 mL MeCN in a 0.5-dram vial and added dropwise into the reaction via syringe followed 
directly by another 0.1 mL MeCN that was used to rinse the vial. The addition of 5 mol% 
catalyst was repeated at two hours after the initial time using the same procedure. A total of 15 
mol% of catalyst was used in this protocol. Upon completion, the reaction mixture was 
concentrated to a minimum amount of solvent. The residue was dissolved in ~20 mL DCM and 
washed with 9 mL sat. NaHCO3 solution (CAUTION: CO2 was released) to remove 
ClCH2CO2H. The aqueous layer was extracted with ~15 mL DCM two times and the combined 
organic layer was dried with Na2SO4. The filtrate was concentrated and purified by flash 
chromatography on silica gel.  
Method C: Slow Catalyst Addition Protocol 
This protocol was used when Method A and Method B gave low conversions. A 40 mL 
vial was charged with substrate (0.3 mmol, 1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 
equiv.) and a stir bar. MeCN (0.6 mL, 0.50 M) was added along the wall to ensure all 
compounds were washed beneath the solvent level and the vial was sealed with a screw cap fitted 
with a PTFE/Silicone septum. The vial was cooled to -36 ºC with 1,2-dichloroethane/dry ice bath 
or to 0 ºC with ice/water bath. A 1.0 mL syringe was filled with a solution of the catalyst (0.03 
mmol, 10 mol%) in MeCN (0.375 mL, 0.083 M). A few drops of this solution were added to the 
reaction. A 10 mL syringe was filled with a solution of H2O2 (204 mg, 3.0 mmol, 10.0 equiv., 
50% wt. in H2O, purchased from Sigma-Aldrich) in MeCN (3.75 mL, 0.8 M). Both syringes 
127 
 
were fitted with 25G needles and loaded to a syringe pump resulting a slow simultaneous 
addition of catalyst and oxidant solutions over 3 hours while maintain at the corresponding 
temperature (1.25 mL/h addition rate set for the H2O2 syringe; 0.125 mL/h for the catalyst 
syringe). Upon completion, the reaction mixture was concentrated to a minimum amount of 
solvent. The residue was dissolved in ~20 mL DCM and washed with 9 mL sat. NaHCO3 
solution (CAUTION: CO2 was released) to remove ClCH2CO2H. The aqueous layer was 
extracted with ~15 mL DCM two times and the combined organic layer was dried with Na2SO4. 
The filtrate was concentrated and purified by flash chromatography on silica gel.  
General Method D: Oxidation of Proline-Containing Peptides 
A 40 mL vial was charged with substrate (0.2 mmol, 1.0 equiv.), catalyst (0.02 mmol, 10 
mol%), AcOH (172  L, 3.0 mmol, 15.0 equiv.), MeCN (0.4 mL, 0.50 M), a stir bar and sealed 
with a screw cap incorporated with PTFE/Silicone septa. The vial was cooled to  36 ºC with 
1,2-dichloroethane/dry ice bath. A separate solution of H2O2 [(56.7  L, 1.0 mmol, 5.0 equiv.), 
50 wt% in H2O, purchased from Sigma-Aldrich] in MeCN (2.5 mL) was loaded into a 3 mL 
syringe fitted with a 25G needle and was added dropwise to the stirring reaction over 1 hour via 
a syringe pump (2.5 mL/h addition rate). Upon completion, the reaction mixture was allowed to 
warm to room temperature and concentrated in vacuo. The residue was dissolved with DCM (20 
mL) and saturated aqueous NaHCO3 (20 mL). The mixture was separated, and the aqueous layer 
was extracted with DCM (2 x 10 mL). The combined organic layers were washed with 0.1 M 
ethylenediaminetetraacetic acid (EDTA) disodium salt solution (30 mL) and the aqueous layer 
was extracted with DCM (2 x 10 mL). The combined organic layers were dried over Na2SO4, 
filtered and concentrated in vacuo. The crude mixture was dissolved with small amount of DCM 
and concentrated onto silica gel (~2 mL) for dry loading onto the column (SiO2, 25 mL) and then 
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eluted with ethyl acetate/CHCl3 to give a desired hemiaminal. Recovered starting material was 
determined as 1H NMR yield with nitrobenzene as an internal standard after the column 
chromatography. 
In all oxidations reported with Mn(CF3-PDP) 32 with General Method A, B, C and D, the 
yields of oxidation products are reported as isolated yields after column chromatography with 
>95% purity. Trace solvent residues are integrated out with quantitative 1H NMR 
characterization of the oxidation product. 
 
2.4.5 Synthesis and Characterization of Starting Materials for C—H Oxidation with Mn(CF3-
PDP) 
General procedure for the synthesis of substrate S27-S30 
 
1-phenylcyclopentane-1-carbonitrile [S27]. 
In a flamed dried 100 mL flask, 1.1715 g (10.0 mmol) of 2-phenylacetonitrile 
was dissolved in 15 mL anhydrous DMF. 632.0 mg (95% purity, 25.0 mmol, 2.5 
equiv.) of NaH was added in portions at 0 ºC and the reaction was allowed to stir 
for 1 hour at 0 ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 equiv.) of 1,4-dibromobutane was added 
dropwise at 0 ºC and the reaction was stirred overnight at room temperature. The reaction was 
quenched carefully with ~10 mL water and extracted with 30 mL EtOAc three times. The 
combined organic layer was washed with 50 mL brine, dried with MgSO4, filtered, and 












SiO2) using 3% EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 1.2535 g (7.31 mmol) of 
pure product as a slightly yellowish oil (73% yield). 
1H-NMR (500 MHz, CDCl3) 7.48 – 7.45 (m, 2H), 7.40 – 7.37 (m, 2H), 7.33 – 7.29 (m, 1H), 2.51 
– 2.47 (m, 2H), 2.12 – 1.91 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 139.9, 129.0, 127.9, 126.1, 
124.5, 47.9, 40.6, 24.4. HRMS (EI+) m/z calculated for C12H12N [M-H]+: 170.09697, found 
170.09660. 
1-(4-(tert-butyl)phenyl)cyclopentane-1-carbonitrile [S28]. 
In a flamed dried 100 mL flask, 1.7326 g (10.0 mmol) of 2-(4-tert-
butylphenyl)acetonitrile was dissolved in 15 mL anhydrous DMF.  632.0 mg 
(95% purity, 25.0 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC 
and the reaction was allowed to stir for 1 hour at 0 ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 equiv.) 
of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was stirred overnight at room 
temperature. The reaction was quenched carefully with ~10 mL water and extracted with 30 mL 
EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 2% EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 1.5612 g 
(6.87 mmol) of pure product as a slightly yellowish solid (69% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.41 – 7.37 (m, 4H), 2.49 – 2.44 (m, 2H), 2.11 – 1.91 (m, 6H), 
1.33 (s, 9H). 13C-NMR (126 MHz, CDCl3) δ 150.8, 136.9, 125.9, 125.8, 124.7, 47.5, 40.5, 34.6, 
31.4, 24.3. HRMS (EI+) m/z calculated for C16H21N [M]+: 227.1674, found 227.1678. 
1-(4-chlorophenyl)cyclopentane-1-carbonitrile [S29]. 
In a flamed dried 50 mL flask, 1.5159 g (10.0 mmol) of 2-(4-chlorophenyl)acetonitrile was 




added in portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 
ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 equiv.) of 1,4-dibromobutane was 
added dropwise at 0 ºC and the reaction was stirred overnight at room 
temperature. The reaction was quenched carefully with ~10 mL water and extracted with 30 mL 
EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 1.6928 
g (8.23 mmol) of pure product as a clear oil (82% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.40 – 7.37 (m, 2H), 7.36 – 7.33 (m, 2H), 2.49 – 2.44 (m, 2H), 
2.08 – 1.90 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 138.5, 133.8, 129.1, 127.5, 124.1, 47.4, 
40.6, 24.3. HRMS (TOF ESI+) m/z calculated for C11H12Cl [M-CN]+: 179.0628, found 179.0635. 
1-(4-fluorophenyl)cyclopentane-1-carbonitrile [S30]. 
In a flamed dried 100 mL flask, 2.7030 g (20.0 mmol) of 2-(4-
fluorophenyl)acetonitrile was dissolved in 30 mL anhydrous DMF.  1.2630 g 
(95% purity, 50.0 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC and 
the reaction was allowed to stir for 1 hour at 0 ºC. 4.3186 g (2.37 mL, 20.0 mmol, 1.0 equiv.) of 
1,4-dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir overnight at 
room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
60 mL EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 2.9857 







1H-NMR (500 MHz, CDCl3) δ 7.42 (dd, J = 8.8, 5.1 Hz, 2H), 7.06 (t, J = 8.6, 8.6 Hz, 2H), 2.50 – 
2.43 (m, 2H), 2.08 – 1.89 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 162.2 (d, J = 247.1 Hz), 135.7 
(d, J = 3.2 Hz), 127.8 (d, J = 8.2 Hz), 124.3, 115.8 (d, J = 21.7 Hz), 47.2, 40.6, 24.2. 19F-NMR 




In a flamed dried 100 mL flask, 4.0538 g (25.0 mmol) of 2-(4-
nitrophenyl)acetonitrile was dissolved in 50 mL anhydrous DMF. 
1.58 g (95% purity, 62.5 mmol, 2.5 equiv.) of NaH was added in 
portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 
5.40 g (3.0 mL, 25.0 mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and 
the reaction was allowed to stir overnight at room temperature. The reaction was quenched 
carefully with ~20 mL water and extracted with 50 mL EtOAc three times. The combined 
organic layer was washed with 50 mL brine, dried with MgSO4, filtered, and concentrated. Flash 
column chromatography on silica (50 mm fritted glass column, 300 mL SiO2) using 10% 
EtOAc/hexanes à 25% EtOAc/hexanes as eluent gave 2.2851 g (10.6 mmol) of 1-(4-
nitrophenyl)cyclopentane-1-carbonitrile as a yellow solid (42% yield). 1H-NMR (500 MHz, 
CDCl3) δ 8.28 – 8.22 (m, 2H), 7.69 – 7.61 (m, 2H), 2.55 (dt, J = 7.1, 4.6 Hz, 2H), 2.17 – 1.92 
(m, 6H). This solid was dissolved in 30 mL MeOH and charged with 228 mg Pd/C (5% wt.) and 
the reaction was stirred under a balloon of H2 overnight to obtain 1-(4-



























7.24 – 7.18 (m, 2H), 6.71 – 6.64 (m, 2H), 3.69 (br. s, 2H), 2.48 – 2.34 (m, 2H), 2.09 – 1.79 (m, 
6H). In a 50 mL flask was charged with 558.9 mg (3.0 mmol, 1 equiv.) of 1-(4-
aminophenyl)cyclopentane-1-carbonitrile, 12 mL acetic acid and 533.2 mg (3.6 mmol, 1.2 
equiv.) of phthalic anhydride. The reaction was refluxed overnight before concentrated. Flash 
column chromatography on silica (50 mm fritted glass column, 300 mL SiO2) using 50% 
EtOAc/hexanes à 100% Acetone as eluent gave 464.5 mg (1.47 mmol) of 1-(4-(1,3-
dioxoisoindolin-2-yl)phenyl)cyclopentane-1-carbonitrile as a slightly brown solid (49% yield).  
1H-NMR (500 MHz, acetone-d6) δ 7.97 – 7.92 (m, 4H), 7.71 – 7.69 (m, 2H), 7.60 – 7.57 (m, 
2H), 2.53 – 2.48 (m, 2H), 2.25 – 2.18 (m, 2H), 2.03 – 2.00 (m, 4H). 13C-NMR (126 MHz, 
acetone-d6) δ 167.7, 140.6, 135.4, 132.92, 132.86, 128.3, 127.5, 124.6, 124.2, 48.5, 40.9, 24.7. 
HRMS (TOF ESI+) m/z calculated for C20H17N2O2 [M+H]+: 317.1290, found 317.1284. 
methyl 3-(1-cyanocyclopentyl)benzoate [S32]. 
In a flamed dried 50 mL flask, 753.4 mg (3.5 mmol) of 3-(1-
cyanocyclopentyl)benzoic acid was dissolved in 20 mL anhydrous DCM. 533.1 
mg (355 µL, 4.2 mmol, 1.2 equiv.) of (COCl)2 was dropwise at 0 ºC, followed by 
a drop of anhydrous DMF and the reaction was allowed to stir for 2 hours at room temperature 
before 10 mL anhydrous MeOH was added. The reaction was stirred overnight and concentrated. 
Flash column chromatography on silica (50 mm fritted glass column, 300 mL SiO2) using 5% 
EtOAc/hexanes as eluent gave 721.3 mg (3.1 mmol) of pure product as a clear oil (90% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.09 (app. t, J = 2.3 Hz, 1H), 7.98 (dt, J = 7.7, 1.3 Hz, 1H), 7.69 
(ddd, J = 7.9, 2.1, 1.0 Hz, 1H), 7.46 (t, J = 7.8, 1H), 3.93 (s, 3H), 2.53 – 2.49 (m, 2H), 2.11 – 





124.1, 52.4, 47.8, 40.6, 24.3. HRMS (TOF ESI+) m/z calculated for C14H16NO2 [M+H]+: 
230.1181, found 230.1179. 
General procedure for the synthesis of substrate S33-S37 
 
1-(3,5-difluorophenyl)cyclopentane-1-carbonitrile [S33]. 
In a flamed dried 50 mL flask, 1.5313 g (10.0 mmol) of 2-(3,5-
difluorophenyl)acetonitrile was dissolved in 15 mL anhydrous DMF. 632.2 mg 
(95% purity, 25.0 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC and 
the reaction was allowed to stir for 1 hour at 0 ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 equiv.) of 
1,4-dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir overnight at 
room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
30 mL EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 2% EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 1.8752 g 
(9.05 mmol) of pure product as a white solid (91% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.02 - 6.97 (m, 2H), 6.78 – 6.74 (m, 1H), 2.51 – 2.43 (m, 2H), 
2.07 – 1.93 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 163.2 (dd, J = 249.6, 12.9 Hz), 143.9 (t, J = 
8.9 Hz), 123.4, 109.6 – 109.5 (m), 103.5 (t, J = 25.2 Hz), 47.7(t, J = 2.2 Hz), 40.6, 24.3. 19F-
NMR (470 MHz, CDCl3) δ -108.62 – -108.66 (m). HRMS (TOF ESI+) m/z calculated for 

















methyl 4-(1-cyanocyclopentyl)benzoate [S34]. 
In a flamed dried 50 mL flask, 1.7519 g (10.0 mmol) of methyl 4-
(cyanomethyl)benzoate was dissolved in 15 mL anhydrous DMF.  632.0 
mg (95% purity, 25.0 mmol, 2.5 equiv.) of NaH was added in portions at 
0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 2.1593 g (1.18 mL, 10.0 mmol, 1.0 
equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was stirred overnight 
at room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
30 mL EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 200 mL SiO2) using 15% EtOAc/hexanes à 30% EtOAc/hexanes as eluent gave 794.0 
mg (3.46 mmol) of pure product as a clear oil (34% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.04 (dd, J = 8.3, 1.4 Hz, 2H), 7.53 (dd, J = 8.4, 1.4 Hz, 2H), 3.92 
(s, 3H), 2.53 – 2.47 (m, 2H), 2.12 – 1.93 (m, 6H).13C-NMR (126 MHz, CDCl3) δ 166.6, 144.9, 
130.3, 129.8, 126.2, 123.9, 52.4, 48.0, 40.8, 24.5. HRMS (TOF ESI+) m/z calculated for 
C14H16NO2 [M+H]+: 230.1181, found 230.1177. 
4-(1-cyanocyclopentyl)benzonitrile [S35]. 
In a flamed dried 50 mL flask, 710.8 mg (5.0 mmol) of 2-(4-
cyanophenyl)acetonitrile was dissolved in 7.5 mL anhydrous DMF.  316.0 
mg (95% purity, 12.5 mmol, 2.5 equiv.) of NaH was added in portions at 0 
ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 1.0797 g (0.59 mL, 5.0 mmol, 1.0 
equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir 
overnight at room temperature. The reaction was quenched carefully with ~10 mL water and 







brine, dried with MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 
mm fritted glass column, 300 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as 
eluent gave 880.1 mg (4.48 mmol) of pure product as a colorless oil (90% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.69 – 7.67 (m, 2H), 7.59 – 7.57 (m, 2H), 2.52 – 2.48 (m, 2H), 
2.09 – 1.94 (m, 6H).13C-NMR (126 MHz, CDCl3) δ 145.2, 132.8, 127.0, 123.3, 118.3, 112.0, 
48.0, 40.7, 24.5. HRMS (EI+) m/z calculated for C13H12N2 [M]+: 196.1000, found 196.1004. 
methyl 1-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxylate [S36]. 
In a flamed dried 50 mL flask, 468.3 mg (2.0 mmol) of methyl 2-(4-
(trifluoromethoxy)phenyl)acetate was dissolved in 4 mL anhydrous 
DMF. 125.0 mg (95% purity, 5.0 mmol, 2.5 equiv.) of NaH was 
added in portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 431.8 mg (0.24 
mL, 2.0 mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction 
was allowed to stir overnight at room temperature. The reaction was quenched carefully with ~10 
mL water and extracted with 30 mL EtOAc three times. The combined organic layer was washed 
with 50 mL brine, dried with MgSO4, filtered, and concentrated. Flash column chromatography 
on silica (50 mm fritted glass column, 300 mL SiO2) using 2.5% EtOAc/hexanes à 5% 
EtOAc/hexanes as eluent gave 260.8 mg (0.91 mmol) of pure product as a colorless oil (45% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.39 – 7.36 (m, 2H), 7.16 – 7.13 (m, 2H), 3.62 (s, 3H), 2.68 – 
2.63 (m, 2H), 1.92 – 1.85 (m, 2H), 1.77 – 1.69 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 176.2, 
148.1 (q, J = 1.9 Hz), 142.1, 128.4, 120.8, 120.6 (q, J = 257.0 Hz), 58.8, 52.6, 36.4, 23.7. 19F-
NMR (471 MHz, CDCl3) δ -57.85. HRMS (TOF ESI+) m/z calculated for C14H16O3F3 [M+H]+: 







In a flamed dried 50 mL flask, 1.000 g (5.46 mmol) of 2-(4-
(difluoromethoxy)phenyl)acetonitrile was dissolved in 12 mL anhydrous 
DMF.  344.8 mg (95% purity, 13.7 mmol, 2.5 equiv.) of NaH was added in 
portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 1.179 g (0.65 mL, 5.46 
mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was 
allowed to stir overnight at room temperature. The reaction was quenched carefully with ~10 mL 
water and extracted with 30 mL EtOAc three times. The combined organic layer was washed 
with 50 mL brine, dried with MgSO4, filtered, and concentrated. Flash column chromatography 
on silica (50 mm fritted glass column, 200 mL SiO2) using 2% EtOAc/hexanes à 5% 
EtOAc/hexanes as eluent gave 1.169 g (4.93 mmol) of pure product as a colorless oil (90% 
yield). Enantiomeric excess (ee) was determined by chiral HPLC (OJ-H, 90:10 
hexanes:isopropanol, 1.0 mL/min, 30 ºC, 224nm): 11%. 
1H-NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.7 Hz, 2H), 7.13 (d, J = 8.7 Hz, 2H), 6.51 (t, J = 
73.6 Hz, 1H), 2.51 – 2.45 (m, 2H), 2.08 – 1.92 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 150.6 (t, 
J = 3.0 Hz), 137.1, 127.7, 124.2, 120.0, 115.8 (t, J = 260.5 Hz), 47.4, 40.6, 24.3. 19F-NMR (470 
MHz, CDCl3) δ -81.4 (d, J = 73.2 Hz). HRMS (TOF ESI+) m/z calculated for C13H13NONaF2 
























In a flamed dried 50 mL flask, 227.7 mg (6.0 mmol, 1.5 
equiv.) LiAlH4 was mixed with 12 mL anhydrous ether, a 
solution of 1.0006 g (4.0 mmol, 1.0 equiv.) of 1-(4-
bromophenyl)cyclopentane-1-carbonitrile 2 in 6 mL anhydrous ether was added dropwise at 0 
ºC.  The reaction was allowed to reflux overnight before quenched with 250 µL water, 250 µL 
15% NaOH and 750 µL water sequentially. After stirring for 1 h, MgSO4 was added and the 
mixture was filtered through Celite. The filtrate was concentrated and redissovled in 20 mL 
toluene, 772.0 mg (4.0 mmol, 1.0equiv.) of 4-nitrophthalic anhydride was added followed by 560 
µL (4.0 mmol, 1.0 equiv.) NEt3. The reaction was refluxed overnight and concentrated. Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 10% 
EtOAc/hexanes à 20% EtOAc/hexanes as eluent gave 790.2 mg (1.84 mmol) of pure product as 
a slightly yellow solid (46% yield over 2 steps). 
1H-NMR (500 MHz, CDCl3) δ 8.57 – 8.55 (m, 2H), 7.95 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 8.1 Hz, 
2H), 7.14 (d, J = 8.4 Hz, 2H), 3.85 (s, 2H), 2.08 – 1.87 (m, 6H), 1.74 – 1.66 (m, 2H). 13C-NMR 
(126 MHz, CDCl3) δ 166.3, 166.1, 151.8, 144.3, 136.2, 133.2, 131.3, 129.3, 129.1, 124.6, 120.6, 
118.8, 53.0, 47.5, 36.2, 22.9. HRMS (TOF ESI+) m/z calculated for C20H18N2O4Br [M+H]+: 





















In a flamed dried 300 mL flask, 2.0102 g (10.0 mmol) of 2-bromobenzoic acid was 
dissolved in 50 mL anhydrous THF. n-Butyl lithium (1.6 M, 13.1 mL, 21.0 mmol) 
was added dropwise at -78 ºC and the reaction was allowed to stir for 1 hour at -78 
ºC. 841.2 mg (0.89 mL, 10.0 mmol, 1.0 equiv.) of cyclopentanone dissolved in 10 mL anhydrous 
THF was added dropwise at -78 ºC and the reaction was allowed to warm to room temperature 
and stir overnight. The reaction was poured into 40 mL water and the aqueous layer was washed 
with 40 mL hexanes and 40 mL ether. The aqueous layer was adjusted to pH between 2-3 with 
3M HCl. 50 mL DCM was added and the mixture was stirred for 1 hour before adjusted to 
neutral pH with 10% K2CO3 solution. Layers are separated and the aqueous layer was extracted 
with 30 mL DCM twice. The combined organic layer was washed with 50 mL brine, dried with 
Na2SO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 10% EtOAc/hexanes à 20% EtOAc/hexanes as eluent gave 631.7 
mg (3.36 mmol) of pure product as a white solid (34% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.84 (dt, J = 8.0, 2.2 Hz, 1H), 7.66 (td, J = 7.5, 1.4 Hz, 1H), 7.49 
(td, J = 7.5, 2.4 Hz, 1H), 7.41 – 7.39 (m, 1H), 2.11 – 2.06 (m, 6H), 1.97 – 1.94 (m, 2H). 13C-
NMR (126 MHz, CDCl3) δ 170.0, 152.8, 134.2, 129.0, 126.3, 125.5, 121.0, 95.6, 39.8, 25.0. 
HRMS (TOF ESI+) m/z calculated for C12H13O2 [M+H]+: 189.0916, found 189.0908. 
 
5'-Bromo-1'-(phenylsulfonyl)spiro[cyclopentane-1,3'-indolin]-2'-one [S40]. 
A 100 mL round bottom flask was charged with a stir bar, 5-Bromooxindole (2.12 g, 10 mmol, 






















was added KOtBu (3.36 g, 30 mmol, 3.0 equiv.) in THF (24 mL) dropwise 
over 30 min, while the temperature was maintained below -15 °C then the 
mixture was stirred. After 10 min, 1,4-dibromobutane (1.43 mL, 12 mmol, 
1.2 equiv.) was added dropwise over 15 min with the temperature being maintained between -10 
°C and -5 °C then the mixture was stirred at 0 °C. After 1 h, the reaction was quenched with 
3.5% aqueous HCl solution (20 mL) and the mixture was stirred at room temperature for 1h. The 
mixture was separated and the yellow organic layer was washed with brine (30 mL), dried with 
Na2SO4, and filtered. The resulting solution diluted with MeCN (10 mL) and THF was removed 
under reduced pressure. MeCN (5 mL) was added and the mixture was cooled to 0 °C. The 
precipitate was collected by filtration and wased with cold MeCN (3 x 3 mL) to provide 1.87 g 
of 5'-bromospiro[cyclopentane-1,3'-indolin]-2'-one in 70% yield as a white solid. A 50 mL round 
bottom flask was charged with a stir bar, 5'-bromospiro[cyclopentane-1,3'-indolin]-2'-one (532 
mg, 2.00 mmol, 1.0 equiv.), benzenesulfonyl chloride (307 µL, 2.40 mmol, 1.2 equiv.) and THF 
(8 mL) and cooled to 0 °C. To the stirred mixture was added LHMDS (402 mg, 2.40 mmol, 1.2 
equiv.) in THF (2.4 mL) dropwise and the mixture was stirred at the same temperature. After 3 
hours, the reaction was quenched with H2O (20 mL) and extracted with EtOAc (3 x 15 mL). The 
combined organic layers were washed with brine (20 mL), dried over Na2SO4, filtered and 
concentrated under reduced pressure. The residue was diluted with DCM and concentrated onto 
silica gel (5 mL) for dry loading onto the column (SiO2, 35 mL) and then eluted with 5% 
EtOAc/hexane to give 596 mg of the product in 73% yield as a white solid. 
1H-NMR (500 MHz, CDCl3) δ 8.06 (dd, J = 8.4, 1.2 Hz, 2H), 7.80 (d, J = 8.7 Hz, 1H), 7.65 (t, J 
= 7.5 Hz, 1H), 7.55 – 7.52 (m, 2H), 7.43 (dd, J = 8.7, 2.1 Hz, 1H), 7.27 (d, J = 2.1 Hz, 1H), 2.09 







134.6, 131.1, 129.3, 127.9, 126.0, 118.3, 115.2, 54.3, 39.8, 26.9. HRMS (TOF ESI+) m/z 
calculated for C18H17BrNO3S [M+H]+: 406.0113, found 406.0110. 
 
1-((cyclopentylmethyl)sulfonyl)-4-fluorobenzene [S41]. 
533  L (5.0 mmol) of 4-flourothiophenol was dissolved in 10 mL (0.5 M) 
acetone.  1.0695 g (6.0 mmol, 1.2 equiv.) of cyclopentylmethyl 
methanesulfonate and 829.3 mg (6.0 mmol, 1.2 equiv.) of K2CO3 was added 
sequentially and the reaction was allowed to stir overnight. The reaction was diluted with 20 mL 
water and extracted with 30 mL EtOAc three times. The combined organic layer was dried with 
Na2SO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 150 mL SiO2) using 1% EtOAc/hexanes à 3% EtOAc/hexanes as eluent gave 746.6 mg 
(3.55 mmol) of (cyclopentylmethyl)(4-fluorophenyl)sulfane intermediate with minor impurity. 
The intermediate was dissolved in 32 mL 1:1 MeOH:H2O and 3.274 g (10.65 mmol, 3.0 equiv.) 
Oxone® was added in portions at 0 ºC. The reaction was allowed to warm up to room 
temperature and stirred overnight. The reaction was diluted with 30 mL water and extracted with 
40 mL ether TWICE. The combined organic layer was washed with 40 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 150 mL SiO2) using 10% EtOAc/hexanes à 20% EtOAc/hexanes as eluent gave 788.2 
mg (3.25 mmol) of pure product as a white solid in 65% yield over 2 steps. 
1H-NMR (500 MHz, CDCl3) δ 7.96 – 7.92 (m, 2H), 7.27 – 7.22 (m, 2H), 3.14 (d, J = 6.9 Hz, 
2H), 2.30 – 2.21 (m, 1H), 1.92 – 1.86 (m, 2H), 1.64 – 1.51 (m, 4H), 1.26 – 1.18 (m, 2H). 13C-
NMR (126 MHz, CDCl3) δ 165.9 (d, J = 255.9 Hz), 136.2, 131.0 (d, J = 9.5 Hz), 116.7 (d, J = 
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22.6 Hz), 62.3, 34.5, 32.8, 24.9. 19F-NMR (470 MHz, CDCl3) δ -104.31. HRMS (TOF ESI+) m/z 
calculated for C12H16O2SF [M+H]+: 243.0855, found 243.0860. 
 
(±)-5-Bromo-3-butyl-2-oxo-1-(phenylsulfonyl)indolin-3-yl acetate [S42]. 
A 100 mL round bottom flask was charged with a stir bar and AlCl3 
(2.67 g, 20 mmol, 2.0 equiv.) under inert atmosphere and placed in an 
ice bath. THF (20 mL) was carefully added to dissolve AlCl3 and the 
ice bath was replaced with a water bath. To the stirred solution was added n-BuLi (1.6 M in 
hexane, 37.5 mL, 60.0 mmol, 6.0 equiv.) dropwise over 30 minutes and the resulting suspension 
was stirred at room temperature. After 1 hour, THF was removed under the reduced pressure and 
the residue was dissolved with toluene (10 mL) under Ar atmosphere. A 20 mL syringe fitted 
with LC PVDF filter (HPLC certified) was used to remove white precipitate of LiCl, and the 
solid was rinsed with toluene (5 mL). A 300 mL round bottom flask was charged with a stir bar 
and 5-bromoisatin and toluene (50 mL) under Ar atmosphere. To the stirred suspension was 
added the prepared solution of Bu3Al in toluene dropwise and the mixture was stirred at 70 °C. 
After 3 hours, the mixture was concentrated under reduced pressure and cooled to 0 °C, then 
quenched with saturated potassium sodium tartrate (100 mL), diluted with EtOAc (100 mL) and 
stirred at room temperature. After 1 hour, aqueous layer was separated and extracted with EtOAc 
(2 x 100 mL). The combined organic layers were washed with brine (50 mL), dried over Na2SO4 
filtered and concentrated under reduced pressure to give 1.76 g of a crude product. A 100 mL 
round bottom flask was charged with a stir bar, the crude mixture (1.76 g, less than 6.19 mmol) 































equiv.), 4-(dimethylamino)pyridine (DMAP, 151 mg, 1.24 mmol, 0.20 equiv.), and acetic 
anhydride (1.76 mL, 18.6 mmol, 3.0 equiv.) and the mixture was stirred at room temperature 
overnight. The reaction was quenched with H2O and extracted with DCM (3 x 20 mL). The 
combined organic layers were washed with H2O (20 mL) and brine (20 mL), dried over Na2SO4, 
filtered, and concentrated under reduced pressure. The residue was diluted with DCM and 
concentrated onto silica gel (15 mL) for dry loading onto the column (SiO2, 150 mL) and then 
eluted with 5% EtOAc/Hexane to afford 1-acetyl-5-bromo-3-butyl-2-oxoindolin-3-yl acetate and 
5-bromo-3-butyl-2-oxoindolin-3-yl acetate. 1-acetyl-5-bromo-3-butyl-2-oxoindolin-3-yl acetate 
(260 mg, 0.706 mmol) could be converted to 5-bromo-3-butyl-2-oxoindolin-3-yl acetate by 
treatment with Na2CO3 (15.0 mg, 0.142 mmol) in MeOH (5 mL) at 0 °C for 30 min. A 100 mL 
round bottom flask was charged with a stir bar, 5-bromo-3-butyl-2-oxoindolin-3-yl acetate (638 
mg, 1.96 mmol, 1.0 equiv.), benzenesulfonyl chloride (375 µL, 2.94 mmol, 1.5 equiv.), and 
DCM (10 mL). To the stirred mixture was added Et3N (546 μL, 3.92 mmol, 2.0 equiv.) and the 
mixture was stirred at 30 °C overnight. The reaction was quenched with H2O and extracted with 
DCM (3 x 20 mL). The combined organic layers were dried over Na2SO4, filtered, and 
concentrated under reduced pressure. The residue was diluted with DCM and concentrated onto 
silica gel (5 mL) for dry loading onto the column (SiO2, 100 mL) and then eluted with 5% à 
EtOAc/Hexane to afford 544 mg (1.17 mmol) of the 5-bromo-1-((4-bromophenyl)sulfonyl)-3-
butyl-2-oxoindolin-3-yl acetate in 60% yield as a white solid. 
1H-NMR (500 MHz, CDCl3) δ 8.06 (d, J = 7.5 Hz, 2H), 7.83 (d, J = 8.7 Hz, 1H), 7.65 (t, J = 7.5 
Hz, 1H), 7.54 – 7.49 (m, 3H), 7.28 (d, J = 2.1 Hz, 1H), 1.91 (s, 3H), 1.97 – 1.86 (m, 2H), 1.27 – 
1.19 (m, 2H), 1.15 – 1.00 (m, 2H), 0.80 (t, J = 7.3 Hz, 3H). 13C-NMR (125 MHz, CDCl3) δ 
172.4, 168.9, 138.4, 137.3, 134.8, 133.2, 129.7, 129.1, 128.2, 126.0, 118.3, 115.3, 79.0, 36.9, 
143 
 
23.8, 22.6, 20.3, 13.8. HRMS (TOF ESI+) m/z calculated for C20H20BrNNaO5S [M+Na]+: 
488.0143, found 488.0130. 
 
N-((4-bromophenyl)sulfonyl)-N-pentylacetamide [S43]. 
In a flamed dried 50 mL flask, 995 mg (3.25 mmol, 1.0 equiv.) of 
4-bromo-N-pentylbenzenesulfonamide, 2.27 mL (16.25 mmol, 5.0 
equiv.) of triethylamine and 39.7 mg (0.33 mmol, 10 mol%) of DMAP was dissolved in 14 mL 
DCM. 0.7 mL (9.75 mmol, 3.0 equiv.) acetic chloride was added dropwise at 0 ºC and the 
reaction was allowed to warm to RT and stir overnight. 14 mL of water was added to quench the 
reaction and the aqueous layer was extracted with 14 mL DCM twice. The combined organic 
layer was washed with 30 mL brine and was dried with Na2SO4. Flash column chromatography 
on silica (150 mm fritted glass column, 200 mL SiO2) using 5% EtOAc/hexanes à 15% 
EtOAc/hexanes as eluent gave 1.122 g (3.16 mmol) of pure product as a sticky colorless oil 
(97% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.78 – 7.75 (m, 2H), 7.70 – 7.67 (m, 2H), 3.77 – 3.74 (m, 2H), 
2.29 (s, 3H), 1.74 – 1.68 (m, 2H), 1.40 – 1.28 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H). 13C-NMR (126 
MHz, CDCl3) δ 170.0, 138.9, 132.6, 129.3, 129.0, 47.6, 29.9, 29.0, 24.9, 22.4, 14.1. HRMS 
































In a flamed dried 50 mL flask, 1.9604 g (10.0 mmol) of 2-(4-
bromophenyl)acetonitrile was dissolved in 15 mL anhydrous DMF. 632.0 mg 
(95% purity, 25.0 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC 
and the reaction was allowed to stir for 1 hour at 0 ºC. 2.2994 g (1.36 mL, 10.0 mmol, 1.0 equiv.) 
of 1,5-dibromopentane was added dropwise at 0 ºC and the reaction was allowed to stir overnight 
at room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
30 mL EtOAc three times. The combined organic layer was washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 1.9307 
g (7.3 mmol) of pure product as a white solid (73% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.53 – 7.50 (m, 2H), 7.38 – 7.35 (m, 2H), 2.15 – 2.11 (m, 2H), 
1.90 – 1.78 (m, 5H), 1.72 (ddd, J = 13.0, 12.8, 4.1 Hz, 2H), 1.32 – 1.22 (m, 1H). 13C-NMR (126 
MHz, CDCl3) δ 140.7, 132.1, 127.5, 122.4, 121.9, 44.2, 37.4, 25.0, 23.7. HRMS (EI+) m/z 
calculated for C13H14NBr [M]+: 263.0310, found 263.0313. 
 
2-((1-(4-bromophenyl)cyclobutyl)methyl)isoindoline-1,3-dione [S45]. 
In a flamed dried 50 mL flask, 232.0 mg (6.12 mmol, 1.5 equiv.) 
LiAlH4 was mixed with 12 mL anhydrous ether, a solution of 
963.0 mg (4.08 mmol, 1.0 equiv.) of 1-(4-



















The reaction was allowed to reflux overnight before quenched with 250 µL water, 250 µL 15% 
NaOH and 750 µL water sequentially. After stirring for 1 h, MgSO4 was added and the mixture 
was filtered through Celite. The filtrate was concentrated and redissovled in 20 mL toluene, 
604.2 mg (4.08 mmol, 1.0 equiv.) of phthalic anhydride was added followed by 570 µL (4.08 
mmol, 1.0 equiv.) triethylamine. The reaction was refluxed overnight and concentrated. Flash 
column chromatography on silica (50 mm fritted glass column, 200 mL SiO2) using 5% 
EtOAc/hexanes à 15% EtOAc/hexanes as eluent gave 1.2621 g (3.41 mmol) of pure product as 
a white solid (84% yield over 2 steps). 
1H-NMR (500 MHz, CDCl3) δ 7.77 (dd, J = 5.4, 3.1 Hz, 2H), 7.69 (dd, J = 5.5, 3.1 Hz, 2H), 7.36 
(d, J = 8.2 Hz, 2H), 7.02 (d, J = 8.3 Hz, 2H), 3.95 (s, 2H), 2.51 (ddd, J = 12.7, 8.7, 4.7 Hz, 2H), 
2.39 – 2.33 (m, 2H), 2.08 (dp, J = 11.4, 8.5 Hz, 1H), 1.87 – 1.79 (m, 1H). 13C-NMR (126 MHz, 
CDCl3) δ 168.5, 146.3, 134.1, 131.8, 131.2, 128.1, 123.4, 120.0, 47.9, 47.8, 31.8, 16.1. HRMS 
(TOF ESI+) m/z calculated for C19H17NO2Br [M+H]+: 370.0443, found 370.0442. 
 
bis(4-chlorophenyl)(cyclobutyl)methanol [S46]. 
In a flamed dried 100 mL flask, 572.8 mg (4.0 mmol, 1.0 equiv.) of N-
methoxy-N-methylcyclobutanecarboxamide was dissolved in 20 mL THF, 11 
mL THF solution containing 12 mmol (3.0 equiv.) freshly made 4-
Chlorophenylmagnesium bromide was added dropwise at -78 ºC. The reaction 
was allowed to stir at -78 ºC for 1h then at RT for 1.5 h. The reaction was quenched with 



















was concentrated, dissolved in 20 mL DCM and washed with 20 mL brine. Followed by drying 
with MgSO4, the crude reaction was transferred into a 100 mL flamed dried flask and dissolved 
in 20 mL THF. Another portion of 11 mL THF solution containing 10 mmol (2.5 equiv.) 4-
Chlorophenylmagnesium bromide was added dropwise at -78 ºC. The reaction was allowed to 
warm up to RT and stirred overnight. The reaction was quenched with saturated NH4Cl solution, 
extracted with 30 mL ether three times. The combined organic layer was washed with 30 mL 
brine and was dried with Na2SO4. Flash column chromatography on silica (150 mm fritted glass 
column, 200 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 905.8 
mg (2.95 mmol) of pure product as a yellow solid (74% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.28 – 7.24 (m, 8H), 3.34 – 3.30 (m, 1H), 2.15 (br. s, 1H), 2.05 – 
1.96 (m, 2H), 1.89 – 1.72 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 144.3, 133.0, 128.4, 127.9, 




In a 50 mL flask, 223.4 mg (0.87 mmol, 1.0 equiv.) of Clorindione was 
dissolved in 4.4 mL acetone followed by 360.7 mg (2.61 mmol, 3.0 
equiv.) K2CO3 and 934 µL (8.70mmol, 10 equiv.) 1-bromobutane. The 
flask was capped with polyethylene cap and sealed with electric tape 
and the reaction was allowed to stir under 60 ºC for 24 hours. The reaction was concentrated, 
dissolved in 20 mL water and extracted with 20 mL EtOAc three times. The combined organic 

















g) using hexanes à 10% EtOAc/hexanes as eluent gave 145.4 mg (0.47 mmol) of pure product 
as a yellow solid (54% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.07 – 8.02 (m, 2H), 7.89 – 7.87 (m, 2H), 7.39 – 7.36 (m, 2H), 
7.28 – 7.25 (m, 2H), 2.24 – 2.19 (m, 2H),1.28 – 1.21 (m, 2H), 1.13 – 1.07 (m, 2H), 0.79 (t, J = 
7.3 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 201.8, 142.0, 136.2, 135.7, 133.8, 129.0, 128.4, 
123.7, 61.6, 36.6, 27.4, 23.2, 13.8. HRMS (TOF ESI+) m/z calculated for C19H18O2Cl [M+H]+: 
313.0995, found 313.0991. 
 
(±)-methyl 2-(3-benzoylphenyl)-2-cyclopentylpropanoate [S48].  
In a 50 mL recovery flask was charged 3.814 g (15 mmol) 
ketoprofen, 25 mL MeOH and 1 mL concentrated H2SO4. The 
reaction was refluxed overnight. After cooled to room temperature, the reaction was poured into 
100 mL water and extract with 50 mL DCM 3 times. Combined organic layer was washed with 
sat. NaHCO3, dried with MgSO4 then purified by a plug of silica. In a 300 mL flamed dried 
flask, 1.3416 g (5 mmol) of ketoprofen methyl ester was dissolved in 50 mL anhydrous THF, 
cooled to -78 ºC and 5.5 mmol (1.1 equiv.) freshly made LDA solution and 0.87 mL (5.0 mmol, 
1.0 equiv.) HMPA was added sequentially. After stirring at -78 ºC for 10 minutes, 1.61 mL 
(2.2355 g, 15 mmol, 3.0 equiv.) of bromocyclopentane was added. The reaction was allowed to 
warm to room temperature and stirred overnight. The reaction was quenched with 10 mL 
saturated NH4Cl, extracted with 30 mL ether 3 times and dried over MgSO4. The crude mixture 
was purified by CombiFlash using a 40 g silica column and eluted with pure hexane à 10% 















1H-NMR (500 MHz, CDCl3) 7.80 – 7.78 (m, 3H), 7.65 (ddd, J = 7.6, 1.6, 1.1 Hz, 1H), 7.61 – 
7.51 (m, 2H), 7.50 – 7.47 (m, 2H), 7.44 – 7.41 (m, 1H), 3.66 (s, 3H), 2.80 (tt, J = 9.3, 7.9 Hz, 
1H), 1.75 – 1.72 (m, 1H), 1.55 (s, 3H), 1.59 – 1.37 (m, 6H), 1.14 (ddt, J = 12.5, 9.8, 7.8 Hz, 1H). 
13C-NMR (126 MHz, CDCl3) δ 196.8, 176.3, 144.2, 137.7, 137.6, 132.6, 130.8, 130.2, 128.6, 
128.4, 128.31, 128.27, 53.0, 52.2, 47.0, 28.6, 27.9, 26.0, 25.8, 18.7. HRMS (TOF ESI+) m/z 
calculated for C22H25O3 [M+H]+: 337.1804, found 337.1793. 
 
1-cyclopentyl-3-(3,4-dichlorophenyl)propan-2-one [S49]. 
In a flamed dried 100 mL flask, 822.0 mg (4.8 mmol, 1.0 equiv.) of 
2-cyclopentyl-N-methoxy-N-methylacetamide was dissolved in 24 
mL anhydrous THF, 11 mL THF solution containing 5.3 mmol (1.1 equiv.) freshly made (3,4-
dichlorobenzyl)magnesium bromide was added dropwise at -78 ºC. The reaction was allowed to 
warm up to room temperature stir at -78 ºC for 1h then at RT for 2 h. The reaction was quenched 
with saturated NH4Cl solution, extracted with 20 mL ether three times. The combined organic 
layer was washed with 20 mL brine, dried with MgSO4 and concentrated. Flash column 
chromatography on silica (150 mm fritted glass column, 150 mL SiO2) using 3% EtOAc/hexanes 
à 5% EtOAc/hexanes as eluent gave 672.8 mg (2.48 mmol) of pure product as a clear oil (52% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.39 (d, J = 8.2 Hz, 1H), 7.29 (d, J = 2.0 Hz, 1H), 7.02 (dd, J = 
8.2, 1.9 Hz, 1H), 3.64 (s, 2H), 2.49 (d, J = 7.2 Hz, 2H), 2.23 (hept, J = 7.3 Hz, 1H), 1.84 – 1.78 

















132.7, 131.5, 131.3, 130.6, 129.0, 48.9, 48.9, 35.6, 32.7, 25.1.HRMS (TOF ESI+) m/z calculated 
for C14H17OCl2 [M+H]+: 271.0656, found 271.0666. 
 
(±)-trans-4-methylcyclohexyl 4-chlorobenzoate [S50]. 
In an oven dried 50 mL recovery flask was charged with trans-4-
methylcyclohexanol 628.0 mg (5.5 mmol, 1.1 equiv.) in 10 mL anhydrous 
DCM. 0.64 mL (5 mmol, 1.0 equiv.) 4-chlorobenzoyl chloride and 1.05 mL 
(7.5 mmol, 1.5 equiv.) of triethylamine was sequentially added at 0 ºC. The 
reaction was warmed to room temperature and stirred overnight before quenched with 30 mL 
water. The aqueous layer was extracted with 30 mL DCM twice and the combined organic layer 
was washed with brine, dried with MgSO4 and concentrated. Flash column chromatography on 
silica (150 mm fritted glass column, 250 mL SiO2) using 1% EtOAc/hexanes à 2% 
EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 986.7 mg (3.90 mmol) of pure product as a 
white solid (78% yield). 
1H-NMR (500 MHz, CDCl3) δ  7.98 – 7.95 (m, 2H), 7.41 – 7.38 (m, 2H), 4.90 (tt, J = 11.1, 4.4 
Hz, 1H), 2.09 – 2.05 (m, 2H), 1.80 – 1.76 (m, 2H), 1.50 – 1.44 (m, 3H), 1.12 – 1.09 (m, 2H), 
0.92 (d, J = 6.6 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 165.4, 139.2, 131.1, 129.5, 128.7, 74.5, 

















(±)-2-methylbutyl 4-chlorobenzoate [S51]. 
In an oven dried 50 mL recovery flask was charged with 2-
methylbutan-1-ol 1.08 mL (881.5 mg, 10.0 mmol, 1.0 equiv.) in 20 
mL anhydrous DCM. 2.56 mL (20.0 mmol, 2.0 equiv.) 4-
chlorobenzoyl chloride and 4.18 mL (30.0 mmol, 3.0 equiv.) of triethylamine was sequencially 
added at 0 ºC. The reaction was warmed to room temperature and stirred overnight before 
quenched with 30 mL water. The aqueous layer was extracted with 30 mL DCM twice and the 
combined organic layer was washed with brine, dried with MgSO4 and concentrated. Flash 
column chromatography on silica (150 mm fritted glass column, 250 mL SiO2) using 1% 
EtOAc/hexanes à 2% EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 2.094 g (9.24 
mmol) of pure product as a clear oil (92% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.98 (d, J = 8.6 Hz, 2H), 7.41 (d, J = 8.6 Hz, 2H), 4.20 (dd, J = 
10.7, 6.0 Hz, 1H), 4.12 (dd, J = 10.7, 6.7 Hz, 1H), 1.90 – 1.81 (m, 1H), 1.51 (dtd, J = 13.3, 7.5, 
5.7 Hz, 1H), 1.27 (dq, J = 13.6, 7.5 Hz, 1H), 1.01 (d, J = 6.8 Hz, 3H), 0.95 (t, J = 7.5 Hz, 3H). 
13C-NMR (126 MHz, CDCl3) δ 165.9, 139.4, 131.1, 129.1, 128.8, 69.9, 34.4, 26.3, 16.7, 11.4. 



















4-cyclopropylbutyl benzoate [S52]. 
In a flame dried 100 mL flask 14.2 mL of 1M diethyl zinc solution 
in toluene was added in 17 mL anhydrous 1,2-dichloroethane.  5.0 g 
(28.4 mmol) CH2ClI was added dropwise over 5 minutes at 0 ºC. The reaction was kept at 0 ºC 
for 5 minutes before 801.3 mg (8.0 mmol) of 5-hexene-1-ol dissolved in 3 mL anhydrous 1,2-
dichloroethane was added dropwise and the reaction was allowed to stir at RT overnight. 20 mL 
sat. NH4Cl solution was used to quench the reaction and the aqueous layer was extracted with 20 
mL DCM 3 times. The combined organic layer was washed with 40 mL 1:1 brine:water and 
dried with MgSO4. The crude mixture was dissovled in 40 mL anhydrous DCM, treated with 
benzoyl chloride (3.374 g, 24.0 mmol, 2.8 mL) and triethylamine (4.048 g, 40 mmol, 5.65 mL) at 
0 ºC, stirred overnight at room temperature before diluted with 50 mL DCM and worked up with 
50 mL 1 M HCl. The organic layer was washed by 50 mL sat. NaHCO3, 50 mL brine, dried with 
Na2SO4 and concentrated. The crude mixture was treated with 2.34 g (9.5 mmol) 70% wt. 
mCPBA to convert the unreacted olefin impurity to the corresponding epoxide, which can be 
removed via column chromotography on silica (50 mm fritted glass column, 200 mL SiO2) using 
5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent to afford 389 mg (1.8 mmol) of pure 
product as a colorless oil (22% yield over 3 steps). 
1H-NMR (500 MHz, CDCl3) δ 8.06 – 8.04 (m, 2H), 7.55 (td, J = 7.3, 1.5 Hz, 1H), 7.44 (t, J = 7.8 
Hz, 2H), 4.32 (t, J = 6.7 Hz, 2H), 1.83 – 1.77 (m, 2H), 1.55 (tt, J = 7.6, 6.6 Hz, 2H), 1.27 (q, J = 














MHz, CDCl3) δ 166.8, 132.9, 130.6, 129.7, 128.4, 65.3, 34.5, 28.7, 26.2, 10.9, 4.6. HRMS (TOF 
ESI+) m/z calculated for C14H18O2Na [M+Na]+: 241.1204, found 241.1212. 
 
1-(4-(tert-butoxy)phenyl)cyclopentane-1-carbonitrile [S53]. 
In a flamed dried 50 mL flask, 1.187 g (6.27 mmol) of 2-(4-(tert-
butoxy)phenyl)acetonitrile was dissolved in 10 mL anhydrous DMF. 396 
mg (95% purity, 15.68 mmol, 2.5 equiv.) of NaH was added in portions at 
0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 1.354 g (0.75 mL, 6.27 mmol, 1.0 
equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir 
overnight at room temperature. The reaction was quenched carefully with ~10 mL water and 
extracted with 30 mL EtOAc three times. The combined organic layer was washed with 50 mL 
brine, dried with MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 
mm fritted glass column, 300 mL SiO2) using 10% EtOAc/hexanes à 20% EtOAc/hexanes as 
eluent gave 1.057 g (4.34 mmol) of pure product as a white solid (69% yield).  
1H-NMR (500 MHz, CDCl3) δ 7.34 – 7.31 (m, 2H), 6.99 – 6.96 (m, 2H), 2.48 – 2.44 (m, 2H), 
2.08 – 1.99 (m, 4H), 1.99 – 1.89 (m, 2H), 1.35 (s, 9H). 13C-NMR (126 MHz, CDCl3) δ 155.1, 
134.5, 126.7, 124.8, 124.3, 78.9, 47.4, 40.6, 29.0, 24.3. HRMS (TOF ESI+) m/z calculated for 
















methyl 1-(4-(tert-butoxy)-3-chlorophenyl)cyclopentane-1-carboxylate [S54]. 
In a 100 mL recovery flask was added 3-chloro-4-hydroxylphenylacetic 
acid 3.30 g (17.7 mmol), 35 mL methanol and 0.4 mL concentrated 
sulfuric acid. The reaction was allowed to reflux overnight. The reaction 
was concentrated, diluted with 50 mL ethyl acetate and neutralized with 
concentrated NaHCO3. The organic layer was dried with MgSO4 and plugged with 20% ethyl 
acetate/hexanes as eluent to get methyl 2-(3-chloro-4-hydroxyphenyl)acetate in quantitative 
yield. The resulted compound was dissolved in 27 mL anhydrous DCM, treated with Mg(ClO4)2 
396 mg (1.77 mmol, 10 mol%) and 8.9 g Boc2O (40.8 mmol, 2.3 equiv.) sequentially. The 
reaction was heated to 40 ºC for 24 hours and filtered through celite. The reaction was purified 
by CombiFlash (40g column, hexanes –> 20% ethyl acetate/hexanes as eluent) to get methyl 2-
(4-(tert-butoxy)-3-chlorophenyl)acetate 2.2624 g (8.81 mmol) in 50% yield. The product was 
dissolved in 18 mL anhydrous DMF in a flame dried 50 mL flask, 556 mg (95% purity, 22.0 
mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC and the reaction was allowed to stir for 1 
hour at 0 ºC. 1.05 mL (8.81 mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC 
and the reaction was allowed to stir overnight at room temperature. The reaction was quenched 
carefully with ~15 mL water and extracted with 30 mL EtOAc three times, washed with 50 mL 
brine, dried with MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 
mm fritted glass column, 200 mL SiO2) using 2% EtOAc/hexanes à 5% EtOAc/hexanes as 























1H-NMR (500 MHz, CDCl3) δ 7.36 (d, J = 2.3 Hz, 1H), 7.13 (dd, J = 8.5, 2.4 Hz, 1H), 7.02 (d, J 
= 8.5 Hz, 1H), 3.62 (s, 3H), 2.63 – 2.58 (m, 2H), 1.89 – 1.83 (m, 2H), 1.75– 1.67 (m, 4H), 1.40 
(s, 9H). 13C-NMR (126 MHz, CDCl3) δ 176.2, 150.8, 139.2, 128.8, 128.8, 125.7, 124.2, 81.3, 
58.5, 52.6, 36.4, 29.0, 23.7. HRMS (TOF ESI+) m/z calculated for C17H23ClO3Na [M+Na]+: 
337.1233, found 337.1227.  
 
(±)-methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-cyclopentylpropanoate [S55]. 
2-(3-chloro-4-hydroxyphenyl)acetic acid (3.3g, 17.7 mmol) was dissolved in 
35 mL MeOH and added concentrated H2SO4 (0.4 mL). The reaction was 
refluxed overnight and concentrated. The residue oil was diluted with ether, 
washed with sat. NaHCO3 twice, water 3 times and brine. The organic layer was dried over 
MgSO4 and concentrated. The crude methyl ester was dissolved in DCM (27 mL), added 
Mg(ClO4)2 (396 mg, 1.77 mmol) and Boc2O (8.9g, 40.8 mmol, 2.3 equiv.). The reaction was 
heated at 40 ºC for 24 hours. The reaction was concentrated and purified by CombiFlash (40 g 
column) eluting with pure hexanes à 80% ethyl acetate/hexanes. Methyl 2-(4-(tert-butoxy)-3-
chlorophenyl)acetate was isolated as clear oil (1.4917 g, 5.81 mmol) in 33% yield. 1H-NMR (500 
MHz, CDCl3) δ 7.30 (d, J = 1.9 Hz, 1H), 7.09 – 7.04 (m, 2H), 3.71 (s, 3H), 3.55 (s, 2H), 1.41 (s, 
9H). In a flame dried 100 mL flask charged with HN(TMS)2 (2.11 g, 13.07 mmol, 2.25 equiv.), 
13 mL anhydrous THF and a stir bar. The flask was cooled to -78 ºC and n-BuLi solution (1.6 M 
in hexanes, 7.6 mL, 12.2 mmol, 2.1 equiv.) was added dropwise and the reaction was stirred at -



















mmol) in 12 mL THF was added and the reaction was stirred at -78 ºC for 30 minutes then at 
room temperature for 20 min. The reaction was cooled back to -78 ºC and charged with 
(iodomethyl)cyclopentane (1.83 g, 8.72 mmol, 1.5 equiv.) and DMPU (1.5 mL, 12.2 mmol, 2.1 
equiv.). The reaction was allowed to gradually warmed up to room temperature and stirred 
overnight. The reaction was quenched with sat. NH4Cl and extracted with ethyl acetate 3 times. 
The combined organic layer was combined, washed with brine, dried with MgSO4 and 
concentrated. The crude material was plugged through silica using 5% ethyl acetate/hexanes to 
obtain a mixture of desired (±)-methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-
cyclopentylpropanoate and dialkylated methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-cyclopentyl-
2-(cyclopentylmethyl)propanoate. The mixture was purified by hydrolyzing in a mixture of 
MeOH (6 mL) and 3M NaOH (6 mL) at 60 ºC for 16h, cooled to room temperature and extracted 
with DCM 3 times to remove the unhydrolyzed methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-
cyclopentyl-2-(cyclopentylmethyl)propanoate. The aqueous layer was acidified with 3M HCl 
and the aqueous layer was extracted with DCM 3 times. The combined organic layer was 
plugged through silica using 5% ethyl acetate/hexanes à 20% acetone/hexanes doped with 1% 
acetic acid to obtain the pure 2-(4-(tert-butoxy)-3-chlorophenyl)-3-cyclopentylpropanoic acid. 
The resulted compound was dissolved in 9 mL benzene and 2 mL MeOH, and treated with 
trimethylsilyldiazomethane (2M solution, 3.5 mL, 7.0 mmol, 2.0 equiv.) for 1 hour. The reaction 
was concentrated and purified by flash column chromatography on silica (50 mm fritted glass 
column, 150 mL SiO2) using 2% EtOAc/hexanes à 5% EtOAc/hexanes as eluent gave 546.2 mg 




1H-NMR (500 MHz, CDCl3) δ 7.33 (d, J = 2.2 Hz, 1H), 7.10 (dd, J = 8.4, 2.2 Hz, 1H), 7.04 (d, J 
= 8.4 Hz, 1H), 3.67 (s, 3H), 3.52 (t, J = 7.8 Hz, 1H), 2.05 (dt, J = 13.4, 7.7 Hz, 1H), 1.78 – 1.69 
(m, 3H), 1.64 – 1.57 (m, 3H), 1.50 – 1.46 (m, 2H), 1.40 (s, 9H), 1.14 – 1.04 (m, 2H). 13C-NMR 
(126 MHz, CDCl3) δ 174.6, 151.2, 135.2, 129.8, 129.2, 126.7, 124.6, 81.4, 52.2, 50.1, 40.1, 38.0, 
32.8, 32.5, 29.0, 25.2 (2 carbons). HRMS (TOF ESI+) m/z calculated for C19H27O3NaCl 
[M+Na]+: 361.1546, found 361.1540. 
General procedure for the synthesis of substrate S56-S57 
 
methyl 1-(3-chloro-4-methoxyphenyl)cyclopentane-1-carboxylate [S56]. 
In a 50 mL flask charged methyl 2-(3-chloro-4-hydroxyphenyl)acetate (2.00 
g, 10 mmol, 1.0 equiv.), K2CO3 (1.38 g, 1.0 equiv.) and anhydrous DMF (20 
mL). MeI (0.65 mL, 1.1 equiv.) was added dropwise and the reaction was stirred overnight. The 
reaction was quenched with water and extracted with DCM and the crude compound was 
plugged through silica with 5% ethyl acetate/hexanes to get methyl 2-(3-chloro-4-
methoxyphenyl)acetate (2.305 g, 9.48 mmol) in 95% yield. The resulted compound was 
dissolved in 15 mL anhydrous DMF, treated with NaH (95%, 599 mg, 23.7 mmol, 2.5 equiv.) at 
0 ºC. After stirring at 0 ºC for 1 h, 1,4-dibromobutane (1.13 mL, 9.48 mmol, 1.0 equiv,) was 
added and the reaction was allowed to warm up to room temperature overnight. The reaction was 
quenched with water and extracted with ether (30 mL) 3 times. The combined organic layer was 
washed with brine and dried over Na2SO4. Flash column chromatography on silica (50 mm 
fritted glass column, 200 mL SiO2) using 2% EtOAc/hexanes à 5% EtOAc/hexanes à 10% 






CO2Me R-I (1.1 equiv.)
K2CO3 (1.0euiv.), DMF
R = CH3 or CD3
NaH (2.5 equiv.)
Br(CH2)4Br (1.0 quiv.)









1H-NMR (500 MHz, CDCl3) δ 7.37 (d, J = 2.4 Hz, 1H), 7.21 (dd, J = 8.6, 2.4 Hz, 1H), 6.86 (d, J 
= 8.6 Hz, 1H), 3.88 (s, 3H), 3.61 (s, 3H), 2.63 – 2.58 (m, 2H), 1.89 – 1.83 (m, 2H), 1.74 – 1.69 
(m, 4H). 13C-NMR (126 MHz, CDCl3) δ 176.3, 153.9, 136.6, 129.0, 126.3, 122.2, 111.9, 58.3, 
56.3, 52.6, 36.4, 23.6. HRMS (TOF ESI+) m/z calculated for C14H18O3Cl [M+H]+: 269.0944, 
found 269.0945. 
methyl 1-(3-chloro-4-(methoxy-d3)phenyl)cyclopentane-1-carboxylate [S57]. 
The compound was prepared in the same procedure as S56 using CD3I from 
methyl 2-(3-chloro-4-hydroxyphenyl)acetate (1.00 g, 5 mmol.). Product was 
isolated as a white solid (515 mg, 1.90 mmol) in 38% yield over 2 steps. 
1H-NMR (500 MHz, CDCl3) δ 7.37 (d, J = 2.4 Hz, 1H), 7.21 (dd, J = 8.6, 2.4 Hz, 1H), 6.85 (d, J 
= 8.6 Hz, 1H), 3.61 (s, 3H), 2.62 – 2.57 (m, 2H), 1.89 – 1.83 (m, 2H), 1.74 – 1.68 (m, 4H). 13C-
NMR (126 MHz, CDCl3) δ 176.3, 153.8, 136.6, 129.0, 126.3, 122.2, 111.8, 58.3, 56.0 – 54.9 (m, 
1C), 52.5, 36.3, 23.6. HRMS (TOF ESI+) m/z calculated for C14H15D3O3Cl [M+H]+: 272.1133, 




To a 300 mL flask added 2-(4-hydroxy-3-methoxyphenyl)acetic acid 
1.8218 g (10mmol, 1.0 equiv.), 2.54 mL TMSCl (20mmol, 2.0 equiv.) 
and 100 mL MeOH. The reaction was sitrred under room temperature 
for 24 hours before diluted with 100 mL DCM and extracted with 100 mL brine. The organic 
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anhydrous DCM, and treated with 1.809 g (12 mmol, 1.2 equiv.) TBSCl, 1.020 g (15 mmol, 1.5 
equiv.) imidazole and 122 mg (1 mmol, 0.1 equiv.) DMAP. The reaction was stirred overnight, 
worked up with water and extracted with DCM. The combined organic layer was washed with 
brine and dried with Na2SO4. The crude product was dissolved in 15 mL anhydrous DMF and 
transferred to a 50 mL flamed dried flask. 632 mg (95% purity, 25 mmol, 2.5 equiv.) of NaH was 
added in portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 1.18 mL (10.0 
mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the reaction was 
allowed to stir overnight at room temperature. The reaction was quenched carefully with ~10 mL 
water and extracted with 30 mL EtOAc three times, washed with 50 mL brine, dried with 
MgSO4, filtered, and concentrated. The product was dissolved in 2 mL THF and added 1.5 mL 
1M TBAF solution and stirred overnight then concentrated. The previous aqueous layer was 
acidified with 3M HCl then extract with 30 mL EtOAc three times. The combined organic layer 
was washed with 50 mL brine, dried with MgSO4, filtered, and concentrated to get 378 mg of 
crude phenol compound. The crude was dissolved in 5 mL anhydrous DCM, cooled to 0 ºC and 
treated with 0.31 mL (1.8 mmol, 1.2 equiv.) of triflate anhydride and 0.18 mL (2.27 mmol, 1.5 
equiv.) of pyridine. The reaction was then stirred for 5 hours at room temperature before 
quenched with ~10 mL water. 15 mL DCM was used to extract the reaction 3 times and the 
combined organic layer was dried with Na2SO4 and concentrated. Flash column chromatography 
on silica (50 mm fritted glass column, 200 mL SiO2) using 5% EtOAc/hexanes à 10% 
EtOAc/hexanes as eluent gave 542.2 mg (1.42 mmol) of pure product as a colorless oil (14% 
yield over 5 steps). 
1H-NMR (500 MHz, CDCl3) δ 7.13 (d, J = 8.4 Hz, 1H), 7.01 (d, J = 2.1 Hz, 1H), 6.96 (dd, J = 
8.5, 2.2 Hz, 1H), 3.91 (s, 3H), 3.64 (s, 3H), 2.68 – 2.63 (m, 2H), 1.90 – 1.85 (m, 2H), 1.77 – 1.71 
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(m, 4H). 13C-NMR (126 MHz, CDCl3) δ 175.8, 151.1, 145.0, 137.6, 122.1, 119.5, 118.87 (d, J = 
321.2 Hz), 112.2, 59.3, 56.3, 52.7, 36.4, 23.7. 19F-NMR (470 MHz, CDCl3) δ -73.9. HRMS 
(TOF ESI+) m/z calculated for C15H18F3O6S [M]+: 383.0771, found 383.0773. 
 
4-(1-cyanocyclopentyl)-2-methylphenyl trifluoromethanesulfonate [S59]. 
To a 50 mL flask added 2-(4-methoxy-3-methylphenyl)acetonitrile1.0 g (6.2 
mmol, 1.0 equiv.), dissolved in 10 mL anhydrous DMF. 392 mg (95% 
purity, 15.5 mmol, 2.5 equiv.) of NaH was added in portions at 0 ºC and the 
reaction was allowed to stir for 1 hour at 0 ºC. 0.74 mL (6.2 mmol, 1.0 equiv.) of 1,4-
dibromobutane was added dropwise at 0 ºC and the reaction was allowed to stir overnight at 
room temperature. The reaction was quenched carefully with ~10 mL water and extracted with 
30 mL EtOAc three times, washed with 50 mL brine, dried with MgSO4, filtered, and 
concentrated. Flash column chromatography on silica (50 mm fritted glass column, 200 mL 
SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 1.2217 g (5.67 mmol) of 
1-(4-methoxy-3-methylphenyl)cyclopentane-1-carbonitrile in 91% yield. 1H-NMR (500 MHz, 
CDCl3) δ 7.23 (dd, J = 8.4, 2.6 Hz, 1H), 7.20 – 7.19 (m, 1H), 6.80 (d, J = 8.4 Hz, 1H), 3.83 (s, 
3H), 2.46 – 2.41 (m, 2H), 2.23 (s, 3H), 2.07 – 1.90 (m, 6H). The product was dissolved in 20 mL 
dry DCM, followed by 28.4 mL BBr3 solution (1M in DCM, 5 equiv.) at -78 ºC. The reaction 
was stirred at -78 ºC for 30 minutes then allowed to stir at room temperature for overnight. The 
reaction was quenched with NaHCO3, separated, the organic layer washed with brine and dried 
with Na2SO4. Flash column chromatography on silica (50 mm fritted glass column, 200 mL 



















of the free phenol in 78% yield. 1H-NMR (500 MHz, CDCl3) δ 7.20 (d, J = 2.5 Hz, 1H), 7.14 
(dd, J = 8.3, 2.5 Hz, 1H), 6.76 (d, J = 8.3 Hz, 1H), 4.68 (br. s, 1H), 2.44 (dq, J = 10.0, 5.8, 5.0 
Hz, 2H), 2.26 (s, 3H), 2.08 – 1.87 (m, 6H). The free phenol was dissolved in 25 mL anhydrous 
DCM, treated with 0.89 mL (5.32 mmol, 1.2 equiv.) Tf2O and 0.54 mL (6.65 mmol, 1.5 equiv.) 
pyridine at 0 ºC then stirred at room temperature overnight. The reaction was quenched with ~10 
mL water. 15 mL DCM was used to extract the reaction 3 times and the combined organic layer 
was dried with Na2SO4 and concentrated. Flash column chromatography on silica (50 mm fritted 
glass column, 200 mL SiO2) using 5% EtOAc/hexanes à 10% EtOAc/hexanes as eluent gave 
1.294 g (3.88 mmol) of pure product as a colorless oil (88% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.41 (d, J = 2.5 Hz, 1H), 7.33 (dd, J = 8.7, 2.5 Hz, 1H), 7.24 (d, J 
= 8.6 Hz, 1H), 2.51 – 2.46 (m, 2H), 2.40 (s, 3H), 2.09 – 1.92 (m, 6H). 13C-NMR (126 MHz, 
CDCl3) δ 147.8, 140.2, 131.6, 130.2, 125.4, 123.9, 121.8, 118.7 (q, J = 320.1 Hz), 47.5, 40.7, 
24.4, 16.7. 19F-NMR (470 MHz, CDCl3) δ -74.1. HRMS (TOF ESI+) m/z calculated for 
C14H15NF3O3S [M+H]+: 334.0725, found 334.0721.  
 
1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopentane-1-carbonitrile [S60]. 
In a flamed dried 50 mL flask, 591.4 mg (3.0 mmol) of 2-(2,2-
difluorobenzo[d][1,3]dioxol-5-yl)acetonitrile was dissolved in 6 mL 
anhydrous DMF. 344.8 mg (95% purity, 13.7 mmol, 2.5 equiv.) of NaH 
was added in portions at 0 ºC and the reaction was allowed to stir for 1 hour at 0 ºC. 647.7 mg 
(0.36 mL, 3.0 mmol, 1.0 equiv.) of 1,4-dibromobutane was added dropwise at 0 ºC and the 




















with ~10 mL water and extracted with 30 mL EtOAc three times. The combined organic layer 
was washed with 50 mL brine, dried with MgSO4, filtered, and concentrated. Flash column 
chromatography on silica (50 mm fritted glass column, 200 mL SiO2) using 5% EtOAc/hexanes 
à 10% EtOAc/hexanes as eluent gave 396.9 mg (1.58 mmol) of pure product as a colorless oil 
(53% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.20 (dd, J = 8.4, 2.0 Hz, 1H), 7.16 (d, J = 1.9 Hz, 1H), 7.05 (d, J 
= 8.4 Hz, 1H), 2.54 – 2.48 (m, 2H), 2.09 – 1.91 (m, 6H). 13C-NMR (126 MHz, CDCl3) δ 144.3, 
143.3, 136.2, 131.8 (t, J = 256.1 Hz), 123.9, 121.6, 109.6, 107.8, 47.7, 40.7, 24.2. 19F-NMR (470 
MHz, CDCl3) δ -49.9. HRMS (TOF ESI+) m/z calculated for C13H11NO2F2 [M]+: 251.0758, 
found 251.0758. 
General Procedure for Reductive Amination: To a round bottom flask equipped with a 
magnetic stir bar was added the corresponding amine (1.0 equiv.), 1,2-dichloroethane (0.1 M), 
the corresponding aldehyde (1.5 equiv.), and AcOH (1% v/v). After 30 minutes, NaBH(OAc)3 
(1.5 equiv.) was added in one portion and reaction solution was stirred overnight at room 
temperature. The reaction was quenched with saturated aqueous NaHCO3 solution and extracted 
with CH2Cl2 3 times. Combined organic layer was washed with saturated aqueous NaHCO3 
solution once and brine once, dried over anhydrous MgSO4, filtered and concentrated under 








According to general procedure for reductive amination, 4-(4-
chlorophenyl)piperidine-4-carbonitrile (2.21 g, 10.0 mmol, 1.0 equiv.), 
valeraldehyde (1.6 mL, 15.0 mmol, 1.5 equiv.), acetic acid (1.0 mL, 1% 
v/v), and NaBH(OAc)3 (3.18 g, 15.0 mmol, 1.5 equiv.) in DCE (100 
mL, 0.1 M) were reacted. Flash column chromatography on silica eluting with 2% MeOH in 
CHCl3 yielded S61 (1.57 g, 5.40 mmol, 54%) as a pale yellow oil. 
1H-NMR (500 MHz, CDCl3) δ 7.44 – 7.41 (m, 2H), 7.37 – 7.34 (m, 2H), 3.04 – 3.00 (m, 2H), 
2.47 – 2.40 (m, 4H), 2.11 – 2.02 (m, 4H), 1.54 – 1.48 (m, 2H), 1.37 – 1.25 (m, 4H), 0.90 (t, J = 
7.1 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 139.0, 134.1, 129.2, 127.2, 121.8, 58.7, 50.8, 42.6, 
36.7, 29.9, 26.8, 22.7, 14.2. HRMS (TOF ESI+) m/z calculated for C17H24N2Cl [M+H]+: 
291.1628, found 291.1624. 
 
4-(4-Chlorophenyl)-1-(cyclopentylmethyl)piperidine-4-carbonitrile [S62]. 
According to general procedure for reductive amination, 4-(4-
chlorophenyl)piperidine-4-carbonitrile (1.10 g, 5.00 mmol, 1.0 equiv.), 
cyclopentanecarbaldehyde (540 mg, 5.50 mmol, 1.1 equiv.), acetic acid 





























DCE (100 mL, 0.1 M) were reacted. Flash column chromatography on silica eluting with 3% 
MeOH in CHCl3 yielded compound S62 (615 mg, 2.03 mmol, 41%) as a pale yellow solid. 
1H-NMR (500 MHz, CDCl3) δ 7.47 – 7.41 (m, 2H), 7.40 – 7.33 (m, 2H), 3.08 – 2.95 (m, 2H), 
2.53 – 2.39 (m, 2H), 2.36 (d, J = 7.3 Hz, 2H), 2.14 – 2.00 (m, 5H), 1.82 – 1.70 (m, 2H), 1.67 – 
1.47 (m, 4H), 1.25 – 1.15 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 139.2, 134.1, 129.3, 127.2, 
122.0, 64.5, 51.1, 42.7, 37.5, 36.8, 31.6, 25.3. HRMS (TOF ESI+) m/z calcd for C18H24N2Cl 
[M+H]+: 303.1628, found 303.1624.  
 
1-(4-Chlorobenzyl)-4-ethylpiperidine [S63]. 
A mixture of 4-ethylpyridine (1.14 mL, 10.0 mmol, 1.0 equiv.), 
platinum(IV) oxide (114 mg, 0.50 mmol, 0.05 equiv.) and HCl solution 
(2.75 ml, 11.0 mmol, 4 M in dioxane, 1.1 equiv.) in methanol (50 ml, 
0.2 M) was hydrogenated at 100 psi overnight. The catalyst was removed by filtration through 
celite and the filtrate evaporated under reduced pressure. The residue was treated with saturated 
aqueous NaHCO3 solution, and extracted with CH2Cl2 twice. The combined organic extracts 
were washed with water and brine. Dried over anhydrous MgSO4, filtered and concentrated 
under reduced pressure. The crude mixture was used in the next step without further purification. 
According to general procedure for reductive amination, the corresponding piperidine (10.0 
mmol, 1.0 equiv.), p-chlorobenzaldehyde (2.11 g, 15.0 mmol, 1.5 equiv.), acetic acid (1.0 mL, 
1% v/v), and NaBH(OAc)3 (3.18 g, 15.0 mmol, 1.5 equiv.) were reacted. Flash column 
chromatography on silica eluting with 10% EtOAc/CHCl3 yielded compound S63 (876 mg, 3.68 
mmol, 37% over 2 steps) as a pale yellow oil. 
N
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1H-NMR (500 MHz, CDCl3) δ 7.31 – 7.22 (m, 4H), 3.45 (s, 2H), 2.84 (dt, J = 12.1, 3.2 Hz, 2H), 
1.95 – 1.90 (m, 2H), 1.67 – 1.63 (m, 2H), 1.29 – 1.09 (m, 5H), 0.87 (t, J = 7.4 Hz, 3H). 13C-
NMR (126 MHz, CDCl3) δ 137.5, 132.6, 130.6, 128.4, 62.9, 54.2, 37.6, 32.2, 29.4, 11.5. HRMS 
(TOF ESI+) m/z calcd for C14H21NCl [M+H]+: 238.1363, found 238.1358.  
 
1-(4-Fluorophenyl)-4-(8-azaspiro[4.5]decan-8-yl)butan-1-one [S64]. 
A stirring mixture of the 4-chloro-1-(4-fluorophenyl)butan-1-
one (1.25 mL, 7.67 mmol, 1.0 equiv.), KI (128 mg, 0.77 mmol, 
0.1 equiv.), NaHCO3 (1.93 g, 23.0 mmol, 3.0 equiv.), and 8-
azaspiro[4.5]decane hydrochloride (1.35 g, 7.67 mmol, 1.0 equiv.) in toluene (15 mL, 0.5 M) 
was heated to reflux for 30 h under N2. After this period, the reaction mixture was cooled down, 
filtered through a celite plug, and the solvent was removed under reduced pressure. Flash column 
chromatography on silica eluting with 5% MeOH/CHCl3 yielded compound S64 (1.44 g, 4.75 
mmol, 62%) as a pale yellow solid. 
1H-NMR (500 MHz, CDCl3) δ 8.01 – 7.98 (m, 2H), 7.11 (t, J = 8.6 Hz, 2H), 2.95 (t, J = 7.2 Hz, 
2H), 2.38 – 2.35 (m, 6H), 1.92 (p, J = 7.2 Hz, 2H), 1.57 – 1.55 (m, 4H), 1.43 – 1.41 (m, 4H), 
1.37 – 1.34 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 198.7, 165.7 (d, J = 254.2 Hz), 133.7 (d, J = 
2.9 Hz), 130.8 (d, J = 9.4 Hz), 115.7 (d, J = 21.9 Hz), 58.3, 51.5, 40.9, 37.7 (overlapped, 4 
carbons), 36.5, 24.4, 22.0. 19F-NMR (470 MHz, CDCl3) δ −106.2. HRMS (TOF ESI+) m/z calcd 


















A suspension of (E/Z)-3-(1-(3,4-difluorophenyl)pent-1-en-1-yl)pyridine 
(857 mg, 3.31 mmol, 1.0 equiv.), 10% Pd/C (359 mg, 0.337 mmol, 0.1 
equiv.) in EtOH (50 mL, 0.07 M) was stirred under a balloon pressure of 
hydrogen for 14 hours. The reaction mixture was filtered through Celite 
with ethyl acetate. The solvent was removed under reduced pressure and the residue was purified 
by flash column chromatography on silica eluting 20% ethyl acetate/hexanes as eluent to yield 
the desired product (560 mg, 2.14 mmol, 65%) as a colorless oil. 
1H-NMR (500 MHz, CDCl3) δ 8.48 (d, J = 2.3 Hz, 1H), 8.44 (dd, J = 4.8, 1.6 Hz, 1H), 7.47 (dt, J 
= 7.9, 2.0 Hz, 1H), 7.21 (dd, J = 7.9, 4.8 Hz, 1H), 7.06 (dt, J = 10.1, 8.3 Hz, 1H), 7.01 (ddd, J = 
11.5, 7.6, 2.3 Hz, 1H), 6.93 (ddt, J = 8.1, 3.8, 1.7 Hz, 1H), 3.85 (t, J = 7.8 Hz, 1H), 2.02 – 1.97 
(m, 2H), 1.36 – 1.29 (m, 2H), 1.24 – 1.17 (m, 2H), 0.85 (t, J = 7.3 Hz, 3H). 13C-NMR (126 MHz, 
CDCl3) δ 150.7 (dd, J = 170.5, 12.7 Hz), 149.6, 149.2 (dd, J = 169.0, 13.4 Hz), 148.0, 141.2 (t, J 
= 4.4 Hz), 139.8, 135.0, 123.8 (dd, J = 6.1, 3.5 Hz), 123.7, 117.4 (d, J = 17.0 Hz), 116.6 (d, J = 
17.2 Hz), 48.2, 35.2, 30.0, 22.6, 14.0. 19F-NMR (470 MHz, CDCl3) δ −137.8 (m), −141.4 (m). 

















To a solution of diisopropylamine (298 mg, 2.95 mmol, 1.2 equiv.) in THF 
(1.5 mL, 2.0 M) at −78 °C was added n-butyllithium (1.8 mL, 2.88 mmol, 
1.6 M in hexanes, 1.15 equiv.) dropwise. The reaction was stirred at −78 °C 
for 15 minutes, then warmed to room temperature for 5 minutes, then cooled 
back down to −78 °C. To the LDA solution was added 4-(4-chlorophenyl)-2-methylpyridine 
(509 mg, 2.5 mmol, 1 equiv.) in THF (5 mL, 0.5 M) dropwise, and this mixture was allowed to 
react for 1 hour at −78 °C. After this period, 1-bromobutane (383 mg, 2.8 mmol, 1.1 equiv.) was 
added dropwise at −78 °C and the reaction was allowed to warm to room temperature and stirred 
overnight. The reaction was quenched with water, and the aqueous layer was extracted with 
CH2Cl2 (3 times). The combined organics were dried over Na2SO4 and concentrated under 
reduced pressure. The residue was purified by flash column chromatography on silica eluting 5% 
à 7.5% à 15% à 25% EtOAc:hexanes to yield the desired product (409 mg, 1.57 mmol, 63% 
yield) as a yellow oil. 
1H-NMR (500 MHz, CDCl3) δ 8.57 (dd, J = 5.2, 0.8 Hz, 1H), 7.60 – 7.52 (m, 2H), 7.50 – 7.40 
(m, 2H), 7.33 – 7.30 (m, 1H), 7.27 (dd, J = 5.2, 1.8 Hz, 1H), 2.84 (dd, J = 9.7, 6.2 Hz, 2H), 1.82 
– 1.76 (m, 2H), 1.40 – 1.37 (m, 4H), 0.91 (t, J = 7.5 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 
163.4, 149.8, 147.6, 137.1, 135.2, 129.4, 128.4, 120.6, 118.9, 38.7, 31.8, 29.8, 22.7, 14.2. HRMS 
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In a flame dried 50 mL recovery flask was charged 5-(4-bromophenyl)-
1H-imidazole (1.115g, 5.0 mmol, 1.0 equiv.) and anhydrous DMF (10 
mL, 0.5 M). NaH (95%, 158 mg, 6.25 mmol, 1.25 equiv.) was added 
portionwise at 0 ºC followed by 1-bromohexane (772 µL, 5.5 mmol, 1.1 equiv.). The reaction 
was allowed to warm up to room temperature and stirred overnight. The reaction was quenched 
with sat. NH4Cl, extracted with ethyl acetate 3 times. The combined organic layer was washed 
with water 3 times, brine and dried with Na2SO4. Flash column chromatography on silica (50 
mm fritted glass column, 200 mL SiO2) using 30% ethyl acetate/hexanes à 50% ethyl 
acetate/hexanes à 80% ethyl acetate/hexanes as eluent twice to get product co-eluded with a 
yellow impurity. The resulted compound was dissolved in a minimum amount of DCM, crashed 
out with pentane, and the solid was washed with pentane until no yellow color was observed in 
the eluent. The product was obtained as white fluffy solid (939 mg, 3.06 mmol, 61% yield). The 
purity of the compound is crucial to the oxidation. 
1H-NMR (500 MHz, CDCl3) δ 7.65 – 7.62 (m, 2H), 7.50 – 7.47 (m, 3H), 7.19 (d, J = 1.3 Hz, 
1H), 3.94 (t, J = 7.1 Hz, 2H), 1.81 (p, J = 7.2 Hz, 2H), 1.35 – 1.28 (m, 6H), 0.89 (t, J = 6.9 Hz, 
3H). 13C-NMR (126 MHz, CDCl3) δ 141.3, 137.6, 133.4, 131.8, 126.4, 120.4, 115.0, 47.5, 31.4, 


















To a stirring solution of benzimidazole (1.0 g, 8.46 mmol, 1.0 equiv.) in THF 
(6 mL, 1.4 M) at 0 °C was added NaH 95% (214 mg, 8.46 mmol, 1.0 equiv.). 
After 30 min, the cyclopentylmethyl 4-methylbenzenesulfonate (2.59 g, 10.2 
mmol, 1.2 equiv.) in THF (2 mL, 5.1 M) was added dropwise and the reaction mixture was 
warmed and stirred under reflux overnight. The reaction was quenched with the addition of H2O. 
The layers were separated, and the aqueous layer was extracted with EtOAc (3 times). The 
combined organic layers were washed with brine (once), dried over MgSO4, filtered, and 
concentrated under reduced pressure. The crude mixture was purified by flash column 
chromatography on silica eluting 30% EtOAc:CHCl3 as eluent to yield the desired product (1.51 
g, 7.54 mmol, 89%) as a white solid. 
1H-NMR (500 MHz, CDCl3) δ 7.86 (s, 1H), 7.83 – 7.74 (m, 1H), 7.43 – 7.35 (m, 1H), 7.33 – 
7.20 (m, 2H), 4.04 (d, J = 7.5 Hz, 2H), 2.43 (hept, J = 7.5 Hz, 1H), 1.74 – 1.60 (m, 4H), 1.60 – 
1.49 (m, 2H), 1.30 – 1.19 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 143.9, 143.1, 134.0, 122.8, 
122.0, 120.4, 109.8, 49.9, 40.3, 30.6, 25.0. HRMS (TOF ESI+) m/z calcd for C13H17N2 [M + H]+: 

















In a 50 mL flame dried flask was added DIPEA (1.84 mL, 13.1 mmol) and 12 mL 
anhydrous THF. n-BuLi (1.6M, 7.8 mL, 12.5 mmol) was added dropwise at -78 ºC 
and kept at -78 ºC for 10 min. After stirred for another 30 min at room temperature, 
the LDA solution was cooled back to -78 ºC and added dropwise into a solution of 
4-methylquinoline (1.45 mL, 11 mmol) in 40 mL anhydrous THF at -78 ºC. After 2.5 h, 1-
bromobutane (1.55 mL, 14.3 mmol, 1.3 equiv.) was added at -78 ºC. The reaction was allowed to 
stir at -78 ºC for another 3 h before warmed up to room temperature and stirred overnight. The 
reaction was worked up with NH4Cl and extracted with ether 3 time. The combined organic layer 
was washed with brine and dried with Na2SO4. Flash column chromatography on silica (50 mm 
fritted glass column, 200 mL SiO2) using 20% ethyl acetate/hexanes à 30% ethyl 
acetate/hexanes as eluent twice to get product as yellowish oil (1.823 g, 9.15 mmol, 83% yield).  
1H-NMR (500 MHz, CDCl3) δ 8.80 (d, J = 4.4 Hz, 1H), 8.11 (d, J = 8.4 Hz, 1H), 8.03 (d, J = 8.5 
Hz, 1H), 7.68 (dd, J = 8.3, 6.8 Hz, 1H), 7.54 (dd, J = 7.5, 6.9 Hz, 1H), 7.22 (d, J = 4.4 Hz, 1H), 
3.07 – 3.03 (m, 2H), 1.76 (p, J = 7.5 Hz, 2H), 1.45 – 1.34 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H). 13C-
NMR (126 MHz, CDCl3) δ 150.3, 148.8, 148.5, 130.4, 129.0, 127.7, 126.3, 123.7, 120.9, 32.2, 
















A 50 mL round bottom flask was charged with a stir bar, (S)-4-chlorophenyl 
glycine (H-ClPhg-OH, 371 mg, 2.0 mmol, 1.0 equiv.), and MeOH and cooled 
to 0 ºC. To the stirred mixture was added TMSCl (1.04 mL, 8.2 mmol, 4.1 
equiv.) dropwise at 0 ºC and the reaction was stirred at room temperature. 
After stirring for 24 h, the reaction was concentrated under reduced pressure to afford (S)-4-
chlorophenylglycine methyl ester hydrochloride (H-ClPhg-OMe•HCl) as a white solid in 
quantitative yield. Longer reaction time causes racemization of the amino acid and smaller 
amount of TMSCl gives lower conversion of the reaction. A 50 mL round bottom flask was 
charged with a stir bar, H-ClPhg-OMe•HCl, N-nitrobenzenesulfonyl norleucine (Ns-Nle-OH, 
633 mg, 2.0 mmol, 1.0 equiv.), O-(7-azabenzotriazol-1-yl)-N,N,N',N'-tetramethyluronium 
hexafluorophosphate (HATU, 761 mg, 2.0 mmol, 1.0 equiv.) and DCM (10 mL) and cooled to 0 
ºC. To this suspension was added iPr2NEt (1 mL) dropwise and the reaction was stirred at 0 ºC. 
After stirring for 6 h, saturated aqueous NaHCO3 (20 mL) was added then the mixture was 
separated and the aqueous layer was extracted with DCM (2 x 10 mL). The combined organic 
layers were washed with 10 wt% of aqueous citric acid (20 mL) and the aqueous layer was 
extracted with DCM (2 x 10 mL). The combined organic layers were washed with brine (20 mL), 
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dissolved with a small amount of DCM and concentrated onto silica gel (10 mL) for dry loading 
onto the column (SiO2, 75 mL) and then eluted with 10% à 30% ethyl acetate/hexanes to give a 
coupling product with a small impurity. The additional column chromatography (SiO2, 75 mL) 
eluted by CHCl3 à 5% ethyl acetate/CHCl3 gave 801 mg (1.61 mmol) of Ns-Nle-ClPhg-OMe 
(+)-S70 as a white solid in 80% yield. 
1H-NMR (500 MHz, CDCl3) 8.13 (d, J = 8.8 Hz, 2H), 7.91 (d, J = 8.8 Hz, 2H), 7.27 (d, J = 8.5 
Hz, 2H), 7.12 (d, J = 8.4 Hz, 2H), 6.97 (d, J = 7.1 Hz, 1H), 5.84 (br. s, 1H), 5.33 (d, J = 7.0 Hz, 
1H), 3.88 (t, J = 6.7 Hz, 1H), 3.69 (s, 3H), 1.76 – 1.69 (m, 1H), 1.61 – 1.55 (m, 1H), 1.31 – 1.20 
(m, 4H), 0.82 (t, J = 6.8 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 170.6, 170.1, 150.1, 145.8, 
135.1, 134.3, 129.3, 128.5, 128.4, 124.3, 57.0, 55.8, 53.4, 33.5, 27.3, 22.2, 13.9. [a]D24 = +124 (c 




The preparation was performed according to the procedure for (+)-S70. 
Fleshly prepared H-ClPhg-OMe•HCl (3.0 mmol, 1.0 equiv.) reacted with 
N-phthaloyl cycloleucine (Phth-CyLeu-OH, 778 mg, 3.0 mmol, 1.0 
equiv.), HATU (1.14 g, 3.0 mmol, 1.0 equiv.), and iPr2NEt (1.5 mL) in DCM (15 mL). The crude 
mixture was dissolved with a small amount of DCM and concentrated onto SiO2 (10 mL) for dry 
loading onto the column (SiO2, 150 mL) and then eluted with 20% ethyl acetate/hexane to afford 
978 mg (2.22 mmol) of Phth-CyLeu-ClPhg-OMe (+)-S71 as a white solid in 74% yield. 
1H-NMR (500 MHz, CDCl3) 7.83 – 7.79 (m, 2H), 7.73 – 7.69 (m, 2H), 7.30 – 7.24 (m, 4H), 6.97 











2H), 2.50 – 2.46 (m, 1H), 1.84 – 1.75 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 171.6, 171.0, 
169.0, 135.0, 134.5, 134.3, 131.8, 129.2, 128.6, 123.4, 70.9, 56.3, 53.1, 35.8, 35.7, 23.7, 23.7. 
[a]D24 = +98.0 (c = 1.01, CHCl3). HRMS (TOF ESI+) m/z calculated for C23H22N2O5Cl [M+H]+: 
411.1217, found 411.1230. 
(+)-methyl methyl (S)-2-(4-chlorophenyl)-2-((2S,3S)-3-methyl-2-((4-
nitrophenyl)sulfonamido)pentanamido)acetate [(+)-S72]. 
The preparation was performed according to the procedure for (+)-S70. 
Fleshly prepared H-ClPhg-OMe•HCl (3.0 mmol, 1.0 equiv.) reacted with N-
nitrobenzenesulfonyl norleucine (Ns-Ile-OH, 949 mg, 3.0 mmol, 1.0 equiv.), 
HATU (1.14 g, 3.0 mmol, 1.0 equiv.), and iPr2NEt (1.5 mL) in DCM (15 mL). The crude 
mixture was dissolved with a small amount of DCM and concentrated onto silica gel (10 mL) for 
dry loading onto the column (SiO2, 75 mL) and then eluted with 10% à 30% ethyl 
acetate/hexanes to give a coupling product with a small impurity. The additional column 
chromatography (SiO2, 75 mL) eluted by CHCl3 à 5% ethyl acetate/CHCl3 gave 1.03 g (2.07 
mmol) of Ns-Ile-ClPhg-OMe (+)-S72 as a white solid in 69% yield. 
1H-NMR (500 MHz, CDCl3) 8.13 – 8.10 (m, 2H), 7.91 – 7.88 (m, 2H), 7.28 (d, J = 8.4 Hz, 2H), 
7.08 (d, J = 8.5 Hz, 2H), 6.66 (br. s, 1H), 5.53 (br. s, 1H), 5.29 (d, J = 6.9 Hz, 1H), 3.72 – 3.69 
(m, 1H), 3.69 (s, 3H), 1.79 (dtd, J = 9.8, 6.4, 3.6 Hz, 1H), 1.44 (ddp, J = 14.9, 7.4, 3.8 Hz, 1H), 
1.12 (ddt, J = 14.1, 9.4, 7.2 Hz, 1H), 0.94 (d, J = 6.8 Hz, 3H), 0.87 (t, J = 7.4 Hz, 3H). 13C-NMR 
(126 MHz, CDCl3) δ 170.6, 169.5, 150.0, 145.7, 135.1, 134.2, 129.3, 128.5, 128.4, 124.2, 61.6, 
55.8, 53.3, 38.6, 24.5, 15.5, 11.3. [a]D24 = +136 (c = 1.04, CHCl3). HRMS (TOF ESI+) m/z 














A round bottom flask was charged with a stir bar, (S)-4-
bromophenylglycine methyl ester hydrochloride (H-BrPhe-OMe•HCl, 1.24 
g, 4.1 mmol, 1.0 equiv.) and DCM (25 mL). To this suspension was added 
iPr2NEt (2 mL) to basify the mixture. Next were added N-nitrobenzenesulfonyl proline (Ns-Pro-
OH, 1.24 g, 4.1 mmol, 1.0 equiv.), N-hydroxybenzotriazole hydrate (HOBt•xH2O, 20% by 
weight H2O, 944 mg) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC•HCl, 788 mg, 5.0 mmol, 1.0 equiv.) and the reaction was stirred overnight at room 
temperature. Saturated aqueous NaHCO3 (20 mL) was added then the mixture was separated and 
the aqueous layer was extracted with DCM (2 x 10 mL). The combined organic layers were 
washed with 10 wt% of aqueous citric acid (20 mL) and the aqueous layer was extracted with 
DCM (2 x 10 mL). The combined organic layers were washed with brine (20 mL), dried over 
Na2SO4, filtered, and concentrated under reduced pressure. The residue was diluted with DCM 
and concentrated under reduced pressure onto silica gel (~8 mL) for dry loading onto the column 
(SiO2, 125 mL) and then eluted with 5% ethyl acetate/CHCl3 to afford 1.74 g (3.22 mmol) of Ns-
Pro-BrPhe-OMe (-)-S73 as a white solid in 79% yield. 
1H-NMR (500 MHz, CDCl3) 8.38 (d, J = 8.8 Hz, 2H), 8.03 (d, J = 8.8 Hz, 2H), 7.41 (d, J = 8.4 
Hz, 2H), 7.05 – 7.01 (m, 3H), 4.88 – 4.80 (m, 1H), 4.15 – 4.13 (m, 1H), 3.78 (s, 3H), 3.40 (ddd, 






















3.2 Hz, 1H), 1.70 – 1.59 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 171.3, 170.2, 150.6, 142.3, 
135.0, 131.8, 131.2, 129.2, 124.7, 121.3, 62.4, 53.2, 52.8, 49.7, 37.5, 30.2, 24.5. [a]D24 = -48.6 (c 




A round bottom flask was charged with a stir bar, (S)-4-fluorophenylglycine 
methyl ester hydrochloride (H-FPhe-OMe•HCl, 1.29 g, 5.5 mmol, 1.0 
equiv.) and DCM (25 mL). To this suspension was added iPr2NEt (2 mL) to 
basify the mixture. Next were added N-nitrobenzenesulfonyl proline (Ns-Pro-OH, 1.65 g, 5.5 
mmol, 1.0 equiv.), N-hydroxybenzotriazole hydrate (HOBt•xH2O, 20% by weight H2O, 1.29 g) 
and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC•HCl, 1.06 g, 5.5 
mmol, 1.0 equiv.) and the reaction was stirred overnight at room temperature. Saturated aqueous 
NaHCO3 (20 mL) was added then the mixture was separated and the aqueous layer was extracted 
with DCM (2 x 10 mL). The combined organic layers were washed with 10 wt% of aqueous 
citric acid (20 mL) and the aqueous layer was extracted with DCM (2 x 10 mL). The combined 
organic layers were washed with brine (20 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was diluted with DCM and concentrated under reduced 
pressure onto silica gel (~8 mL) for dry loading onto the column (SiO2, 125 mL) and then eluted 
with 5% ethyl acetate/CHCl3 to afford 1.87 g (3.90 mmol) of Ns-Pro-FPhe-OMe (-)-S74 as a 
white solid in 71% yield. 
1H-NMR (500 MHz, CDCl3) 8.38 – 8.36 (m, 2H), 8.04 – 8.02 (m, 2H), 7.12 – 7.09 (m, 2H), 7.04 









3.40 (ddt, J = 9.9, 6.8, 3.1 Hz, 1H), 3.24 – 3.15 (m, 2H), 3.04 (dd, J = 14.1, 7.1 Hz, 1H), 2.10 – 
2.08 (m, 1H), 1.70 – 1.59 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 171.4, 170.2, 162.1 (d, J = 
245.6 Hz), 150.6, 142.3, 131.7 (d, J = 3.3 Hz), 130.9 (d, J = 7.9 Hz), 129.1, 124.7, 115.5 (d, J = 
21.2 Hz), 62.4, 53.4, 52.7, 49.7, 37.2, 30.2, 24.5. 19F-NMR (470 MHz, CDCl3) δ -115.8. [a]D25 = 
-69.1 (c = 1.02, CHCl3). HRMS (TOF ESI+) m/z calculated for C21H23N3O7FCl [M+H]+: 
480.1241, found 480.1234. 
(-)-methyl (S)-3-(4-chlorophenyl)-2-((S)-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-
carboxamido)propanoate [(-)-S75]. 
A round bottom flask was charged with a stir bar, (S)-4-chlorophenylglycine 
methyl ester hydrochloride (H-ClPhe-OMe•HCl, 1.25 g, 5.0 mmol, 1.0 
equiv.) and DCM (25 mL). To this suspension was added iPr2NEt (2 mL) to 
basify the mixture. Next were added N-nitrobenzenesulfonyl proline (Ns-Pro-OH, 1.50 g, 5.0 
mmol, 1.0 equiv.), N-hydroxybenzotriazole hydrate (HOBt•xH2O, 20% by weight H2O, 1.15 g) 
and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC•HCl, 959 mg, 5.0 
mmol, 1.0 equiv.) and the reaction was stirred overnight at room temperature. Saturated aqueous 
NaHCO3 (20 mL) was added then the mixture was separated and the aqueous layer was extracted 
with DCM (2 x 10 mL). The combined organic layers were washed with 10 wt% of aqueous 
citric acid (20 mL) and the aqueous layer was extracted with DCM (2 x 10 mL). The combined 
organic layers were washed with brine (20 mL), dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The residue was diluted with DCM and concentrated under reduced 
pressure onto silica gel (~8 mL) for dry loading onto the column (SiO2, 125 mL) and then eluted 
with 5% ethyl acetate/CHCl3 to afford 2.04 g (4.11 mmol) of Ns-Pro-ClPhe-OMe (-)-S75 as a 









1H-NMR (500 MHz, CDCl3) 8.39 – 8.36 (m, 2H), 8.04 – 8.01 (m, 2H), 7.26 – 7.23 (m, 2H), 7.08 
– 7.04 (m, 3H), 4.85 – 4.81 (m, 1H), 4.15 – 4.13 (m, 1H), 3.77 (s, 3H), 3.40 (ddd, J = 9.9, 6.8, 
3.1 Hz, 1H), 3.25 – 3.15 (m, 2H), 3.04 (dd, J = 14.0, 7.1 Hz, 1H), 2.11 – 2.07 (m, 1H), 1.70 – 
1.58 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 171.4, 170.3, 150.8, 142.8, 134.6, 133.3, 130.8, 
129.2, 128.9, 124.6, 62.5, 53.4, 52.7, 49.7, 37.5, 30.2, 24.6. [a]D25 = -56.2 (c = 0.87, CHCl3). 
HRMS (TOF ESI+) m/z calculated for C21H23N3O7SCl [M+H]+: 496.0945, found 496.0941. 
(-)-4-((S)-3-methoxy-2-((S)-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-carboxamido)-3-
oxopropyl)phenyl pivalate [(-)-S76]. 
A round bottom flask was charged with a stir bar, (S)-4-(2-amino-3-
methoxy-3-oxopropyl)phenyl pivalate trifluoroacetic acid complex (H-
OPivPhe-OMe•TFA, 1.18 g, 3.0 mmol, 1.0 equiv.) and DCM (15 mL). To 
this suspension was added iPr2NEt (0.6 mL) to basify the mixture. Next were added N-
nitrobenzenesulfonyl proline (Ns-Pro-OH, 901 mg, 3.0 mmol, 1.0 equiv.), N-
hydroxybenzotriazole hydrate (HOBt•xH2O, 20% by weight H2O, 557 mg) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride (EDC•HCl, 581 mg, 3.0 mmol, 1.0 equiv.) 
and the reaction was stirred overnight at room temperature. Saturated aqueous NaHCO3 (20 mL) 
was added then the mixture was separated and the aqueous layer was extracted with DCM (2 x 
10 mL). The combined organic layers were washed with 10 wt% of aqueous citric acid (20 mL) 
and the aqueous layer was extracted with DCM (2 x 10 mL). The combined organic layers were 
washed with brine (20 mL), dried over Na2SO4, filtered, and concentrated under reduced 
pressure. The residue was purified by flash column chromotagraphy (SiO2, 200 mL) and then 









was rotvaped with pentane 3 times to remove trace solvent residue to afford 1.01 g (1.80 mmol) 
of Ns-Pro-OPivPhe-OMe (-)-S76 as a white solid in 60% yield. 
1H-NMR (500 MHz, CDCl3) 8.37 (d, J = 8.8 Hz, 2H), 8.03 (d, J = 8.8 Hz, 2H), 7.14 (d, J = 8.4 
Hz, 2H), 6.99 – 6.96 (m, 3H), 4.85 (td, J = 7.5, 5.6 Hz, 1H), 4.16 – 4.14 (m, 1H), 3.78 (s, 3H), 
3.38 (ddd, J = 10.3, 7.2, 3.3 Hz, 1H), 3.26 (dd, J = 14.1, 5.6 Hz, 1H), 3.21 – 3.18 (m, 1H), 3.06 
(dd, J = 14.1, 7.2 Hz, 1H), 2.09 – 2.06 (m, 1H), 1.68 – 1.56 (m, 3H), 1.33 (s, 9H). 13C-NMR (126 
MHz, CDCl3) δ 177.1, 171.5, 170.2, 150.6, 150.4, 142.6, 133.3, 130.3, 129.2, 124.7, 121.8, 62.4, 
53.3, 52.7, 49.8, 39.2, 37.4, 30.3, 27.3, 24.5. [a]D25 = -51.0 (c = 0.96, CHCl3). HRMS (TOF 
ESI+) m/z calculated for C26H32N3O9S [M+H]+: 562.1859, found 562.1861. 
 
(-)-methyl (2-(4-bromophenyl)acetyl)-L-prolinate [(-)-88]. 
The preparation was performed according to the procedure for (+)-S70. 4-
Bromophenylacetic acid (1.08 g, 5.0 mmol, 1.0 equiv.) reacted with H-Pro-
OMe•HCl (828 mg, 5.0 mmol, 1.0 equiv.), EDC•HCl (959 g, 5.0 mmol, 1.0 equiv.), HOBt•xH2O 
(1.15 g), and iPr2NEt (2 mL) in DCM (25 mL). The crude mixture was purified by flash column 
chromatography by using 5% ethyl acetate/CHCl3 as eluent to afford 1.65 g (5.06 mmol) product 
as a colorless oil in quantitative yield. 
A pair of rotamers are observed by NMR. 1H-NMR (500 MHz, CDCl3) 7.45 – 7.42 (m, 2H), 7.17 
– 7.11 (m, 2H), 4.50 (dd, J = 8.5, 3.9 Hz) & 4.42 (dd, J = 8.5, 2.6 Hz, 1H combined), 3.72 (s) & 
3.69 (s, 3H combined), 3.72 – 3.45 (m, 4H), 2.23 – 1.89 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 
















46.8, 41.3 & 41.1, 31.6 & 29.3, 25.0 & 22.6. [a]D25 = -53.8 (c = 1.02, CHCl3). HRMS (TOF 
ESI+) m/z calculated for C14H17NO3Br [M+H]+: 326.0392, found 326.0392. 
 
2.4.6 Results and Characterization of C—H Oxidation Products with Mn(CF3-PDP) 
3-oxo-1-phenylcyclopentane-1-carbonitrile [38]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-phenylcyclopentane-1-carbonitrile S27 (85.6 mg, 0.500 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 mol%), ClCH2CO2H (709 
mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (340 mg, 5.0 mmol, 10.0 equiv.), MeCN (1.0 mL in 
40 mL vial, 6.25 mL with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was 
worked up with 15 mL saturated NaHCO3 and DCM as described in General Method A. Flash 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 10% 
acetone/hexanes à 20% acetone/hexanes as eluent. Fractions contain products were collected 
and the yield was obtained by 1H NMR analysis by adding nitrobenzene as internal standard. 
Run 1: (8.1 mg, 0.044 mmol, 8.7% yield), (17.7 mg, 0.103 mmol, 20.7% rsm). Run 2: (8.8 mg, 
0.048 mmol, 9.5% yield), (20.4 mg, 0.120 mmol, 24.0% rsm). Run 3: (9.9 mg, 0.053 mmol, 
10.7% yield), (19.8 mg, 0.116 mmol, 23.1% rsm). Average: 9.6% yield ± 1.0%, 22.6% rsm ± 
1.7%. 
1H-NMR (500 MHz, CDCl3) δ 7.46 – 7.37 (m, 5H), 3.06 (d, J = 18.2 Hz, 1H), 2.86 – 2.79 (m, 
2H), 2.70 – 2.63 (m, 1H), 2.56 – 2.43 (m, 2H).13C-NMR (126 MHz, CDCl3) δ 212.2, 137.6, 
129.5, 128.9, 125.9, 122.6, 50.0, 44.2, 36.8, 36.5. HRMS (EI+) m/z calculated for C12H11ON 







The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-(4-tert-butylphenyl)cyclopentane-1-carbonitrile S28 (113.7 mg, 
0.500 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 
mol%), ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (340 
mg, 5.0 mmol, 10.0 equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction 
was run at 0 ºC with ice bath. The reaction was worked up with 15 mL saturated NaHCO3 and 
DCM as described in General Method A. Flash column chromatography on silica (35 mm fritted 
glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent 
afforded product as a white solid. 
Run 1: (78.0 mg, 0.323 mmol, 64.6% yield), (11.8 mg, 0.052 mmol, 10.4% rsm). Run 2: (79.7 
mg, 0.330 mmol, 66.0% yield), (10.8 mg, 0.048 mmol, 9.5% rsm). Run 3: (79.1 mg, 0.328 
mmol, 65.6% yield), (13.1 mg, 0.058 mmol, 11.5% rsm). Average: 65.4% yield ± 0.7%, 10.5% 
rsm ± 1.0%. 
1H-NMR (500 MHz, CDCl3) δ 7.46 – 7.44 (m, 2H), 7.39 – 7.36 (m, 2H), 3.03 (d, J = 18.2 Hz, 
1H), 2.84 – 2.78 (m, 2H), 2.69 – 2.61 (m, 1H), 2.54 – 2.42 (m, 2H), 1.33 (s, 9H). 13C-NMR (126 
MHz, CDCl3) δ 212.4, 152.0, 134.5, 126.4, 125.6, 122.8, 50.0, 43.8, 36.7, 36.4, 34.7, 31.3. 
HRMS (EI+) m/z calculated for C16H19ON [M]+: 241.1467, found 241.1468. 
1-(4-chlorophenyl)-3-oxocyclopentane-1-carbonitrile [40]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-(4-chlorophenyl)cyclopentane-1-carbonitrile S29 (102.8 mg, 
0.500 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 








equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was run at 0 ºC with 
ice bath. The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in 
General Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded product as a 
clear oil. 
Run 1: (86.8 mg, 0.395 mmol, 79.0% yield), (6.3 mg, 0.031 mmol, 6.2% rsm). Run 2: (90.6 mg, 
0.413 mmol, 82.5% yield), (10.9 mg, 0.053 mmol, 10.6% rsm). Run 3: (89.1 mg, 0.406 mmol, 
81.1% yield), (9.9 mg, 0.048 mmol, 9.6% rsm). Average: 80.9% yield ± 1.8%, 8.8% rsm ± 
2.3%. 
1H-NMR (500 MHz, CDCl3) δ 7.43 – 7.38 (m, 4H), 3.05 (d, J = 18.1 Hz, 1H), 2.86 – 2.81 (m, 
1H), 2.75 (d, J = 18.1 Hz, 1H), 2.67 (dt, J = 18.5, 9.2 Hz, 1H), 2.52 (ddd, J = 19.0, 8.3, 3.9 Hz, 
1H), 2.42 (ddd, J = 13.0, 9.9, 8.1 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 211.6, 136.1, 134.9, 
129.7, 127.3, 122.2, 49.8, 43.8, 36.7, 36.3. HRMS (TOF ESI+) m/z calculated for C11H10OCl 
[M-CN]+: 193.0420, found 193.0423. 
Site of oxidation was confirmed based on a combination of 1H, gDQCOSY, gHSQC and gHMBC 
NMRs. 
1-(4-fluorophenyl)-3-oxocyclopentane-1-carbonitrile [41]. 
The reaction was run with General Method B: Iterative Catalyst Addition 
Protocol: 1-(4-fluorophenyl)cyclopentane-1-carbonitrile S30 (94.6 mg, 0.500 
mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (3 times addition of 33.9 mg, 0.025 
mmol, 5 mol% batch; 15 mol% in total),  ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. 
H2O2 (340 mg, 5.0 mmol, 10.0 equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). 






NaHCO3 and DCM as described in General Method A. Flash column chromatography on silica 
(35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes 
as eluent afforded product as a clear oil. 
Run 1: (57.9 mg, 0.285 mmol, 57.0% yield), (9.3 mg, 0.049 mmol, 9.8% rsm). Run 2: (58.4 mg, 
0.287 mmol, 57.4% yield), (9.3 mg, 0.049 mmol, 9.8% rsm). Run 3: (55.6 mg, 0.273 mmol, 
54.6% yield), (9.9 mg, 0.052 mmol, 10.5% rsm). Average: 56.3% yield ± 1.5%, 10.0% rsm ± 
0.4%. 
1H-NMR (500 MHz, CDCl3) δ 7.45 – 7.42 (m, 2H), 7.15 – 7.12 (m, 2H), 3.06 (d, J = 18.1 Hz, 
1H), 2.84 (dddd, J = 12.7, 8.5, 3.9, 1.8 Hz, 1H), 2.75 (d, J = 18.1 Hz, 1H), 2.67 (ddd, J = 18.5, 
9.7, 8.3 Hz, 1H), 2.52 (dddt, J = 18.9, 8.2, 3.9, 1.1 Hz, 1H), 2.42 (ddd, J = 13.0, 9.9, 8.1 Hz, 1H). 
13C-NMR (126 MHz, CDCl3) δ 211.8, 162.7 (d, J = 249.0 Hz), 133.4 (d, J = 3.3 Hz), 127.7 (d, J 
= 8.4 Hz), 122.4, 116.5 (d, J = 21.9 Hz), 50.0, 43.6, 36.7, 36.4. 19F-NMR (470 MHz, CDCl3) δ -
113.0. HRMS (TOF ESI+) m/z calculated for C12H11NOF [M+H]+: 204.0825, found 204.0833. 
1-(4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-oxocyclopentane-1-carbonitrile [42]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: 1-(4-(1,3-dioxoisoindolin-2-
yl)phenyl)cyclopentane-1-carbonitrile S31 (94.9 mg, 0.300 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 
4:1 MeCN:DCM (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC 
with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described 








mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent afforded product as a 
white solid. 
Run 1: (60.8 mg, 0.184 mmol, 61.3% yield), (17.4 mg, 0.055 mmol, 18.3% rsm). Run 2: (64.8 
mg, 0.196 mmol, 65.3% yield), (20.1 mg, 0.064 mmol, 21.2% rsm). Run 3: (61.5 mg, 0.186 
mmol, 62.1% yield), (18.8 mg, 0.060 mmol, 19.8% rsm). Average: 62.9% yield ± 2.1%, 19.8% 
rsm ± 1.5%. 
1H-NMR (500 MHz, acetone-d6) δ  7.98 – 7.93 (m, 4H), 7.78 (d, J = 8.6 Hz, 2H), 7.65 (d, J = 8.6 
Hz, 2H), 3.14 (d, J = 17.9 Hz, 1H), 3.05 (d, J = 17.8 Hz, 1H), 2.94 (dddd, J = 12.9, 5.8, 4.2, 1.9 
Hz, 1H), 2.72 – 2.55 (m, 3H). 13C-NMR (126 MHz, acetone-d6) δ 212.4, 167.7, 138.8, 135.5, 
133.5, 132.9, 128.5, 127.5, 124.2, 123.4, 50.5, 45.2, 37.2, 36.4. HRMS (TOF ESI+) m/z 
calculated for C20H15N2O3 [M+H]+: 331.1083, found 331.1074. 
methyl 3-(1-cyano-3-oxocyclopentyl)benzoate [43]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: methyl 3-(1-cyanocyclopentyl)benzoate S32 (114.6 mg, 0.500 mmol, 
1.0 equiv), (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 mol%), ClCH2CO2H 
(709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (340 mg, 5.0 mmol, 10.0 equiv.), 
MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in General 
Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 15% acetone/hexanes à 25% acetone/hexanes as eluent afforded product as a white solid. 
Run 1: (89.9 mg, 0.370 mmol, 73.9% yield), (15.5 mg, 0.068 mmol, 13.5% rsm). Run 2: (88.8 






mmol, 70.6% yield), (20.6 mg, 0.090 mmol, 17.9% rsm). Average: 72.5% yield ± 1.7%, 16.6% 
rsm ± 2.7%. Selectivity= 72.5/(100-16.6) = 87%. 
1H-NMR (500 MHz, CDCl3) δ 8.11 (s, 1H), 8.06 (d, J = 7.7 Hz, 1H), 7.70 – 7.68 (m, 1H), 7.54 
(t, J = 7.8 Hz, 1H), 3.95 (s, 3H), 3.10 (d, J = 18.2 Hz, 1H), 2.90 – 2.85 (m, 1H), 2.81 (d, J = 18.0 
Hz, 1H), 2.74 – 2.67 (m, 1H), 2.59 – 2.53 (m, 1H), 2.48 (ddd, J = 12.9, 10.3, 8.1 Hz, 1H). 13C-
NMR (126 MHz, CDCl3) δ 211.5, 166.2, 138.0, 131.5, 130.5, 130.0, 129.7, 126.8, 122.1, 52.5, 
49.9, 44.2, 36.8, 36.2. HRMS (TOF ESI+) m/z calculated for C14H14NO3 [M+H]+: 244.0974, 
found 244.0969. 
Condition with Fe(CF3-PDP): The reaction was conducted in slow addition protocol,30 same as 
Entry 10 of Table 7. In a 40 mL vial was charged with methyl 3-(1-cyanocyclopentyl)benzoate 
S32 (68.8 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) 
and a stir bar. A 1mL syringe was charged with a solution of (R,R)-Fe(CF3-PDP) catalyst (101.6 
mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.375 mL). A 10 mL syringe was charged with a 
solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in MeCN (3.75 mL). Both syringes were 
fitted with 25G needles and the solution was added dropwise via syringe pump over 1 hour. 
Upon completion of addition, the reaction was concentrated in vacuo to a minimum amount of 
MeCN and purified by column chromatography on silica (35 mm fritted glass column, 150 mL 
SiO2) using 15% acetone/hexanes à 25% acetone/hexanes as eluent to give both recovered 
starting material and product. Result: (8.0 mg, 0.033 mmol, 10.9% yield), 0% rsm. Selectivity = 
10.9/(100-0) = 11%. 
1-(3,5-difluorophenyl)-3-oxocyclopentane-1-carbonitrile [44]. 
The reaction was run with General Method A: Single Catalyst Addition Protocol: 1-(3,5-
difluorophenyl)cyclopentane-1-carbonitrile S33 (103.6 mg, 0.500 mmol, 1.0 equiv), (R,R)-
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Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 mol%), ClCH2CO2H (709 mg, 7.5 
mmol, 15.0 equiv.), 50% wt. H2O2 (340 mg, 5.0 mmol, 10.0 equiv.), MeCN 
(1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was run at 0 ºC 
with ice bath. The reaction was worked up with 15 mL saturated NaHCO3 
and DCM as described in General Method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as 
eluent afforded product as a white solid. 
Run 1: (73.1 mg, 0.331 mmol, 66.1% yield), (16.3 mg, 0.079 mmol, 15.7% rsm). Run 2: (73.5 
mg, 0.332 mmol, 66.4% yield), (24.2 mg, 0.117 mmol, 23.4% rsm). Run 3: (71.3 mg, 0.322 
mmol, 64.4% yield), (23.0 mg, 0.111 mmol, 22.2% rsm). Average: 65.6% yield ± 1.1%, 20.4% 
rsm ± 4.1%. Selectivity = 65.6/(100-20.4) = 82%. 
1H-NMR (500 MHz, CDCl3) δ 7.03 – 6.98 (m, 2H), 6.87 – 6.83 (m, 1H), 3.05 (d, J = 18.8 Hz, 
1H), 2.83 (dddd, J = 12.7, 8.4, 3.7, 1.9 Hz, 1H), 2.74 – 2.64 (m, 2H), 2.58 – 2.52 (m, 1H), 2.41 
(ddd, J = 13.0, 10.3, 8.2 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 210.8, 163.5 (dd, J = 251.3, 
12.9 Hz), 141.3 (t, J = 9.0 Hz), 121.5, 109.6 – 109.4 (m), 104.6 (t, J = 25.1 Hz), 49.7, 44.1 (t, J = 
2.2 Hz), 36.7, 36.2. 19F-NMR (470 MHz, CDCl3) δ -107.0 (t, J = 7.7 Hz). HRMS (TOF ESI+) 
m/z calculated for C11H9OF2 [M-CN]+: 195.0621, found 195.0622. 
Condition with Fe(CF3-PDP): The reaction was conducted in slow addition protocol,30 same as 
Entry 10 of Table 7. In a 40 mL vial was charged with 1-(3,5-difluorophenyl)cyclopentane-1-
carbonitrile S33 (62.2 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 equiv.), MeCN 
(0.60 mL) and a stir bar. A 1mL syringe was charged with a solution of (R,R)-Fe(CF3-PDP) 
catalyst (101.6 mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.375 mL). A 10 mL syringe was 







syringes were fitted with 25G needles and the solution was added dropwise via syringe pump 
over 1 hour. Upon completion of addition, the reaction was concentrated in vacuo to a minimum 
amount of MeCN and purified by column chromatography on silica (35 mm fritted glass column, 
150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent to give both 
recovered starting material and product. Result: (7.6 mg, 0.034 mmol, 11.4% yield), (23.0 mg, 
0.111 mmol, 37.0% rsm). Selectivity = 11.4/(100-37.0) = 18%. 
methyl 4-(1-cyano-3-oxocyclopentyl)benzoate [45]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: methyl 4-(1-cyanocyclopentyl)benzoate S34 (68.8 
mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 
10 mol%),  ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 
10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC 
with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described 
in General Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent afforded product as a 
white solid. 
Run 1: (60.3 mg, 0.248 mmol, 82.6% yield), (9.1 mg, 0.040 mmol, 13.2% rsm). Run 2: (61.3 
mg, 0.252 mmol, 83.9% yield), (8.6 mg, 0.038 mmol, 12.5% rsm). Run 3: (61.7 mg, 0.254 
mmol, 84.6% yield), (6.9 mg, 0.030 mmol, 10.0% rsm). Average: 83.7% yield ± 1.0%, 11.9% 
rsm ± 1.7%. Selectivity = 83.7/(100-11.9) = 95%. 
1H-NMR (500 MHz, CDCl3) δ 8.11 – 8.09 (m, 2H), 7.55 – 7.52 (m, 2H), 3.93 (s, 3H), 3.08 (d, J 
= 18.2 Hz, 1H), 2.87 – 2.78 (m, 2H), 2.71 – 2.65 (m, 1H), 2.54 (dddt, J = 18.8, 8.0, 3.6, 1.0 Hz, 






130.8, 130.7, 126.0, 122.0, 52.5, 49.8, 44.4, 36.7, 36.4. HRMS (TOF ESI+) m/z calculated for 
C14H14NO3 [M+H]+: 244.0974, found 244.0971. 
Condition with Fe(CF3-PDP): The reaction was conducted in slow addition protocol,30 same as 
Entry 10 of Table 7. In a 40 mL vial was charged with methyl 4-(1-cyanocyclopentyl)benzoate 
S34 (68.8 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) 
and a stir bar. A 1mL syringe was charged with a solution of (R,R)-Fe(CF3-PDP) catalyst (101.6 
mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.375 mL). A 10 mL syringe was charged with a 
solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in MeCN (3.75 mL). Both syringes were 
fitted with 25G needles and the solution was added dropwise via syringe pump over 1 hour. 
Upon completion of addition, the reaction was concentrated in vacuo to a minimum amount of 
MeCN and purified by column chromatography on silica (35 mm fritted glass column, 150 mL 
SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent to give both recovered 
starting material and product. Result: (20.2 mg, 0.083 mmol, 27.6% yield), (4.8 mg, 0.021 
mmol, 7.0% rsm). Selectivity = 27.6/(100-7.0) = 30%. 
4-(1-cyano-3-oxocyclopentyl)benzonitrile [46]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 4-(1-cyanocyclopentyl)benzonitrile S35 (58.9 mg, 0.300 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H 
(425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 
mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. The 
reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in General Method 
A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 






Run 1: (46.3 mg, 0.220 mmol, 73.4% yield), (12.2 mg, 0.062 mmol, 20.7% rsm). Run 2: (45.6 
mg, 0.217 mmol, 72.3% yield), (11.7 mg, 0.060 mmol, 19.9% rsm). Run 3: (43.8 mg, 0.208 
mmol, 69.4% yield), (12.7 mg, 0.065 mmol, 21.6% rsm). Average: 71.7% yield ± 2.1%, 20.7% 
rsm ± 0.8%. Selectivity = 71.7/(100-20.7)= 90%. 
1H-NMR (500 MHz, CDCl3) δ 7.73 (d, J = 8.8 Hz, 2H), 7.60 – 7.58 (m, 2H), 3.05 (d, J = 18.1 
Hz, 1H), 2.87 – 2.81 (m, 1H), 2.76 (d, J = 18.2 Hz, 1H), 2.71 – 2.63 (m, 1H), 2.57 – 2.50 (m, 
1H), 2.43 (ddd, J = 12.9, 10.3, 8.1 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 210.8, 142.5, 133.2, 
126.8, 121.4, 117.9, 112.9, 49.5, 44.4, 36.6, 36.1. HRMS (EI+) m/z calculated for C13H10ON2 
[M]+: 210.07932, found 210.07932. 
Condition with Fe(CF3-PDP): The reaction was conducted in slow addition protocol,30 same as 
Entry 10 of Table 7. In a 40 mL vial was charged with 4-(1-cyanocyclopentyl)benzonitrile S35 
(58.9 mg, 0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and 
a stir bar. A 1mL syringe was charged with a solution of (R,R)-Fe(CF3-PDP) catalyst (101.6 mg, 
0.075 mmol, 0.25 equiv.) in MeCN (0.375 mL). A 10 mL syringe was charged with a solution of 
H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G 
needles and the solution was added dropwise via syringe pump over 1 hour. Upon completion of 
addition, the reaction was concentrated in vacuo to a minimum amount of MeCN and purified by 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 10% 
acetone/hexanes à 20% acetone/hexanes as eluent to give both recovered starting material and 
product. Result: (34.9 mg, 0.166 mmol, 55.3% yield), (4.5 mg, 0.023 mmol, 7.6% rsm). 





methyl 3-oxo-1-(4-(trifluoromethoxy)phenyl)cyclopentane-1-carboxylate [46]. 
The reaction was run with General Method B: Iterative Catalyst 
Addition Protocol: methyl 1-(4-
(trifluoromethoxy)phenyl)cyclopentane-1-carboxylate S36 (72.1 mg, 
0.250 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (3 times addition of 16.9 mg, 0.013 mmol, 5 mol% 
batch; 15 mol% in total), ClCH2CO2H (354 mg, 3.75 mmol, 15.0 equiv.), 50% wt. H2O2 (170 
mg, 2.5 mmol, 10.0 equiv.), MeCN (0.5 mL in 40 mL vial, 3.13 mL with oxidant). The reaction 
was run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM as described in General Method A. Flash column chromatography on silica (35 mm fritted 
glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent 
afforded product as a clear oil. 
Run 1: (57.0 mg, 0.189 mmol, 75.4% yield), 0% rsm. Run 2: (58.4 mg, 0.193 mmol, 77.2% 
yield), 0% rsm. Run 3: (59.8 mg, 0.198 mmol, 79.1% yield), 0% rsm. Average: 77.2% yield ± 
1.8%, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.39 – 7.36 (m, 2H), 7.22 – 7.20 (m, 2H), 3.67 (s, 3H), 3.26 (d, J 
= 17.9 Hz, 1H), 3.01 – 2.96 (m, 1H), 2.58 (d, J = 17.9 Hz, 1H), 2.38 – 2.28 (m, 3H). 13C-NMR 
(126 MHz, CDCl3) δ 214.9, 174.5, 148.7, 139.8, 128.2, 121.2, 120.5 (q, J = 257.4 Hz), 54.7, 
53.2, 48.3, 37.1, 33.1. 19F-NMR (471 MHz, CDCl3) δ -57.9. HRMS (TOF ESI+) m/z calculated 
for C14H14O4F3 [M+H]+: 303.0844, found 303.0838. 
1-(4-(difluoromethoxy)phenyl)-3-oxocyclopentane-1-carbonitrile [48]. 
The reaction was run with General Method B: Iterative Catalyst Addition Protocol: 1-(4-
(difluoromethoxy)phenyl)cyclopentane-1-carbonitrile S37 (71.2 mg, 0.300 mmol, 1.0 equiv), 






total), ClCH2CO2H (425 mg, 4.50 mmol, 15.0 equiv.), 50% wt. H2O2 204 mg, 
3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). 
The reaction was run at 0 ºC with ice bath. The reaction was worked up with 
9 mL saturated NaHCO3 and DCM as described in General Method B. Flash 
column chromatography on silica (35 mm fritted glass column, 100 mL SiO2) using 10% 
acetone/hexanes à 20% acetone/hexanes à 30% acetone/hexanes as eluent afforded product as 
a clear oil. 
Run 1: (40.7 mg, 0.162 mmol, 54.0% yield), 0% rsm. Run 2: (42.1 mg, 0.168 mmol, 55.9% 
yield), 0% rsm. Run 3: (40.4 mg, 0.161 mmol, 53.6% yield), 0% rsm. Average: 54.5% yield ± 
1.2%, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.47 – 7.44 (m, 2H), 7.22 – 7.18 (m, 2H), 6.54 (t, J = 73.2 Hz, 
1H), 3.06 (d, J = 18.1 Hz, 1H), 2.84 (dddd, J = 12.7, 8.5, 3.9, 1.9 Hz, 1H), 2.78 – 2.74 (m, 1H), 
2.69 – 2.64 (m, 1H), 2.52 (dddt, J = 18.9, 8.2, 3.9, 1.0 Hz, 1H), 2.43 (ddd, J = 12.9, 9.9, 8.1 Hz, 
1H). 13C-NMR (126 MHz, CDCl3) δ 211.6, 151.2 (t, J = 2.9 Hz), 134.7, 127.5, 122.3, 120.6, 
115.6 (t, J = 261.6 Hz), 50.0, 43.7, 36.7, 36.5. 19F-NMR (471 MHz, CDCl3) δ -81.4. HRMS 
(TOF ESI+) m/z calculated for C13H11NO2F2Na [M+Na]+: 274.0656, found 274.0662. 
Better selectivity can be obtained using General Method A: Single Catalyst Addition Protocol. 1-
(4-(difluoromethoxy)phenyl)cyclopentane-1-carbonitrile S37 (71.2 mg, 0.300 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 
equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL 
with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL 







Run 1: (32.5 mg, 0.129 mmol, 43.1% yield), (24.8 mg, 0.105 mmol, 34.8% rsm). Run 2: (34.9 
mg, 0.139 mmol, 46.3% yield), (20.1 mg, 0.085 mmol, 28.2% rsm). Run 3: (36.4mg, 0.145 
mmol, 48.3% yield), (21.6 mg, 0.091 mmol, 30.3% rsm). Average: 45.9% yield ± 2.6%, 31.1% 
rsm ± 3.4%. 
2-((1-(4-bromophenyl)-3-oxocyclopentyl)methyl)-5-nitroisoindoline-1,3-dione [49]. 
The reaction was run with General Method A: Single 
Catalyst Addition Protocol: 2-((1-(4-
bromophenyl)cyclopentyl)methyl)-5-nitroisoindoline-1,3-
dione S38 (128.8 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%),  ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was allowed to stir at 
0 ºC for ~30 min to facilitate the solubility of starting material before adding H2O2 and run at 0 
ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as 
described in General Method A. Flash column chromatography on silica (35 mm fritted glass 
column, 150 mL SiO2) using 15% acetone/hexanes à 25% acetone/hexanes as eluent afforded 
product as a white solid. 
Run 1: (76.1 mg, 0.172 mmol, 57.2% yield), <10% rsm. Run 2: (80.7 mg, 0.182 mmol, 60.7% 
yield), <10% rsm. Run 3: (83.8 mg, 0.189 mmol, 63.0% yield), <10% rsm. Average: 60.3% 
yield ± 2.9%, <10% rsm. 
1H-NMR (500 MHz, CDCl3) δ 8.60 – 8.58 (m, 2H), 8.01 – 7.99 (m, 1H), 7.44 (dd, J = 8.5, 1.9 
Hz, 2H), 7.17 – 7.15 (m, 2H), 3.98 (d, J = 14.0 Hz, 1H), 3.91 (d, J = 14.1 Hz, 1H), 2.76 (d, J = 
17.8 Hz, 1H), 2.71 (d, J = 18.2 Hz, 1H), 2.52 – 2.44 (m, 2H), 2.38 – 2.21 (m, 2H). 13C-NMR 









121.7, 119.1, 49.2, 49.2, 47.7, 36.3, 32.5. HRMS (TOF ESI+) m/z calculated for C20H16N2O5Br 
[M+H]+: 443.0243, found 443.0237. 
3'H-spiro[cyclopentane-1,1'-isobenzofuran]-3,3'-dione [50]. 
The reaction was run with a modified procedure according to General 
Method A: Single Catalyst Addition Protocol: 3'H-spiro[cyclopentane-1,1'-
isobenzofuran]-3'-one S39 (94.1 mg, 0.500 mmol, 1.0 equiv), (R,R)-Mn(CF3-
PDP) (67.8 mg, 0.050 mmol, 10 mol%),  ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. 
H2O2 (340 mg, 5.0 mmol, 10.0 equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). 
The reaction was run at 0 ºC with ice bath. The reaction was concentrated to a minimal amount 
of solvent and directly load to column purification. Flash column chromatography on silica (35 
mm fritted glass column, 150 mL SiO2) using 30% acetone/hexanes à 50% acetone/hexanes as 
eluent afforded product co-eluted with chloroacetic acid. The yield of product was determined by 
adding nitrobenzene as internal standard via quantitative 1H NMR. The chloroacetic acid can be 
later removed by NaHCO3 wash with a slight loss of desired product. 
Run 1: (59.8 mg, 0.296 mmol, 59.1% yield), <10% rsm. Run 2: (63.3 mg, 0.313 mmol, 62.7% 
yield), <10% rsm. Run 3: (64.7 mg, 0.320 mmol, 64.1% yield), <10% rsm. Average: 62.0% 
yield ± 2.6%, <10% rsm. 
1H-NMR (500 MHz, methylene chloride-d2) δ 7.89 (dt, J = 7.6, 1.0 Hz, 1H), 7.76 (td, J = 7.6, 1.1 
Hz, 1H), 7.59 (td, J = 7.5, 0.9 Hz, 1H), 7.52 (dt, J = 7.7, 0.9 Hz, 1H), 2.80 (d, J = 18.4 Hz, 1H), 
2.82 – 2.72 (m, 1H), 2.67 (ddt, J = 18.6, 2.9, 1.1 Hz, 1H), 2.63 – 2.50 (m, 2H), 2.39 (dddd, J = 
13.7, 9.4, 2.9, 1.4 Hz, 1H). 13C-NMR (126 MHz, methylene chloride-d2) δ 213.4, 169.1, 150.8, 
135.1, 130.3, 126.7, 126.2, 121.7, 90.8, 50.3, 38.0, 36.6. HRMS (TOF ESI+) m/z calculated for 







The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 5'-Bromo-1'-(phenylsulfonyl)spiro[cyclopentane-1,3'-indolin]-2'-
one S40 (81.3 mg, 0.200 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (27.1 mg, 
0.020 mmol, 10 mol%), ClCH2CO2H (284 mg, 3.0 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 
2.0 mmol, 10.0 equiv.), MeCN (0.4 mL in 40 mL vial, 2.50 mL with oxidant). The reaction was 
run at 0 ºC with ice bath. The reaction was worked up with 6 mL saturated NaHCO3 and DCM as 
described in General Method A. The crude mixture was dissolved with a small amount of DCM 
and concentrated onto silica (2 mL) for dry loading onto the column (35 mL silica) and then 
eluted with 10% EtOAc/hexane à 20% EtOAc/hexane à 40% EtOAc/hexane to afford 51a as a 
white solid and 51b alcohol diastereomers mixtures as a white solid. The recovered starting 
material was recycled 1X with same oxidation protocol. 
Run 1: cycle 1: (20.1 mg, 0.0478 mmol, 23.9% yield of 51a), (10.4 mg, 0.0246 mmol, 12.3% 
yield of 51b), (38.7 mg, 0.0953 mmol, 47.6% rsm). cycle 2: (7.9 mg, 0.0188 mmol, 19.7% yield 
of 51a), (4.7 mg, 0.0111 mmol, 11.6% yield of 51b), (18.5 mg, 0.0455 mmol, 47.8% rsm). 
Overall: (28.0 mg, 0.066 mmol, 33.3% yield of 51a), (15.1 mg, 0.0358 mmol, 17.9% yield of 
51b), (18.5 mg, 0.0455 mmol, 22.8% rsm). 
Run 2: cycle 1: (20.7 mg, 0.0493 mmol, 24.6% yield of 51a), (10.3 mg, 0.244 mmol, 12.2% 
yield of 51b), (37.4 mg, 0.0921 mmol, 46.0% rsm). cycle 2: (8.2 mg, 0.195 mmol, 21.2% yield 
of 51a), (4.5 mg, 0.0107 mmol, 11.6% yield of 51b), (17.8 mg, 0.0438 mmol, 47.6% rsm). 
Overall: (28.9 mg, 0.0688 mmol, 34.4% yield of 51a), (14.8 mg, 0.0350 mmol, 17.5% yield of 








Run 3: cycle 1: (21.0 mg, 0.0500 mmol, 25.0% of 51a), (10.4 mg, 0.246 mmol, 12.3% yield of 
51b), (39.6 mg, 0.0975 mmol, 48.7% rsm). cycle 2: (8.0 mg, 0.0190 mmol, 19.5% yield of 51a), 
(4.3 mg, 0.0102 mmol, 10.4% yield of 51b), (17.0 mg, 0.0418 mmol, 42.9% rsm). Overall: (29.0 
mg, 0.0690 mmol, 34.5% yield of 51a), (14.7 mg, 0.0348 mmol, 17.4% yield of 51b), (17.0 mg, 
0.0418 mmol, 20.9% rsm). 
Average: (34.1% yield of 51a ± 0.7%), (17.6% yield of 51b ± 0.3%), (21.9% rsm ± 1.0%). 
1H-NMR (500 MHz, CDCl3) δ 8.06 (d, J = 8.6 Hz, 2H), 7.85 (d, J = 8.7 Hz, 1H), 7.69 (td, J = 
7.5, 1.2 Hz, 1H), 7.56 (t, J = 8.0 Hz, 2H), 7.51 (dd, J = 8.7, 2.1 Hz, 1H), 7.29 (d, J = 1.8 Hz, 1H), 
2.75 (ddd, J = 18.8, 9.1 Hz, 1H), 2.57 (d, J = 19.0 Hz, 1H), 2.55 – 2.48 (m, 1H), 2.38 (d, J = 18.5 
Hz, 1H), 2.40 – 2.34 (m, 1H), 2.15 (dd, J = 13.5, 9.0 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 
213.5, 177.5, 137.6, 137.4, 135.0, 133.4, 132.4, 129.5, 127.9, 126.0, 118.6, 115.7, 51.0, 47.2, 
36.3, 34.5. HRMS (TOF ESI+) m/z calculated for C18H15BrNO4S [M+H]+: 419.9905, found 
419.9897. 
5'-Bromo-3-hydroxy-1'-(phenylsulfonyl)spiro[cyclopentane-1,3'-indolin]-2'-one [51b]. 
The ratio of diastereomers is approximately 1.5:1 and could be separated 
by using preparative TLC. The reduction of 51a using NaBH4 provided 
two diastereomers of alcohol and the spectroscopic data of them are 
consistent with those of both diastereomers of 51b. 
Diastereomer 1: 1H-NMR (500 MHz, CDCl3) δ 8.05 (d, J = 7.7 Hz, 2H), 7.77 (d, J = 8.7 Hz, 
1H), 7.66 (t, J = 7.5 Hz, 1H), 7.63 (d, J = 2.1 Hz, 1H), 7.54 (t, J = 7.9 Hz, 2H), 7.42 (dd, J = 8.7, 
2.1 Hz, 1H), 4.66 – 4.62 (m, 1H), 2.32 (dd, J = 14.3, 4.9 Hz, 1H), 2.15 – 2.01 (m, 3H), 1.96 – 








180.2, 138.0, 137.3, 137.2, 134.7, 131.3, 129.4, 127.9, 127.7, 118.7, 115.0, 74.3, 53.5, 47.3, 38.7, 
36.6. HRMS (TOF ESI+) m/z calculated for C18H17BrNO4S [M+H]+: 422.0062, found 422.0072. 
Diastereomer 2: 1H-NMR (500 MHz, CDCl3) δ  8.06 (d, J = 8.1 Hz, 2H), 7.81 (d, J = 8.7 Hz, 
1H), 7.68 (t, J = 7.5 Hz, 1H), 7.56 (t, J = 7.9 Hz, 2H), 7.46 (dd, J = 8.7, 2.0 Hz, 1H), 7.24 (d, J = 
2.1 Hz, 1H), 4.50 (dtt, J = 10.2, 5.1, 2.3 Hz, 1H), 3.25 (dd, J = 10.1, 3.0 Hz, 1H), 2.31 (dt, J = 
13.7, 8.1 Hz, 1H), 2.23 – 2.16 (m, 1H), 2.11 – 2.01 (m, 3H), 1.88 (ddd, J = 13.9, 9.0, 5.3 Hz, 
1H). 13C-NMR (126 MHz, CDCl3) δ 181.6, 137.7, 137.5, 136.0, 135.0, 131.7, 129.5, 128.0, 
125.9, 118.7, 115.5, 74.6, 54.3, 47.3, 38.2, 36.8. HRMS (TOF ESI+) m/z calculated for 
C18H17BrNO4S [M+H]+: 422.0062, found 422.0062. 
3-(((4-fluorophenyl)sulfonyl)methyl)cyclopentan-1-one [52]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-((cyclopentylmethyl)sulfonyl)-4-fluorobenzene S41 (121.2 mg, 
0.500 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 
mol%), ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (340 mg, 5.0 mmol, 10.0 
equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was run at 0 ºC with 
ice bath. The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in 
General Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 15% acetone/hexanes à 25% acetone/hexanes à 40% acetone/hexanes as 
eluent afforded product as a clear oil. 
Run 1: (84.0 mg, 0.328 mmol, 65.6% yield), 0% rsm. Run 2: (84.6 mg, 0.330 mmol, 66.0% 
yield), 0% rsm. Run 3: (79.0 mg, 0.308 mmol, 61.6% yield), 0% rsm. Average: 64.4% yield ± 







1H-NMR (500 MHz, CDCl3) δ 7.97 – 7.93 (m, 2H), 7.29 – 7.25 (m, 2H), 3.27 (dd, J = 14.0, 6.0 
Hz, 1H), 3.20 (dd, J = 14.0, 7.7 Hz, 1H), 2.76 – 2.66 (m, 1H), 2.55 (dd, J = 18.6, 7.7 Hz, 1H), 
2.38 – 2.30 (m, 2H), 2.22 – 2.14 (m, 1H), 1.96 (dd, J = 18.4, 10.8 Hz, 1H), 1.69 (dtd, J = 12.5, 
10.8, 8.3 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 216.4, 166.0 (d, J = 257.1 Hz), 135.6 (d, J = 
3.3 Hz), 130.9 (d, J = 9.6 Hz), 117.0 (d, J = 22.6 Hz), 61.4, 44.3, 37.9, 31.6, 29.5. 19F-NMR (470 
MHz, CDCl3) δ -103.2. HRMS (TOF ESI+) m/z calculated for C12H14O3SF [M+H]+: 257.0648, 
found 257.0646. 
Site of oxidation was assigned based on a combination of 1H, gCOSY, gHSQC and gHMBC 
NMRs. 
5-Bromo-2-oxo-3-(3-oxobutyl)-1-(phenylsulfonyl)indolin-3-yl acetate [53]. 
The reaction was run with General Method B: Iterative Catalyst 
Addition Protocol: 5-bromo-1-((4-bromophenyl)sulfonyl)-3-butyl-2-
oxoindolin-3-yl acetate S42 (93.3 mg, 0.200 mmol, 1.0 equiv), (R,R)-
Mn(CF3-PDP) (3 times addition of 20.4 mg, 0.015 mmol, 5 mol% batch; 15 mol% in total), 
ClCH2CO2H (284 mg, 3.0 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 2.0 mmol, 10.0 equiv.), 
MeCN (0.4 mL in 40 mL vial, 2.50 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 6 mL saturated NaHCO3 and DCM as described in General 
Method B. The crude mixture was dissolved with a small amount of DCM and concentrated onto 
silica (2 mL) for dry loading onto the column (silica, 30 mL) and then eluted with 15% 
EtOAc/hexane à 30% EtOAc/hexane to afford 22 as a white solid. 
Run 1: (59.2 mg, 0.123 mmol, 61.6% yield), (13.2 mg, 0.0283 mmol, 14.2% rsm). Run 2: (59.1 









mmol, 60.4% yield), (15.0 mg, 0.0322 mmol, 16.1% rsm). Average: 61.2% yield ± 0.7%, 
14.9% rsm ± 1.0%. 
1H-NMR (500 MHz, CDCl3) δ 8.05 (d, J = 7.7 Hz, 2H), 7.83 (d, J = 8.7 Hz, 1H), 7.69 – 7.65 (m, 
1H), 7.55 – 7.50 (m, 3H), 7.29 (d, J = 2.1 Hz, 1H), 2.55 (ddd, J = 18.0, 10.6, 5.1 Hz, 1H), 2.43 
(ddd, J = 18.0, 10.3, 5.0 Hz, 1H), 2.31 – 2.25 (m, 1H), 2.10 (s, 3H), 2.14 – 2.08 (m, 1H), 1.91 (s, 
3H). 13C-NMR (125 MHz, CDCl3) δ 206.0, 171.8, 168.7, 138.0, 137.1, 134.9, 133.5, 129.4, 
129.2, 128.2, 126.0, 118.5, 115.4, 77.8, 35.7, 30.8, 30.1, 20.2. HRMS (TOF ESI+) m/z calculated 
for C20H18BrNNaO6S [M+Na]+: 501.9936, found 501.9922. 
N-((4-bromophenyl)sulfonyl)-N-(4-oxopentyl)acetamide [54a]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: N-((4-bromophenyl)sulfonyl)-N-
pentylacetamide S43 (104.5 mg, 0.300 mmol, 1.0 equiv), (R,R)-
Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with 
oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with saturated 
9 mL NaHCO3 and DCM as described in General Method A. Flash column chromatography on 
silica (35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% 
acetone/hexanes as eluent afforded N-((4-bromophenyl)sulfonyl)-N-(3-oxopentyl)acetamide (g-
ketone, 54b) product as a colorless oil and N-((4-bromophenyl)sulfonyl)-N-(4-
oxopentyl)acetamide (d-ketone, 54a) product as a colorless oil. 
Run 1: (23.2 mg, 0.064 mmol, 21.3% yield of g-ketone 54b), (64.7 mg, 0.179 mmol, 59.6% 
yield of d-ketone 54a), (80.9% overall yield, 2.8:1 d:g ratio), <10% rsm. Run 2: (23.6 mg, 0.065 









(83.4% overall yield, 2.8:1 d:g ratio), <10% rsm. Run 3: (24.1 mg, 0.066 mmol, 22.1% yield of 
g-ketone 54b), (63.2 mg, 0.175 mmol, 58.2% yield of d-ketone 54a), (80.3% overall yield, 2.6:1 
d:g ratio), <10% rsm. Average: 81.5% yield ± 1.6%, 2.8:1 d:g ratio, <10% rsm. 
1H-NMR (500 MHz, CDCl3) 7.76 (d, J = 8.2 Hz, 2H), 7.68 (d, J = 8.8 Hz, 2H), 3.80 – 3.52 (m, 
2H), 2.53 (m, 2H), 2.31 (s, 3H), 2.15 (s, 3H), 1.99 – 1.92 (m, 2H). 13C-NMR (126 MHz, CDCl3) 
δ 207.6, 170.2, 138.5, 132.6, 129.3, 129.1, 46.5, 40.1, 30.0, 24.9, 23.7. HRMS (TOF ESI+) m/z 
calculated for C13H17NO4SBr [M+H]+: 362.0062, found 362.0067. 
N-((4-bromophenyl)sulfonyl)-N-(3-oxopentyl)acetamide [54b]. 
 1H-NMR (500 MHz, methylene Chloride-d2) 7.78 – 7.75 (m, 2H), 
7.73 – 7.71 (m, 2H), 3.98 – 3.95 (m, 2H), 2.88 – 2.85 (m, 2H), 
2.43 (q, J = 7.3 Hz, 2H), 2.32 (s, 3H), 1.02 (t, J = 7.3 Hz, 3H). 13C-
NMR (126 MHz, methylene Chloride-d2) δ 209.2, 170.3, 138.8, 133.2, 129.6, 129.5, 42.9, 42.5, 
36.5, 25.3, 7.9. HRMS (TOF ESI+) m/z calculated for for C13H17NO4SBr [M+H]+: 362.0062, 
found 362.0053. 
1-(4-bromophenyl)-3-oxocyclohexane-1-carbonitrile [55a]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-(4-bromophenyl)cyclohexane-1-carbonitrile S44 (79.3 mg, 
0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with 
ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in 
General Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 












bromophenyl)-3-oxocyclohexane-1-carbonitrile (3-ketone, 55a) product as a white solid and 1-
(4-bromophenyl)-4-oxocyclohexane-1-carbonitrile (4-ketone, 55b) as a white solid. 
Run 1: (34.7 mg, 0.125 mmol, 41.5% yield of 3-ketone 55a), (18.7 mg, 0.067 mmol, 22.4% 
yield of 4-ketone 55b), (63.9% overall yield, 1.86:1 3-ketone:4-ketone ratio), (13.4 mg, 0.051 
mmol, 16.9% rsm). Run 2: (34.5 mg, 0.124 mmol, 41.3% yield of 3-ketone 55a), (18.5 mg, 
0.067 mmol, 22.2% yield of 4-ketone 55b), (63.5% overall yield, 1.86:1 3-ketone:4-ketone 
ratio), (16.3 mg, 0.062 mmol, 20.6% rsm). Run 3: (34.2 mg, 0.123 mmol, 41.0% yield of 3-
ketone 55a), (19.2 mg, 0.069 mmol, 23.0% yield of 4-ketone 55b), (64.0% overall yield, 1.78:1 
3-ketone:4-ketone ratio), (12.8 mg, 0.049 mmol, 16.2% rsm). Average: 63.8% yield ± 0.3%, 
1.83:1 3-ketone:4-ketone ratio, 17.9% rsm ± 2.4%. 
1H-NMR (500 MHz, CDCl3) δ 7.58 – 7.55(m, 2H), 7.36 – 7.33 (m, 2H), 2.88 (dt, J = 14.6, 1.8 
Hz, 1H), 2.82 (d, J = 14.7, 1H), 2.57 (dddd, J = 14.8, 5.8, 3.7, 1.6 Hz, 1H), 2.43 – 2.34 (m, 2H), 
2.26 – 2.06 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 205.1, 137.6, 132.6, 127.4, 122.9, 120.9, 
50.6, 45.4, 40.2, 36.3, 22.4. HRMS (EI+) m/z calculated for C13H12ONBr [M]+: 277.0102, found 
277.0103. 
Site of oxidation was assigned based on a combination of 1H, gDQCOSY, gHSQC NMRs. 
1-(4-bromophenyl)-4-oxocyclohexane-1-carbonitrile [55b]. 
1H-NMR (500 MHz, CDCl3) δ 7.59 – 7.55 (m, 2H), 7.41 – 7.38 (m, 2H), 
2.91 (ddd, J = 15.0, 13.8, 5.7 Hz, 2H), 2.58 (ddt, J = 15.6, 4.4, 2.1 Hz, 2H), 
2.47 (ddt, J = 14.3, 5.9, 3.1 Hz, 2H), 2.25 (ddd, J = 13.9, 13.9, 4.3 Hz, 2H). 
13C-NMR (126 MHz, CDCl3) δ 206.9, 137.8, 132.5, 127.3, 122.8, 120.9, 









The reaction was run with General Method B: Iterative 
Catalyst Addition Protocol using 4:1 MeCN: DCM as solvent to 
improve the solubility of the starting material: 2-((1-(4-
bromophenyl)cyclobutyl)methyl)isoindoline-1,3-dione S45 (111.1 mg, 0.300 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) (3 times addition of 20.4 mg, 0.015 mmol, 5 mol% batch; 15 mol% in 
total), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), 4:1 MeCN: DCM mixture (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction 
was allowed to stir at 0 ºC for ~5 min to facilitate the solubility of starting material before adding 
H2O2 and run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 
and DCM as described in General Method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as 
eluent afforded product as a white solid. 
Run 1: (67.7 mg, 0.176 mmol, 58.7% yield), (14.9 mg, 0.040 mmol, 13.4% rsm). Run 2: (65.4 
mg, 0.170 mmol, 56.7% yield), (23.2 mg, 0.063 mmol, 20.9% rsm). Run 3: (63.9 mg, 0.166 
mmol, 55.4% yield), (20.9 mg, 0.056 mmol, 18.8% rsm). Average: 56.9% yield ± 1.7%, 17.7% 
rsm ± 3.9%. 
1H-NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.5, 3.1 Hz, 2H), 7.45 
(d, J = 8.4 Hz, 2H), 7.17 (d, J = 8.4 Hz, 2H), 4.04 (s, 2H), 3.68 – 3.63 (m, 2H), 3.45 – 3.39 (m, 
2H). 13C-NMR (126 MHz, CDCl3) δ 204.1, 168.5, 142.7, 134.5, 131.9, 131.6, 128.9, 123.7, 











The reaction was run with General Method A: Single Catalyst Addition 
Protocol: Bis(4-chlorophenyl)(cyclobutyl)methanol S46 (92.2 mg, 0.300 
mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 
mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run 
at 0 ºC with ice bath. The reaction was worked up with saturated 9 mL NaHCO3 and DCM as 
described in General Method A. Flash column chromatography on silica (35 mm fritted glass 
column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded 
2-(bis(4-chlorophenyl)(hydroxy)methyl)cyclobutan-1-one (g-ketone, 57b) product as a white 
solid and 3-(bis(4-chlorophenyl)(hydroxy)methyl)cyclobutan-1-one (d-ketone, 57a) product as a 
light yellow oil. 
Run 1: (16.8 mg, 0.052 mmol, 17.4% yield of g-ketone 57b), (32.2 mg, 0.100 mmol, 33.4% 
yield of d-ketone 57a), (50.8% overall yield, 1.9:1 d:g ratio), 0% rsm. Run 2: (16.5 mg, 0.051 
mmol, 17.1% yield of g-ketone 57b), (33.0 mg, 0.103 mmol, 34.3% yield of d-ketone 57a), 
(51.4% overall yield, 2.0:1 d:g ratio), 0% rsm. Run 3: (17.4 mg, 0.054 mmol, 18.1% yield of g-
ketone 57b), (34.8 mg, 0.108 mmol, 36.1% yield of d-ketone 57a), (54.2% overall yield, 2.0:1 
d:g ratio), 0% rsm. Average: 52.2% yield ± 1.8%, 2.0:1 d:g ratio, 0% rsm. 
1H-NMR (500 MHz, methylene chloride-d2) δ 7.35 – 7.30 (m, 8H), 3.39 (tt, J = 8.7, 6.6 Hz, 1H), 
3.08 – 2.93 (m, 4H), 2.63 (br. s, 1H). 13C-NMR (126 MHz, methylene chloride-d2) δ 206.3, 
144.8, 133.8, 129.1, 128.1, 78.3, 48.5, 33.3. HRMS (EI+) m/z calculated for C17H14O2Cl2 [M]+: 









1H-NMR (500 MHz, methylene chloride-d2) δ 7.33 – 7.27 (m, 8H), 4.43 – 4.38 
(m, 1H), 3.02 – 2.94 (m, 1H), 2.80 – 2.72 (m, 2H), 2.02 (app. td, J = 9.1, 7.4 
Hz, 2H). 13C-NMR (126 MHz, methylene chloride-d2) δ 208.4, 144.2, 144.1, 
133.9, 133.5, 128.9, 128.85, 128.83, 128.0, 77.9, 68.8, 45.2, 14.0. HRMS (EI+) 
m/z calculated for C17H14O2Cl2 [M]+: 320.0371, found 320.0374. 
2-(4-chlorophenyl)-2-(3-oxobutyl)-1H-indene-1,3(2H)-dione [58]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: 2-butyl-2-(4-chlorophenyl)-1H-indene-1,3(2H)-
dione S47 (93.8 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 
mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 
equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL 
with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 
saturated 9 mL NaHCO3 and DCM as described in General Method A. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 
acetone/hexanes à 30% acetone/hexanes as eluent afforded product as a white solid. 
Run 1: (57.7 mg, 0.177 mmol, 58.9% yield), (13.0 mg, 0.042 mmol, 13.9% rsm). Run 2: (58.8 
mg, 0.180 mmol, 60.0% yield), (13.0 mg, 0.042 mmol, 13.9% rsm). Run 3: (60.8 mg, 0.186 
mmol, 62.0% yield), (13.4 mg, 0.043 mmol, 14.3% rsm). Average: 60.3% yield ± 1.6%, 14.0% 
rsm ± 0.2%. 
1H-NMR (500 MHz, CDCl3) δ 8.04 – 8.00 (m, 2H), 7.91 – 7.87 (m, 2H), 7.38 (d, J = 8.6 Hz, 











206.9, 200.9, 141.3, 136.4, 134.3, 134.1, 129.1, 128.6, 124.0, 59.8, 38.6, 30.0, 29.3. HRMS 
(TOF ESI+) m/z calculated for C19H16O3Cl [M+H]+: 327.0788, found 327.0795. 
methyl 2-(3-benzoylphenyl)-2-(3-oxocyclopentyl)propanoate [59a]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: methyl 2-(3-benzoylphenyl)-2-
cyclopentylpropanoate S48 (110.6 mg, 0.300 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 
equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL 
with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in General Method A. Flash column chromatography 
on silica (35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 30% 
acetone/hexanes à 40% acetone/hexanes as eluent afforded methyl 2-(3-benzoylphenyl)-2-(3-
oxocyclopentyl)propanoate (d-ketone, 59a) product as a yellow oil and methyl 2-(3-
benzoylphenyl)-2-(2-oxocyclopentyl)propanoate (g-ketone, 59b) as a yellow oil. 
Run 1: (52.7 mg, 0.150 mmol, 50.1% yield of d-ketone 59a), (6.3 mg, 0.018 mmol, 6.0% yield 
of g-ketone 59b), (56.1% overall yield, 8.3:1 d-ketone:g-ketone ratio), 0% rsm. Run 2: (48.4 
mg, 0.138 mmol, 46.1% yield of d-ketone 59a), (5.3 mg, 0.015 mmol, 5.1% yield of g-ketone 
59b), (51.2% overall yield, 9.0:1 d-ketone:g-ketone ratio), 0% rsm. Run 3: (46.8 mg, 0.134 
mmol, 44.6% yield of d-ketone 59a), (4.7 mg, 0.013 mmol, 4.5% yield of g-ketone 59b), (49.1% 
overall yield, 9.9:1 d-ketone:g-ketone ratio), 0% rsm. Average: 52.1% yield ± 3.6%, 9.1:1 d-
ketone:g-ketone ratio, 0% rsm. 
The d-ketone product 59a is isolated as a mixture of ~1:1 ratio of diastereomers. Overlap of 







1H-NMR (500 MHz, CDCl3) δ 7.80 – 7.74(m, 3H), 7.70 – 7.67 (m, 1H), 7.62 – 7.59 (m, 1H), 
7.54 – 7.44 (m, 4H), 3.71 & 3.70 (s, 3H), 3.09 – 2.99 (m, 1H), 2.43 –  2.04 (m, 4H), 1.89 – 1.68 
(m, 1H), 1.65 & 1.63 (s, 3H), 1.57 – 1.47 (m, 1H). 13C-NMR (126 MHz, CDCl3) δ 218.1, 217.8, 
196.6, 196.5, 175.5, 175.4, 142.3, 142.1, 137.9, 137.5, 132.81, 132.79, 130.6, 130.5, 130.20, 
130.19, 129.3, 129.2, 128.6, 128.54, 128.47, 127.9, 127.8, 52.57, 52.56, 52.3, 52.2, 44.9, 44.8, 
41.4, 40.9, 38.8, 38.7, 25.1, 24.6, 18.94, 18.92. HRMS (TOF ESI+) m/z calculated for C22H23O4 
[M+H]+: 351.1596, found 351.1599. 
methyl 2-(3-benzoylphenyl)-2-(2-oxocyclopentyl)propanoate [59b]. 
The g-ketone product 59b is isolated as a single diastereomer.  
1H-NMR (500 MHz, CDCl3) δ 7.87 (t, J = 1.9 Hz, 1H), 7.80 – 7.78 
(m, 2H), 7.69 – 7.66 (m, 2H), 7.62 – 7.59 (m, 1H), 7.51 – 7.43 (m, 
3H), 3.72 (s, 3H), 3.39 (dd, J = 13.3, 7.8 Hz, 1H), 2.40 – 2.35 (m, 1H), 2.12 – 2.04 (m, 1H), 1.98 
– 1.95 (m, 1H), 1.80 – 1.73 (m, 2H), 1.56 (s, 3H), 1.57 – 1.51 (m, 1H).13C-NMR (126 MHz, 
CDCl3) δ 217.3, 196.7, 175.0, 142.1, 137.8, 137.5, 132.8, 130.6, 130.2, 129.2, 128.6, 128.4, 
128.0, 56.9, 52.8, 50.1, 39.0, 25.9, 20.2, 17.1.HRMS (TOF ESI+) m/z calculated for C22H23O4 
[M+H]+: 351.1596, found 351.1599. 
3-(3-(3,4-dichlorophenyl)-2-oxopropyl)cyclopentan-1-one [60a]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: 1-cyclopentyl-3-(3,4-dichlorophenyl)propan-
2-one S49 (81.4 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with 











General Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 
mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded 2-(3-(3,4-
dichlorophenyl)-2-oxopropyl)cyclopentan-1-one (g-ketone, 60b) product as a white solid and 3-
(3-(3,4-dichlorophenyl)-2-oxopropyl)cyclopentan-1-one (d-ketone, 60a) product as a light 
yellow oil. 
Run 1: (11.3 mg, 0.040 mmol, 13.2% yield of g-ketone 60b), (35.0 mg, 0.123 mmol, 40.9% 
yield of d-ketone 60a), (54.1% overall yield, 3.1:1 d:g ratio), 0% rsm. Run 2: (10.7 mg, 0.038 
mmol, 12.5% yield of g-ketone 60b), (32.3 mg, 0.113 mmol, 37.8% yield of d-ketone 60a), 
(50.3% overall yield, 3.0:1 d:g ratio), 0% rsm. Run 3: (11.2 mg, 0.040 mmol, 13.1% yield of g-
ketone 60b), (35.2 mg, 0.124 mmol, 41.2% yield of d-ketone 60a), (54.3% overall yield, 3.1:1 
d:g ratio), 0% rsm. Average: 52.9% yield ± 2.3%, 3.1:1 d:g ratio, 0% rsm. 
1H-NMR (500 MHz, methylene chloride-d2) δ 7.42 (d, J = 8.2 Hz, 1H), 7.31 (d, J = 2.0 Hz, 1H), 
7.05 (dd, J = 8.3, 2.1 Hz, 1H), 3.67 (s, 2H), 2.69 – 2.55 (m, 3H), 2.44 – 2.38 (m, 1H), 2.27 – 2.09 
(m, 3H), 1.71 (ddd, J = 18.2, 9.9, 1.2 Hz, 1H), 1.51 – 1.41 (m, 1H). 13C-NMR (126 MHz, 
methylene chloride-d2) δ 218.4, 205.9, 135.0, 132.8, 132.0, 131.5, 131.0, 129.7, 49.2, 48.2, 45.0, 
38.7, 32.7, 29.7. HRMS (TOF ESI+) m/z calculated for C14H15O2Cl2 [M+H]+: 285.0449, found 
285.0453. 
Site of oxidation was assigned based on a combination of 1H, gDQCOSY, gHSQC, gHMBC 
NMRs. 
2-(3-(3,4-dichlorophenyl)-2-oxopropyl)cyclopentan-1-one [60b]. 
 1H-NMR (500 MHz, methylene chloride-d2) δ 7.41 (d, J = 8.2 Hz, 
1H), 7.31 (d, J = 2.1 Hz, 1H), 7.05 (dd, J = 8.3, 2.1 Hz, 1H), 3.72 (d, 








7.2 Hz, 1H), 2.50 – 2.43 (m, 1H), 2.32 – 2.19 (m, 2H), 2.13 (ddd, J = 18.7, 11.1, 8.9 Hz, 1H), 
2.04 – 1.98 (m, 1H), 1.84 – 1.74 (m, 1H), 1.52 – 1.43 (m, 1H). 13C-NMR (126 MHz, methylene 
chloride-d2) δ 220.0, 205.6, 135.1, 132.8, 132.1, 131.5, 130.9, 129.8, 49.1, 45.5, 42.6, 37.8, 29.9, 
21.3. HRMS (TOF ESI+) m/z calculated for C14H15O2Cl2 [M+H]+: 285.0449, found 285.0442. 
Site of oxidation was assigned based on a combination of 1H, gCOSY, gHSQC, gHMBC NMRs. 
(±)-trans-4-methyl-3-oxocyclohexyl 4-chlorobenzoate [61a]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. (±)-trans-4-methylcyclohexyl 4-chlorobenzoate S50 (75.8 mg, 
0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 
mg, 3.0 mmol, 10.0 equiv.), 4:1 MeCN:DCM (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The 
reaction was run at 0 ºC with ice bath. The reaction was worked up with saturated 9 mL NaHCO3 
and DCM as described in General Method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mL SiO2) using 10% ethyl acetate/hexanes à 20% ethyl 
acetate/hexanes à 30% ethyl acetate/hexanes as eluent afforded (±)-trans-4-methyl-3-
oxocyclohexyl 4-chlorobenzoate (g-ketone, 61a) as a white solid and (±)-trans-4-hydroxy-4-
methylcyclohexyl 4-chlorobenzoate (d-alcohol, 61b) as a white solid. A trace amount (<5% 
yield) of (±)-trans-4-methyl-2-oxocyclohexyl 4-chlorobenzoate (b-ketone) can be observed. 
Run 1: (24.9 mg, 0.093 mmol, 31.1% yield of g-ketone 61a), (20.6 mg, 0.077 mmol, 25.6% 
yield of d-alcohol 61b), (56.7% overall yield, 1.21:1 K:A ratio), (13.3 mg, 0.053 mmol, 17.5% 
rsm). Run 2: (26.8 mg, 0.101 mmol, 33.5% yield of g-ketone 61a), (23.1 mg, 0.086 mmol, 
28.7% yield of d-alcohol 61b), (62.2% overall yield, 1.17:1 K:A ratio), (12.5 mg, 0.049 mmol, 







(40.0 mg, 0.150 mmol, 30.0% yield of g-ketone 61a), (35.1 mg, 0.131 mmol, 26.1% yield of d-
alcohol 61b), (56.1% overall yield, 1.15:1 K:A ratio), (21.8 mg, 0.086 mmol, 17.3% rsm). 
Average: 31.5% yield ± 1.8% of g-ketone, 26.8% yield ± 1.7% of d-alcohol, 58.3% overall 
yield with 1.2:1 K:A ratio, 17.1% rsm ± 0.6%. 
1H-NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.5 Hz, 2H), 7.42 (d, J = 8.5 Hz, 2H), 5.21 (tt, J = 
10.2, 4.7 Hz, 1H), 2.92 (ddd, J = 13.6, 5.0, 2.0 Hz, 1H), 2.57 (ddd, J = 13.6, 10.7, 1.3 Hz, 1H), 
2.42 – 2.33 (m, 2H), 2.15 – 2.11 (m, 1H), 1.91 (tdd, J = 12.7, 10.2, 4.0 Hz, 1H), 1.42 (dtd, J = 
13.8, 12.0, 3.6 Hz, 1H), 1.10 (d, J = 6.6 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 208.9, 164.7, 
139.7, 131.2, 128.9, 128.6, 72.6, 47.0, 44.4, 30.4, 29.2, 14.5. HRMS (TOF ESI+) m/z calculated 
for C14H15O3ClNa [M+Na]+: 289.0607, found 289.0601. 
(±)-trans-4-hydroxy-4-methylcyclohexyl 4-chlorobenzoate [61b]. 
1H-NMR (500 MHz, CDCl3) δ 7.97 (d, J = 8.6 Hz, 2H), 7.40 (d, J = 8.5 Hz, 
2H), 4.97 (tt, J = 9.4, 4.7 Hz, 1H), 1.95 – 1.85 (m, 4H), 1.79 – 1.74 (m, 2H), 
1.57 (ddd, J = 13.7, 11.4, 4.7 Hz, 2H), 1.28 (s, 3H), 1.25 (br. s, 1H).13C-NMR 
(126 MHz, CDCl3) δ 165.3, 139.3, 131.1, 129.3, 128.8, 73.0, 68.8, 36.7, 30.1, 
27.4. HRMS (TOF ESI+) m/z calculated for C14H17O3ClNa [M+Na]+: 291.0764, found 291.0770. 
(±)-2-methyl-3-oxobutyl 4-chlorobenzoate [62a]. 
 The reaction was run with General Method C: Slow Catalyst 
Addition Protocol: 2-methylbutyl 4-chlorobenzoate S51 (113.4 mg, 
0.500 mmol, 1.0 equiv), ClCH2CO2H (709 mg, 7.5 mmol, 15.0 
equiv.) were dissolved in MeCN (1.0 mL). (R,R)-Mn(CF3-PDP) (67.8 mg, 0.050 mmol, 10 
mol%) and MeCN (0.625 mL) added in a 1 mL syringe, 50% wt. H2O2 (340 mg, 5.0 mmol, 10.0 











dichloroethane/dry ice bath. The reaction was worked up with 15 mL saturated NaHCO3 and 
DCM as described in General Method C. Flash column chromatography on silica (35 mm fritted 
glass column, 150 mL SiO2) using 10% ethyl acetate/hexanes à 20% ethyl acetate/hexanes à 
35% ethyl acetate/hexanes as eluent afforded 2-(±)-methyl-3-oxobutyl 4-chlorobenzoate (g-
ketone, 62a) product as a yellow oil and (±)-2-hydroxy-2-methylbutyl 4-chlorobenzoate (b-
alcohol, 62b) as a yellow oil. 
Run 1: (45.7 mg, 0.190 mmol, 38.0% yield of g-ketone 62a), (21.6 mg, 0.089 mmol, 17.8% 
yield of b-alcohol 62b), (55.8% overall yield, 2.13:1 K:A ratio), <10% rsm. Run 2: (47.7 mg, 
0.198 mmol, 39.6% yield of g-ketone 62a), (23.6 mg, 0.097 mmol, 19.4% yield of b-alcohol 
62b), (59.0% overall yield, 2.04:1 K:A ratio), <10% rsm. Run 3: (47.7 mg, 0.198 mmol, 39.6% 
yield of g-ketone 62a), (22.4 mg, 0.092 mmol, 18.5% yield of b-alcohol 62b), (58.1% overall 
yield, 2.14:1 K:A ratio), <10% rsm. Average: 39.1% yield ± 0.9% of g-ketone, 18.5% yield ± 
0.8% of b-alcohol, 57.6% overall yield with 2.1:1 K:A, <10% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.91 (d, J = 8.8 Hz, 2H), 7.39 (d, J = 8.7 Hz, 2H), 4.47 (ddd, J = 
11.1, 7.3, 0.7 Hz, 1H), 4.39 (ddd, J = 11.1, 5.5, 0.7 Hz, 1H), 3.04 – 2.97 (m, 1H), 2.23 (s, 3H), 
1.21 (d, J = 7.2 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 209.3, 165.5, 139.7, 131.1, 128.9, 
128.4, 66.1, 46.2, 28.8, 13.5. HRMS (TOF ESI+) m/z calculated for C12H14O3Cl [M+H]+: 
241.0631, found 241.0627. The NMR data matches with the literature.18  
Oxidation with TFDO: The reaction was performed according to the reported condition in 
literature18 using TFDO generated according to method described in Section 2.5.3. In a 1-dram 
vial charged with 2-methylbutyl 4-chlorobenzoate S51 (11.3 mg, 0.05 mmol, 1.0 equiv.) and a 
stir bar. 0.5 mL DCM freshly obtained from SDS was transferred into the vial via plastic syringe 
equipped with micropipette tip. The reaction was cooled to -20 ºC, and 0.38 mL 0.4M TFDO 
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solution was added into the vial in 1-2 portions and the reaction was kept at -20 ºC for 48 h. The 
reaction was concentrated on rotvap to remove all volatiles and the crude mixture was analyzed 
by 1H NMR with nitrobenzene added as internal standard. 
Run 1: (2.8 mg, 0.012 mmol, 23.3% yield of g-ketone 62a), (5.6 mg, 0.023 mmol, 46.1% yield 
of b-alcohol 62b), (69.4% overall yield, 1:2.0 K:A ratio), (1.2 mg, 0.005 mmol, 10.6% rsm). 
Run 2: (2.5 mg, 0.010 mmol, 20.8% yield of g-ketone 62a), (5.1 mg, 0.021 mmol, 42.0% yield 
of b-alcohol 62b), (62.8% overall yield, 1:2.0 K:A ratio), (1.9 mg, 0.008 mmol, 16.8% rsm). 
Average: 22.1% yield of g-ketone, 44.1% yield of b-alcohol, 66.2% overall yield with 1:2.0 
K:A, 13.7% rsm. 
(±)-2-hydroxy-2-methylbutyl 4-chlorobenzoate [62b]. 
1H-NMR (500 MHz, CDCl3) 7.99 – 7.97 (m, 2H), 7.43 – 7.41 (m, 
2H), 4.25 – 4.20 (m, 2H), 1.90 (br. s, 1H), 1.64 (q, J = 7.5 Hz, 2H), 
1.28 (s, 3H), 0.98 (t, J = 7.5 Hz, 3H). 13C-NMR (126 MHz, CDCl3) 
165.9, 139.8, 131.1, 128.9, 128.5, 72.3, 71.5, 31.9, 23.6, 8.1. HRMS (TOF ESI+) m/z calculated 
for C12H14ClO2 [M-OH]+: 225.0677, found 225.0687. The NMR data matches with the 
literature.18 
4-cyclopropyl-4-oxobutyl benzoate [63a]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol. 4-cyclopropylbutyl benzoate S52 (65.5 mg, 
0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H 
(425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 
mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. The 










A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 5% 
ethyl acetate/hexanes à 15% ethyl acetate/hexanes à 40% ethyl acetate/hexanes as eluent 
afforded 4-cyclopropyl-4-oxobutyl benzoate (ketone, 63a), 4-cyclopropyl-4-hydroxybutyl 
benzoate (alcohol, 63b) and 4-(2-chloroacetoxy)-4-cyclopropylbutyl benzoate (ester, 63c) 
products as colorless oils. 
Run 1: (31.2 mg, 0.134 mmol, 44.8% yield of ketone 63a), (6.4 mg, 0.027 mmol, 9.1% yield of 
alcohol 63b), (6.3 mg, 0.020 mmol, 6.8% yield of ester 63c), (5.6 mg, 0.026 mmol, 8.6% rsm), 
(60.7% combined oxidation yield, 69.3% mass balance). Run 2: (28.5 mg, 0.123 mmol, 40.9% 
yield of ketone 63a), (7.3 mg, 0.031 mmol, 10.4% yield of alcohol 63b), (6.5 mg, 0.021 mmol, 
7.0% yield of ester 63c), (5.0 mg, 0.023 mmol, 7.6% rsm), (58.3% combined oxidation yield, 
65.9% mass balance). Run 3: (32.3 mg, 0.139 mmol, 46.4% yield of ketone 63a), (6.9 mg, 0.029 
mmol, 9.8% yield of alcohol 63b), (6.0 mg, 0.019 mmol, 6.4% yield of ester 63c), (5.2 mg, 0.024 
mmol, 7.9% rsm), (62.6% combined oxidation yield, 70.5% mass balance). Average: 44.0% 
yield ± 2.8% of ketone, 9.8% yield ± 0.7% of alcohol, 6.7% yield ± 0.3% of ester, 8.0% rsm 
± 0.5%, 60.5% overall oxidation yield with 68.5% mass balance. 
1H-NMR (500 MHz, CDCl3) δ 8.04 (dt, J = 8.3, 1.2 Hz, 2H), 7.58 – 7.54 (m, 1H), 7.44 (td, J = 
7.7, 1.3 Hz, 2H), 4.34 (t, J = 6.4 Hz, 2H), 2.74 (t, J = 7.3 Hz, 2H), 2.09 (tt, J = 7.5, 6.9 Hz, 2H), 
1.94 (tdd, J = 7.9, 5.1, 4.0 Hz, 1H), 1.05 – 1.02 (m, 2H), 0.87 (ddt, J = 7.3, 4.0, 3.1 Hz, 2H). 13C-
NMR (126 MHz, CDCl3) δ 209.8, 166.6, 133.0, 130.3, 129.6, 128.4, 64.3, 39.8, 23.1, 20.6, 10.9. 
HRMS (TOF ESI+) m/z calculated for C14H16O3Na [M+Na]+: 255.0997, found 255.0991. 
4-cyclopropyl-4-hydroxybutyl benzoate [63b]. 
1H-NMR (500 MHz, CDCl3) δ 8.05 – 8.03 (m, 2H), 7.55 (td, J = 





2.94 – 2.90 (m, 1H), 2.00 – 1.86 (m, 2H), 1.81 – 1.72 (m, 2H), 1.70 (br. s, 1H), 0.93 (qt, J = 8.3, 
4.9 Hz, 1H), 0.57 – 0.48 (m, 2H), 0.31 – 0.21 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 166.8, 
133.0, 130.5, 129.7, 128.5, 76.6, 65.2, 33.6, 25.3, 18.1, 3.0, 2.7. HRMS (TOF ESI+) m/z 
calculated for C14H18O3Na [M+Na]+: 257.1154, found 257.1147. 
4-(2-chloroacetoxy)-4-cyclopropylbutyl benzoate [63c]. 
1H-NMR (500 MHz, CDCl3) δ 8.05 – 8.03 (m, 2H), 7.58 – 7.55 (m, 
1H), 7.45 (t, J = 7.8 Hz, 2H), 4.39 (dt, J = 8.9, 5.5 Hz, 1H), 4.33 (t, 
J = 5.8 Hz, 2H), 4.08 (s, 2H), 1.91 – 1.82 (m, 4H), 1.06 – 0.99 (m, 
1H), 0.61 (tdd, J = 8.5, 5.9, 4.6 Hz, 1H), 0.53 (tdd, J = 8.9, 6.8, 5.2 Hz, 1H), 0.46 (ddt, J = 9.5, 
5.9, 4.8 Hz, 1H), 0.33 – 0.29 (m, 1H). 13C-NMR (126 MHz, CDCl3) δ 167.3, 166.7, 133.1, 130.3, 
129.7, 128.5, 80.9, 64.6, 41.3, 31.3, 24.9, 15.2, 3.6, 3.4. HRMS (TOF ESI+) m/z calculated for 
C16H19O4ClNa[M+Na]+: 333.0870, found 333.0864. 
1-(4-(tert-butoxy)phenyl)-3-oxocyclopentane-1-carbonitrile [64]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol: 1-(4-(tert-butoxy)phenyl)cyclopentane-1-carbonitrile S53 (73.0 
mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 
10 mol%),  ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 
10.0 equiv.), 4:1 MeCN:DCM (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was 
run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as 
described in General method A. Flash column chromatography on silica (35 mm fritted glass 
column, 150 mL SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent. All 
fractions are collected and analyzed by 1H NMR with nitrobenzene as internal standard. 











methyl 1-(4-(tert-butoxy)-3-chlorophenyl)-3-oxocyclopentane-1-carboxylate [65]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol. Methyl 1-(4-(tert-butoxy)-3-
chlorophenyl)cyclopentane-1-carboxylate S54 (93.2 mg, 0.300 mmol, 
1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 
MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in the general 
method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 10% acetone/hexanes à 20% acetone /hexanes à 30% acetone /hexanes as eluent 
afforded product as a clear oil. 
Run 1: (71.9 mg, 0.221 mmol, 73.8% yield), 0% rsm. Run 2: (69.0 mg, 0.212 mmol, 70.8% 
yield), 0% rsm. Run 3: (71.7 mg, 0.221 mmol, 73.6% yield), 0% rsm. Average: 72.7% yield ± 
1.7%, 0% rsm.  
1H-NMR (500 MHz, CDCl3) δ 7.34 (d, J = 2.3 Hz, 1H), 7.11 (dd, J = 8.5, 2.4 Hz, 1H), 7.07 (d, J 
= 8.5 Hz, 1H), 3.66 (s, 3H), 3.21 (d, J = 17.9 Hz, 1H), 2.93 (dddd, J = 11.4, 7.7, 4.1, 1.9 Hz, 1H), 
2.56 (d, J = 18.0 Hz, 1H), 2.36 – 2.27 (m, 3H), 1.40 (s, 9H). 13C-NMR (126 MHz, CDCl3) 215.1, 
174.5, 151.7, 136.7, 129.4, 128.6, 125.4, 124.3, 81.6, 54.4, 53.1, 48.3, 37.1, 33.0, 29.0. HRMS 
(TOF ESI+) m/z calculated for C17H22ClO4 [M+H]+: 325.1207, found 325.1204. 
methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-(3-oxocyclopentyl)propanoate [66a]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol. Methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-












Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with 
oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in the general method A. Flash column 
chromatography on silica (35 mm fritted glass column, 100 mL SiO2) using 5% ethyl 
acetate/hexanes à 15% ethyl acetate/hexanes à 25% ethyl acetate/hexanes as eluent afforded 
clean e-ketone (66a) and d-ketone (66b) with small impurity as clear oil. 
The position of oxidation was assigned by analogy with all other compounds examined where 
oxidation is preferred at the sites most remote from electron-withdrawing groups (ester in this 
case). The assignment can be further supported by the relative 1H chemical shift of the benzylic 
proton where the proton in d-ketone (66b) is more downfield than the proton in e-ketone (66a). 
Run 1: (44.1 mg, 0.125 mmol, 41.7% yield of e-ketone 66a), (13.1 mg, 0.037 mmol, 12.4% 
yield of d-ketone 66b), (54.1% overall yield, 3.36:1 e:d ratio), <10% rsm. Run 2: (43.7 mg, 
0.124 mmol, 41.3% yield of e-ketone 66a), (12.1 mg, 0.034 mmol, 11.4% yield of d-ketone 
66b), (52.7% overall yield, 3.62:1 e:d ratio), <10% rsm. Run 3: (45.2 mg, 0.128 mmol, 42.7% 
yield of e-ketone 66a), (13.1 mg, 0.037 mmol, 12.4% yield of d-ketone 66b), (55.1% overall 
yield, 3.44:1 e:d ratio), <10% rsm Average: 41.9% yield ± 0.7% of e-ketone, 12.1% yield ± 
0.6% of d-ketone, 54.0% overall yield with 3.5:1 e:d ratio, <10% rsm. 
e-ketone (66a) was isolated as a mixture of diastereomers with ~1:1 ratio. 1H-NMR (500 MHz, 
CDCl3) δ 7.33 (t, J = 2.3 Hz, 1H), 7.09 (app. ddd, J = 8.1, 4.4, 2.1 Hz, 1H), 7.05 (d, J = 8.3 Hz, 
1H), 3.68 (s, 3H), 3.54 (app. td, J = 7.7, 4.2 Hz, 1H), 2.39 – 1.99 (m, 6H), 1.96 – 1.75 (m, 2H), 
1.57 – 1.48 (m, 1H), 1.41 (s, 9H). 13C-NMR (126 MHz, CDCl3) 218.6 & 218.5, 174.0 & 173.9, 
151.6, 134.33 & 134.25, 129.7 & 129.6, 129.5 & 129.4, 126.63 & 126.57, 124.7 & 124.6, 81.5, 
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52.42 & 52.40, 49.3 & 49.2, 45.1 & 44.8, 39.5 & 39.4, 38.6 & 38.5, 35.3 & 35.2, 29.7 & 29.5, 
29.1. HRMS (TOF ESI+) m/z calculated for C19H25ClO4Na [M+Na]+: 375.1339, found 375.1330. 
methyl 2-(4-(tert-butoxy)-3-chlorophenyl)-3-(2-oxocyclopentyl)propanoate [66b]. 
d-ketone (66b) was isolated as a mixture of diastereomers with ~1:1 ratio 
and contain a minor impurity. 1H-NMR (500 MHz, CDCl3) δ 7.33 (app. 
dd, J = 9.8, 2.2 Hz, 1H), 7.12 – 7.09 (m, 1H), 7.05 – 7.03 (m, 1H), 3.66 (s, 
3H), 3.71 – 3.65 (m, 1H), 2.32 – 1.85 (m, 6H), 1.76 – 1.66 (m, 2H), 1.54 – 
1.44 (m, 1H), 1.40 (s, 9H). 13C-NMR (126 MHz, CDCl3) 220.3 & 220.2, 173.8 & 173.7, 151.44 
& 151.36, 134.4 & 133.9, 129.79 & 129.76, 129.2, 126.8 & 126.5, 124.51 & 124.48, 81.3, 52.19 
& 52.16, 48.6 & 48.3, 46.9 & 46.6, 37.89 & 37.87, 33.7 & 33.5, 30.2 & 29.8, 28.9, 20.64 & 
20.61. HRMS (TOF ESI+) m/z calculated for C19H25ClO4Na [M+Na]+: 375.1339, found 
375.1337. 
methyl 1-(3-chloro-4-methoxyphenyl)-3-oxocyclopentane-1-carboxylate [67]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: methyl 1-(3-chloro-4-methoxyphenyl)cyclopentane-
1-carboxylate S56 (80.6 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-
PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. 
H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). 
The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated 
NaHCO3 and DCM as described in General Method A. Flash column chromatography on silica 
(35 mm fritted glass column, 150 mL SiO2) using 20% acetone/hexanes à 40% acetone/hexanes 












Run 1: (32.8 mg, 0.116 mmol, 38.7% yield), (11.5 mg, 0.043 mmol, 14.3% rsm). Run 2: (27.0 
mg, 0.096 mmol, 31.8% yield), (14.6 mg, 0.054 mmol, 18.1% rsm). Run 3: (29.4 mg, 0.104 
mmol, 34.7% yield), (13.8 mg, 0.051 mmol, 17.1% rsm). Average: 35.1% yield ± 3.5%, 16.5% 
rsm ± 2.0%. 
1H-NMR (500 MHz, CDCl3) δ 7.36 (d, J = 2.4 Hz, 1H), 7.19 (dd, J = 8.6, 2.4 Hz, 1H), 6.90 (d, J 
= 8.6 Hz, 1H), 3.89 (s, 3H), 3.66 (s, 3H), 3.21 (dd, J = 17.9, 2.0 Hz, 1H), 2.96 – 2.91 (m, 1H), 
2.57 (d, J = 17.9 Hz, 1H), 2.36 – 2.26 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 215.1, 174.6, 
154.6, 134.2, 128.7, 126.0, 122.9, 112.1, 56.3, 54.2, 53.1, 48.3, 37.1, 33.0. HRMS (TOF ESI+) 
m/z calculated for C14H16O4Cl [M+H]+: 283.0737, found 283.0733. 
methyl 1-(3-chloro-4-(methoxy-d3)phenyl)-3-oxocyclopentane-1-carboxylate [68]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol: methyl 1-(3-chloro-4-(methoxy-
d3)phenyl)cyclopentane-1-carboxylate S57 (81.5 mg, 0.300 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 
15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 
mL with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 
mL saturated NaHCO3 and DCM as described in General Method A. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 20% 
acetone/hexanes à 40% acetone/hexanes as eluent to obtain pure product as a white solid. 
Run 1: (33.4 mg, 0.117 mmol, 39.0% yield), (10.1 mg, 0.037 mmol, 12.4% rsm). Run 2: (34.6 
mg, 0.121 mmol, 40.4% yield), (9.5 mg, 0.035 mmol, 11.7% rsm). Run 3: (36.3 mg, 0.127 
mmol, 42.3% yield), (9.9 mg, 0.036 mmol, 12.1% rsm). Average: 40.6% yield ± 1.7%, 12.1% 







1H-NMR (500 MHz, CDCl3) δ 7.35 (d, J = 2.4 Hz, 1H), 7.18 (dd, J = 8.6, 2.4 Hz, 1H), 6.89 (d, J 
= 8.6 Hz, 1H), 3.65 (s, 3H), 3.20 (dd, J = 17.9, 2.0 Hz, 1H), 2.95 – 2.90 (m, 1H), 2.56 (d, J = 
17.9 Hz, 1H), 2.35 – 2.27 (m, 3H). 13C-NMR (126 MHz, CDCl3) δ 215.0, 174.61, 154.5, 134.2, 
128.6, 126.0, 122.8, 112.1, 55.84 – 55.18 (m, 1 carbon), 54.18, 53.11, 48.28, 37.04, 32.99. 
HRMS (TOF ESI+) m/z calculated for C14H13D3O4Cl [M+H]+: 286.0925, found 286.0924. 
methyl 1-(3-methoxy-4-(((trifluoromethyl)sulfonyl)oxy)phenyl)-3-oxocyclopentane-1-
carboxylate [69]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol. Methyl 1-(3-methoxy-4-
(((trifluoromethyl)sulfonyl)oxy)phenyl)cyclopentane-1-carboxylate S58 
(114.7 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 
MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in General 
Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 15% ethyl acetate/hexanes à 35% ethyl acetate/hexanes à 60% ethyl acetate/hexanes as 
eluent afforded product as a white solid. 
Run 1: (64.6 mg, 0.163 mmol, 54.3% yield), (9.3 mg, 0.024 mmol, 8.1% rsm). Run 2: (59.6 mg, 
0.150 mmol, 50.1% yield), (13.3 mg, 0.035 mmol, 11.6% rsm). Run 3: (61.8 mg, 0.156 mmol, 
52.0% yield), (8.6 mg, 0.022 mmol, 7.5% rsm). Average: 52.1% yield ± 2.1%, 9.1% rsm ± 
2.1%.  
1H-NMR (500 MHz, methylene chloride-d2) δ 7.22 (d, J = 8.5 Hz, 1H), 7.02 (d, J = 2.2 Hz, 1H), 







2.93 (m, 1H), 2.57 (d, J = 17.8 Hz, 1H), 2.39 – 2.30 (m, 3H). 13C-NMR (126 MHz, methylene 
chloride-d2) 214.6, 174.6, 151.9, 143.7, 138.5, 122.9, 119.7, 119.3 (q, J = 320.4 Hz), 112.4, 56.9, 
55.5, 53.6, 48.7, 37.4, 33.5. 19F-NMR (471 MHz, methylene chloride-d2) δ -74.3. HRMS (TOF 
ESI+) m/z calculated for C15H15O7F3SNa [M+Na]+: 419.0388, found 419.0386. 
4-(1-cyano-3-oxocyclopentyl)-2-methylphenyl trifluoromethanesulfonate [70]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 4-(1-cyanocyclopentyl)-2-methylphenyl 
trifluoromethanesulfonate S59 (100.0 mg, 0.300 mmol, 1.0 equiv), (R,R)-
Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with 
oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in General Method A. Flash column chromatography 
on silica (35 mm fritted glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% 
acetone/hexanes à 40% acetone/hexanes as eluent afforded product as a clear oil. 
Run 1: (61.3 mg, 0.176 mmol, 58.8% yield), (21.9 mg, 0.066 mmol, 21.9% rsm). Run 2: (61.4 
mg, 0.177 mmol, 59.0% yield), (23.1 mg, 0.069 mmol, 23.1% rsm). Run 3: (60.2 mg, 0.173 
mmol, 57.8% yield), (21.9 mg, 0.066 mmol, 21.9% rsm). Average: 58.5% yield ± 0.6%, 22.3% 
rsm ± 0.7%.  
1H-NMR (500 MHz, CDCl3) δ 7.42 (d, J = 2.3 Hz, 1H), 7.34 (dd, J = 8.7, 2.4 Hz, 1H), 7.32 (d, J 
= 8.7 Hz, 1H), 3.07 (d, J = 18.1 Hz, 1H), 2.85 (dddd, J = 12.9, 8.5, 3.8, 1.9 Hz, 1H), 2.76 (d, J = 
18.2 Hz, 1H), 2.73 – 2.66 (m, 1H), 2.55 (dddt, J = 18.9, 8.2, 3.8, 1.1 Hz, 1H), 2.43 (s, 3H), 2.46 
– 2.40 (m, 1H). 13C-NMR (126 MHz, CDCl3) 211.3, 148.4, 137.7, 132.5, 130.0, 125.2, 122.4, 







73.66. HRMS (TOF ESI+) m/z calculated for C14H12NO4F3SNa [M+Na]+: 370.0337, found 
370.0350. 
1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-3-oxocyclopentane-1-carbonitrile [71]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopentane-1-
carbonitrile S60 (75.4 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) 
(40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 
(204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The 
reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 
and DCM as described in General Method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mL SiO2) using 10% ethyl acetate/hexanes à 25% ethyl 
acetate/hexanes à 50% ethyl acetate/hexanes as eluent afforded product as a clear oil. 
Run 1: (43.6 mg, 0.164 mmol, 54.8% yield), (19.1 mg, 0.076 mmol, 25.3% rsm). Run 2: (45.8 
mg, 0.173 mmol, 57.6% yield), (19.0 mg, 0.076 mmol, 25.2% rsm). Run 3: (42.2 mg, 0.159 
mmol, 53.0% yield), (23.5 mg, 0.094  mmol, 31.2% rsm). Average: 55.1% yield ± 2.3%, 
27.2% rsm ± 3.4%.  
1H-NMR (500 MHz, CDCl3) δ 7.19 – 7.17 (m, 2H), 7.13 – 7.12 (m, 1H), 3.07 (d, J = 18.0 Hz, 
1H), 2.85 (dddd, J = 12.5, 8.5, 3.9, 1.9 Hz, 1H), 2.73 (d, J = 18.1 Hz, 1H), 2.73 – 2.65 (m, 1H), 
2.54 (ddd, J = 19.0, 8.2, 3.9 Hz, 1H), 2.41 (ddd, J = 13.0, 10.1, 8.2 Hz, 1H). 13C-NMR (126 
MHz, CDCl3) 211.1, 144.7, 144.0, 133.8, 131.8 (t, J = 257.4 Hz), 122.1, 121.5, 110.2, 107.7, 
50.1, 44.1, 36.7, 36.5. 19F-NMR (471 MHz, CDCl3) δ -49.8. HRMS (TOF ESI+) m/z calculated 









General procedure for the HBF4•OEt2 protection 
 In a flamed dried 40 mL vial were charged with substrate (0.3 mmol, 1.0 equiv.) and a 
stir bar. 1.2 mL anhydrous DCM was added to dissolve the substrate and the vial was flushed 
with an argon stream and then cooled to 0 ºC. HBF4•OEt2 (45.5 µL, 1.1 equiv.) was added via 
syringe and the reaction was allowed to stir at 0 ºC for 30 minutes then 1 h at room temperature. 
The reaction was concentrated in vacuo and left on high vacuum overnight (12-24 h). Resultant 
HBF4 salt were used as substrates following the corresponding oxidation protocol described in 
Section 2.4.4.  
4-(4-chlorophenyl)-1-(4-oxopentyl)piperidine-4-carbonitrile [72a]. 
Substrate 4-(4-chlorophenyl)-1-pentylpiperidine-4-carbonitrile S61 
(87.2 mg, 0.300 mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 
µL, 0.330 mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25 M) 
according to the general procedure for the HBF4•OEt2 protection. 
The reaction was run with General Method C: Slow Catalyst Addition Protocol at 0 ºC: the 
resultant S61•HBF4 (0.300 mmol, 1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The 
reaction was run at 0 ºC with ice/water bath. The reaction was worked up with 9 mL saturated 
NaHCO3 and DCM as described in General Method C. Flash column chromatography on silica 
using 2% MeOH/CHCl3 as eluent afforded 4-(4-chlorophenyl)-1-(4-oxopentyl)piperidine-4-
carbonitrile (d-ketone, 72a) product as a yellow oil. 4-(4-chlorophenyl)-1-(3-









Run 1: (56.1 mg, 0.184 mmol, 61.3% yield of d-ketone 72a), (4.3 mg, 0.014 mmol, 4.7% yield 
of g-ketone 72b), (66.0% overall yield, 13.0:1 d-ketone:g-ketone ratio), (2.4 mg. 0.008 mmol, 
2.8% rsm). Run 2: (58.2 mg, 0.191 mmol, 63.6% yield of d-ketone 72a), (4.0 mg, 0.013 mmol, 
4.4% yield of g-ketone 72b), (68.0% overall yield, 14.4:1 d-ketone:g-ketone ratio), (2.3 mg. 
0.008 mmol, 2.6% rsm). Run 3: (56.0 mg, 0.184 mmol, 61.3% yield of d-ketone 72a), (5.2 mg, 
0.017 mmol, 5.7% yield of g-ketone 72b), (67.0% overall yield, 10.8:1 d-ketone:g-ketone ratio), 
(3.7 mg. 0.013 mmol, 4.3% rsm). Average: 67.0% yield ± 1.0%, 12.6:1 d-ketone:g-ketone 
ratio, 3.2% rsm ± 0.9%. 
1H-NMR (400 MHz, CDCl3) δ 7.44 – 7.41 (m, 2H), 7.38 – 7.35 (m, 2H), 3.01 – 2.97 (m, 2H), 
2.48 – 2.41 (m, 6H), 2.16 (s, 3H), 2.10 – 1.99 (m, 4H), 1.80 (p, J = 7.2 Hz, 2H). 13C-NMR (126 
MHz, CDCl3) δ 208.5, 138.8, 134.1, 129.2, 127.1, 121.7, 57.5, 50.6, 42.5, 41.4, 36.6, 30.3, 21.2. 
HRMS (TOF ESI+) m/z calculated for C17H22N2OCl [M+H]+: 305.1421, found 305.1427. 
Other oxidation conditions for substrate S61: 
Oxidizing the S61•HBF4 using General Method A: Single Catalyst Addition Protocol: the 
resultant S61•HBF4 (0.300 mmol, 1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with 
ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in the 
general method A and columned with same column conditions. Drop in conversion and 
maintained selectivity was observed under this condition.  
Run 1: (23.5 mg, 0.077 mmol, 25.7% yield of d-ketone 72a), (1.8 mg, 0.006 mmol, 2.0% yield 
of g-ketone 72b), (27.7% overall yield, 12.9:1 d-ketone:g-ketone ratio), (52.9 mg. 0.182 mmol, 
60.7% rsm). Run 2: (21.3 mg, 0.070 mmol, 23.3% yield of d-ketone 72a), (1.6 mg, 0.005 mmol, 
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1.7% yield of g-ketone 72b), (25.0% overall yield, 13.7:1 d-ketone:g-ketone ratio), (53.8 mg. 
0.185 mmol, 61.7% rsm). Average: 26.4% yield, 13.3:1 d-ketone:g-ketone ratio, 61.2% rsm. 
Oxidizing the S61•HBF4 using modified procedure of General Method C: Slow Catalyst 
Addition Protocol at -36 ºC: the resultant S61•HBF4 (0.300 mmol, 1.0 equiv.), ClCH2CO2H 
(425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% 
wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 
3.75 mL with oxidant). The reaction was run at -36 ºC with dry ice/1,2-dichloroethane bath. The 
reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in the general 
method C and columned with same column conditions. A decrease in conversion and yield of 
ketone products was observed at this low temperature.  
Run 1: (44.5 mg, 0.146 mmol, 48.7% yield of d-ketone 72a), (3.0 mg, 0.010 mmol, 3.3% yield 
of g-ketone 72b), (52.0% overall yield, 14.8:1 d-ketone:g-ketone ratio), (29.0 mg. 0.100 mmol, 
33.2% rsm).  
Oxidizing the S61 using General Method C: Slow Catalyst Addition Protocol without 
protection with HBF4•OEt2: Substrate 4-(4-chlorophenyl)-1-pentylpiperidine-4-carbonitrile 
S61 (87.2 mg, 0.300 mmol, 1.0 equiv), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-
Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The 
reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was worked up 
with 9 mL saturated NaHCO3 and DCM as described in the general method C. No product 
formed without the HBF4•OEt2 protection indicating it is still necessary even with 
ClCH2COOH used in reaction media. 
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Run 1: (79.6 mg, 0.274 mmol, 91.2% rsm). Run 2: (79.2 mg, 0.272 mmol, 90.8% rsm). Run 3: 
(79.7 mg, 0.274 mmol, 91.3% rsm). Average: 91.1% rsm ± 0.2%. 
4-(4-chlorophenyl)-1-((3-oxocyclopentyl)methyl)piperidine-4-carbonitrile [73]. 
Substrate 4-(4-chlorophenyl)-1-(cyclopentylmethyl)piperidine-4-
carbonitrile S62 (90.9 mg, 0.300 mmol, 1.0 equiv), was protected with 
HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 
mL, 0.25M) according to the general procedure for the HBF4•OEt2 
protection. The reaction was run with General Method C: Slow Catalyst Addition Protocol: 
the resultant S62•HBF4 (0.300 mmol, 1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The 
reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was worked up 
with 9 mL saturated NaHCO3 and DCM as described in General Method C. Flash column 
chromatography on silica using 3% MeOH/CHCl3 as eluent afforded product as a pale yellow 
solid. 
Site of oxidation was confirmed based on a combination of 1H, gHSQC and gHMBC NMRs. 
Run 1: (76.1 mg, 0.240 mmol, 80.1% yield), 0% rsm. Run 2: (76.2 mg, 0.240 mmol, 80.2% 
yield), 0% rsm. Run 3: (74.9 mg, 0.236 mmol, 78.8% yield), 0% rsm. Average: 79.7% yield ± 
0.8%, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.44 – 7.42 (m, 2H), 7.39 – 7.36 (m, 2H), 3.01 – 2.96 (m, 2H), 
2.55 – 2.27 (m, 7H), 2.22 – 2.12 (m, 2H), 2.11 – 2.01 (m, 4H), 2.00 – 1.91 (m, 1H), 1.74 – 1.56 







50.9, 43.9, 42.5, 37.9, 36.7, 36.7, 34.7, 27.7. HRMS (TOF ESI+) m/z calculated for 
C18H22N2OCl [M+H]+: 317.1421, found 317.1424. 
1-(1-(4-chlorobenzyl)piperidin-4-yl)ethan-1-one [74]. 
Substrate 1-(4-chlorobenzyl)-4-ethylpiperidine S63 (71.3 mg, 0.300 
mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 
mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to 
the general procedure for the HBF4•OEt2 protection. The reaction was run with General 
Method C: Slow Catalyst Addition Protocol at 0 ºC: the resultant S63•HBF4 (0.300 mmol, 1.0 
equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 
mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 
0.38 mL with catalyst, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. The 
reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in General Method 
C. Flash column chromatography on silica using 2% MeOH/CHCl3 as eluent afforded product as 
a pale yellow solid. 
Run 1: (38.5 mg, 0.153 mmol, 51.0% yield), (11.6 mg, 0.049 mmol, 16.3% rsm). Run 2: (37.5 
mg, 0.149 mmol, 49.7% yield), (13.8 mg, 0.058 mmol, 19.3% rsm). Run 3: (38.2 mg, 0.152 
mmol, 50.6% yield), (14.1 mg, 0.059 mmol, 19.8% rsm). Average: 50.4% yield ± 0.7%, 18.5% 
rsm ± 1.9%. 
1H-NMR (500 MHz, CDCl3) δ 7.28 – 7.23 (m, 4H), 3.45 (s, 2H), 2.86 (dt, J = 11.9, 3.6 Hz, 2H), 
2.28 (tt, J = 11.5, 3.8 Hz, 1H), 2.13 (s, 3H), 2.00 (td, J = 11.6, 2.5 Hz, 2H), 1.82 (dt, J = 13.3, 2.9 
Hz, 2H), 1.65 (dtd, J = 13.2, 11.6, 3.8 Hz, 2H). 13C-NMR (126 MHz, CDCl3) δ 211.1, 137.0, 
132.8, 130.4, 128.5, 62.5, 53.1, 49.4, 27.9, 27.8. HRMS (TOF ESI+) m/z calculated for 









yl)butan-1-one S64 (91.0 mg, 0.300 mmol, 1.0 equiv), was 
protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 1.1 
equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general 
procedure for the HBF4•OEt2 protection. The reaction was run with General Method C: 
Slow Catalyst Addition Protocol: the resultant S64•HBF4 (0.300 mmol, 1.0 equiv.), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL 
with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry 
ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in 
General Method C. Flash column chromatography on silica using 5% MeOH/CHCl3 as eluent 
afforded product as a pale yellow solid. 
Run 1: (82.8 mg, 0.261 mmol, 87.0% yield), 0% rsm. Run 2: (79.7 mg, 0.251 mmol, 83.7% 
yield), 0% rsm. Run 3: (78.1 mg, 0.246 mmol, 82.0% yield), 0% rsm. Average: 84.2% yield ± 
2.5%, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 8.01 – 7.98 (m, 2H), 7.13 – 7.10 (m, 2H), 2.96 (t, J = 7.1 Hz, 2H), 
2.58 – 2.54 (m, 2H), 2.40 (t, J = 7.2 Hz, 2H), 2.26 – 2.20 (m, 4H), 2.10 (s, 2H), 1.94 (p, J = 7.1 
Hz, 2H), 1.80 (t, J = 7.9 Hz, 2H), 1.58 – 1.49 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 219.3, 
198.5, 165.7 (d, J = 254.4 Hz), 133.7 (d, J = 3.0 Hz), 130.8 (d, J = 9.2 Hz), 115.7 (d, J = 22.1 
Hz), 58.0, 50.6 (2 carbons), 50.1 (broad), 38.5, 36.6 (2 carbons), 36.4, 36.3, 34.5 (broad), 21.9. 
19F-NMR (470 MHz, CDCl3) δ -106.1. HRMS (TOF ESI+) m/z calculated for C19H25NO2F 








Substrate 3-(1-(3,4-difluorophenyl)pentyl)pyridine S65 (78.4 mg, 0.300 
mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 
wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general 
procedure for the HBF4•OEt2 protection. The reaction was run with 
General Method C: Slow Catalyst Addition Protocol: the resultant S65•HBF4 (0.300 mmol, 
1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 
mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 
0.38 mL with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM as described in General Method C. Flash column chromatography on silica using 2% 
MeOH/CHCl3 as eluent afforded product as a pale yellow oil. 
Run 1: (44.9 mg, 0.163 mmol, 54.4% yield), (10.2 mg, 0.039 mmol, 13.0% rsm). Run 2: (44.5 
mg, 0.162 mmol, 53.9% yield), (9.7 mg, 0.037 mmol, 12.4% rsm). Run 3: (44.2 mg, 0.161 
mmol, 53.5% yield), (8.4 mg, 0.032 mmol, 10.7% rsm). Average: 53.9% yield ± 0.5%, 12.0% 
rsm ± 1.2%. 
1H-NMR (500 MHz, CDCl3) 8.47 – 8.45 (m, 2H), 7.48 (dt, J = 8.0, 1.9 Hz, 1H), 7.22 (dd, J = 
7.9, 4.7 Hz, 1H), 7.08 (dt, J = 10.1, 8.3 Hz, 1H), 7.00 (ddd, J = 11.4, 7.5, 2.2 Hz, 1H), 6.94 – 
6.91 (m, 1H), 3.91 (t, J = 7.9 Hz, 1H), 2.38 (t, J = 6.7 Hz, 2H), 2.30 – 2.25 (m, 2H), 2.07 (s, 3H). 
13C-NMR (126 MHz, CDCl3) δ 207.8, 151.0 (dd, J = 155.9, 12.6 Hz), 149.7, 149.1 (dd, J = 
155.0, 12.7 Hz), 148.6, 140.4 (t, J = 4.4 Hz), 139.1, 135.1, 123.9, 123.9 (q, J = 3.4 Hz), 117.7 (d, 







137.30 (dt, J = 20.8, 10.1 Hz), -140.79 (dt, J = 20.3, 9.9 Hz). HRMS (TOF ESI+) m/z calculated 
for C16H16NOF2 [M+H]+: 276.1200, found 276.1196. 
5-(4-(4-chlorophenyl)pyridin-2-yl)pentan-2-one [77a]. 
Substrate 4-(4-chlorophenyl)-2-pentylpyridine S66 (77.9 mg, 0.300 mmol, 
1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 
1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general procedure 
for the HBF4•OEt2 protection. The reaction was run with General 
Method C: Slow Catalyst Addition Protocol: the resultant S66•HBF4 (0.300 mmol, 1.0 
equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 
mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 
0.38 mL with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM as described in General Method C. Flash column chromatography on silica using 20% 
ethyl acetate/hexanes as eluent afforded 5-(4-(4-chlorophenyl)pyridin-2-yl)pentan-2-one (d-
ketone, 77a) product as a yellow oil and 1-(4-(4-chlorophenyl)pyridin-2-yl)pentan-3-one (g-
ketone, 77b) as a yellow oil. 
Run 1: (56.0 mg, 0.205 mmol, 68.2% yield of d-ketone 77a), (11.8 mg, 0.043 mmol, 14.4% 
yield of g-ketone 77b), (82.6% overall yield, 4.7:1 d-ketone:g-ketone ratio), (7.0 mg. 0.027 
mmol, 9.0% rsm). Run 2: (52.1 mg, 0.190 mmol, 63.4% yield of d-ketone 77a), (11.4 mg, 0.042 
mmol, 13.9% yield of g-ketone 77b), (77.3% overall yield, 4.6:1 d-ketone:g-ketone ratio), (12.1 
mg. 0.047 mmol, 15.5% rsm). Run 3: (51.2 mg, 0.187 mmol, 62.4% yield of d-ketone 77a), 







ketone ratio), (12.1 mg. 0.049 mmol, 16.3% rsm). Average: 78.3% yield ± 3.9%, 4.8:1 d-
ketone:g-ketone ratio, 13.6% rsm ± 4.0%. 
1H-NMR (500 MHz, CDCl3) δ 8.56 (d, J = 5.2 Hz, 1H), 7.57 – 7.55 (m, 2H), 7.46 – 7.44 (m, 
2H), 7.33 (d, J = 1.5 Hz, 1H), 7.29 (dd, J = 5.2, 1.8 Hz, 1H), 2.85 (dd, J = 8.4, 6.9 Hz, 2H), 2.52 
(t, J = 7.3 Hz, 2H), 2.14 (s, 3H), 2.06 (app. p, J = 7.5 Hz, 2H). 13C-NMR (126 MHz, CDCl3) δ 
208.8, 162.2, 149.9, 147.8, 136.9, 135.4, 129.4, 128.4, 120.7, 119.2, 43.1, 37.6, 30.1, 23.9. 
HRMS (TOF ESI+) m/z calculated for C16H17NOCl [M+H]+: 274.0999, found 274.0990. 
1-(4-(4-chlorophenyl)pyridin-2-yl)pentan-3-one [77b]. 
 1H-NMR (500 MHz, CDCl3) δ 8.54 (d, J = 5.2 Hz, 1H), 7.57 – 7.54 (m, 
2H), 7.46 – 7.43 (m, 2H), 7.37 (d, J = 1.7 Hz, 1H), 7.28 (dd, J = 5.2, 1.8 Hz, 
1H), 3.13 (t, J = 7.2 Hz, 2H), 2.97 (t, J = 7.3 Hz, 2H), 2.48 (q, J = 7.3 Hz, 
2H), 1.06 (t, J = 7.3 Hz, 3H).13C-NMR (126 MHz, CDCl3) δ 210.8, 161.5, 
149.9, 147.7, 136.9, 135.3, 129.4, 128.4, 121.1, 119.2, 41.3, 36.2, 32.0, 8.0. 
HRMS (TOF ESI+) m/z calculated for C16H17NOCl [M+H]+: 274.0999, found 274.0992. 
6-(5-(4-bromophenyl)-1H-imidazol-1-yl)hexan-2-one [78]. 
Substrate 5-(4-bromophenyl)-1-hexyl-1H-imidazole S67 (92.2 mg, 0.300 
mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 
54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general 
procedure for the HBF4•OEt2 protection. The reaction was run with 
General Method C: Slow Catalyst Addition Protocol: the resultant S67•HBF4 (0.300 mmol, 
1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 
mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 












dichloroethane/dry ice bath. The reaction was concentrated to a minimum amount of solvent and 
dissolved in ~15 mL DCM. 15 mL 1M NaOH solution was added and the mixture was stirred 
vigorously at RT for 30 minutes before layers was separated. The aqueous layer was extracted 
with 30 mL DCM twice and the combined organic layer was dried with Na2SO4. Flash column 
chromatography on silica (35 mm fritted glass column, 100 mL SiO2) using 2% MeOH/CH2Cl2 
à 5% MeOH/CH2Cl2 à 10% MeOH/CH2Cl2 as eluent afforded 6-(5-(4-bromophenyl)-1H-
imidazol-1-yl)hexan-2-one (e-ketone 78) and a mixture of ketones in other positions as a pale 
yellow oil. 
Run 1: (30.1 mg, 0.094 mmol, 31.2% yield of e-ketone 78), (17.4 mg, 0.054 mmol, 18.1% yield 
of ketone mixtures in other positions), (49.3% overall yield, 1.7:1 e-ketone:other ketones ratio), 
<10% rsm. Run 2: (32.3 mg, 0.101 mmol, 33.5% yield of e-ketone 78), (17.4 mg, 0.054 mmol, 
18.1% yield of ketone mixtures in other positions), (51.6% overall yield, 1.9:1 e-ketone:other 
ketones ratio), <10% rsm. Run 3: (29.8 mg, 0.093 mmol, 30.9% yield of e-ketone 78), (16.1 mg, 
0.050 mmol, 16.7% yield of ketone mixtures in other positions), (47.6% overall yield, 1.9:1 e-
ketone:other ketones ratio), <10% rsm. Average: 49.5% yield ± 2.0%, 1.8:1 e-ketone:other 
ketones ratio, <10% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.63 (d, J = 8.2 Hz, 2H), 7.49 – 7.47 (m, 3H), 7.19 (s, 1H), 3.95 
(t, J = 7.1 Hz, 2H), 2.47 (t, J = 7.0 Hz, 2H), 2.13 (s, 3H), 1.84 – 1.78 (m, 2H), 1.64 – 1.58 (m, 
2H). 13C-NMR (126 MHz, CDCl3) δ 207.9, 141.5, 137.5, 133.3, 131.8, 126.4, 120.5, 114.9, 47.3, 






Other oxidation conditions for substrate S67: 
Oxidizing S67 using General Method C: Slow Catalyst Addition Protocol without protection 
with HBF4•OEt2: Substrate 5-(4-bromophenyl)-1-hexyl-1H-imidazole S67 (92.2 mg, 0.300 
mmol, 1.0 equiv), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 
0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 
mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath. The reaction was concentrated to a minimum amount of solvent and 
dissolved in ~15 mL DCM. 15 mL 1M NaOH solution was added and the mixture was stirred 
vigorously at RT for 30 minutes before layers was separated. The aqueous layer was extracted 
with 30 mL DCM twice and the combined organic layer was dried with Na2SO4. Flash column 
chromatography with the same condition and eluents was generously collected and concentrated 
via rotvap. The residue was analyzed by quantitative 1H-NMR using nitrobenzene as internal 
standard. No product formed without the HBF4•OEt2 protection indicating it is still 
necessary even with ClCH2COOH was used for the less basic imidazole substrate. 
Run 1: 0% product, 0% rsm. 
Oxidizing S67•HBF4 using Fe(CF3-PDP): Substrate 5-(4-bromophenyl)-1-hexyl-1H-imidazole 
S43 (92.2 mg, 0.300 mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 
wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general procedure for the 
HBF4•OEt2 protection. The reaction was conducted in slow addition protocol,30 same as Entry 
10 of Table 7. In a 40 mL vial was charged with S67•HBF4 (0.30 mmol, 1.0 equiv), AcOH (90.1 
mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged with a 
solution of (S,S)-Fe(CF3-PDP) catalyst (101.6 mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.38 
mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in 
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MeCN (3.75 mL). Both syringes were fitted with 25G needles and the solution was added 
dropwise via syringe pump over 1 hour. Upon completion of addition, the reaction was 
concentrated in vacuo to a minimum amount of MeCN and dissolved in ~15 mL DCM. 15 mL 
1M NaOH solution was added and the mixture was stirred vigorously at RT for 30 minutes 
before layers was separated. The aqueous layer was extracted with 30 mL DCM twice and the 
combined organic layer was dried with Na2SO4. Flash column chromatography with the same 
condition and eluents was generously collected and concentrated via rotvap. The residue was 
analyzed by quantitative 1H-NMR using nitrobenzene as internal standard. No product formed 
with the Fe(CF3-PDP) catalyst indicating the protonated imidazole substituted with an 
aromatic ring is still prone to aromatic oxidation with Fe catalyst. 
Run 1: <10% rsm + ketone products combined. 
3-((1H-benzo[d]imidazol-1-yl)methyl)cyclopentan-1-one [79a]. 
Substrate 1-(cyclopentylmethyl)-1H-benzo[d]imidazole S68 (60.1 mg, 
0.300 mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 
mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the 
general procedure for the HBF4•OEt2 protection. The reaction was run with General Method 
B: Iterative Catalyst Addition Protocol: the resultant S68•HBF4 (0.300 mmol, 1.0 equiv.), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (3 time addition of 20.4 mg, 
0.015 mmol, 5 mol%; 15 mol% used in total), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 
MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The reaction was 
run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in General Method B. Flash column chromatography 







yl)methyl)cyclopentan-1-one (d-ketone, 79a) and 2-((1H-benzo[d]imidazol-1-
yl)methyl)cyclopentan-1-one (g-ketone, 79b) as brown solid. 
Run 1: (31.9 mg, 0.149 mmol, 49.6% yield of d-ketone 79a), (3.1 mg, 0.014 mmol, 4.8% yield 
of g-ketone 79b), (54.4% overall yield, 10.3:1 d-ketone:g-ketone ratio), 0% rsm. Run 2: (33.4 
mg, 0.156 mmol, 52.0% yield of d-ketone 79a), (3.5 mg, 0.016 mmol, 5.4% yield of g-ketone 
79b), (57.4% overall yield, 9.6:1 d-ketone:g-ketone ratio), 0% rsm. Run 3: (32.1 mg, 0.150 
mmol, 49.9% yield of d-ketone 79a), (2.9 mg, 0.014 mmol, 4.5% yield of g-ketone 79b), (54.4% 
overall yield, 11.1:1 d-ketone:g-ketone ratio), 0% rsm. Average: 55.4% yield ± 1.7%, 10.3:1 d-
ketone:g-ketone ratio, 0% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.82 – 7.80 (m, 1H), 7.40 – 7.38 (m, 1H), 7.33 – 
7.27 (m, 2H), 4.27 (dd, J = 14.4, 6.8 Hz, 1H), 4.20 (dd, J = 14.4, 7.5 Hz, 1H), 2.85 – 2.75 (m, 
1H), 2.41 – 2.31 (m, 2H), 2.22 – 2.14 (m, 1H), 2.14 – 2.06 (m, 1H), 1.97 (ddd, J = 18.3, 10.2, 1.4 
Hz, 1H), 1.71 – 1.63 (m, 1H). 13C-NMR (126 MHz, CDCl3) δ 216.3, 143.9, 142.9, 133.9, 123.3, 
122.5, 120.7, 109.5, 49.1, 42.8, 38.0, 37.7, 27.4. HRMS (TOF ESI+) m/z calculated for 
C13H15N2O [M+H]+: 215.1184, found 215.1181. 
Oxidizing S68 using General Method B: Iterative Catalyst Addition Protocol without 
protection with HBF4•OEt2: Substrate 1-(cyclopentylmethyl)-1H-benzo[d]imidazole S68 
(60.1mg, 0.300 mmol, 1.0 equiv), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-
PDP) (3 time addition of 20.4 mg, 0.015 mmol, 5 mol%; 15 mol% used in total), 50% wt. H2O2 
(204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL 
with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction 
was worked up with 9 mL saturated NaHCO3 and DCM as described in General Method B. Flash 
column chromatography with the same condition and eluents was generously collected and 
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concentrated via rotvap. The residue was analyzed by quantitative 1H-NMR using nitrobenzene 
as internal standard. No product formed without the HBF4•OEt2 protection indicating it is 
still necessary even with ClCH2COOH was used for the less basic benzimidazole substrate. 
Run 1: <5% product, <5% rsm. 
Oxidizing S68•HBF4 using Fe(CF3-PDP): Substrate 1-(cyclopentylmethyl)-1H-
benzo[d]imidazole S68 (60.1mg, 0.300 mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 
µL, 0.330 mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general 
procedure for the HBF4•OEt2 protection. The reaction was conducted in slow addition 
protocol,30 same as Entry 10 of Table 7. In a 40 mL vial was charged with S68•HBF4 (0.30 
mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 equiv.), MeCN (0.60 mL) and a stir bar. A 
1mL syringe was charged with a solution of (S,S)-Fe(CF3-PDP) catalyst (101.6 mg, 0.075 mmol, 
0.25 equiv.) in MeCN (0.38 mL). A 10 mL syringe was charged with a solution of H2O2 (183.6 
mg, 2.7 mmol, 9.0 equiv.) in MeCN (3.75 mL). Both syringes were fitted with 25G needles and 
the solution was added dropwise via syringe pump over 1 hour. Upon completion of addition, the 
reaction was concentrated in vacuo to a minimum amount of MeCN and dissolved in ~15 mL 
DCM. 15 mL 1M NaOH solution was added and the mixture was stirred vigorously at RT for 30 
minutes before layers was separated. The aqueous layer was extracted with 30 mL DCM twice 
and the combined organic layer was dried with Na2SO4. Flash column chromatography with the 
same condition and eluents was generously collected and concentrated via rotvap. The residue 
was analyzed by quantitative 1H-NMR using nitrobenzene as internal standard. No product 
formed with the Fe(CF3-PDP) catalyst indicating the protonated benzimidazole is still 
prone to aromatic oxidation with Fe catalyst. 




1H-NMR (500 MHz, CDCl3) δ 7.88 (s, 1H), 7.82 – 7.80 (m, 1H), 7.41 – 7.39 
(m, 1H), 7.33 – 7.27 (m, 2H), 4.52 (dd, J = 14.8, 4.6 Hz, 1H), 4.34 (dd, J = 
14.8, 6.8 Hz, 1H), 2.64 – 2.58 (m, 1H), 2.39 (ddq, J = 18.7, 8.1, 1.7 Hz, 1H), 
2.17 (dddt, J = 12.2, 8.2, 6.2, 1.9 Hz, 1H), 2.07 (ddd, J = 19.2, 10.9, 8.9 Hz, 1H), 1.97 (dddt, J = 
13.1, 8.9, 6.7, 2.0 Hz, 1H), 1.81 – 1.72 (m, 1H), 1.53 (qd, J = 11.9, 6.6 Hz, 1H). 13C-NMR (126 
MHz, CDCl3) δ 217.8, 143.9, 143.5, 134.1, 123.3, 122.4, 120.7, 109.7, 50.3, 43.9, 38.0, 28.1, 
20.4. HRMS (TOF ESI+) m/z calculated for C13H15N2O [M+H]+: 215.1184, found 215.1188. 
5-(quinolin-4-yl)pentan-2-one [80a]. 
Substrate 4-pentylquinoline S69 (59.8 mg, 0.300 mmol, 1.0 equiv), was protected 
with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 
0.25M) according to the general procedure for the HBF4•OEt2 protection. The 
reaction was run with General Method C: Slow Catalyst Addition Protocol: the 
resultant S69•HBF4 (0.300 mmol, 1.0 equiv.), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 
(R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 
equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL with catalyst, 3.75 mL with oxidant). The 
reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was concentrated to 
a minimum amount of solvent and dissolved in ~15 mL DCM. 15 mL 1M NaOH solution was 
added and the mixture was stirred vigorously at RT for 30 minutes before layers was separated. 
The aqueous layer was extracted with 30 mL DCM twice and the combined organic layer was 
dried with Na2SO4. Flash column chromatography on silica (35 mm fritted glass column, 100 mL 










afforded 5-(quinolin-4-yl)pentan-2-one (d-ketone, 80a) and 1-(quinolin-4-yl)pentan-3-one (g-
ketone, 80b) as pale yellow oil. 
Run 1: (42.6 mg, 0.200 mmol, 66.6% yield of d-ketone 80a), (11.3 mg, 0.053 mmol, 17.7% 
yield of g-ketone 80b), (84.3% overall yield, 3.8:1 d-ketone:g-ketone ratio), <5% rsm. Run 2: 
(42.7 mg, 0.200 mmol, 66.7% yield of d-ketone 80a), (11.7 mg, 0.055 mmol, 18.3% yield of g-
ketone 80b), (85.0% overall yield, 3.6:1 d-ketone:g-ketone ratio), <5% rsm. Run 3: (41.3 mg, 
0.194 mmol, 64.5% yield of d-ketone 80a), (11.5 mg, 0.054 mmol, 18.0% yield of g-ketone 80b), 
(82.5% overall yield, 3.6:1 d-ketone:g-ketone ratio), <5% rsm. Average: 83.9% yield ± 1.3%, 
3.7:1 d-ketone:g-ketone ratio, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 8.79 (d, J = 4.3 Hz, 1H), 8.11 – 8.07 (m, 2H), 7.69 (dd, J = 8.4, 
6.8 Hz, 1H), 7.56 (dd, J = 8.3, 6.8 Hz, 1H), 7.22 – 7.19 (m, 1H), 3.07 (dd, J = 9.6, 6.8 Hz, 2H), 
2.54 – 2.51 (m, 2H), 2.13 (s, 3H), 2.03 (p, J = 7.1 Hz, 2H). 13C-NMR (126 MHz, CDCl3) δ 
208.2, 150.3, 148.5, 147.8, 130.4, 129.2, 127.6, 126.6, 123.7, 121.0, 42.9, 31.4, 30.2, 23.9. 
HRMS (TOF ESI+) m/z calculated for C14H16NO [M+H]+: 214.1232, found 214.1232. 
Oxidizing S69 using General Method C: Slow Catalyst Addition Protocol without protection 
with HBF4•OEt2: Substrate 4-pentylquinoline S69 (59.8 mg, 0.300 mmol, 1.0 equiv), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL 
with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry 
ice bath. The reaction was concentrated to a minimum amount of solvent and dissolved in ~15 
mL DCM. 15 mL 1M NaOH solution was added and the mixture was stirred vigorously at RT 
for 30 minutes before layers was separated. The aqueous layer was extracted with 30 mL DCM 
twice and the combined organic layer was dried with Na2SO4. Flash column chromatography 
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with the same condition and eluents was generously collected and concentrated via rotvap. The 
residue was analyzed by quantitative 1H-NMR using nitrobenzene as internal standard. No 
product formed without the HBF4•OEt2 protection indicating quinoline substrate 
deactivate the catalyst in reaction conditions. 
Run 1: <5% product, (45.7 mg, 0.229 mmol, 76.5% rsm). 
Oxidizing S69•HBF4 using Fe(CF3-PDP): Substrate 4-pentylquinoline S69 (59.8 mg, 0.300 
mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 1.1 equiv.) in 
CH2Cl2 (1.2 mL, 0.25M) according to the general procedure for the HBF4•OEt2 protection. 
The reaction was conducted in slow addition protocol, same as Entry 10 of Table 7.12 In a 40 mL 
vial was charged with S69•HBF4 (0.30 mmol, 1.0 equiv), AcOH (90.1 mg, 1.5 mmol, 5.0 
equiv.), MeCN (0.60 mL) and a stir bar. A 1mL syringe was charged with a solution of (S,S)-
Fe(CF3-PDP) catalyst (101.6 mg, 0.075 mmol, 0.25 equiv.) in MeCN (0.38 mL). A 10 mL 
syringe was charged with a solution of H2O2 (183.6 mg, 2.7 mmol, 9.0 equiv.) in MeCN (3.75 
mL). Both syringes were fitted with 25G needles and the solution was added dropwise via 
syringe pump over 1 hour. Upon completion of addition, the reaction was concentrated in vacuo 
to a minimum amount of MeCN and dissolved in ~15 mL DCM. 15 mL 1M NaOH solution was 
added and the mixture was stirred vigorously at RT for 30 minutes before layers was separated. 
The aqueous layer was extracted with 30 mL DCM twice and the combined organic layer was 
dried with Na2SO4. Flash column chromatography with the same condition and eluents was 
generously collected and concentrated via rotvap. The residue was analyzed by quantitative 1H-
NMR using nitrobenzene as internal standard. No product formed with the Fe(CF3-PDP) 




Run 1: <5% product, <5% rsm. 
1-(quinolin-4-yl)pentan-3-one [80b]. 
1H-NMR (500 MHz, CDCl3) δ 8.80 – 8.79 (m, 1H), 8.12 (d, J = 8.3 Hz, 1H), 8.01 
(d, J = 8.5 Hz, 1H), 7.71 (t, J = 6.9 Hz, 1H), 7.57 (t, J = 6.9 Hz, 1H), 7.24 – 7.21 
(m, 1H), 3.37 (t, J = 7.7 Hz, 2H), 2.88 (t, J = 7.7 Hz, 2H), 2.44 (q, J = 7.3 Hz, 2H), 
1.07 (t, J = 7.3 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 209.7, 150.4, 148.5, 147.2, 
130.5, 129.3, 127.4, 126.7, 123.4, 120.9, 42.2, 36.3, 25.9, 7.9. HRMS (TOF ESI+) m/z calculated 
for C14H16NO [M+H]+: 214.1232, found 214.1222. 
(+)-methyl (S)-2-(4-chlorophenyl)-2-((S)-2-((4-nitrophenyl)sulfonamido)-5-
oxohexanamido)acetate [(+)-81]. 
The reaction was run with General Method B: Iterative Catalyst Addition 
Protocol: Ns-Nle-ClPhg-OMe (+)-S70 (99.6 mg, 0.200 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) (3 times addition of 13.6 mg, 0.010 mmol, 5 mol% 
batch; 15 mol% in total), ClCH2CO2H (284 mg, 3.00 mmol, 15.0 equiv.), 
50% wt. H2O2 (136 mg, 2.0 mmol, 10.0 equiv.), MeCN (0.4 mL in 40 mL vial, 2.5 mL with 
oxidant). The reaction was run at 0 ºC with ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in General Method B. The combined organic layer 
was additionally washed with 30 mL 0.1M Na2EDTA solution and dried with Na2SO4. The crude 
mixture was concentrated and redissolved with small amount of DCM and concentrated onto 
silica gel (2 mL) for dry loading onto the column (SiO2, 30 mL) and then eluted with 10% à 
20% ethyl acetate/CHCl3 to afford a product as a white solid. 
Run 1: (56.2 mg, 0.110 mmol, 54.9% yield), (13.6 mg, 0.027 mmol, 13.7% rsm). Run 2: (56.4 













mmol, 55.8% yield), (15.4 mg, 0.031 mmol, 15.5% rsm). Average: 55.3% yield ± 0.5%, 14.7% 
rsm ± 0.9%. 
1H-NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.8 Hz, 2H), 7.89 (d, J = 8.8 Hz, 2H), 7.38 (d, J = 7.2 
Hz, 1H), 7.27 (d, J = 7.7 Hz, 2H), 7.09 (d, J = 8.1 Hz, 2H), 6.11 (d, J = 8.4 Hz, 1H), 5.27 (d, J = 
7.1 Hz, 1H), 3.88 (td, J = 8.8, 3.8 Hz, 1H), 3.68 (s, 3H), 2.84 (ddd, J = 19.0, 9.6, 4.0 Hz, 1H), 
2.60 (ddd, J = 18.9, 6.3, 4.1 Hz, 1H), 2.19 (s, 3H), 2.06 (ddt, J = 13.9, 9.4, 4.0 Hz, 1H), 1.75 
(dddd, J = 13.9, 9.8, 6.2, 4.1 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 210.0, 170.4, 169.7, 150.1, 
145.2, 135.1, 134.2, 129.3, 128.5, 128.5, 124.3, 56.0, 55.6, 53.3, 38.9, 30.3, 28.2. [a]D24 = +146 
(c = 1.07, CHCl3). HRMS (TOF ESI+) m/z calculated for C21H22N3O8SClNa [M+Na]+: 
534.0714, found 534.0729. 
Condition with Fe(CF3-PDP): The reaction was conducted in slow addition protocol,30 same as 
Entry 10 of Supplementary Table 1. In a 40 mL vial was charged with Ns-Nle-ClPhg-OMe (+)-
S70 (99.6 mg, 0.200 mmol, 1.0 equiv), AcOH (60.1 mg, 1.0 mmol, 5.0 equiv.), MeCN (0.40 mL) 
and a stir bar. A 1mL syringe was charged with a solution of (R,R)-Fe(CF3-PDP) catalyst (67.8 
mg, 0.050 mmol, 0.25 equiv.) in MeCN (0.25 mL). A 10 mL syringe was charged with a solution 
of H2O2 (122.4 mg, 1.8 mmol, 9.0 equiv.) in MeCN (2.5 mL). Both syringes were fitted with 
25G needles and the solution was added dropwise via syringe pump over 1 hour. Upon 
completion of addition, the reaction was concentrated in vacuo to a minimum amount of MeCN. 
The crude mixture was concentrated and redissolved with small amount of DCM and 
concentrated onto silica gel (2 mL) for dry loading onto the column (SiO2, 30 mL) and then 
eluted with 10% à 20% ethyl acetate/CHCl3 and the result was analyzed by quantitative 1H 
NMR with nitrobenzene as internal standard.  





The reaction was run with General Method A: Single Catalyst Addition 
Protocol: Phth-CyLeu-ClPhg-OMe (+)-S71 (88.2 mg, 0.200 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%), 
ClCH2CO2H (284 mg, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 
2.0 mmol, 10.0 equiv.), MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction was 
run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as 
described in General Method A. The combined organic layer was additionally washed with 30 
mL 0.1M Na2EDTA solution and dried with Na2SO4. The crude mixture was concentrated and 
redissolved with small amount of DCM and concentrated onto silica gel (2 mL) for dry loading 
onto the column (SiO2, 30 mL) and then eluted with 10% à 20% ethyl acetate/CHCl3 to afford a 
product as a white solid. 
Run 1: (52.8 mg, 0.116 mmol, 58.0% yield), <10% rsm. Run 2: (54.3 mg, 0.119 mmol, 59.7% 
yield), <10% rsm. Run 3: (54.1 mg, 0.119 mmol, 59.5% yield), <10% rsm. Average: 59.1% 
yield ± 0.9%, <10% rsm. 
The product is a mixture of diastereomers with ~1:1 diastereomeric ratio. 1H-NMR (500 MHz, 
CDCl3) δ 7.88 – 7.85 (m, 2H), 7.80 – 7.77 (m, 2H), 7.32 – 7.23 (m, 3H), 7.20 (d, J = 8.5 Hz, 
1H), 7.10 (d, J = 6.6 Hz) & 7.05 (d, J = 6.5 Hz, 1H combined), 5.47 – 5.44 (m, 1H), 3.68 (s) & 
3.65 (s, 3H combined), 3.48 – 3.36 (m, 1H), 3.14 – 3.09 (m) & 2.96 – 2.87 (m, 3H combined), 
2.47 – 2.33 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 212.9 & 212.9, 170.7 & 170.7, 170.3 & 












66.6, 56.5 & 56.3, 53.3 & 53.3, 47.8 & 47.7, 36.0 & 36.0, 32.1 & 32.1. HRMS (TOF ESI+) m/z 
calculated for C23H20N2O6Cl [M+H]+: 455.1010, found 455.1028. 
(+)-methyl (S)-2-(4-chlorophenyl)-2-((2S,3R)-3-methyl-2-((4-nitrophenyl)sulfonamido)-4-
oxopentanamido)acetate [(+)-83]. 
The reaction was run with General Method B: Iterative Catalyst Addition 
Protocol with recycle the recovered starting material once: Ns-Ile-ClPhg-
OMe (+)-S72 (99.6 mg, 0.200 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (3 
times addition of 13.6 mg, 0.010 mmol, 5 mol% batch; 15 mol% in total), 
ClCH2CO2H (284 mg, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 2.0 mmol, 10.0 equiv.), 
MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in General 
Method B. The combined organic layer was additionally washed with 30 mL 0.1M Na2EDTA 
solution and dried with Na2SO4. The crude mixture was concentrated and redissolved with small 
amount of DCM and concentrated onto silica gel (2 mL) for dry loading onto the column (SiO2, 
30 mL) and then eluted with 10% ethyl acetate/CHCl3 to afford a product as a white solid and 
recovered starting material. The recovered starting material was recycled to the oxidation with 
the same protocol and the products from both cycles are combined. 
Run 1: cycle 1: (35.0 mg, 0.068 mmol, 34.2% yield), (<5% yield of 3º alcohol was also 
observed), (34.2 mg, 0.069 mmol, 34.3% rsm); cycle 2: (9.5 mg, 0.019 mmol, 27.0% yield), 
(13.0 mg, 0.026 mmol, 38.0% rsm); overall: (44.5 mg, 0.087 mmol, 43.5% yield), (<5% yield of 
3º alcohol), (13.0 mg, 0.026 mmol, 13.1% rsm). Run 2: (35.5 mg, 0.069 mmol, 34.7% yield), 
(<5% yield of 3º alcohol was also observed), (34.8 mg, 0.070 mmol, 34.9% rsm); cycle 2: (9.6 










mmol, 44.0% yield), (<5% yield of 3º alcohol), (14.1 mg, 0.028 mmol, 14.2% rsm). Run 3: 
(35.4 mg, 0.069 mmol, 34.6% yield), (<5% yield of 3º alcohol was also observed), (34.9 mg, 
0.070 mmol, 35.0% rsm); cycle 2: (10.4 mg, 0.020 mmol, 29.1% yield), (13.6 mg, 0.027 mmol, 
39.2% rsm); overall: (45.8 mg, 0.089 mmol, 44.7% yield), (<5% yield of 3º alcohol), (13.6 mg, 
0.027 mmol, 13.7% rsm). Average: 44.1% yield ± 0.6%, <5% 3º alcohol, 9:1 K:A ratio, 
13.7% rsm ± 0.6%. 
1H-NMR (500 MHz, DMSO-d6) δ 9.06 (d, J = 7.1 Hz, 1H), 8.69 (d, J = 9.5 Hz, 1H), 8.13 (d, J = 
8.9 Hz, 2H), 7.83 (d, J = 8.8 Hz, 2H), 7.43 (d, J = 8.5 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 5.00 (d, 
J = 7.0 Hz, 1H), 4.19 (t, J = 10.0 Hz, 1H), 3.54 (s, 3H), 2.80 – 2.74 (m, 1H), 2.14 (s, 3H), 1.01 
(d, J = 7.1 Hz, 3H). 13C-NMR (126 MHz, DMSO-d6) δ 208.8, 170.2, 168.5, 149.2, 146.2, 134.1, 
133.2, 129.5, 128.6, 128.0, 123.9, 57.4, 55.3, 52.4, 48.6, 28.8, 13.1. [a]D24 = +164 (c = 0.97, 




The reaction was run with General Method D: Oxidation of Proline-
Containing Peptides: Ns-Pro-BrPhe-OMe (-)-S73 (108 mg, 0.200 
mmol, 1.0 equiv), (S,S)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 
mol%), AcOH (172 µL, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (68 mg, 1.0 mmol, 5.0 equiv.), 
MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction was run at -36 ºC with dry 
ice/1,2-dichloroethane bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM. The combined organic layer was additionally washed with 30 mL 0.1M Na2EDTA 










amount of DCM and concentrated onto silica gel (2 mL) for dry loading onto the column (SiO2, 
30 mL) and then eluted with 10% ethyl acetate/CHCl3 to afford a product as a colorless oil and 
recovered starting material.  
Run 1: (78.7 mg, 0.141 mmol, 70.7% yield), (9.2 mg, 0.017 mmol, 8.5% rsm). Run 2: (76.2 mg, 
0.137 mmol, 68.5% yield), (9.5 mg, 0.018 mmol, 8.8% rsm). Run 3: (75.4 mg, 0.136 mmol, 
67.8% yield), (8.2 mg, 0.015 mmol, 7.6% rsm). Average: 69.0% yield ± 1.5%, 8.3% rsm ± 
0.6%. 
The product is isolated as a mixture of diastereomers approximately 5:1 ratio. 1H-NMR (500 
MHz, CDCl3) δ 8.32 – 8.28 (m, 2H), 8.06 – 8.00 (m, 2H), 7.45 – 7.38 (m, 2H), 7.19 – 7.10 (m, 
1H), 7.08 – 7.02 (m, 2H), 5.63 (dt, J = 8.8, 4.2 Hz) & 5.54 (d, J = 3.8 Hz, 1H combined), 4.91 – 
4.72 (m, 1H), 4.26 – 4.19 (m, 2H), 3.76 – 3.71 (m, 3H), 3.14 – 3.10 (m, 1H), 3.01 – 2.96 (m, 
1H), 2.07 – 1.76 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 171.4, 171.3, 171.1, 170.4, 150.5, 
150.3, 144.9, 144.0, 134.9, 134.9, 131.9, 131.8, 131.2, 131.2, 129.3, 128.8, 124.6, 124.2, 123.8, 
121.3, 86.2, 85.1, 62.5, 61.6, 53.4, 53.3, 52.8, 52.7, 37.4, 37.3, 33.3, 32.9, 29.2, 28.7. HRMS 
(TOF ESI-) m/z calculated for C21H21N3O8SBr [M-H]-: 554.0233, found 554.0225. 
methyl (2S)-3-(4-fluorophenyl)-2-((2S)-5-hydroxy-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-
carboxamido)propanoate [85]. 
The reaction was run with General Method D: Oxidation of Proline-
Containing Peptides: Ns-Pro-FPhe-OMe (-)-S74 (95.9 mg, 0.200 mmol, 
1.0 equiv), (S,S)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%), AcOH 
(172 µL, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (68 mg, 1.0 mmol, 5.0 equiv.), MeCN (0.4 mL 
in 40 mL vial, 2.5 mL with oxidant). The reaction was run at -36 ºC with dry ice/1,2-










combined organic layer was additionally washed with 30 mL 0.1M Na2EDTA solution and dried 
with Na2SO4. The crude mixture was concentrated and redissolved with small amount of DCM 
and concentrated onto silica gel (2 mL) for dry loading onto the column (SiO2, 30 mL) and then 
eluted with 10% ethyl acetate/CHCl3 to afford a product as a colorless oil and recovered starting 
material.  
Run 1: (61.5 mg, 0.124 mmol, 62.1% yield), (5.8 mg, 0.012 mmol, 6.0% rsm). Run 2: (59.9 mg, 
0.121 mmol, 60.4% yield), (3.7 mg, 0.007 mmol, 3.9% rsm). Run 3: (60.7 mg, 0.123 mmol, 
61.3% yield), (6.2 mg, 0.013 mmol, 6.5% rsm). Average: 61.3% yield ± 0.9%, 5.5% rsm ± 
1.4%. 
The product is isolated as a mixture of diastereomers approximately 5:1 ratio. 1H-NMR (500 
MHz, CDCl3) δ 8.32 – 8.28 (m, 2H), 8.08 – 8.00 (m, 2H), 7.22 – 7.07 (m, 3H), 6.99 – 6.96 (m, 
2H), 5.62 (m) & 5.54 (m, 1H combined), 4.74 (q, J = 6.9 Hz, 1H), 4.27 – 4.18 (m, 1H), 3.94 (br. 
s) & 3.77 (br. s, 1H combined), 3.74 (s) & 3.72 (s, 3H combined), 3.14 (dd, J = 14.2, 5.4 Hz, 
1H), 3.01 (dd, J = 14.1, 6.9 Hz, 1H), 2.09 – 1.74 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 171.4, 
170.9, 162.3 (d, J = 245.8 Hz), 150.7, 144.4, 131.64 - 131.62 (m, 1C), 131.1 (d, J = 8.0 Hz), 
129.3 & 128.9, 124.7 & 124.3, 115.71 (d, J = 21.0 Hz), 86.4 & 85.2, 62.7 & 61.9, 53.7, 52.7, 
37.4, 33.4 & 32.9, 29.3 & 28.8. 19F-NMR (470 MHz, CDCl3) δ -115.6. HRMS (TOF ESI+) m/z 
calculated for C21H22N3O8SNaF [M+H]+: 518.1009, found 518.0995. 
methyl (2S)-3-(4-chlorophenyl)-2-((2S)-5-hydroxy-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-
carboxamido)propanoate [86]. 
The reaction was run with General Method D: Oxidation of Proline-
Containing Peptides: Ns-Pro-ClPhe-OMe (-)-S75 (99.2 mg, 0.200 










AcOH (172 µL, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (68 mg, 1.0 mmol, 5.0 equiv.), MeCN 
(0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction was run at -36 ºC with dry ice/1,2-
dichloroethane bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM. The 
combined organic layer was additionally washed with 30 mL 0.1M Na2EDTA solution and dried 
with Na2SO4. The crude mixture was concentrated and redissolved with small amount of DCM 
and concentrated onto silica gel (2 mL) for dry loading onto the column (SiO2, 30 mL) and then 
eluted with 10% ethyl acetate/CHCl3 to afford a product as a colorless oil and recovered starting 
material.  
Run 1: (69.3 mg, 0.135 mmol, 67.7% yield), (11.0 mg, 0.022 mmol, 11.1% rsm). Run 2: (73.9 
mg, 0.144 mmol, 72.2% yield), (9.8 mg, 0.020 mmol, 9.9% rsm). Run 3: (71.5 mg, 0.140 mmol, 
69.8% yield), (9.7 mg, 0.020 mmol, 9.8% rsm). Average: 69.9% yield ± 2.3%, 10.3% rsm ± 
0.7%. 
The product is isolated as a mixture of diastereomers approximately 5:1 ratio. 1H-NMR (500 
MHz, CDCl3) δ 8.33 – 8.29 (m, 2H), 8.06 – 7.99 (m, 2H), 7.27 – 7.25 (m, 2H), 7.18 – 7.06 (m, 
3H), 5.64 – 5.61 (m) & 5.54 – 5.52 (m, 1H combined), 4.78 – 4.73 (m, 1H), 4.27 – 4.18 (m, 1H), 
4.01 (d, J = 5.4 Hz, 1H), 3.77 – 3.72 (m, 3H), 3.15 (ddd, J = 14.0, 11.6, 5.4 Hz, 1H), 3.01 (dd, J 
= 14.1, 7.0 Hz, 1H), 2.08 – 1.76 (m, 4H). 13C-NMR (126 MHz, CDCl3) δ 171.4, 171.3, 171.0, 
170.3, 150.5, 150.4, 144.9, 144.1, 134.4, 134.3, 133.3, 133.3, 130.9, 130.8, 129.3, 129.1, 128.9, 
128.8, 124.6, 124.3, 86.3, 85.1, 62.6, 61.7, 53.5, 53.4, 52.8, 52.7, 37.4, 37.3, 33.3, 32.8, 29.2, 






Other oxidation conditions for substrate S75: 
Condition with Fe(CF3-PDP): The reaction was proceeded with the same procedure by 
replacing (S,S)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%) with (S,S)-Fe(CF3-PDP) (27.1 
mg, 0.020 mmol, 10 mol%). Run 1: 0% yield, (20.0 mg, 0.040 mmol, 20.2% rsm). 
Condition with Fe(PDP): The reaction was proceeded with the standard iterative addition 
protocol reported with (S,S)-Fe(PDP).11 Run 1: trace yield, (18.5 mg, 0.037 mmol, 18.7% rsm). 
4-((2S)-2-((2S)-5-hydroxy-1-((4-nitrophenyl)sulfonyl)pyrrolidine-2-carboxamido)-3-methoxy-3-
oxopropyl)phenyl pivalate [87]. 
The reaction was run with General Method D: Oxidation of Proline-
Containing Peptides with slightly modifications: Ns-Pro-OPivPhe-
OMe (-)-S76 (112.3 mg, 0.200 mmol, 1.0 equiv), (S,S)-Mn(CF3-PDP) 
(27.1 mg, 0.020 mmol, 10 mol%), AcOH (172 µL, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (102 
mg, 1.5 mmol, 7.5 equiv.), MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The hydrogen 
peroxide solution was added over 3 hours at -36 ºC with dry ice/1,2-dichloroethane bath. The 
reaction was worked up with 9 mL saturated NaHCO3 and DCM. The combined organic layer 
was additionally washed with 30 mL 0.1M Na2EDTA solution and dried with Na2SO4. The crude 
mixture was concentrated and purified with column chromatography (SiO2, 100 mL) and then 
eluted with 20% ethyl acetate/CHCl3 à 40% ethyl acetate/CHCl3 to afford a product as a white 
solid and recovered starting material.  
Run 1: (82.6 mg, 0.143 mmol, 71.5% yield), (31.6 mg, 0.056 mmol, 28.1% rsm). Run 2: (78.5 
mg, 0.136 mmol, 68.0% yield), (32.8 mg, 0.058 mmol, 29.2% rsm). Run 3: (79.1 mg, 0.137 
mmol, 68.5% yield), (31.2 mg, 0.056 mmol, 27.8% rsm). Average: 69.3% yield ± 1.9%, 28.4% 










The product is isolated as a mixture of diastereomers approximately 5:1 ratio. 1H-NMR (500 
MHz, CDCl3) δ 8.32 – 8.28 (m, 2H), 8.07 – 7.98 (m, 2H), 7.18 – 7.12 (m, 2H), 7.04 – 6.92 (m, 
3H), 5.61 – 5.53 (m, 1H), 4.92 – 4.71 (m, 1H), 4.22 (br. s, 1H), 3.90 – 3.72 (m, 4H), 3.22 – 3.15 
(m, 1H), 3.08 – 3.00 (m, 1H), 2.08 – 1.66 (m, 4H), 1.34 (s, 9H). 13C-NMR (126 MHz, CDCl3) δ 
177.7, 171.4, 171.1, 150.3, 150.2, 144.4, 133.2, 130.4 & 130.2, 129.3 & 128.8, 124.5 & 124.2, 
121.9 & 121.8, 86.1, 62.4, 53.2, 52.6, 39.1, 37.1, 33.5, 29.2, 27.1. HRMS (TOF ESI-) m/z 
calculated for C26H30N3O10S [M-H]-: 576.1657, found 576.1652. 
Condition with Fe(CF3-PDP): The reaction was proceeded with the same procedure by 
replacing (S,S)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%) with (S,S)-Fe(CF3-PDP) (27.1 




The reaction was run with General Method D: Oxidation of Proline-
Containing Peptides: methyl (2-(4-bromophenyl)acetyl)-L-prolinate (-)-88 
(65.2 mg, 0.200 mmol, 1.0 equiv), (S,S)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%), AcOH 
(172 µL, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (68 mg, 1.0 mmol, 5.0 equiv.), MeCN (0.4 mL 
in 40 mL vial, 2.5 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry 
ice bath. After the completion of oxidation, the mixture was filer through a silica plug (SiO2,15 
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compound was transferred into a new 40 mL vial with DCM and dried on high vacuum for 2 
hours. In a sealed tube charged with a stir bar and 1 mL anhydrous 1,2-dichloroethane and TfOH 
(177 µL, 2.0 equiv.) was added under Ar. The crude hemiaminal was dissolved in 2 mL 
anhydrous 1,2-dichloroethane under Ar and transferred into the sealed tube dropwise. The 
hemiaminal vial was rinsed with another 2 mL anhydrous 1,2-dichloroethane and transferred into 
the sealed tube. The reaction was heated at 90 ºC for 2 hours. After the reaction completed the 
mixture was diluted with water and basified with sat. NaHCO3. The aqueous layer was extracted 
with DCM x3. The combined organic layer dried with Na2SO4, filtered and concentrated. The 
crude mixture was purified by column chromatography (SiO2, 25 mL) and elueted with pure 
CHCl3 à 20% ethyl acetate/CHCl3 to give product as a colorless oil. 
Run 1: 30.1 mg, 0.093 mmol, 46.4% yield. Run 2: 28.7 mg, 0.089 mmol, 44.3% yield. Run 3: 
30.8 mg, 0.095 mmol, 47.5% yield. Average: 46.1% yield ± 1.6%. 
The product is isolated as a mixture of diastereomers approximately 1.5:1 ratio. 1H-NMR (500 
MHz, CDCl3) δ 7.37 (dd, J = 8.1, 1.6 Hz, 1H), 7.30 – 7.27 (m, 1H), 7.06 – 7.03 (m, 1H), 4.88 – 
4.84 (m) & 4.70 (dd, J = 11.0, 5.9 Hz, 1H combined), 4.57 (d, J = 9.3 Hz) & 4.51 (t, J = 8.4 Hz, 
1H combined), 3.76 (s) & 3.64 (s, 3H combined), 3.66 – 3.48 (m, 2H), 2.65 – 2.31 (m, 2H), 2.22 
– 1.88 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 172.6 & 171.8, 167.5 &166.9, 138.3 & 137.5, 
132.0 & 131.4, 130.9 & 130.8, 129.14 & 129.06, 127.5 & 127.1, 120.9, 60.1, 59.9, 58.2, 57.8, 
52.7, 52.6, 38.7, 38.0, 31.5, 29.5, 28.9, 28.3. HRMS (TOF ESI+) m/z calculated for 






2.4.7 Late-Stage Oxidation of Complex Molecules with Mn(CF3-PDP) 
Efavirenz: 
(±)-6-chloro-4-(cyclopropylethynyl)-1-hexanoyl-4-(trifluoromethyl)-1,4-dihydro-2H-
benzo[d][1,3]oxazin-2-one [90]  
In a flame dried 50 mL recovery flask charged with (±)-efavirenz (1.263 g, 4.0 
mmol, 1.0 equiv.) in anhydrous THF (8 mL, 0.5 M), NaH (95%, 121 mg. 4.8 
mmol, 1.2 equiv.) was added at 0 ºC and the reaction was kept at 0 ºC for 10 
min. Hexanoyl chloride (531 µL, 3.8 mmol, 0.95 equiv.) was added and the 
reaction was stirred at room temperature overnight. The reaction was diluted 
with water and extracted with ethyl acetate. The organic layer was washed with 30 mL 1 M 
acetic acid solution, 30 mL sat. NaHCO3 then brine. The combined organic layer was dried over 
Na2SO4 and concentrated. Purified by CombiFlash (40 g column) flushing with hexanes à 
100% ethyl acetate/hexanes yield product as a white solid (567 mg, 1.37 mmol) in 34% yield.  
1H-NMR (500 MHz, methylene chloride-d2) 7.65 (d, J = 8.9 Hz, 1H), 7.61 (d, J = 2.4 Hz, 1H), 
7.48 (dd, J = 8.9, 2.4 Hz, 1H), 3.04 – 2.98 (m, 1H), 2.90 (dt, J = 17.4, 7.4 Hz, 1H), 1.72 – 1.69 
(m, 2H), 1.42 – 1.30 (m, 5H), 0.94 – 0.89 (m, 5H), 0.86 – 0.79 (m, 2H). 13C-NMR (126 MHz, 
methylene chloride-d2) δ 173.8, 148.4, 133.0, 132.3, 131.2, 126.9, 125.1, 123.4, 122.5 (q, J = 
286.5 Hz), 97.4, 78.3 (q, J = 35.1 Hz), 65.6, 38.6, 31.7, 25.0, 23.0, 14.2, 9.3, 9.2, -0.3. 19F-NMR 
(471 MHz, methylene chloride-d2) δ -78.5. HRMS (TOF ESI+) m/z calculated for 











The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 6-chloro-4-(cyclopropylethynyl)-1-hexanoyl-4-(trifluoromethyl)-1,4-
dihydro-2H-benzo[d][1,3]oxazin-2-one 90 (82.8 mg, 0.200 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) 32 (27.1 mg, 0.020 mmol, 10 mol%), ClCH2CO2H (284 
mg, 3.0 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 2.0 mmol, 10.0 equiv.), 
MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction was run at 0 ºC with ice bath. 
The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in the General 
Method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
using 10% ethyl acetate/hexanes à 25% ethyl acetate/hexanes à 50% ethyl acetate/hexanes as 
eluent afforded d-ketone (91a) and g-ketone (91b) products as white solid. 
Run 1: (11.3 mg, 0.026 mmol, 13.2% yield of g-ketone 91b), (36.5 mg, 0.085 mmol, 42.7% 
yield of d-ketone 91a), (55.9% overall yield, 3.2:1 d:g ratio), (18.3 mg, 0.044 mmol, 22.1% rsm). 
Run 2: (13.0 mg, 0.030 mmol, 15.2% yield of g-ketone 91b), (36.9 mg, 0.086 mmol, 43.1% 
yield of d-ketone 91a), (58.3% overall yield, 2.8:1 d:g ratio), (17.9 mg, 0.043 mmol, 21.6% rsm). 

































yield of d-ketone 91a), (58.3% overall yield, 3.2:1 d:g ratio), (21.1 mg, 0.051 mmol, 25.5% rsm). 
Average: 57.5% yield ± 1.4%, 3.1:1 d:g ratio, 23.1% rsm ± 2.1%. 
1H-NMR (500 MHz, methylene chloride-d2) 7.66 (d, J = 8.9 Hz, 1H), 7.62 (d, J = 2.4 Hz, 1H), 
7.48 (dd, J = 8.9, 2.4 Hz, 1H), 3.05 (ddd, J = 17.8, 7.7, 6.7 Hz, 1H), 2.91 (dt, J = 17.7, 7.3 Hz, 
1H), 2.53 (t, J = 7.2 Hz, 2H), 2.11 (s, 3H), 1.95 (p, J = 7.2 Hz, 2H), 1.41 (tt, J = 8.3, 5.0 Hz, 1H), 
0.95 – 0.92 (m, 2H), 0.83 (tdd, J = 6.2, 5.5, 3.2 Hz, 2H). 13C-NMR (126 MHz, methylene 
chloride-d2) δ 208.0, 173.2, 148.4, 132.8, 132.5, 131.2, 127.0, 125.2, 123.5, 122.5 (q, J = 286.7 
Hz), 97.6, 78.4 (q, J = 35.1 Hz), 65.5, 42.6, 37.6, 30.2, 19.3, 9.3, 9.2, -0.3. 19F-NMR (471 MHz, 
methylene chloride-d2) δ -78.5. HRMS (TOF ESI+) m/z calculated for C20H17NO4F3NaCl 
[M+Na]+: 450.0696, found 450.0706. 
(±)-1-(6-chloro-4-(cyclopropylethynyl)-2-oxo-4-(trifluoromethyl)-2H-benzo[d][1,3]oxazin-
1(4H)-yl)hexane-1,4-dione [91b]. 
 1H-NMR (500 MHz, methylene chloride-d2) 7.61 (d, J = 2.5 Hz, 1H), 7.59 (d, 
J = 8.9 Hz, 1H), 7.46 (dd, J = 8.9, 2.4 Hz, 1H), 3.28 (ddd, J = 18.4, 7.5, 5.0 Hz, 
1H), 3.14 (ddd, J = 18.4, 7.0, 4.7 Hz, 1H), 2.90 – 2.78 (m, 2H), 2.49 (q, J = 7.4 
Hz, 2H), 1.43 (tt, J = 8.3, 5.0 Hz, 1H), 1.04 (t, J = 7.3 Hz, 3H), 0.95 – 0.92 (m, 
2H), 0.86 – 0.83 (m, 2H). 13C-NMR (126 MHz, methylene chloride-d2) δ 
209.5, 173.6, 148.1, 133.0, 132.3, 131.3, 127.1, 125.0, 123.1, 122.50 (q, J = 286.8 Hz), 97.6, 
78.5 (q, J = 35.2 Hz), 65.5, 37.2, 36.2, 33.2, 9.24, 9.22, 8.1, -0.2. 19F-NMR (471 MHz, 
methylene chloride-d2) δ -78.7. HRMS (TOF ESI+) m/z calculated for C20H17NO4F3NaCl 












g-secretase modulator analogue: 
 
(±)-Methyl 2-((2SR,4RS)-1-((RS)-1-(4-chlorophenyl)pentyl)-2-(4-
(trifluoromethyl)phenyl)piperidin -4-yl)acetate [92]. 
A mixture of methyl (±)-2-((2SR,4RS)-2-(4-
(trifluoromethyl)phenyl)piperidin-4-yl)acetate (557 mg, 1.85 mmol, 1.0 
equiv.), 4-chlorobenzaldehyde (268 mg, 1.91 mmol, 1.03 equiv.), and 
benzotriazole (228 mg, 1.91 mmol, 1.03 equiv.) in toluene (10 ml, 0.18 
M) was refluxed with a Dean-Stark apparatus for 18 hours. After cooling to room temperature, 
the solvent was evaporated, and the residual gum was dissolved in CH2Cl2 (17 ml, 0.11 M). In 
another flask, a solution of ZnCl2•OEt2 (5.8 mL, 5.4 mmol, 1M in Et2O, 3.1 equiv.) was added 
dropwise to a solution of butylmagnesium chloride (2.8 mL, 5.55 mmol, 2M in Et2O, 3.1 equiv.) 
in Et2O (3 mL, final concentration = 0.48 M) at 0 °C. The cooling bath was removed, and the 
mixture was stirred at room temperature for 1 hour, then recooled in an ice bath. The portion of 
the solution of the benzotriazole adduct in CH2Cl2 was added over 5 minutes, the cooling bath 
was removed, and the reaction was stirred at room temperature for 20 hours. After this period, 
the reaction was quenched with saturated aqueous solution of NH4Cl. The mixture was 
partitioned with CH2Cl2 and H2O. The aqueous layer was extracted with CH2Cl2 (twice) and the 
combined extracts were washed with water (once), dried over MgSO4, filtered, and concentrated 




















silica eluting 5% EtOAc/hexanes as eluent to yield the desired product (691 mg, 1.43 mmol, 
77%) as a colorless oil. 
1H-NMR (500 MHz, CDCl3) δ 7.63 (d, J = 8.0 Hz, 2H), 7.56 (d, J = 7.8 Hz, 2H), 7.29 – 7.21 (m, 
2H), 7.21 – 7.15 (m, 2H), 3.70 (dd, J = 11.0, 2.8 Hz, 1H), 3.62 (s, 3H), 3.41 (dd, J = 7.8, 6.2 Hz, 
1H), 2.67 (dt, J = 11.6, 3.5 Hz, 1H), 2.32 (td, J = 11.8, 2.5 Hz, 1H), 2.23 (dd, J = 15.3, 6.7 Hz, 
1H), 2.16 (dd, J = 15.3, 7.5 Hz, 1H), 1.99 – 1.86 (m, 1H), 1.80 (dq, J = 13.0, 3.0 Hz, 1H), 1.77 – 
1.69 (m, 2H), 1.63 (dt, J = 13.0, 3.1 Hz, 1H), 1.36 – 1.27 (m, 1H), 1.21 – 1.15 (m, 2H), 1.12 (dd, 
J = 12.4, 4.1 Hz, 1H), 1.07 – 0.98 (m, 1H), 0.80 (t, J = 7.3 Hz, 3H), 0.85 – 0.71 (m, 1H). 13C-
NMR (126 MHz, CDCl3) δ 173.1, 148.8 (q, J = 1.0 Hz), 140.5, 132.3, 130.1, 129.7 (q, J = 32.3 
Hz), 128.2 (2 carbons), 125.8 (q, J = 3.4 Hz), 124.3 (q, J = 271.8 Hz), 64.6, 60.9, 51.6, 44.6, 
42.9, 41.0, 33.9, 32.5, 29.6, 23.0, 22.3, 14.1. 19F-NMR (470 MHz, CDCl3) δ −62.7. HRMS (TOF 




(4-(trifluoromethyl)phenyl)piperidin -4-yl)acetate 92 (154.0 mg, 0.300 
mmol, 1.0 equiv), was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 
54 wt.%, 1.1 equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general 
procedure for the HBF4•OEt2 protection. The reaction was run with General Method C: 
Slow Catalyst Addition Protocol at 0 ºC: the resultant 92•HBF4 (0.300 mmol, 1.0 equiv.), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL 








was worked up with 9 mL saturated NaHCO3 and DCM as described in General Method C. Flash 
column chromatography on silica using 15% MeOH/CHCl3 as eluent afforded product as a pale 
yellow oil. 
Run 1: (76.6 mg, 0.154 mmol, 51.5% yield), (23.0 mg, 0.048 mmol, 15.9% rsm). Run 2: (85.3 
mg, 0.172 mmol, 57.3% yield), (13.2 mg, 0.027 mmol, 9.1% rsm). Run 3: (84.4 mg, 0.170 
mmol, 56.7% yield), (13.8 mg, 0.029 mmol, 9.5% rsm). Average: 55.2% yield ± 3.2%, 11.5% 
rsm ± 3.8%. 
1H-NMR (500 MHz, CDCl3) δ7.63 (d, J = 8.0 Hz, 2H), 7.57 (d, J = 7.9 Hz, 2H), 7.29 – 7.23 (m, 
2H), 7.16 – 7.09 (m, 2H), 3.72 (dd, J = 11.0, 2.8 Hz, 1H), 3.61 (s, 3H), 3.39 (dd, J = 10.6, 3.7 
Hz, 1H), 2.69 (dt, J = 11.4, 3.4 Hz, 1H), 2.38 (td, J = 11.8, 2.5 Hz, 1H), 2.27 – 2.01 (m, 5H), 
1.98 (s, 3H), 1.96 – 1.85 (m, 2H), 1.81 (dq, J = 12.9, 2.9 Hz, 1H), 1.64 (dt, J = 13.5, 2.5 Hz, 1H), 
1.35 – 1.27 (m, 1H), 1.11 (qd, J = 12.2, 3.8 Hz, 1H). 13C-NMR (126 MHz, CDCl3) δ 207.8, 
172.9, 148.5, 139.3, 132.8, 130.0, 129.7 (q, J = 32.0 Hz), 128.4, 128.2, 125.8 (q, J = 3.8 Hz), 
124.2 (q, J = 272.1 Hz), 64.4, 60.6, 51.6, 44.4, 42.8, 41.3, 41.0, 33.7, 32.3, 30.1, 16.1. 19F-NMR 
(470 MHz, CDCl3) δ −62.7. HRMS (TOF ESI+) m/z calculated for C26H30NO3F3Cl [M+H]+: 














In a 20 mL vial charge with (±)-citalopram•HBr (commercially available 
from Sigma-Aldrich, 121.6 mg, 0.30 mmol, 1.0 equiv.) in 3 mL DCM. 3mL 
3M NaOH solution was added and the reaction was stirred for 30 min. The 
reaction was extracted with 20 mL DCM 3 times and the combined organic 
layer was dried over Na2SO4 and concentrated. The residue was transferred into a 40 mL vial and 
the free amine citalopram was protected with HBF4•OEt2 (45.5 µL, 0.330 mmol, 54 wt.%, 1.1 
equiv.) in CH2Cl2 (1.2 mL, 0.25M) according to the general procedure for the HBF4•OEt2 
protection. The reaction was run with General Method A: Single Catalyst Addition Protocol 
with slightly modification: the resultant citalopram•HBF4 (0.300 mmol, 1.0 equiv.), 
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), (R,R)-Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 
mol%), 50% wt. H2O2 (40.8 mg, 0.6 mmol, 2.0 equiv.), MeCN (0.6 mL in 40 mL vial, 0.38 mL 
with catalyst, 3.75 mL with oxidant). The reaction was run at -36 ºC with dry ice/1,2-
dichloroethane bath. The reaction was concentrated, redissolved in 15 mL DCM and quenched 
with 10 mL 1M NaOH solution for 30 min. The aqueous layer was extracted with 20 mL DCM 3 
times and the combined organic layer was dried over Na2SO4 and concentrated. Flash column 
chromatography on silica (35 mm fritted glass column, 50 mL SiO2) using 5% methanol/DCM 








    Mn(CF3-PDP) 1
    ClCH2CO2H, H2O2;


























50% yield. The crude hemiacetal was transferred into an oven-dried 40 mL vial and dried on 
high vacuum overnight. The crude hemiacetal was charged with 2-naphthol (43.3 mg, 0.3 mmol, 
1.0 equiv.) and anhydrous DCM (1.6 mL), cooled to -78 ºC and BF3•OEt2 (73.8 µL, 0.6 mmol, 
2.0 equiv.) was added dropwise. The reaction was allowed to react at -78 ºC for 1 h and 0 ºC for 
2 h before diluted with DCM (10 mL) and quenched with 1M NaOH (15 mL) for 20 min. The 
aqueous layer was extracted with 20 mL DCM 3 times and the combined organic layer was dried 
over Na2SO4 and concentrated. Flash column chromatography on silica (35 mm fritted glass 
column, 50 mL SiO2) using 2% methanol/DCM à 5% methanol/DCM à 10% methanol/DCM 
à 20% methanol/DCM as eluent afforded arylated product as a mixture of diastereomers. 
Run 1: 62.9 mg, 0.135 mmol, 3.0:1 d.r., 44.9% yield over 2 steps. Run 2: 59.0 mg, 0.126 mmol, 
3.4:1 d.r., 42.2% yield over 2 steps. Run 3: 56.3 mg, 0.121 mmol, 3.2:1 d.r., 40.2% yield over 2 
steps. Average: 42.4% yield ± 2.4%, 3.2:1 d.r. 
The site of arylation was assigned based on a combination of 1H, gHSQC and gHMBC NMRs. 
The assigned site of reaction matches the reported arylation of proline-hemiaminal with 2-
naphthanol.32  
Major diastereomer: 1H-NMR (500 MHz, CDCl3) δ 7.85 – 7.79 (m, 3H), 7.67 – 7.63 (m, 2H), 
7.55 – 7.48 (m, 3H), 7.38 (dd, J = 7.8, 6.8 Hz, 1H), 7.26 – 7.25 (m, 1H), 7.12 (s, 1H), 7.07 (t, J = 
8.6 Hz, 2H), 6.94 (s, 1H), 2.86 (dt, J = 12.9, 7.3 Hz, 1H), 2.54 (ddd, J = 11.9, 8.3, 6.1 Hz, 1H), 
2.41 (s, 6H), 2.46 – 2.38 (m, 2H), 1.81 – 1.70 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 162.4 (d, 
J = 247.2 Hz), 154.9, 148.3, 143.4, 137.3 (d, J = 3.0 Hz), 132.9, 132.3, 131.4, 129.3, 129.0, 
127.6, 127.2 (d, J = 8.1 Hz),126.2, 123.4, 122.6, 121.0, 120.0, 118.6, 115.9 (d, J = 21.4 Hz), 
113.0, 112.5, 90.7, 78.7, 58.9, 44.4, 38.7, 21.1. 19F-NMR (470 MHz, CDCl3) δ −114.4. HRMS 
(TOF ESI+) m/z calcd for C30H28N2O2F [M+H]+: 467.2135, found: 467.2135. 
254 
 
Minor diastereomer is mixed with the major diastereomer and cannot be cleanly characterized. 
Rapid generation of drug metabolite efavirenz: 
(-)-methyl (R)-2-(3-chloro-4-(methylsulfonyl)phenyl)-3-cyclopentylpropanoate [(-)-97]. 
In a flame dried 50 mL recovery flask, (R)-2-(3-chloro-4-
(methylsulfonyl)phenyl)-3-cyclopentylpropanoic acid synthesized 
according to literature procedure34 (814 mg, 2.46 mmol, 1.0 equiv.) was 
dissolved in MeOH (24.6 mL) and cooled to -30 ºC. SOCl2 (1.25 mL, 17.2 
mmol, 7.0 equiv.) was added dropwise and the reaction was warmed up to room temperature 
then refluxed at 70 ºC for 8 h. The reaction was concentrated and plugged through a silica plug 
eluting with 40% ethyl acetate/hexanes to afford product as a colorless oil (777.0 mg, 2.25 
mmol) in 92% yield. The enantiomeric excess (ee) was determined by chiral HPLC (AD-RH, 
55:45 MeCN:H2O, 0.5 mL/min flow rate, 254 nm): 93%. 
1H-NMR (500 MHz, CDCl3) δ 8.09 (d, J = 8.2 Hz, 1H), 7.53 (d, J = 1.6 Hz, 1H), 7.41 (dd, J = 
8.2, 1.7 Hz, 1H), 3.69 (s, 3H), 3.69 – 3.65 (m, 1H), 3.26 (s, 3H), 2.09 (ddd, J = 13.4, 8.3, 7.2 Hz, 
1H), 1.84 – 1.79 (m, 1H), 1.77 – 1.71 (m, 2H), 1.63 – 1.58 (m, 3H), 1.53 – 1.43 (m, 2H), 1.16 – 
1.05 (m, 2H). 13C-NMR (126 MHz, CDCl3) δ 173.3, 147.2, 136.9, 132.8, 131.5, 131.1, 127.4, 
52.6, 50.6, 42.9, 39.9, 37.9, 32.9, 32.3, 25.2 (2 carbons). [a]D25 = -44.8º (c = 0.87, CHCl3). 























Chart 4. HPLC trace for (-)-97 synthesized according to the described procedure 









methyl (2R)-2-(3-chloro-4-(methylsulfonyl)phenyl)-3-(3-oxocyclopentyl)propanoate [98]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. methyl (R)-2-(3-chloro-4-(methylsulfonyl)phenyl)-3-
cyclopentylpropanoate (-)-97 (103.5 mg, 0.300 mmol, 1.0 equiv), (R,R)-
Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 
4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), MeCN (0.6 mL in 40 
mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath. The reaction was 
worked up with 9 mL saturated NaHCO3 and DCM as described in General Method A. Flash 
column chromatography on silica (35 mm fritted glass column, 100 mL SiO2) using 30% ethyl 
acetate/hexanes à 50% ethyl acetate/ as eluent afforded clean e-ketone (98) as a colorless oil 
and a fraction of d-ketone with small impurities. 
Run 1: (57.6 mg, 0.161 mmol, 53.5% yield of e-ketone, 1:1 d.r.), (~14% yield of d-ketone), <5% 
rsm. Run 2: (59.2 mg, 0.165 mmol, 55.0% yield of e-ketone, 1:1 d.r.), (~12% yield of d-ketone), 
<5% rsm. Run 3: (58.5 mg, 0.163 mmol, 54.3% yield of e-ketone, 1:1 d.r.), (~14% yield of d-
ketone), <5% rsm. Average: 54.3% yield ± 0.8% of e-ketone, 1:1 d.r., <5% rsm. 
e-ketone 98 was isolated as a mixture of diastereomers with ~1:1 ratio. 1H-NMR (500 MHz, 
methylene chloride-d2) δ 8.08 (dd, J = 8.3, 0.9 Hz, 1H), 7.57 – 7.55 (m, 1H), 7.45 – 7.42 (m, 
1H), 3.74 – 3.71 (m, 1H), 3.67 (s, 3H), 3.24 (s, 3H), 2.34 – 1.91 (m, 7H), 1.84 – 1.75 (m, 1H), 























172.49, 146.42 & 146.37, 137.1, 132.7, 131.35 & 131.32, 131.0, 127.25 & 127.22, 52.4, 49.6 & 
49.5, 44.7 & 44.3, 42.7, 38.97 & 38.94, 38.30 & 38.25, 34.98 & 34.92, 29.5 & 29.1. HRMS 




In a 20 mL vial charged with methyl (2R)-2-(3-chloro-4-
(methylsulfonyl)phenyl)-3-(3-oxocyclopentyl)propanoate 98 (95.9 mg, 
0.267 mmol) and 3:1 THF/H2O solution (0.8 mL). LiOH•H2O (56.0 mg, 
1.335 mmol, 5 equiv,) was added in 1 portion at 0 ºC and the reaction was 
stirred at room temp for 24 hours. The reaction was cooled back to 0 ºC and quenched with 1M 
KHSO4 solution until pH=2. The resulting mixture was extracted with 15 mL ethyl acetate, and 
the aqueous layer was extracted with 15 mL ethyl acetate twice. Combined organic layer was 
washed with brine and dried over MgSO4 to obtain the crude acid. After drying under high 
vacuum overnight, the acid was dissolved in anhydrous DCM (2.7 mL) in an oven dried 20 mL 
vial, added oxalyl chloride (35 µL, 0.294 mmol, 1.1 equiv.) and 1 drop of DMF at 0 ºC. The 
reaction was kept at 0 ºC for 10 min then room temp for 25 min to get a soluble solution of acid 
chloride. A solution of 2-aminopyrazine (55.9 mg, 0.59 mmol, 2.2 equiv.), pyridine (47 µL, 0.59 
mmol, 2.2 equiv.) in anhydrous THF (2.2 mL) was added to the reaction and solid was crushed 





























column chromatography on silica (35 mm fritted glass column, 50 mL SiO2) using 70% ethyl 
acetate/hexanes à 90% ethyl acetate/ as eluent afforded product as a white solid. 
Result: 60.9 mg, 0.144 mmol, 54% yield over 2 steps. 
Product is a diastereomeric mixture with ~1:1 d.r. 1H-NMR (500 MHz, methanol-d4) δ 9.40 (s, 
1H), 8.38 – 8.32 (m, 2H), 8.12 (d, J = 8.3 Hz, 1H), 7.82 – 7.80 (m, 1H), 7.70 – 7.68 (m, 1H), 
4.10 – 4.04 (m, 1H), 3.34 (s, 3H), 2.44 – 1.90 (m, 8H), 1.69 – 1.60 (m, 1H). This NMR matches 
the reported spectra.34 The reported d-ketone isomer has a benzylic peak at 4.21 – 4.41 ppm. 
Better NMR can be obtained by using the more soluble chloroform solvent: 1H-NMR (500 MHz, 
CDCl3) δ 9.51 (s, 1H), 8.43 (t, J = 17.1 Hz, 1H), 8.35 (d, J = 2.5 Hz, 1H), 8.19 (s, 1H), 8.11 
(ddd, J = 7.3, 4.6, 2.5 Hz, 1H), 7.63 – 7.61 (m, 1H), 7.51 (ddd, J = 8.4, 3.9, 1.7 Hz, 1H), 3.78 – 
3.77 (m, 1H), 3.28 (s, 3H), 2.47 – 2.29 (m, 3H), 2.25 – 1.82 (m, 5H), 1.63 – 1.55 (m, 1H).13C-
NMR (126 MHz, CDCl3) 217.9, 169.9, 147.8, 146.6, 146.4, 142.2, 141.0, 137.2, 133.4, 131.7, 
131.4 & 131.3, 127.1 & 127.1, 45.0 & 44.7, 43.0, 39.6, 39.68 & 39.53, 39.64 & 39.49, 35.3 & 












Sequential Oxidation of Ethinylestradiol Derivative 100 




In a flamed dried 100 mL flask, 2.4 mL (27.0 mmol, 1.5 equiv.) 
methyl propinolate was dissolved in 36 mL anhydrous THF. 
16.9 mL 1.6 M n-BuLi (27.0 mmol, 1.5 equiv.) solution was 
added slowly at -78 ºC and the mixture was stirred at -78 ºC for 10 min after which the 
organolithium reagent solution was cannulated into a 100 mL flame dried flask containing 6.38 g 
(18.0 mmol, 1.0 equiv.) pivalated estrone in 36 mL anhydrous THF at -78 ºC. The reaction was 
stirred at -78 ºC for 30 min then at room temperature for 10 min. Saturated NH4Cl was added to 
quench the reaction and the aqueous layer was extracted with 3 x 30 mL ether. The combined 
organic layer was washed with 20 mL brine, dried with MgSO4 and concentrated. The crude 
mixture was purified by CombiFlash (40g silica column) using hexanes à 30% EtOAc/hexanes 
gradient eluent to provide 4.60 g (10.48 mmol) of pure product as a slightly yellow solid (58% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.27 (d, J = 7.3 Hz, 1H), 6.81 (dd, J = 8.4, 2.6 Hz, 1H), 6.76 (d, J 
= 2.4 Hz, 1H), 3.79 (s, 3H), 2.87 – 2.85 (m, 2H), 2.42 – 2.36 (m, 2H), 2.28 (td, J = 11.1, 4.3 Hz, 
1H), 2.09 – 2.02 (m, 2H), 1.90 – 1.77 (m, 4H), 1.67 (ddd, J = 12.0, 10.6, 7.4 Hz, 1H), 1.58 – 1.37 
(m, 4H), 1.34 (s, 9H), 0.90 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 177.5, 154.1, 149.0, 138.2, 




















27.3, 27.1, 26.3, 23.1, 12.8. [a]D23 = -14.6 (c = 0.96, CHCl3). HRMS (TOF ESI+) m/z calculated 
for C27H35O5 [M+H]+: 439.2484, found 439.2476. 
Benzylic oxidation of ethinylestradiol derivative (-)-100 
Condition I: 
The reaction was run with General Method A: Single Catalyst Addition Protocol: methyl 3-
((8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-3-(pivaloyloxy)-7,8,9,11,12,13,14,15,16,17-
decahydro-6H-cyclopenta[a]phenanthren-17-yl)propiolate (-)-100 (131.6 mg, 0.300 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (20.3 mg, 0.015 mmol, 5 mol%), ClCH2CO2H (213 mg, 2.25 mmol, 
7.5 equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 4:1 MeCN:DCM mixture (0.6 mL in 
40 mL vial, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry 
ice bath and worked up with 9 mL saturated NaHCO3 and DCM as described in General Method 
A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 
20% EtOAc/hexanes à 25% EtOAc/hexanes à 50% EtOAc/hexanes as eluent afforded 
benzylic ketone oxidation product (-)-101 as a white solid. 
Run 1: (100.6 mg, 0.222 mmol, 74.1% yield of benzylic ketone (-)-101), 0% rsm. Run 2: (95.9 
mg, 0.212 mmol, 70.6% yield of benzylic ketone (-)-101), 0% rsm. Average: 72.4% yield of 
benzylic ketone (-)-101, 0% rsm. 
This oxidation can be scaled up with further reduction of catalyst loading to 2 mol% 
without loss of reactivity. The reaction was run with General Method A: Single Catalyst 
Addition Protocol: methyl 3-((8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-3-(pivaloyloxy)-
7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)propiolate (-)-100 
(1316 mg, 3.0 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (81.3 mg, 0.060 mmol, 2 mol%), 
ClCH2CO2H (2.126 g, 22.5 mmol, 7.5 equiv.), 50% wt. H2O2 (2040 mg, 30.0 mmol, 10.0 
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equiv.), 4:1 MeCN:DCM mixture (6 mL in 100 mL recovery flask with a stir bar, 37.5 mL with 
oxidant in a 60 mL syringe). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath 
and worked up with 40 mL saturated NaHCO3 and DCM as described in General Method A.  
Run 1: (998.9 mg, 2.207 mmol, 73.6% yield of benzylic ketone (-)-101), 0% rsm. 
Condition II:  
The reaction was run with General Method A: Single Catalyst Addition Protocol: methyl 3-
((8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-3-(pivaloyloxy)-7,8,9,11,12,13,14,15,16,17-
decahydro-6H-cyclopenta[a]phenanthren-17-yl)propiolate (-)-100 (877.1 mg, 2.000 mmol, 1.0 
equiv), (R,R)-Mn(CF3-PDP) (135.5 mg, 0.100 mmol, 5 mol%), ClCH2CO2H (1.418 g, 15.0 
mmol, 7.5 equiv.), 50% wt. H2O2 (272 mg, 4.0 mmol, 2.0 equiv.), 4:1 MeCN:DCM mixture (4.0 
mL in 50 mL recovery flask, 25.0 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath and worked up with 30 mL saturated NaHCO3 and DCM as 
described in General Method A. Flash column chromatography on silica (50 mm fritted glass 
column, 200 mm SiO2) using 20% EtOAc/hexanes à 30% EtOAc/hexanes à 40% 
EtOAc/hexanes à 60% EtOAc/hexanes as eluent afforded benzylic ketone oxidation product (-)-
101 and benzylic alcohol oxidation product (-)-102 separately as white solids. 
Run 1: (359.2 mg, 0.790 mmol, 39.5% yield of benzylic alcohol (-)-102), (262.5 mg, 0.580 
mmol, 29.0% yield of benzylic ketone (-)-101), (159.3 mg, 0.363 mmol, 18.2% rsm). Run 2: 
(386.0 mg, 0.849 mmol, 42.5% yield of benzylic alcohol (-)-102), (248.6 mg, 0.549 mmol, 
27.5% yield of benzylic ketone (-)-101), (153.4 mg, 0.350 mmol, 17.5% rsm). Average: 41.0% 






1H-NMR (749 MHz, methylene chloride-d2) δ 7.67 (d, J = 2.7 Hz, 
1H), 7.48 (d, J = 8.6 Hz, 1H), 7.24 (dd, J = 8.5, 2.7 Hz, 1H), 3.77 
(s, 3H), 2.73 (dd, J = 16.8, 3.4 Hz, 1H), 2.61 (td, J = 10.9, 4.7 Hz, 
1H), 2.49 (dtd, J = 13.3, 4.4, 2.8 Hz, 1H), 2.39 (ddd, J = 14.0, 9.3, 5.8 Hz, 1H), 2.35 (br. s, 1H), 
2.31 (dd, J = 16.8, 13.4 Hz, 1H), 2.06 (ddd, J = 13.9, 12.0, 3.6 Hz, 1H), 2.03 – 1.99 (m, 1H), 
1.92 – 1.80 (m, 4H), 1.66 (qd, J = 12.5, 4.5 Hz, 1H), 1.48 – 1.41 (m, 1H), 1.35 (s, 9H), 0.91 (s, 
3H). 13C-NMR (126 MHz, methylene chloride-d2) δ 197.2, 177.6, 154.3, 150.3, 144.6, 134.1, 
127.4, 127.3, 120.2, 90.7, 80.1, 78.5, 53.3, 50.2, 48.1, 44.2, 43.1, 40.7, 39.5, 39.1, 33.1, 27.4, 
26.0, 23.2, 12.8. [a]D24 = -40.8 (c = 1.00, CHCl3). HRMS (TOF ESI+) m/z calculated for 
C27H33O6 [M+H]+: 453.2277, found 453.2274. 
(-)-methyl 3-((6R,8R,9S,13S,14S,17S)-6,17-dihydroxy-13-methyl-3-(pivaloyloxy)-
7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)propiolate [(-)-102]. 
1H-NMR (749 MHz, methylene chloride-d2) δ 7.35 (d, J = 8.6 Hz, 
1H), 7.05 (d, J = 2.6 Hz, 1H), 6.94 (dd, J = 8.5, 2.6 Hz, 1H), 4.76 
(br. s, 1H), 3.76 (s, 3H), 2.43 – 2.40 (m, 1H), 2.37 (ddd, J = 13.9, 
9.7, 5.7 Hz, 1H), 2.31 (s, 1H), 2.21 (td, J = 11.4, 4.4 Hz, 1H), 2.05 (ddd, J = 13.9, 11.9, 3.9 Hz, 
1H), 2.01 – 1.98 (m, 2H), 1.85 – 1.78 (m, 4H), 1.71 (td, J = 11.6, 7.5 Hz, 1H), 1.65 – 1.54 (m, 
2H), 1.51 – 1.45 (m, 1H), 1.34 (s, 9H), 0.92 (s, 3H). 13C-NMR (126 MHz, methylene chloride-
d2) δ 177.8, 154.4, 150.0, 140.0, 138.1, 126.9, 123.0, 121.6, 91.1, 80.3, 78.3, 67.6, 53.2, 50.0, 
48.5, 44.1, 39.5, 39.2, 36.6, 33.9, 33.5, 27.4, 26.3, 23.3, 13.0. [a]D24 = -34.4 (c = 0.98, CHCl3). 
HRMS (TOF ESI+) m/z calculated for C27H34O6Na [M+Na]+: 477.2253, found 477.2252. 
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The stereochemistry of the benzylic alcohol was assigned based on the NMR of the following 




In a 20 mL vial, 444.9 mg (0.98 mmol, 1.0 equiv.) methyl 3-
((6R,8R,9S,13S,14S,17S)-6,17-dihydroxy-13-methyl-3-
(pivaloyloxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-
cyclopenta[a]phenanthren-17-yl)propiolate (-)-102 was dissolved in 3 mL anhydrous DCM. 111 
µL (1.18 mmol, 1.2 equiv.) acetic anhydride and 164 µL (1.18 mmol, 1.2 equiv.) triethylamine 
were added sequentially at 0 °C and the reaction was warmed to room temperature. Another 
batch of both 0.6 equiv. acetic anhydride and 0.6 equiv. triethylamine were added after 24 and 48 
hours at room temperature. The crude mixture was loaded directly on silica (50 mm fritted glass 
column, 200 mm SiO2) using 20% EtOAc/hexanes à 50% EtOAc/hexanes gradient eluent gave 
419.0 mg (0.84 mmol) of pure product as a white solid (86% yield). 
1H-NMR (749 MHz, methylene chloride-d2) δ 7.38 (d, J = 8.6 Hz, 1H), 6.98 (dd, J = 8.5, 2.6 Hz, 
1H), 6.95 (d, J = 2.5 Hz, 1H), 5.97 (dd, J = 4.4, 2.1 Hz, 1H), 3.76 (s, 3H), 2.44 (dt, J = 13.3, 3.8 
Hz, 1H), 2.40 (br. s, 1H), 2.37 (ddd, J = 13.9, 9.6, 5.6 Hz, 1H), 2.24 (td, J = 11.4, 4.4 Hz, 1H), 
2.05 (s, 3H), 2.07 – 2.00 (m, 2H), 1.87 – 1.77 (m, 4H), 1.71 – 1.63 (m, 2H), 1.58 (qd, J = 12.4, 
4.9 Hz, 1H), 1.43 (qd, J = 12.1, 5.9 Hz, 1H), 1.33 (s, 9H), 0.93 (s, 3H). 13C-NMR (126 MHz, 



















80.3, 78.3, 69.4, 53.2, 49.8, 48.4, 44.0, 39.5, 39.2, 34.7, 34.1, 33.4, 27.4, 26.3, 23.3, 21.9, 13.0. 
[a]D24 = +25.1 (c = 0.94, CHCl3). HRMS (TOF ESI+) m/z calculated for C29H36O7Na [M+Na]+: 
519.2359, found 519.2355. 
Assignment of stereochemistry: 5.97 (dd, J = 4.4, 2.1 Hz, 1H) is assigned as the benzylic proton 
bearing OAc substitution based on HMBC and HSQC 1H-13C 2D NMRs. The small coupling 
constants (4.4Hz and 2.1Hz) suggests the benzylic proton is in pseudo-equatorial conformation. 
This assignment can be further confirmed by the single crystal structure of the remote oxidation 
product. 




The reaction was run with General Method A: Single Catalyst Addition Protocol with 1X 
recycle of the recovered starting material: methyl 3-((8R,9S,13S,14S,17S)-17-hydroxy-13-
methyl-6-oxo-3-(pivaloyloxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-
cyclopenta[a]phenanthren-17-yl)propiolate (-)-101 (135.8 mg, 0.300 mmol, 1.0 equiv), (R,R)-
Mn(CF3-PDP) (40.7 mg, 0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.50 mmol, 15.0 
equiv.), 50% wt. H2O2 (204 mg, 3.0 mmol, 10.0 equiv.), 4:1 MeCN:DCM mixture (0.6 mL in 40 
mL vial, 3.75 mL with oxidant). The reaction was run at 0 ºC with ice bath and worked up with 9 
mL saturated NaHCO3 and DCM as described in General Method A. Flash column 




















acetone/hexanes à 25% acetone/hexanes à 40% acetone/hexanes as eluent afforded remote 
oxidation product (-)-104 and recovered starting material as white solids. The recovered starting 
material was transferred into a 2-dram vial and re-subjected to single catalyst addition C—H 
oxidation conditions: (R,R)-Mn(CF3-PDP) (10 mol%),  ClCH2CO2H (15.0 equiv.), 50% wt. H2O2 
(10.0 equiv.), 4:1 MeCN:DCM mixture (0.25 M with starting material in 2-dram vial to enable 
full dissolvation of starting material, 1.25 mL per 0.1 mmol starting material with oxidant). 
Run 1: cycle 1: (55.6 mg, 0.119 mmol, 39.6% yield), (30.5 mg, 0.067 mmol, 22.5% rsm); cycle 
2: (11.5 mg, 0.025 mmol, 36.4% yield), (<5 mg, rsm); overall: (67.1 mg, 0.143 mmol, 47.7% 
yield), <5% rsm. Run 2: cycle 1: (55.3 mg, 0.118 mmol, 39.3% yield), (31.1 mg, 0.069 mmol, 
22.9% rsm); cycle 2: (10.1 mg, 0.022 mmol, 31.3% yield), (<5 mg, rsm); overall: (65.4 mg, 
0.140 mmol, 46.5% yield), <5% rsm. Average: 47.1% yield, <5% rsm. 
1H-NMR (749 MHz, methylene chloride-d2) δ 7.67 (d, J 
= 2.6 Hz, 1H), 7.45 (d, J = 8.6 Hz, 1H), 7.25 (dd, J = 8.5, 
2.7 Hz, 1H), 4.30 (dd, J = 11.2, 4.7 Hz, 1H), 3.77 (s, 3H), 
2.80 (br. s, 1H), 2.76 – 2.71 (m, 2H), 2.56 (dt, J = 12.5, 
4.7 Hz, 1H), 2.38 (ddd, J = 13.9, 9.5, 5.6 Hz, 1H), 2.26 (dd, J = 16.9, 13.4 Hz, 1H), 2.16 (br. s, 
1H), 2.08 (ddd, J = 13.9, 11.9, 4.0 Hz, 1H), 2.00 (dtd, J = 13.3, 11.0, 3.5 Hz, 1H), 1.85 (dddd, J 
= 12.1, 9.4, 7.7, 4.0 Hz, 1H), 1.77 (td, J = 11.4, 7.7 Hz, 1H), 1.70 (td, J = 12.4, 11.2 Hz, 1H), 
1.55 (qd, J = 12.1, 5.6 Hz, 1H), 1.35 (s, 9H), 0.95 (s, 3H). 13C-NMR (126 MHz, methylene 
chloride-d2) δ 196.7, 177.6, 154.3, 150.6, 143.6, 134.0, 127.6, 127.1, 120.4, 90.2, 80.3, 78.5, 
74.9, 55.3, 52.0, 49.1, 43.9, 42.1, 39.9, 39.5, 38.4, 34.8, 27.4, 23.0, 7.7. [a]D24 = -63.3 (c = 1.00, 










The site of remote oxidation was assigned based on 2D NMR analysis including DQCOSY, 
HSQC, HMBC and NOESY. The assignment was further confirmed by the crystal structure of the 
remote oxidation product (-)-104. 
Crystal Structure for (-)-104 
Ethanol was added dropwisely to a half dram vial containing 5 mg of (-)-104 with ~0.2 
mL hexanes until the material fully dissolved. The vial was loosely capped allowing n-pentane to 
diffuse into the mixture. Single crystal for X-ray crystallography analysis was obtained in ~ 2 
days. 
Diagram 4. Crystal Structure for (-)-104 
 
--------------------------------------------------------------------------------------------------------------------- 
Table 15. Crystal Data and Structure Refinement for (-)-104 
Empirical formula  C27 H32 O7 
Formula weight  468.52 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  I2 











Table 15. (cont.) 
 b = 9.1936(3) Å b= 97.5430(10)°. 
 c = 27.3628(11) Å g = 90°. 
Volume 2693.04(17) Å3 
Z 4 
Density (calculated) 1.156 Mg/m3 
Absorption coefficient 0.680 mm-1 
F(000) 1000 
Crystal size 0.360 x 0.296 x 0.285 mm3 
Theta range for data collection 3.258 to 68.446°. 
Index ranges -13<=h<=12, -11<=k<=10, -32<=l<=32 
Reflections collected 34276 
Independent reflections 4888 [R(int) = 0.0451] 
Completeness to theta = 67.679° 100.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7488 and 0.6815 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4888 / 234 / 369 
Goodness-of-fit on F2 1.074 
Final R indices [I>2sigma(I)] R1 = 0.0413, wR2 = 0.1168 
R indices (all data) R1 = 0.0420, wR2 = 0.1175 
Absolute structure parameter 0.14(9) 
Extinction coefficient 0.0040(4) 
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Table 15. (cont.) 
Largest diff. peak and hole 0.231 and -0.170 e.Å-3 
--------------------------------------------------------------------------------------------------------------------- 
Crystallographic data for 104 can be obtained free of charge from 
www.ccdc.cam.ac.uk/structures/ with deposit number CCDC 1869258. 
Author’s Response to the Level B alert in the checkcif report: The hydroxyl group protons were 
located in the difference map and assigned to the most reasonable H-bonding geometries. H1D 
points toward a void space that is likely at least partially occupied by ethanol, which can act as 
the acceptor for H1D. See _publ_section_exptl_refinement section for more details on how the 
hydroxyl H atoms were located and assigned. 





The reaction was run with General Method A: Single Catalyst Addition Protocol: methyl 3-
((6R,8R,9S,13S,14S,17S)-6-acetoxy-17-hydroxy-13-methyl-3-(pivaloyloxy)-
7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl)propiolate (+)-103 
(99.3 mg, 0.200 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) (27.1 mg, 0.020 mmol, 10 mol%),  
ClCH2CO2H (284 mg, 3.00 mmol, 15.0 equiv.), 50% wt. H2O2 (136 mg, 2.0 mmol, 10.0 equiv.), 



















0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and DCM as 
described in General Method A. Flash column chromatography on silica (35 mm fritted glass 
column, 150 mm SiO2) using 20% acetone/hexanes à 30% acetone/hexanes à 50% 
acetone/hexanes as eluent afforded remote oxidation product (+)-105 and recovered starting 
material as white solids.  
Run 1: (31.3 mg, 0.061 mmol, 30.5% remote alcohol (+)-105 yield), (16.7 mg, 0.034 mmol, 
16.8% rsm); Run 2: (35.1 mg, 0.068 mmol, 34.2% remote alcohol (+)-105 yield), (15.6 mg, 
0.031 mmol, 15.7% rsm); Run 3: (31.3 mg, 0.061 mmol, 30.5% remote alcohol (+)-105 yield), 
(17.7 mg, 0.036 mmol, 17.8% rsm) . Average: 31.7% ± 2.1% remote alcohol (+)-105 yield, 
16.8% ± 1.1% rsm. 
1H-NMR (749 MHz, methylene chloride-d2) δ 7.35 (dd, J = 8.5, 
1.2 Hz, 1H), 6.99 (dd, J = 8.5, 2.6 Hz, 1H), 6.97 (d, J = 2.5 Hz, 
1H), 5.99 (dd, J = 4.6, 2.0 Hz, 1H), 4.23 (dd, J = 11.1, 4.7 Hz, 
1H), 3.76 (s, 3H), 2.92 (br. s, 1H), 2.52 (dt, J = 12.5, 4.6 Hz, 1H), 2.38 – 2.32 (m, 2H), 2.26 (br. 
s, 1H), 2.09 – 2.05 (m, 1H), 2.06 (s, 3H), 2.02 (dt, J = 14.2, 2.4 Hz, 1H), 1.83 (dtdd, J = 13.0, 
9.4, 6.4, 3.3 Hz, 1H), 1.77 (ddd, J = 13.5, 11.0, 2.6 Hz, 1H), 1.65 – 1.60 (m, 3H), 1.54 (qd, J = 
12.0, 5.5 Hz, 1H), 1.33 (s, 9H), 0.98 (s, 3H). 13C-NMR (126 MHz, methylene chloride-d2) δ 
177.7, 170.8, 154.4, 150.1, 138.0, 136.0, 126.7, 123.4, 122.4, 90.6, 80.4, 78.3, 75.3, 69.3, 53.3, 
52.4, 48.7, 42.8, 39.5, 38.5, 35.2, 33.9, 33.9, 27.4, 23.1, 21.9, 7.8. [a]D25 = +2.7 (c = 0.78, 




The site of remote oxidation was assigned based on 2D NMR analysis including DQCOSY, 
HSQC, HMBC and NOESY. The assignment was further confirmed by the crystal structure of the 
remote oxidation product (+)-105. 
Crystal structure for (+)-105 
Ethyl acetate was added dropwisely to a half dram vial containing 5 mg of (+)-105 with 
~0.2 mL n-pentane until the material fully dissolved. The vial was loosely capped allowing n-
pentane to diffuse into the mixture. Single crystal for X-ray crystallography analysis was 
obtained in ~ 2 days. 
Diagram 5. Crystal Structure for (+)-105 
 
--------------------------------------------------------------------------------------------------------------------- 
Table 16. Crystal Data and Structure Refinement for (+)-105 
Empirical formula  C58 H74 O17  [2(C29H36O8)·H2O] 
Formula weight  1043.17 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P21 












Table 16. (cont.) 
 b = 16.7429(4) Å b= 101.6660(7)°. 
 c = 15.5965(4) Å g = 90°. 
Volume 2753.97(12) Å3 
Z 2 
Density (calculated) 1.258 Mg/m3 
Absorption coefficient 0.757 mm-1 
F(000) 1116 
Crystal size 0.292 x 0.222 x 0.155 mm3 
Theta range for data collection 2.893 to 68.442°. 
Index ranges -12<=h<=12, -20<=k<=20, -18<=l<=18 
Reflections collected 28965 
Independent reflections 10030 [R(int) = 0.0386] 
Completeness to theta = 67.679° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7531 and 0.6795 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 10030 / 12 / 717 
Goodness-of-fit on F2 1.096 
Final R indices [I>2sigma(I)] R1 = 0.0438, wR2 = 0.1094 
R indices (all data) R1 = 0.0467, wR2 = 0.1122 
Absolute structure parameter -0.08(7) 
Extinction coefficient 0.0109(5) 
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Table 16. (cont.) 
Largest diff. peak and hole 0.487 and -0.285 e.Å-3 
--------------------------------------------------------------------------------------------------------------------- 
Crystallographic data for 105 can be obtained free of charge from 
www.ccdc.cam.ac.uk/structures/ with deposit number CCDC 1869259. 




To a 1 dram vial charged with methyl 3-((6R,8R,9S,13S,14S,17S)-6-acetoxy-17-hydroxy-13-
methyl-3-(pivaloyloxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-
yl)propiolate (+)-103 (24.8 mg, 0.05 mmol, 1.0 equiv) in 0.5 mL anhydrous DCM (0.1 M). 0.25 
mL freshly made TFDO (0.4 M in trifluoroacetone, 0.1 mmol, 2.0 equiv.) was added in 1-2 
portions at -20 ºC. The reaction was wrapped with aluminum foil and allowed to stir at -20 ºC. 
The reaction as monitored by TLC and full conversion of starting material was reached after 40 
min. The reaction was concentrated and purified by CombiFlash (12g column) to yield tertiary 
benzylic alcohol product (+)-106 as white solid. 
Run 1: 21.7 mg, 0.042 mmol, 84.6% yield. Run 2: 21.2 mg, 0.041 mmol, 82.7% yield. 
Average: 83.7% yield. 
1H-NMR (500 MHz, methylene chloride-d2) δ 7.59 (d, J = 8.6 Hz, 1H), 7.05 (dd, J = 8.6, 2.5 Hz, 

















2.06 (s, 3H), 2.22 – 2.02 (m, 5H), 1.86 (td, J = 13.7, 4.3 
Hz, 1H), 1.78 – 1.69 (m, 2H), 1.64 (ddd, J = 12.7, 4.3, 
2.6 Hz, 1H), 1.58 (br. s, 1H), 1.42 (tt, J = 12.1, 6.1 Hz, 
1H), 1.34 (s, 9H), 0.94 (s, 3H). 13C-NMR (126 MHz, 
methylene chloride-d2) δ 177.5, 170.9, 154.4, 151.3, 140.6, 136.0, 126.6, 123.9, 123.0, 91.1, 
80.2, 78.2, 69.9, 69.2, 53.3, 48.3, 43.1, 39.5, 39.3, 37.6, 32.9, 29.5, 27.9, 27.4, 23.2, 21.8, 12.3. 
[a]D25 = +17.9 (c = 0.61, CHCl3). HRMS (TOF ESI+) m/z calculated for C29H36O8Na [M+Na]+: 
535.2308, found 535.2305. 
 
2.4.8 Gram Scale Oxidation with Mn(CF3-PDP) 
Gram-scale reaction on S29 using 5 mol% Mn(CF3-PDP): 
The reaction was run with reduced catalyst and chloroacetic acid loading according to a modified 
General Method A: Single Catalyst Addition Protocol with a scale up of appropriate 
apparatus. 1-(4-chlorophenyl)cyclopentane-1-carbonitrile S29 (1028 mg, 5.0 mmol, 1.0 equiv), 
(R,R)-Mn(CF3-PDP) (339 mg, 0.25 mmol, 5 mol%), ClCH2CO2H (3.545 g, 37.5 mmol, 7.5 
equiv.), 50% wt. H2O2 (3400 mg, 50.0 mmol, 10.0 equiv.), MeCN (10 mL in 100 mL recovery 
flask with a stir bar, 60 mL with oxidant in a 60 mL syringe). The reaction was run at 0 ºC with 
ice bath. The reaction was worked up with 80 mL saturated NaHCO3 and DCM as described in 
General Method A. Flash column chromatography on silica (50 mm fritted glass column, 200 
mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded product 40 as 
a clear oil. 










Small scale oxidation of efavirenz derivative 90 using 5 mol% Mn(CF3-PDP): 
The reaction was run with a modified General Method A: Single Catalyst Addition Protocol. 
6-chloro-4-(cyclopropylethynyl)-1-hexanoyl-4-(trifluoromethyl)-1,4-dihydro-2H-
benzo[d][1,3]oxazin-2-one 90 (82.8 mg, 0.200 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) 32 (13.6 
mg, 0.010 mmol, 5 mol%), ClCH2CO2H (284 mg, 3.0 mmol, 15.0 equiv.), 50% wt. H2O2 (136 
mg, 2.0 mmol, 10.0 equiv.), MeCN (0.4 mL in 40 mL vial, 2.5 mL with oxidant). The reaction 
was run at 0 ºC with ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM as described in the General Method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mL SiO2) using 10% ethyl acetate/hexanes à 25% ethyl 
acetate/hexanes à 50% ethyl acetate/hexanes as eluent afforded d-ketone (91a) and g-ketone 
(91b) products as white solid. 
Run 1: (10.9 mg, 0.026 mmol, 12.7% yield of g-ketone 91b), (31.9 mg, 0.075 mmol, 37.3% 
yield of d-ketone 91a), (50.0% overall yield, 2.9:1 d:g ratio), (26.0 mg, 0.063 mmol, 31.4% rsm). 
Gram scale oxidation of efavirenz derivative 90 using 5 mol% Mn(CF3-PDP): 
The reaction was run with a modified General Method A: Single Catalyst Addition Protocol. 
6-chloro-4-(cyclopropylethynyl)-1-hexanoyl-4-(trifluoromethyl)-1,4-dihydro-2H-
benzo[d][1,3]oxazin-2-one 90 (2.4831 g, 6.0 mmol, 1.0 equiv), (R,R)-Mn(CF3-PDP) 32 (406.6 
mg, 0.030 mmol, 5 mol%), ClCH2CO2H (8.504 g, 90.0 mmol, 15.0 equiv.), 50% wt. H2O2 (4.080 
g, 60.0 mmol, 10.0 equiv.), MeCN (12 mL in a 300 mL round bottom flask to dissolve catalyst, 
substrate and chloroacetic acid) + MeCN(75 mL with oxidant, divided into two equal batches 
and loaded into 2 50 mL syringes). The reaction was run at 0 ºC with ice bath to maintain the 
temperature of the 300 mL round bottom flask. After 1.5 hours of addition that deplete the first 
syringe of oxidant solution, the second syringe with remaining half oxidant solution is loaded to 
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syringe pump and continue addition. Upon the completion of all oxidant addition, the reaction 
was worked up with a solution of 100 mL saturated NaHCO3 and 100 mL water, 3 X 100 mL 
DCM was used to extract, and the organic layer is dried with Na2SO4. The crude reaction was 
loaded to Celite and purified directly on CombiFlash using a 40 g column flashing with 0% ethyl 
acetate/hexanes à 25% ethyl acetate/hexanes as eluent afforded d-ketone (91a) and g-ketone 
(91b) products as white solid. Recovered starting material 90 was collected and rotvaped into a 
100 mL recovery flask and recycled 1X using the same oxidation protocol (equivalence of all 
reagents were calculated based on the amount of recovered 90 from the first oxidation). 
Run 1: cycle 1: (210.0 mg, 0.491 mmol, 8.2% yield of g-ketone 91b), (882.7 mg, 2.06 mmol, 
34.4% yield of d-ketone 91a), (604.4 mg, 1.46 mmol, 24.3% rsm). cycle 2: (47.8 mg, 0.117 
mmol, 7.6% yield of g-ketone 91b), (208.1 mg, 0.486 mmol, 33.2% yield of d-ketone 91a), 
(151.5 mg, 0.366 mmol, 25.1% rsm). Overall: (257.8 mg, 0.603 mmol, 10.0% yield of g-ketone 
91b), (1090.8 mg, 2.55 mmol, 42.5% yield of d-ketone 91a), (52.5% overall yield, 4.3:1 d:g 
ratio), (151.5 mg, 0.366 mmol, 6.1% rsm). Run 2: cycle 1: (187.4 mg, 0.438 mmol, 7.3% yield 
of g-ketone 91b), (826.4 mg, 1.93 mmol, 32.2% yield of d-ketone 91a), (738.1 mg, 1.78 mmol, 
29.7% rsm). cycle 2: (55.4 mg, 0.129 mmol, 7.3% yield of g-ketone 91b), (267.4 mg, 0.625 
mmol, 35.1% yield of d-ketone 91a), (189.0 mg, 0.457 mmol, 25.7% rsm). Overall: (242.8 mg, 
0.568 mmol, 9.5% yield of g-ketone 91b), (1093.8 mg, 2.56 mmol, 42.6% yield of d-ketone 91a), 
(52.1% overall yield, 4.5:1 d:g ratio), (189.0 mg, 0.457 mmol, 7.6% rsm). Average: 52.3% 






2.4.9 Reaction Development for 3º C—H Oxidation with Mn(PDP) 
1-(4-chlorophenyl)-4-methylpentyl acetate [107]. 
638.2 mg (3.0 mmol) of 1-(4-chlorophenyl)-4-methylpentan-1-ol was 
dissolved in 15 mL anhydrous pyridine.  1.531 g (1.42 mL, 15.0 mmol, 5.0 
equiv.) of acetic anhydride was added dropwisely at 0 ºC and the reaction was allowed to stir 
overnight before concentrated under reduced pressure. The residue was diluted with 30 mL DCM 
and washed with 30 mL 1M HCl solution TWICE followed by 20 mL brine. The organic layer 
was dried with MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 
mm fritted glass column, 300 mm SiO2) using 5% EtOAc/hexanes as eluent gave 735.6 mg (2.89 
mmol) of pure product as a colorless oil (96% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.31 (d, J = 8.4 Hz, 2H), 7.26 (d, J = 8.5 Hz, 2H), 5.65 (t, J = 7.0 
Hz, 1H), 2.06 (s, 3H), 1.91 – 1.84 (m, 1H), 1.77 – 1.70 (m, 1H), 1.53 (hept, J = 6.7 Hz, 1H), 1.20 
(dddd, J = 13.6, 11.6, 6.9, 5.0 Hz, 1H), 1.07 (dddd, J = 13.5, 11.8, 6.8, 5.0 Hz, 1H), 0.86 (dd, J = 
6.6, 3.1 Hz, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.4, 139.5, 133.7, 128.7, 128.1, 75.8, 34.6, 
34.2, 28.0, 22.6, 22.6, 21.4. HRMS (ESI) m/z calculated for C14H19O2NaCl [M+Na]+: 277.0971, 
found 277.0982. 
Entry 1 
The reaction was conducted according to the iterative addition protocol.10 In a 40 mL vial was 
charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 equiv.), 
Fe(PDP) catalyst 35 (14.0 mg, 0.015 mmol, 0.05 equiv.), AcOH (9.0 mg, 0.15 mmol, 0.5 equiv.), 
MeCN (0.45 mL) and a stir bar. The vial was stirred vigorously and a solution of H2O2 (50 wt%, 
24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL syringe equipped with 25G needle was 





temperature and a second batch of catalyst (14.0 mg, 0.015 mmol, 0.05 equiv.) and AcOH (9.0 
mg, 0.15 mmol, 0.5 equiv.) dissolved in 0.3 mL MeCN was added via pipette. This was followed 
by a solution of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL syringe 
equipped with 25G needle dropwise over 60-75 seconds. After another 10 minutes a third batch 
of catalyst and H2O2 was added in the same manner. The third addition was allowed to stir for 10 
minutes for a total reaction time of 30 minutes. Significant decrease in yield was observed 
when the peroxide solution was added rapidly. 
Upon completion of the reaction, the mixture was concentrated in vacuo to a minimum amount 
of MeCN. 20 mL ether was added to crush the iron complex out and the mixture was filtered via 
a Celite® plug. The filtrate was dried over Na2SO4, concentrated and analyzed by quantitative 1H 
NMR analysis with nitrobenzene added as internal standard. 
Run 1: 0 % product, (21.1 mg, 0.083 mmol, 27.6% rsm). Run 2: 0% product, (22.1 mg, 0.087 
mmol, 28.9% rsm). Run 3: 0% product, (27.5 mg, 0.108 mmol, 36.0% rsm). Average: 0% 
yield, 30.8% rsm ± 4.5%. Selectivity = 0/(100-30.8) = 0%. 
Entry 2 
The reaction was conducted according to the iterative addition protocol.10 In a 40 mL vial was 
charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 equiv.), 
Mn(PDP) catalyst 36 (14.0 mg, 0.015 mmol, 0.05 equiv.), AcOH (9.0 mg, 0.15 mmol, 0.5 
equiv.), MeCN (0.45 mL) and a stir bar. The vial was stirred vigorously and a solution of H2O2 
(50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL syringe equipped with 25G needle 
was added dropwise over 60-75 seconds.  The reaction was allowed to stir for 10 minutes at 
room temperature and a second batch of catalyst (14.0 mg, 0.015 mmol, 0.05 equiv.) and AcOH 
(9.0 mg, 0.15 mmol, 0.5 equiv.) dissolved in 0.3 mL MeCN was added via pipette. This was 
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followed by a solution of H2O2 (50 wt%, 24.5 mg, 1.2 equiv.) in MeCN (3.75 mL) in a 10 mL 
syringe equipped with 25G needle dropwise over 60-75 seconds. After another 10 minutes a 
third batch of catalyst and H2O2 was added in the same manner. The third addition was allowed 
to stir for 10 minutes for a total reaction time of 30 minutes. Significant decrease in yield was 
observed when the peroxide solution was added rapidly. 
Upon completion of the reaction, the mixture was concentrated in vacuo to a minimum amount 
of MeCN. 20 mL ether was added to crush the iron complex out and the mixture was filtered via 
a Celite® plug. The filtrate was dried over Na2SO4, concentrated and analyzed by quantitative 1H 
NMR analysis with nitrobenzene added as internal standard. 
Run 1: (25.8 mg, 0.095 mmol, 31.8% product), (46.2 mg, 0.181 mmol, 60.4% rsm). Run 2: 
(26.9 mg, 0.099 mmol, 33.1% product), (44.0 mg, 0.173 mmol, 57.6% rsm). Run 3: (26.0 mg, 
0.096 mmol, 32.0% yield), (47.8 mg, 0.188 mmol, 62.6% rsm) Average: 32.3% yield ± 0.7%, 
60.2% rsm ± 2.5%. Selectivity = 32.3/(100-60.2) = 81%. 
Entry 3 
The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 
equiv), CH3COOH (270.2 mg, 4.5 mmol, 15.0 equiv.), Mn(PDP) catalyst 36 (27.9 mg, 0.03 
mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe was charged with a 
solution of H2O2 (102 mg, 1.5 mmol, 5.0 equiv.) in MeCN (3.75 mL), fitted with 25G needles 
and the solution was added dropwise via syringe pump over 1 hours (3.75 mL/hour). Upon 
completion of addition, the reaction was concentrated in vacuo to a minimum amount of MeCN 
and purified by column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) 
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using 10% acetone/hexanes à 20% acetone/hexanes à 30% acetone/hexanes as eluent to give 
both recovered starting material and product.  
Run 1: (43.9 mg, 0.162 mmol, 54.0% yield), (27.9 mg, 0.110 mmol, 36.5% rsm). Run 2: (40.7 
mg, 0.150 mmol, 50.1% yield), (31.3 mg, 0.122 mmol, 41.0% rsm) Run 3: (41.1 mg, 0.152 
mmol, 50.6% yield), (34.4 mg, 0.135 mmol, 45.0% rsm). Average: 51.6% yield ± 2.1%, 40.8% 
rsm ± 4.3%. Selectivity = 51.6/(100-40.8) = 87%. 
Entry 4 
The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 
equiv), CH3COOH (270.2 mg, 4.5 mmol, 15.0 equiv.), Mn(PDP) catalyst 36 (27.9 mg, 0.03 
mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe was charged with a 
solution of H2O2 (102 mg, 1.5 mmol, 5.0 equiv.) in MeCN (3.75 mL), fitted with 25G needles 
and the solution was added dropwise via syringe pump over 1 hours (3.75 mL/hour) while the 
reaction vial was maintained at 0 ºC. Upon completion of addition, the reaction was concentrated 
in vacuo to a minimum amount of MeCN and purified by column chromatography on silica (35 
mm fritted glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes à 
30% acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (48.3 mg, 0.178 mmol, 59.5% yield), (15.5 mg, 0.061 mmol, 20.3% rsm). Run 2: (48.2 
mg, 0.178 mmol, 59.3% yield), (21.5 mg, 0.084 mmol, 28.1% rsm). Run 3: (45.0 mg, 0.166 
mmol, 55.4% yield), (17.8 mg, 0.070 mmol, 23.3% rsm). Average: 58.1% yield ± 2.3%, 23.9% 






The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 
equiv), CH3COOH (270.2 mg, 4.5 mmol, 15.0 equiv.), Mn(PDP) catalyst 36 (27.9 mg, 0.03 
mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe was charged with a 
solution of H2O2 (102 mg, 1.5 mmol, 5.0 equiv.) in MeCN (3.75 mL), fitted with 25G needles 
and the solution was added dropwise via syringe pump over 1 hours (3.75 mL/hour) while the 
reaction vial was maintained at -36 ºC with 1,2-dichloroethane/dry ice bath. Upon completion of 
addition, the reaction was concentrated in vacuo to a minimum amount of MeCN and purified by 
column chromatography on silica (35 mm fritted glass column, 150 mL SiO2) using 10% 
acetone/hexanes à 20% acetone/hexanes à 30% acetone/hexanes as eluent to give both 
recovered starting material and product.  
Run 1: (49.9 mg, 0.184 mmol, 61.3% yield), (15.8 mg, 0.062 mmol, 20.7% rsm). Run 2: (51.3 
mg, 0.189 mmol, 63.2% yield), (22.9 mg, 0.090 mmol, 30.0% rsm). Run 3: (45.2 mg, 0.167 
mmol, 55.6% yield), (19.3 mg, 0.076 mmol, 25.2% rsm). Average: 60.0% yield ± 4.0%, 25.3% 
rsm ± 4.6%. Selectivity = 60.0/(100-25.3) = 80%. 
Entry 6 
The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 
equiv), ClCH2COOH (425 mg, 4.5 mmol, 15.0 equiv.), Mn(PDP) catalyst 36 (27.9 mg, 0.03 
mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe was charged with a 
solution of H2O2 (102 mg, 1.5 mmol, 5.0 equiv.) in MeCN (3.75 mL), fitted with 25G needles 
and the solution was added dropwise via syringe pump over 1 hours (3.75 mL/hour) while the 
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reaction vial was maintained at -36 ºC with 1,2-dichloroethane/dry ice bath. Upon completion of 
addition, the reaction was concentrated in vacuo and concentrated in vacuo to a minimum 
amount of MeCN. The residue was dissolved in ~20 mL DCM and washed with 9 mL sat. 
NaHCO3 solution (CAUTION: CO2 was released) to remove ClCH2CO2H. The aqueous layer 
was extracted with ~15 mL DCM twice and the combined organic layer was dried with Na2SO4. 
After filtration, the reaction was purified by column chromatography on silica (35 mm fritted 
glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes à 30% 
acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (53.3 mg, 0.197 mmol, 65.7% yield), (12.0 mg, 0.047 mmol, 15.7% rsm). Run 2: (54.1 
mg, 0.200 mmol, 66.6% yield), (11.3 mg, 0.044 mmol, 14.8% rsm). Run 3: (53.1 mg, 0.196 
mmol, 65.4% yield), (12.3 mg, 0.048 mmol, 16.1% rsm). Average: 65.9% yield ± 0.6%, 15.5% 
rsm ± 0.7%. Selectivity = 65.9/(100-15.5) = 80%. 
Entry 7 
The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (127.4 mg, 0.50 mmol, 1.0 
equiv), ClCH2COOH (709 mg, 7.5 mmol, 15.0 equiv.), Mn(PDP) catalyst 36 (46.6 mg, 0.05 
mmol, 0.10 equiv.) MeCN (1.0 mL) and a stir bar. A 10 mL syringe was charged with a solution 
of H2O2 (170 mg, 2.5 mmol, 5.0 equiv.) in MeCN (6.25 mL), fitted with 25G needles and the 
solution was added dropwise via syringe pump over 3 hours (2.05 mL/hour) while the reaction 
vial was maintained at -36 ºC with 1,2-dichloroethane/dry ice bath. Upon completion of addition, 
the reaction was concentrated in vacuo and concentrated in vacuo to a minimum amount of 
MeCN. The residue was dissolved in ~30 mL DCM and washed with 15 mL sat. NaHCO3 
solution (CAUTION: CO2 was released) to remove ClCH2CO2H. The aqueous layer was 
283 
 
extracted with ~15 mL DCM twice and the combined organic layer was dried with Na2SO4. 
After filtration, the reaction was purified by column chromatography on silica (35 mm fritted 
glass column, 150 mL SiO2) using 10% acetone/hexanes à 20% acetone/hexanes à 30% 
acetone/hexanes as eluent to give both recovered starting material and product.  
Run 1: (96.7 mg, 0.357 mmol, 71.4% yield), (13.8 mg, 0.054 mmol, 10.8% rsm). Run 2: (94.0 
mg, 0.347 mmol, 69.4% yield), (20.0 mg, 0.079 mmol, 15.7% rsm). Run 3: (90.5 mg, 0.334 
mmol, 66.9% yield), (26.5 mg, 0.104 mmol, 20.8% rsm). Average: 69.2% yield ± 2.3%, 15.8% 
rsm ± 5.0%. Selectivity = 69.2/(100-15.8) = 82.2%. 
Entry 8 
The reaction was conducted with Method A: single catalyst addition protocol. In a 40 mL vial 
was charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (76.4 mg, 0.30 mmol, 1.0 
equiv), ClCH2COOH (425 mg, 4.5 mmol, 15.0 equiv.), Fe(PDP) catalyst 35 (27.9 mg, 0.03 
mmol, 0.10 equiv.) MeCN (0.60 mL) and a stir bar. A 10 mL syringe was charged with a 
solution of H2O2 (102 mg, 1.5 mmol, 5.0 equiv.) in MeCN (3.75 mL), fitted with 25G needles 
and the solution was added dropwise via syringe pump over 1 hours (3.75 mL/hour) while the 
reaction vial was maintained at -36 ºC with 1,2-dichloroethane/dry ice bath. Upon completion of 
addition, the reaction was concentrated in vacuo and concentrated in vacuo to a minimum 
amount of MeCN. The residue was dissolved in ~30 mL DCM and washed with 15 mL sat. 
NaHCO3 solution (CAUTION: CO2 was released) to remove ClCH2CO2H. The aqueous layer 
was extracted with ~15 mL DCM twice and the combined organic layer was dried with Na2SO4. 
The crude reaction was concentrated and analyzed by quantitative 1H NMR analysis with 
nitrobenzene added as internal standard. 




This reaction was conducted according to the reported general procedure.6 In a 20 mL vial 
charged with 1-(4-chlorophenyl)-4-methylpentyl acetate 107 (63.7 mg, 0.25 mmol, 1.0 equiv.), a 
magnetic stir bar and a solution of cis-Ru(dtbpy)2Cl2 (8.9 mg, 13 µmol, 0.05 equiv.) in 2.0 mL 
acetic acid. 2.0 mL water was added to the vial and the purple solution was stirred at room 
temperature for 2 min before a single portion of H5IO6 (114 mg, 0.50 mmol, 2.0 equiv.) was 
added. The reaction was wrapped with aluminum foil and stirred at room temperature for 4 
hours. The reaction was transferred to a separatory funnel with 4 mL CH2Cl2 and 30 mL water. 
The aqueous layer was extracted with 3 x 15 mL CH2Cl2 and the combined organic layer was 
dried over Na2SO4. The crude reaction was concentrated and analyzed by quantitative 1H NMR 
analysis with nitrobenzene added as internal standard. 
Run 1: (22.8 mg, 0.084 mmol, 33.7% yield), (22.6 mg, 0.089 mmol, 35.5% rsm). Run 2: (20.5 
mg, 0.076 mmol, 30.2% yield), (20.8 mg, 0.082 mmol, 32.7% rsm). Run 3: (19.2 mg, 0.071 
mmol, 28.3% yield), (18.3 mg, 0.072 mmol, 28.7% rsm).  Average: 30.7% yield ± 2.7%, 
32.3% rsm ± 3.4%. Selectivity = 30.7/(100-32.3) = 45%. 
Characterization of 1-(4-chlorophenyl)-4-hydroxy-4-methylpentyl acetate [108]. 
1H-NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.5 Hz, 2H), 7.27 (d, J = 8.5 Hz, 
2H), 5.68 (dd, J = 7.6, 6.3 Hz, 1H), 2.07 (s, 3H), 1.98 (dddd, J = 13.3, 12.2, 
7.6, 4.6 Hz, 1H), 1.85 (dddd, J = 13.4, 11.9, 6.3, 4.6 Hz, 1H), 1.51 (ddd, J = 13.4, 12.2, 4.6 Hz, 
1H), 1.39 (br. s, 1H), 1.39 – 1.31 (m, 1H), 1.20 (s, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.4, 
139.2, 133.8, 128.8, 128.1, 75.8, 70.6, 39.3, 31.2, 29.5, 29.4, 21.4. HRMS (ESI) m/z calculated 







2.4.10 Compounds Characterization for 3º C—H Oxidation with Mn(PDP) 
4-methyl-1-phenylpentyl acetate [S78]. 
792.8 mg (4.3 mmol) of 4-methyl-1-phenylpentan-1-ol was dissolved in 22 mL 
anhydrous pyridine.  2.175 g (2.0 mL, 21.3 mmol, 5.0 equiv.) of acetic 
anhydride was added dropwisely at 0 ºC and the reaction was allowed to stir overnight before 
concentrated under reduced pressure. The residue was diluted with 30 mL DCM and washed 
with 30 mL 1M HCl solution twice followed by 20 mL brine. The organic layer was dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mm SiO2) using 3% EtOAc/hexanes à5% EtOAc/hexanes as eluent gave 871.6 mg 
(3.96 mmol) of pure product as a colorless oil (93% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.36 – 7.31 (m, 4H), 7.29 (ddd, J = 8.8, 3.8, 2.4 Hz, 1H), 5.71 
(dd, J = 7.5, 6.4 Hz, 1H), 2.07 (s, 3H), 1.94 – 1.87 (m, 1H), 1.80 – 1.75 (m, 1H), 1.57 – 1.52 (m, 
1H), 1.25 – 1.21 (m, 1H), 1.13 – 1.09 (m, 1H), 0.87 (d, J = 3.1 Hz, 3H), 0.86 (d, J = 3.1 Hz, 3H). 
13C-NMR (126 MHz, CDCl3) δ 170.5, 141.0, 128.5, 127.9, 126.7, 76.5, 34.7, 34.4, 28.0, 22.6, 
22.6, 21.4. HRMS (ESI) m/z calculated for C14H20O2Na [M+Na]+: 243.1361, found 243.1365. 
4-hydroxy-4-methyl-1-phenylpentyl acetate [109]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 4-methyl-1-phenylpentyl acetate S78 (110.2 mg, 0.500 mmol, 1.0 
equiv), (R,R)-Mn(PDP) (46.6 mg, 0.050 mmol, 10 mol%), ClCH2CO2H (709 mg, 7.5 mmol, 15.0 
equiv.), 50% wt. H2O2 (170 mg, 2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL 
with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction 
was worked up with 15 mL saturated NaHCO3 and DCM as described in the general method A. 






acetone/hexanes à 20% acetone/hexanes as eluent afforded product as a slightly yellow color 
oil. 
Run 1: (40.7 mg, 0.172 mmol, 34.4% yield), <5% rsm. Run 2: (41.3 mg, 0.175 mmol, 35.0% 
yield), <5% rsm. Run 3: (41.8 mg, 0.177 mmol, 35.4% yield), <5% rsm. Average: 34.9% yield 
± 0.5%, <5% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.36 – 7.32 (m, 4H), 7.28 (ddd, J = 7.0, 5.3, 3.3 Hz, 1H), 5.73 
(dd, J = 7.6, 6.2 Hz, 1H), 2.07 (s, 3H), 2.00 (dddd, J = 13.5, 12.2, 7.6, 4.6 Hz, 1H), 1.88 (dddd, J 
= 13.5, 12.1, 6.2, 4.6 Hz, 1H), 1.53 (ddd, J = 13.6, 12.1, 4.7 Hz, 1H), 1.40 – 1.30 (m, 2H), 1.19 
(s, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.5, 140.7, 128.6, 128.0, 126.6, 76.5, 70.6, 39.4, 31.3, 
29.4, 29.4, 21.4. HRMS (ESI) m/z calculated for C14H20O3Na [M+Na]+: 259.1310, found 
259.1305. 
1-(4-tert-butyl)phenyl)-4-methylpentyl acetate [S79]. 
This compound is synthesized in similar protocal as S78. 
1H-NMR (500 MHz, CDCl3) δ 7.28 – 7.23 (m, 2H), 7.18 – 7.13 (m, 
2H), 5.60 (dd, 1H, J = 7.9, 6.1 Hz), 1.96 (s, 3H), 1.86 – 1.75 (m, 1H), 
1.71 – 1.63 (m, 1H), 1.51 – 1.40 (m, 1H), 1.22 (s, 9H), 1.19 – 1.07 (m, 1H), 1.06 – 0.98 (m, 1H), 
0.77 (dd, 6H, J = 6.6, 2.8 Hz). 13C-NMR (126 MHz, CDCl3) δ 170.60, 150.80, 137.93, 126.42, 
125.43, 76.39, 34.79, 34.67, 34.30, 31.48, 28.03, 22.65, 22.64, 21.50. HRMS (ESI) m/z 
calculated for C18H28O2Na [M+Na]+: 299.1987, found 299.1982. 
1-(4-(tert-butyl)phenyl)-4-hydroxy-4-methylpentyl acetate [110]. 
 The reaction was run with General Method A: Single Catalyst 
Addition Protocol. 1-(4-tert-butyl)phenyl)-4-methylpentyl acetate 






0.030 mmol, 10 mol%), ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (102 mg, 
1.5 mmol, 5.00 equiv.), MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was 
run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was worked up with 9 mL 
saturated NaHCO3 and DCM as described in the general method A. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 5% ethyl 
acetate/hexanes à 30% ethyl acetate/hexanes as eluent afforded product as a slightly yellow 
color oil. 
Run 1: (55.5 mg, 0.190 mmol, 63% yield), (10.5 mg, 0.038 mmol, 13% rsm). Run 2: (51.1 mg, 
0.175 mmol, 58% yield), (6.8 mg, 0.025 mmol, 8% rsm). Run 3: (52.0 mg, 0.178 mmol, 59% 
yield), (10.5 mg, 0.038 mmol, 13% rsm). Average: 60% yield ± 2.6, 11% rsm ± 2.9%. 
1H-NMR (500 MHz, CDCl3) δ 7.29 – 7.25(s, 2H), 7.20 – 7.15 (m, 2H), 5.64 (dd, 1H, J = 7.7, 6.2 
Hz), 1.97 (s, 3H), 1.95 – 1.86 (m, 1H), 1.84 – 1.75 (m, 1H), 1.45 (ddd, 1H, J = 13.5, 12.2, 4.6 
Hz), 1.37 – 1.19 (m, 2H), 1.22 (s, 9H), 1.11 (s, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.57, 
150.91, 137.54, 126.39, 125.47, 76.31, 70.68, 39.56, 34.65, 31.45, 31.26, 29.43, 29.36, 21.44. 
HRMS (ESI) m/z calculated for C18H28O3Na [M+Na]+: 315.1936, found 315.1929. 
1-(4-fluorophenyl)-4-methylpentyl acetate [S80]. 
981.4 mg (5.0 mmol) of 1-(4-fluorophenyl)-4-methylpentan-1-ol was 
dissolved in 25 mL anhydrous pyridine.  2.552 g (2.4 mL, 25.0 mmol, 5.0 
equiv.) of acetic anhydride was added dropwisely at 0 ºC and the reaction was allowed to stir 
overnight before concentrated under reduced pressure. The residue was diluted with 60 mL DCM 
and washed with 60 mL 1M HCl solution twice followed by 40 mL brine. The organic layer was 





fritted glass column, 300 mm SiO2) using 3% EtOAc/hexanes à5% EtOAc/hexanes as eluent 
gave 1.028 g (4.31 mmol) of pure product as a colorless oil (86% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.31 – 7.28 (m, 2H), 7.02 (t, J = 8.7 Hz, 2H), 5.66 (t, J = 7.0 Hz, 
1H), 2.06 (s, 3H), 1.89 (dddd, J = 13.8, 11.4, 7.6, 5.0 Hz, 1H), 1.77 – 1.69 (m, 1H), 1.57 – 1.49 
(m, 1H), 1.21 (dddd, J = 13.5, 11.6, 6.8, 5.0 Hz, 1H), 1.06 (dddd, J = 13.3, 11.6, 6.9, 5.1 Hz, 
1H), 0.86 (dd, J = 6.6, 3.3 Hz, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.3, 160.0 (d, J = 247.2 
Hz), 129.3 (d, J = 8.3 Hz), 128.3 (d, J = 13.6 Hz), 127.7 (d, J = 4.2 Hz), 124.3 (d, J = 3.4 Hz), 
115.6 (d, J = 21.9 Hz), 70.6 (d, J = 2.3 Hz), 34.4, 33.5, 27.9, 22.6, 22.6, 21.3.19F-NMR (470 
MHz, CDCl3) δ -114.93. HRMS (EI) m/z calculated for C14H19O2F [M]+: 238.13691, found 
238.13661. 
1-(4-fluorophenyl)-4-hydroxy-4-methylpentyl acetate [111]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(4-fluorophenyl)-4-methylpentyl acetate S80 (119.2 mg, 0.500 
mmol, 1.0 equiv), (R,R)-Mn(PDP) (46.6 mg, 0.050 mmol, 10 mol%),  ClCH2CO2H (709 mg, 7.5 
mmol, 15.0 equiv.), 50% wt. H2O2 (140 mg, 2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL 
vial, 6.25 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. 
The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in the 
general method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm 
SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded product as a clear 
oil. 
Run 1: (84.3 mg, 0.332 mmol, 66.3% yield), (11.7 mg, 0.049 mmol, 9.8% rsm). Run 2: (84.6 






mmol, 64.3% yield), (18.0 mg, 0.076 mmol, 15.1% rsm). Average: 65.7 % yield ± 1.2%, 
12.3% rsm ± 2.7%. 
1H-NMR (500 MHz, CDCl3) δ 7.32 – 7.29 (m, 2H), 7.05 – 7.00 (m, 2H), 5.69 (dd, J = 7.6, 6.3 
Hz, 1H), 2.06 (s, 3H), 1.98 (dddd, J = 13.3, 12.2, 7.6, 4.6 Hz, 1H), 1.85 (dddd, J = 13.4, 12.1, 
6.3, 4.5 Hz, 1H), 1.51 (ddd, J = 13.4, 12.2, 4.6 Hz, 1H), 1.38 – 1.31 (m, 2H), 1.19 (s, 6H). 13C-
NMR (126 MHz, CDCl3) δ 170.5, 162.5 (d, J = 246.2 Hz), 136.5 (d, J = 3.2 Hz), 128.5 (d, J = 
8.0 Hz), 115.5 (d, J = 21.4 Hz), 75.8, 70.6, 39.4, 31.3, 29.5, 29.4, 21.4. 19F-NMR (470 MHz, 
CDCl3) δ -114.72. HRMS (ESI) m/z calculated for C14H19O3NaF [M+Na]+: 277.1216, found 
277.1219. 
1-(4-bromophenyl)-4-methylpentyl acetate [S81]. 
771.5 mg (3.0 mmol) of 1-(4-bromophenyl)-4-methylpentan-1-ol was 
dissolved in 15 mL anhydrous pyridine.  1.531 g (1.42 mL, 15.0 mmol, 5.0 
equiv.) of acetic anhydride was added dropwisely at 0 ºC and the reaction was allowed to stir 
overnight before concentrated under reduced pressure. The residue was diluted with 30 mL DCM 
and washed with 30 mL 1M HCl solution twice followed by 20 mL brine. The organic layer was 
dried with MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm 
fritted glass column, 300 mm SiO2) using 3% EtOAc/hexanes à5% EtOAc/hexanes as eluent 
gave 827.6 mg (2.77 mmol) of pure product as a colorless oil (92% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.48 – 7.45 (m, 2H), 7.21 – 7.19 (m, 2H), 5.63 (dd, J = 7.5, 6.5 
Hz, 1H), 2.06 (s, 3H), 1.87 (dddd, J = 13.7, 11.3, 7.6, 5.0 Hz, 1H), 1.73 (dddd, J = 13.6, 11.4, 
6.4, 5.1 Hz, 1H), 1.53 (dp, J = 13.3, 6.6 Hz, 1H), 1.20 (dddd, J = 13.4, 11.5, 6.8, 5.0 Hz, 1H), 





CDCl3) δ 170.4, 140.0, 131.7, 128.4, 121.8, 75.9, 34.5, 34.2, 28.0, 22.6, 22.6, 21.4. HRMS (ESI) 
m/z calculated for C14H19O2NaBr [M+Na]+: 321.0466, found 321.0473. 
1-(4-bromophenyl)-4-hydroxy-4-methylpentyl acetate [112]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(4-bromophenyl)-4-methylpentyl acetate S81 (89.8 mg, 0.300 
mmol, 1.0 equiv), (R,R)-Mn(PDP) (27.9 mg, 0.030 mmol, 10 mol%),  ClCH2CO2H (425 mg, 4.5 
mmol, 15.0 equiv.), 50% wt. H2O2 (102 mg, 1.5 mmol, 5.00 equiv.), MeCN (0.6 mL in 40 mL 
vial, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. 
The reaction was worked up with 9 mL saturated NaHCO3 and DCM as described in the general 
method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm SiO2) 
using 10% acetone/hexanes à 20% acetone/hexanes as eluent afforded product as a clear oil. 
Run 1: (62.3 mg, 0.198 mmol, 65.8% yield), (15.8 mg, 0.053 mmol, 17.6% rsm). Run 2: (63.7 
mg, 0.202 mmol, 67.3% yield), (11.7 mg, 0.039 mmol, 13.0% rsm). Run 3: (64.0 mg, 0.203 
mmol, 67.6% yield), (12.9 mg, 0.043 mmol, 14.3% rsm). Average: 66.9% yield ± 1.0%, 15.0% 
rsm ± 2.4%. 
1H-NMR (500 MHz, CDCl3) δ 7.46 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4 Hz, 2H), 5.66 (dd, J = 
7.6, 6.3 Hz, 1H), 2.06 (s, 3H), 1.96 (dddd, J = 13.6, 12.3, 7.6, 4.6 Hz, 1H), 1.84 (dddd, J = 13.6, 
12.3, 6.3, 4.6 Hz, 1H), 1.50 (ddd, J = 13.6, 12.1, 4.6 Hz, 1H), 1.33 (ddd, J = 13.5, 12.1, 4.5 Hz, 
1H), 1.18 (s, 6H). The alcohol proton is not showing up due to peak broadening. 13C-NMR (126 
MHz, CDCl3) δ 170.4, 139.7, 131.7, 128.4, 121.9, 75.8, 70.6, 39.3, 31.1, 29.5, 29.4, 21.3. HRMS 








4-methyl-1-(4-(trifluoromethoxy)phenyl)pentyl acetate [S82]. 
1.2061 g (4.6 mmol) of 4-methyl-1-(4-(trifluoromethoxy)phenyl)pentan-1-
ol was dissolved in 23 mL anhydrous pyridine.  2.3481 g (2.20 mL, 23.0 
mmol, 5.0 equiv.) of acetic anhydride was added dropwisely at 0 ºC and the reaction was allowed 
to stir overnight before concentrated under reduced pressure. The residue was diluted with 40 
mL DCM and washed with 40 mL 1M HCl solution TWICE followed by 30 mL brine. The 
organic layer was dried with MgSO4, filtered, and concentrated. Flash column chromatography 
on silica (50 mm fritted glass column, 300 mm SiO2) using 3% EtOAc/hexanes à5% 
EtOAc/hexanes as eluent gave 1.2234 g (4.02 mmol) of pure product as a colorless oil (87% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.37 – 7.34 (m, 2H), 7.19 – 7.17 (m, 2H), 5.69 (dd, J = 7.7, 6.2 
Hz, 1H), 2.07 (s, 3H), 1.94 – 1.85 (m, 1H), 1.74 (dddd, J = 13.7, 11.3, 6.3, 5.1 Hz, 1H), 1.58 – 
1.49 (m, 1H), 1.22 (dddd, J = 13.3, 11.5, 6.8, 4.9 Hz, 1H), 1.09 (dddd, J = 13.3, 11.6, 6.8, 5.1 Hz, 
1H), 0.86 (dd, J = 6.6, 3.0 Hz, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.4, 148.8 (q, J = 2.2 Hz), 
139.8, 128.1, 121.0, 120.6 (q, J = 257.1 Hz), 75.7, 34.6, 34.3, 28.0, 22.6, 21.3. 19F-NMR (470 
MHz, CDCl3) δ -58.34. HRMS (ESI) m/z calculated for C15H19O3F3Na [M+Na]+: 327.1184, 
found 327.1177. 
4-hydroxy-4-methyl-1-(4-(trifluoromethoxy)phenyl)pentyl acetate [113]. 
The reaction was run with General Method A: Single Catalyst 
Addition Protocol. 4-methyl-1-(4-(trifluoromethoxy)phenyl)pentyl 
acetate S82 (91.3 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(PDP) (27.9 mg, 0.030 mmol, 10 
mol%),  ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (102 mg, 1.5 mmol, 5.00 








with 1,2-dichloroethane/dry ice bath. The reaction was worked up with 9 mL saturated NaHCO3 
and DCM as described in the general method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mm SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as 
eluent afforded product as a clear oil. 
Run 1: (67.9 mg, 0.212 mmol, 70.7% yield), (13.7 mg, 0.045 mmol, 15.0% rsm). Run 2: (72.4 
mg, 0.226 mmol, 75.4% yield), (11.5 mg, 0.038 mmol, 12.6% rsm). Run 3: (69.6 mg, 0.217 
mmol, 72.4% yield), (15.7 mg, 0.052 mmol, 17.2% rsm). Average: 72.8% yield ± 2.4%, 14.9% 
rsm ± 2.3%. 
1H-NMR (500 MHz, CDCl3) δ 7.36 (d, J = 8.6 Hz, 2H), 7.18 (d, J = 9.0 Hz, 1H), 5.72 (dd, J = 
7.8, 6.1 Hz, 1H), 2.07 (s, 3H), 1.99 (tdd, J = 12.5, 7.8, 4.6 Hz, 1H), 1.86 (tdd, J = 13.2, 6.0, 4.6 
Hz, 1H), 1.52 (td, J = 12.9, 4.6 Hz, 1H), 1.39 – 1.32 (m, 2H), 1.20 (s, 6H). 13C-NMR (126 MHz, 
CDCl3) δ 170.4, 148.9 (d, J = 2.0 Hz), 139.4, 128.1, 121.1, 120.6 (q, J = 257.3 Hz), 75.6, 70.6, 
39.3, 31.3, 29.5, 29.4, 21.3. 19F-NMR (470 MHz, CDCl3) δ -58.24. HRMS (ESI) m/z calculated 
for C15H19O4F3Na [M+Na]+: 343.1133, found 343.1131. 
tert-butyl 4-(1-acetoxy-4-methylpentyl)benzoate [S83]. 
738.3 mg (2.65 mmol) of tert-butyl 4-(1-hydroxy-4-
methylpentyl)benzoate and 624.5 mg (0.57 mL, 8.0 mmol, 3.0 equiv.) of 
acetic chloride was dissolved in 13 mL anhydrous DCM.  1.342 g (1.85 mL, 13.3 mmol, 5.0 
equiv.) of triethylamine was added dropwisely at 0 ºC and the reaction was allowed to stir 
overnight before concentrated under reduced pressure. The residue was diluted with 20 mL DCM 
and washed with 20 mL 1M HCl solution twice followed by 20 mL brine. The organic layer was 





fritted glass column, 300 mm SiO2) using 3% EtOAc/hexanes à5% EtOAc/hexanes as eluent 
gave  392.5 mg (1.22 mmol) of pure product as a colorless oil (46% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.4 Hz, 2H), 7.36 (d, J = 8.3 Hz, 2H), 5.71 (dd, J = 
7.5, 6.4 Hz, 1H), 2.07 (s, 3H), 1.88 (dddd, J = 13.6, 11.2, 7.5, 4.9 Hz, 1H), 1.76 (dddd, J = 13.6, 
11.4, 6.3, 5.1 Hz, 1H), 1.58 (s, 9H), 1.55 – 1.48 (m, 1H), 1.21 (dddd, J = 13.3, 11.6, 6.8, 4.9 Hz, 
1H), 1.07 (dddd, J = 13.3, 11.6, 6.8, 5.1 Hz, 1H), 0.85 (dd, J = 6.6, 3.1 Hz, 6H). 13C-NMR (126 
MHz, CDCl3) δ 170.4, 165.6, 145.5, 131.6, 129.7, 126.4, 81.1, 76.1, 34.5, 34.3, 28.3, 28.0, 22.6, 
21.4. HRMS (ESI) m/z calculated for C19H28O4Na [M+Na]+: 343.1885, found 343.1884. 
tert-butyl 4-(1-acetoxy-4-hydroxy-4-methylpentyl)benzoate [114]. 
 The reaction was run with General Method A: Single Catalyst 
Addition Protocol. tert-butyl 4-(1-acetoxy-4-methylpentyl)benzoate S83 
(96.1 mg, 0.300 mmol, 1.0 equiv), (R,R)-Mn(PDP) (27.9 mg, 0.030 mmol, 10 mol%),  
ClCH2CO2H (425 mg, 4.5 mmol, 15.0 equiv.), 50% wt. H2O2 (102 mg, 1.5 mmol, 5.00 equiv.), 
MeCN (0.6 mL in 40 mL vial, 3.75 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath. The reaction was worked up with 9 mL saturated NaHCO3 and 
DCM as described in the general method A. Flash column chromatography on silica (35 mm 
fritted glass column, 150 mm SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as 
eluent afforded product as a clear oil. 
Run 1: (71.0 mg, 0.211 mmol, 70.3% yield), (18.4 mg, 0.057 mmol, 19.1% rsm). Run 2: (74.6 
mg, 0.222 mmol, 73.9% yield), (13.4 mg, 0.042 mmol, 14.0% rsm). Run 3: (74.1 mg, 0.220 
mmol, 73.5% yield), (15.2 mg, 0.047 mmol, 15.8% rsm). Average: 72.6% yield ± 2.0%, 16.3% 






1H-NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.0 Hz, 2H), 7.36 (d, J = 8.2 Hz, 2H), 5.74 (t, J = 6.8 
Hz, 1H), 2.08 (s, 3H), 1.98 (tdd, J = 12.5, 7.6, 3.8 Hz, 1H), 1.88 (tdd, J = 13.2, 6.2, 4.6 Hz, 1H), 
1.58 (s, 9H), 1.51 (td, J = 12.8, 4.6 Hz, 1H), 1.41 – 1.32 (m, 2H), 1.18 (s, 6H). 13C-NMR (126 
MHz, CDCl3) δ 170.4, 165.5, 145.2, 131.7, 129.8, 126.3, 81.2, 76.0, 70.6, 39.2, 31.2, 29.5, 29.4, 
28.3, 21.3. HRMS (ESI) m/z calculated for C19H28O5Na [M+Na]+: 359.1834, found 359.1826. 
1-(4-cyanophenyl)-4-methylpentyl acetate [S84]. 
226.5 mg (1.11 mmol) of 1-(4-cyanophenyl)-4-methylpentan-1-ol was 
dissolved in 5.5 mL anhydrous DCM.  226.6 mg (0.21 mL, 2.22 mmol, 2.0 
equiv.) of acetic anhydride, 336.9 mg (0.46 mL, 3.33 mmol, 3.0 equiv.) of trimethylamine and 
13.4 mg (0.11 mmol, 10 mol%) of 4-Dimethylaminopyridine was added sequentially at 0 ºC and 
the reaction was allowed to stir overnight before concentrated under reduced pressure. The 
residue was diluted with 30 mL DCM and washed with 30 mL water TWICE followed by 20 mL 
brine. The organic layer was dried with MgSO4, filtered, and concentrated. Flash column 
chromatography on silica (35 mm fritted glass column, 150 mm SiO2) using 10% 
EtOAc/hexanes à 30% EtOAc/hexanes as eluent gave 252.6 mg (1.03 mmol) of pure product as 
a colorless oil (93% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.65 – 7.62 (m, 2H), 7.43 – 7.41 (m, 2H), 5.68 (dd, J = 7.7, 6.0 
Hz, 1H), 2.09 (s, 3H), 1.87 (dddd, J = 13.8, 11.3, 7.8, 4.9 Hz, 1H), 1.74 (dddd, J = 13.8, 11.2, 
6.0, 5.1 Hz, 1H), 1.53 (dp, J = 13.3, 6.7 Hz, 1H), 1.21 (dddd, J = 13.4, 11.6, 6.9, 4.9 Hz, 1H), 
1.08 (dddd, J = 13.2, 11.6, 6.8, 5.1 Hz, 1H), 0.86 (dd, J = 6.6, 2.7 Hz, 6H). 13C-NMR (126 MHz, 
CDCl3) δ 170.3, 146.4, 132.5, 127.2, 118.8, 111.8, 75.7, 34.4, 34.3, 27.9, 22.6, 22.5, 21.3. 






1-(4-cyanophenyl)-4-hydroxy-4-methylpentyl acetate [115]. 
 The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(4-cyanophenyl)-4-methylpentyl acetate S84 (122.7 mg, 0.500 
mmol, 1.0 equiv), (R,R)-Mn(PDP) (46.6 mg, 0.050 mmol, 10 mol%),  ClCH2CO2H (709 mg, 7.5 
mmol, 15.0 equiv.), 50% wt. H2O2 (170 mg, 2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL 
vial, 6.25 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. 
The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in the 
general method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm 
SiO2) using 10% acetone/hexanes à 25% acetone/hexanes à 40% acetone/hexanes as eluent 
afforded product as a clear oil. 
Run 1: (97.0 mg, 0.371 mmol, 74.2% yield), (17.5 mg, 0.071 mmol, 14.3% rsm). Run 2: (101.3 
mg, 0.387 mmol, 77.5% yield), (18.9 mg, 0.077 mmol, 15.4% rsm). Run 3: (99.5 mg, 0.381 
mmol, 76.1% yield), (18.8 mg, 0.076 mmol, 15.1% rsm). Average: 75.9% yield ± 1.7%, 14.9% 
rsm ± 0.6%. 
1H-NMR (500 MHz, CDCl3) δ 7.64 (d, J = 8.2 Hz, 2H), 7.43 (d, J = 8.4 Hz, 2H), 5.73 (dd, J = 
7.8, 5.8 Hz, 1H), 2.10 (s, 3H), 1.98 (dddd, J = 13.7, 12.3, 7.8, 4.7 Hz, 1H), 1.87 (dddd, J = 13.7, 
12.0, 5.8, 4.7 Hz, 1H), 1.52 (ddd, J = 13.6, 12.0, 4.7 Hz, 1H), 1.37 (ddd, J = 13.6, 12.1, 4.6 Hz, 
1H), 1.30 (br. s, 1H), 1.20 (s, 3H), 1.20 (s, 3H). 13C-NMR (126 MHz, CDCl3) δ 170.3, 146.1, 
132.4, 127.1, 118.7, 111.7, 75.6, 70.4, 39.0, 31.1, 29.5, 29.3, 21.2. HRMS (ESI) m/z calculated 
for C15H19NO3Na [M+Na]+: 284.1263, found 284.1259. 
1-(3-fluorophenyl)-4-methylpentyl acetate [S85]. 
729.0 mg (4.0 mmol) of 1-(3-fluorophenyl)-4-methylpentan-1-ol was dissolved in 20 mL 






dropwisely at 0 ºC and the reaction was allowed to stir overnight before 
concentrated under reduced pressure. The residue was diluted with 60 mL DCM 
and washed with 60 mL 1M HCl solution twice followed by 40 mL brine. The 
organic layer was dried with MgSO4, filtered, and concentrated. Flash column chromatography 
on silica (50 mm fritted glass column, 300 mm SiO2) using 3% EtOAc/hexanes à5% 
EtOAc/hexanes as eluent gave 712.7 mg (2.99 mmol) of pure product as a colorless oil (75% 
yield). 
1H-NMR (500 MHz, CDCl3) δ 7.35 (td, J = 7.5, 1.8 Hz, 1H), 7.28 – 7.24 (m, 1H), 7.13 (td, J = 
7.5, 1.2 Hz, 1H), 7.03 (ddd, J = 10.4, 8.2, 1.2 Hz, 1H), 6.00 (dd, J = 7.7, 6.1 Hz, 1H), 2.09 (s, 
3H), 1.91 (dddd, J = 13.0, 11.2, 7.7, 5.1 Hz, 1H), 1.85 – 1.78 (m, 1H), 1.59 – 1.51 (m, 1H), 1.25 
(dddd, J = 13.4, 11.6, 6.9, 5.1 Hz, 1H), 1.13 (dddd, J = 13.3, 11.1, 6.8, 5.3 Hz, 1H), 0.87 (dd, J = 
6.6, 1.6 Hz, 6H). 13C-NMR (126 MHz, CDCl3) δ 170.3, 161.0, 159.0, 129.4, 129.3, 128.4, 128.3, 
127.7, 127.7, 124.3, 124.3, 115.7, 115.5, 70.6, 70.6, 34.4, 33.5, 27.9, 22.6, 22.6, 21.3. 19F-NMR 
(470 MHz, CDCl3) δ -118.61. HRMS (ESI) m/z calculated for C14H19O2NaF [M+Na]+: 259.1110, 
found 259.1114. 
1-(3-fluorophenyl)-4-hydroxy-4-methylpentyl acetate [116]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(3-fluorophenyl)-4-methylpentyl acetate S85 (119.2 mg, 0.500 
mmol, 1.0 equiv), (R,R)-Mn(PDP) (46.6 mg, 0.050 mmol, 10 mol%),  
ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (140 mg, 2.5 mmol, 5.00 equiv.), 
MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was run at -36 ºC with 1,2-
dichloroethane/dry ice bath. The reaction was worked up with 15 mL saturated NaHCO3 and 








fritted glass column, 150 mm SiO2) using 10% acetone/hexanes à 20% acetone/hexanes as 
eluent afforded product as a clear oil. 
Run 1: (71.2 mg, 0.280 mmol, 56.0% yield), (16.5 mg, 0.069 mmol, 13.8% rsm). Run 2: (72.4 
mg, 0.285 mmol, 56.9% yield), (14.8 mg, 0.062 mmol, 12.4% rsm). Run 3: (70.4 mg, 0.277 
mmol, 55.3% yield), (16.7 mg, 0.070 mmol, 14.0% rsm). Average: 56.1% yield ± 0.8%, 13.4% 
rsm ± 0.9%. 
1H-NMR (500 MHz, CDCl3) δ 7.36 (td, J = 7.5, 1.8 Hz, 1H), 7.28 – 7.24 (m, 1H), 7.13 (td, J = 
7.5, 1.2 Hz, 1H), 7.04 (ddd, J = 10.4, 8.1, 1.3 Hz, 1H), 6.02 (dd, J = 7.6, 6.1 Hz, 1H), 2.09 (s, 
3H), 2.05 – 1.89 (m, 2H), 1.56 (ddd, J = 13.4, 12.1, 4.7 Hz, 1H), 1.44 – 1.37 (m, 2H), 1.20 (s, 
6H). 13C-NMR (126 MHz, CDCl3) δ 170.3, 160.9, 158.9, 129.5, 129.4, 128.0, 127.9, 127.7, 
127.7, 124.4, 124.3, 115.8, 115.6, 70.6, 70.5, 70.5, 39.2, 30.4, 29.4, 29.4, 21.3. 19F-NMR (470 
MHz, CDCl3) δ -118.48. HRMS (ESI) m/z calculated for C14H19O3NaF [M+Na]+: 277.1216, 
found 277.1208. 
1-(2-chlorophenyl)-4-methylpentyl acetate [S86]. 
1.017 g (4.8 mmol) of 1-(2-chlorophenyl)-4-methylpentan-1-ol was dissolved in 
25 mL anhydrous pyridine.  2.918 g (2.26 mL, 23.9 mmol, 5.0 equiv.) of acetic 
anhydride was added dropwisely at 0 ºC and the reaction was allowed to stir overnight before 
concentrated under reduced pressure. The residue was diluted with 40 mL DCM and washed 
with 40 mL 1M HCl solution twice followed by 40 mL brine. The organic layer was dried with 
MgSO4, filtered, and concentrated. Flash column chromatography on silica (50 mm fritted glass 
column, 300 mm SiO2) using 5% EtOAc/hexanes as eluent gave 1.174 g (4.61 mmol) of pure 




1H-NMR (500 MHz, CDCl3) δ 7.38 (dd, J = 7.8, 1.7 Hz, 1H), 7.34 (dd, J = 7.9, 1.4 Hz, 1H), 7.28 
– 7.24 (m, 1H), 7.20 (td, J = 7.6, 1.8 Hz, 1H), 6.11 (t, J = 6.6 Hz, 1H), 2.10 (s, 3H), 1.84 – 1.79 
(m, 2H), 1.56 (dp, J = 13.3, 6.7 Hz, 1H), 1.32 – 1.17 (m, 2H), 0.88 (d, J = 6.4 Hz, 6H). 13C-NMR 
(126 MHz, CDCl3) δ 170.2, 139.1, 132.4, 129.7, 128.7, 127.1, 127.0, 73.0, 34.5, 33.5, 27.9, 22.7, 
22.5, 21.3. HRMS (ESI) m/z calculated for C14H19O2NaCl [M+Na]+: 277.0971, found 277.0964. 
1-(2-chlorophenyl)-4-hydroxy-4-methylpentyl acetate [117]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 1-(2-chlorophenyl)-4-methylpentyl acetate S86 (127.4 mg, 0.500 
mmol, 1.0 equiv), (R,R)-Mn(PDP) (46.6 mg, 0.050 mmol, 10 mol%),  ClCH2CO2H (709 mg, 7.5 
mmol, 15.0 equiv.), 50% wt. H2O2 (170 mg, 2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL 
vial, 6.25 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. 
The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in the 
general method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm 
SiO2) using 10% acetone/hexanes à 20% acetone/hexanes à 30% acetone/hexanes as eluent 
afforded product as a clear oil. 
Run 1: (74.8 mg, 0.276 mmol, 55.2% yield), (29.1 mg, 0.114 mmol, 22.9% rsm). Run 2: (75.6 
mg, 0.279 mmol, 55.8% yield), (23.3 mg, 0.091 mmol, 18.3% rsm). Run 3: (77.0 mg, 0.284 
mmol, 56.9% yield), (21.8 mg, 0.086 mmol, 17.1% rsm). Average: 56.0% yield ± 0.9%, 19.4% 
rsm ± 3.1%. 
1H-NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.8 Hz, 1H), 7.33 (d, J = 7.9 Hz, 1H), 7.25 (t, J = 7.5 
Hz, 1H), 7.21 – 7.18 (m, 1H), 6.12 (t, J = 6.6 Hz, 1H), 2.09 (s, 3H), 1.96 – 1.86 (m, 2H), 1.58 






CDCl3) 170.2, 138.7, 132.3, 129.7, 128.9, 127.1, 127.0, 72.9, 70.6, 39.2, 30.4, 29.4, 29.3, 21.2. 
HRMS (ESI) m/z calculated for C14H19O3NaCl [M+Na]+: 293.0920, found 293.0913. 
2-(4-chlorophenyl)-5-methylhexan-2-ol [S87]. 
In a flame dried 100 mL recovery flask, 2.872 g (15.0 mmol) of para-bromo-
chlorobenzene was dissolved in 40 mL anhydrous THF. 9.4 mL 1.6 M n-
BuLi (1.0 equiv.) was added dropwisely at -78 ºC into the solution and the reaction was allowed 
to stir at -78 ºC for 30 minutes. A solution of 2.055 g (2.54 mL, 18 mmol, 1.2 equiv.) 5-methyl-
2-hexanone in 3 mL anhydrous THF was added dropwisely at -78 ºC and the reaction was 
allowed to slowly raise to room temperature and stir overnight. The reaction was quenched with 
10 mL saturated NH4Cl solution and extracted with 30 mL ether twice. The combined organic 
layer was washed with 30 mL saturated NaCl solution and dried with MgSO4, filtered, and 
concentrated. Flash column chromatography on silica (50 mm fritted glass column, 300 mm 
SiO2) using 10% EtOAc/hexanes as eluent gave 1.287 g (5.68 mmol) of pure product as a 
colorless oil (38% yield). 
1H-NMR (500 MHz, CDCl3) δ 7.37 – 7.34 (m, 2H), 7.31 – 7.28 (m, 2H), 1.83 – 1.71 (m, 2H), 
1.70 (br. s, 1H), 1.53 (s, 3H), 1.44 (tt, J = 13.2, 6.6 Hz, 1H), 1.13 (dddd, J = 12.9, 11.8, 6.6, 5.1 
Hz, 1H), 0.98 (dddd, J = 13.0, 11.8, 6.8, 5.1 Hz, 1H), 0.84 (d, J = 4.6 Hz, 3H), 0.83 (d, J = 4.5 
Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 146.7, 132.4, 128.3, 126.5, 74.6, 42.1, 32.9, 30.4, 28.4, 
22.7, 22.6. HRMS (EI) m/z calculated for C13H19OCl [M+Na]+: 226.1124, found 226.1125. 
2-(4-chlorophenyl)-5-methylhexane-2,5-diol [118]. 
The reaction was run with General Method A: Single Catalyst Addition 
Protocol. 2-(4-chlorophenyl)-5-methylhexan-2-ol S87 (113.4 mg, 0.500 








mmol, 15.0 equiv.), 50% wt. H2O2 (170 mg, 2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL 
vial, 6.25 mL with oxidant). The reaction was run at -36 ºC with 1,2-dichloroethane/dry ice bath. 
The reaction was worked up with 15 mL saturated NaHCO3 and DCM as described in the 
general method A. Flash column chromatography on silica (35 mm fritted glass column, 150 mm 
SiO2) using 20% acetone/hexanes à 30% acetone/hexanes as eluent afforded product as a 
slightly pink colored oil. 
Run 1: (85.0 mg, 0.350 mmol, 70.0% yield), <10% rsm. Run 2: (84.3 mg, 0.347 mmol, 69.5% 
yield), <10% rsm. Run 3: (80.4 mg, 0.331 mmol, 66.3% yield), < 10% rsm. Average: 68.6% 
yield ± 2.0%, <10% rsm. 
1H-NMR (500 MHz, CDCl3) δ 7.38 – 7.35 (m, 2H), 7.32 – 7.28 (m, 2H), 2.07 (br. s, 2H), 1.99 – 
1.88 (m, 2H), 1.54 (s, 3H), 1.45 – 1.41 (m, 1H), 1.36 – 1.30 (m, 1H), 1.20 (s, 3H), 1.17 (s, 3H). 
13C-NMR (126 MHz, CDCl3) δ 146.7, 132.3, 128.4, 126.6, 74.2, 70.9, 38.4, 37.6, 31.1, 30.1, 
29.2. HRMS (ESI) m/z calculated for C13H19O2NaCl [M+Na]+: 265.0971, found 265.0974. 
Stereoretention Study: 
(S)-3-methylpentyl benzoate [119]. 
510.9 mg (0.62 mL, 5.0 mmol) of (S)-3-methylpentanol was dissolved in 10 mL 
anhydrous DCM.  1.406 g (1.16 mL, 10.0 mmol, 2.0 equiv.) of benzoyl chloride 
and 1.518 g (2.09 mL, 15.0 mmol, 3.0 equiv.) of trimethylamine was added dropwisely at 0 ºC. 
61.0 mg (0.5 mmol, 10 mol%) 4-dimethylaminopyridine was added and the reaction was allowed 
to stir overnight. The reaction was diluted with 20 mL DCM and washed with 40 mL 1M HCl, 
40 mL saturated NaHCO3 followed by 40 mL brine. The organic layer was dried with Na2SO4, 




200 mm SiO2) using 5% EtOAc/hexanes as eluent gave 882.2 mg (4.3 mmol) of pure product as 
a colorless oil (86% yield). 
1H-NMR (500 MHz, CDCl3) δ 8.05 – 8.03 (m, 2H), 7.55 (td, J = 7.2, 1.3 Hz, 1H), 7.44 (t, J = 7.8 
Hz, 2H), 4.40 – 4.32 (m, 2H), 1.86 – 1.77 (m, 1H), 1.61 – 1.54 (m, 2H), 1.42 (dqd, J = 12.6, 7.5, 
5.0 Hz, 1H), 1.28 – 1.20 (m, 1H), 0.96 (d, J = 6.3 Hz, 3H), 0.91 (t, J = 7.4 Hz, 3H). 13C-NMR 
(126 MHz, CDCl3) δ 166.8, 132.9, 130.7, 129.7, 128.5, 63.7, 35.3, 31.7, 29.6, 19.2, 11.4. HRMS 
(ESI) m/z calculated for C13H19O2 [M+H]+: 207.1385, found 207.1376. 
Determination of the enantiomeric excess of the substrate 119:  
The enantiomeric excess of substrate 119 was determined by 
synthesizing a para-nitro benzoate analogue S88 using the same bottle of 
(S)-3-methylpentanol and para-nitrobenzoyl choride instead of benzoyl chloride with the same 
procedure. 1H-NMR (500 MHz, CDCl3) δ 8.30 – 8.28 (m, 2H), 8.22 – 8.20 (m, 2H), 4.46 – 4.37 
(m, 2H), 1.87 – 1.80 (m, 1H), 1.64 – 1.53 (m, 2H), 1.47 – 1.38 (m, 1H), 1.30 – 1.21 (m, 1H), 
0.97 (d, J = 6.5 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H). The enantiomeric excess was determined by 
using chiral HPLC with a Chiralcel OJ-H column, 30 ºC, 99:1 hexanes:isopropanol, 0.5 mL/min. 




























Chart 6. HPLC trace of S88 (absorption at 254nm – time): 
 
Oxidation of (S)-3-methylpentyl benzoate [119] under standard conditions 
 
The reaction was run with General Method A: Single Catalyst Addition Protocol. (S)-
3-methylpentyl benzoate 119 (103.1 mg, 0.500 mmol, 1.0 equiv), (R,R)-Mn(PDP) (46.6 mg, 
0.050 mmol, 10 mol%), ClCH2CO2H (709 mg, 7.5 mmol, 15.0 equiv.), 50% wt. H2O2 (170 mg, 
2.5 mmol, 5.00 equiv.), MeCN (1.0 mL in 40 mL vial, 6.25 mL with oxidant). The reaction was 
run at -36 ºC with 1,2-dichloroethane/dry ice bath. The reaction was worked up with 15 mL 
saturated NaHCO3 and DCM as described in the general method A. Flash column 











MeCN, -36 ºC, 3 hours
+
97% e.e. 97% e.e.
304 
 
acetate/hexanes à 15% ethyl acetate/hexanes à 25% ethyl acetate/hexanes as eluent afforded 
tertiary alcohol and ketone oxidation products separately. 
Run 1: (29.7 mg, 0.134 mmol, 26.7% alcohol yield), (18.7 mg, 0.085 mmol, 17.0% 
ketone yield), (41.0 mg, 0.199 mmol, 39.8% rsm). Run 2: (32.0 mg, 0.144 mmol, 28.8% alcohol 
yield), (18.5 mg, 0.084 mmol, 16.8% ketone yield), (46.0 mg, 0.223 mmol, 44.6% rsm). Run 3: 
(30.2 mg, 0.136 mmol, 27.2% alcohol yield), (14.9 mg, 0.068 mmol, 13.5% ketone yield), (54.8 
mg, 0.266 mmol, 53.6% rsm). Average: 27.6% alcohol yield ± 1.1%, 15.8% ketone yield ± 
1.1%, 45.8% rsm ± 6.7%. 
(R)-3-methyl-4-oxopentyl benzoate [121]. 
1H-NMR (500 MHz, CDCl3) δ 8.01 (d, J = 7.9 Hz, 1H), 7.58 – 7.54 (m, 1H), 7.44 
(t, J = 7.7 Hz, 2H), 4.33 (t, J = 6.4 Hz, 2H), 2.73 (h, J = 7.0 Hz, 1H), 2.18 (s, 3H), 
1.78 (dq, J = 14.2, 6.2 Hz, 1H), 1.19 (d, J = 7.0 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 211.6, 
166.6, 133.1, 130.2, 129.7, 128.5, 63.1, 44.1, 31.6, 28.5, 16.7. HRMS (ESI) m/z calculated for 
C13H17O3 [M+H]+: 221.1178, found 221.1168. 
(R)-3-hydroxy-3-methylpentyl benzoate [120]. 
1H-NMR (500 MHz, CDCl3) δ 8.03 (dd, J = 8.1, 1.5 Hz, 2H), 7.57 – 7.54 (m, 1H), 
7.44 (t, J = 7.8 Hz, 2H), 4.50 (t, J = 6.9 Hz, 2H), 1.96 (td, J = 6.9, 4.1 Hz, 2H), 
1.59 (dt, J = 15.1, 6.9 Hz, 3H), 1.26 (s, 3H), 0.95 (t, J = 7.5 Hz, 3H). 13C-NMR (126 MHz, 
CDCl3) δ 166.8, 133.1, 130.4, 129.6, 128.5, 72.3, 61.9, 39.5, 35.1, 26.7, 8.4. HRMS (ESI) m/z 











Determination of the enantiomeric excess of the tertiary oxidation product:  
The enantiomeric excess was determined by using chiral HPLC with a Chiralcel AD-RH column, 
30 ºC, 45:55 acetonitrile:water, 0.5 mL/min. tR(minor) = 22.9 min, tR(major) = 26.5 min. 
Enantiometric excess of 3 runs: Run 1: 97%. Run 2: 97%. Run 3: 97%. Average e.e. 97%. 
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